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Abstract The porcine epidemic diarrhoea virus (PEDV), 
a member of the Coronaviridae family, causes acute 
diarrhoea and dehydration in pigs. Although it was ﬁrst 
identiﬁed in Europe, it has become increasingly problem-
atic in many Asian countries, including Korea, China, 
Japan, the Philippines, and Thailand. The economic 
impacts of the PEDV are substantial, given that it results 
in signiﬁcant morbidity and mortality in neonatal piglets 
and is associated with increased costs related to vaccina-
tion and disinfection. Recently, progress has been made 
in understanding the molecular epidemiology of PEDV, 
thereby leading to the development of new vaccines. In 
the current review, we ﬁrst describe the molecular and 
genetic characteristics of the PEDV. Then we discuss its 
molecular epidemiology and diagnosis, what vaccines are 
available, and how PEDV can be treated.
Keywords Porcine epidemic diarrhoea virus. Review. 
Molecular epidemiology. Diagnosis. Vaccine
Introduction
Porcine epidemic diarrhoea (PED), which was ﬁrst ob-
served among English feeder and fattening pigs in 1971 
[1], is a devastating enteric disease that manifests as spo-
radic outbreaks during the winter, leading to damage on 
breeding farms. Characterised by watery diarrhoea, PED 
resembles transmissible gastroenteritis (TGE), but has less 
of an effect on suckling pigs (< 4-to 5-week old); this is 
what allowed PED to ﬁrst be distinguished from the TGE 
virus and other recognized enteropathogenic agents. As it 
spread through Europe, the disease was named ‘epidemic 
viral diarrhoea (EVD).’ Unlikely what the disease used to 
outbreak in fattening pigs, different types of EVD caused 
acute diarrhoea in pigs of all ages in 1976. This type of 
EVD was classiﬁed as EVD type 2 [1], different from the 
previously recognized type 1 [2]. EVD type2 was turned 
out to be caused by a coronavirus-like agent in 1978 [3, 
4] using experimentally designed CV777 which caused 
enteropathogenic infection in both piglets [3] and fatten-
ing swine. This was when the disease started to be called 
as ‘Porcine Epidemic Diarrhoea (PED)’ [4].
Both transmissible gastroenteritis virus (TGEV) and 
porcine epidemic diarrhoea virus (PEDV) are classiﬁed 
into group 1 of the genus Coronavirus. PEDV ranges in 
diameter from 95 to 1990 nm (mean diameter: 130 nm), 
including its projection. As in many particles with a ten-
dency to a round shape, the PEDV contains a centrally 
located electron-opaque body; it also possesses widely 
spaced club-shaped projections measuring 18–23 nm in 
length. The internal structure of the virus remains un-
known. The PEDV is sensitive to ether and chloroform 
and has a density in sucrose of 1.18 g/ml. The virus pos-
sesses a glycosylated peplomer (spike, S) protein, Poll (P1), 
envelope (E), glycosylated membrane (M) protein, and an 
unglycosylated RNA-binding nucleocapsid (N) protein 
[5]. Cell culture-adapted PEDV loses its infectivity when 
heated to C60°C for 30 min, but is moderately stable at 
50°C; further, the virus is stable between pH 5.0 and 9.0 at 
4°C and between pH 6.5 and 7.5 at 37°C[6]. PEDV shows 
no haemagglutinating activity [6].
The PEDV propagates by orally inoculating piglets, after 
which, during the early stages of diarrhoea, it collects in 
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the tissues and contents of the small intestine [3]. Vero 
(African green monkey kidney) cells support the serial 
propagation of PEDV and grow successfully in laboratory 
conditions; however, growth of the virus depends on the 
presence of trypsin in the cell culture medium. Cytopathic 
effects consist of vacuolation and formation of syncytia.
During the 1980s and 1990s, PED was prevalent through-
out Europe, in countries such as Belgium, England, Ger-
many, France, the Netherlands, and Switzerland (Table 1). 
PED is currently a source of concern in Asia, where out-
breaks are often more acute and severe than those observed 
in Europe. In this respect, and in their high mortality rates, 
these resemble TGEV outbreaks. For example, Japanese 
outbreaks between September 1993 and June 1994 re-
sulted in 14,000 deaths, with mortality ranging from 30 
to 100% in suckling pigs. During these epidemics, adult 
pigs showed only temporary decreases in appetite and 
milk production [7]. Another PED epidemic occurred in 
the winter of 1996, during which 39,509 of 56,256 infant 
farrow-to-ﬁnish piglets died after experiencing diarrhoea. 
Between January 1992 and December 1993, 56.3% of 
viral enteric cases in infant pigs surveyed in Korea were 
attributable to PEDV, rather than TGEV. The vast majority 
of outbreaks (90%) involved piglets < 10-day-old [8]. The 
clinical lesions of PEDV in the small intestine of piglets 
were similar to those of TGEV. Lesions are conﬁned to 
the small intestine, which is distended with yellow ﬂuid 
(Fig. 1). PED outbreaks also occurred in Thailand from 
2007 to 2008. Most of the affected farms reported that 
the disease ﬁrst occurred in farrowing barns; 100% of 
newborn piglets were subsequently lost. Between August 
1997 and July 1999, 50.4% of 1,258 enteric cases across 5 
Korean provinces were diagnosed as PED [9]; further, a 
Korean abattoir serosurvey found PEDV seroprevalences 
of 17.6–79% (mean of 45%) in samples from 469 pigs from 
seven provinces. Cumulatively, these results suggest that 
the virus had become endemic in some areas [10] (Table 1). 
However, recent outbreaks seemed to be concentrated in 
certain countries where pork industry is prevalent, such 
as Philippines, South Korea and China.
Molecular and genetic characteristics of 
the PEDV
PEDV is an enveloped virus possessing an approximately 
28 kb, positive-sense, single-stranded RNA genome with 
a 5' capand a 3' polyadenylated tail [11, 12]. The genome 
comprises a 5' untranslated region (UTR), a 3' UTR, and 
at least seven open reading frames (ORFs) that encode 4 
structural proteins [spike (S), envelope (E), membrane 
(M), and nucleocapsid (N)] and three non-structural pro-
teins (replicases 1a and 1b, and ORF3); these are arranged 
on the genome in the order 5'-replicase (1a/1b)–S-ORF3–
E–M– N–3' (Fig. 2)[1, 5, 13–19].
The polymerase gene consists of 2 large ORFs, 1a and 1b, 
that cover the 5' two-third of the genome and encode the 
non-structural replicase polyproteins (replicases 1a and 
1b). Genes for the major structural proteins S (150–220 
kDa), E (7 kDa), M (20–3' kDa), and N (58 kDa) are lo-
cated downstream of the polymerase gene [15, 18, 20]. 
The ORF3 gene, which is an accessory gene, is located 
between the structural genes. It encodes an accessory 
protein, the number and sequence of which varies among 
different coronaviruses [20].
The PEDV S protein is a type I glycoprotein composed of 
1,383 amino acids (aa). It contains a signal peptide (1–18 
aa), neutralising epitopes (499–638, 748–755, 764–771, and 
1,368–1,374 aa), a transmembrane domain (1,334–1,356 
aa), and a short cytoplasmic domain. The S protein can 
also be divided into S1 (1–789 aa) and S2 (790–1,383 aa) 
domains based on its homology with S proteins of other 
coronaviruses [21–26]. Like other coronavirus S proteins, 
the PEDV S protein is a glycoprotein peplomer (surface 
antigen) on the viral surface, where it plays a pivotal role 
in regulating interactions with speciﬁc host cell receptor 
glycoproteins to mediate viral entry, and stimulating in-
duction of neutralising antibodies in the natural host [15, 
21–23, 26, 27]. Moreover, it is associated with growth 
adaptation in vitro, and attenuation of virulence in vivo 
[28, 29]. Thus, the S glycoprotein would be a primary 
target for the development of effective vaccines against 
PEDV. Additional studies of this structure are essential 
for understanding the genetic relationships between, and 
diversity of, PEDV isolates, the epidemiological status of 
PEDV in the ﬁeld, and the association between genetic 
mutations and viral function [29–33]. It was reported 
that aminopeptidase N is the receptor of TGEV, human 
coronavirus 229E (HcoV229E) and feline coronavirus 
(FeCoV) which all belong to group I coronavirus includ-
ing PEDV [34].
The PEDV M protein, the most abundant envelope com-
ponent, is a triple-spanning structural membrane glyco-
protein with a short amino-terminal domain on the outside 
of the virus and a long carboxy-terminal domain on the 
inside [35]. The M protein not only plays an important 
role in the viral assembly process [36, 37] but also induces 
antibodies that neutralise the virus in the presence of its 
complement [37, 38]. The M protein may play a role in 
α-interferon (α-IFN) induction [39]. Coexpression of M 
and E proteins allowed the formation of pseudoparticles, 
which exhibited interferogenic activity similar to that of 
complete virions [40]. Additional work on the M glyco-
protein should increase our understanding of the genetic 
relationships between, and the diversity of PEDV isolates 
and the epidemic situation of PEDV in the ﬁeld [30, 41–45].
The N protein, which binds to virion RNA and provides 
a structural basis for the helical nucleocapsid, is a basic 
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Table 1: Published cases of PEDV outbreaks from several countries (1978–2011)
Publication 
year
Country Description Reference
1978 England Porcine epidemic diarrhoea type II was reproduced in experimental pigs 
of various ages by oral dosing with minced intestine from a naturally oc-
curring case of the disease. Virus-like particles which probably represent 
an unidentiﬁed coronavirus were seen by EM the faeces and intestinal 
epithelium of infected animals.
Res Vet Sci. 1978 
Sep; 25(2):255–
256 
1978 Belgium Coronavirus-like particles were detected by EM in the intestinal contents 
of pigs during a diarrheal outbreak on 4 swine breeding farms in 1977. 
Diarrhoea was reproduced in experimental pigs with one of the isolates, 
designated CV777, which was found to be distinct from the 2 known 
porcine coronaviruses, transmissible gastroenteritis virus and hemagglu-
tinating encephalomyelitis virus.
Arch Virol. 
1978;58(3): 
243–247
1993 The 
Czech 
Republic
PEDV was diagnosed in two swine herds. The causal agent was demon-
strated in intestinal contents by EM and identiﬁed by immune EM.
Vet Med (Praha). 
1993;38(6):333–
341 
1994 Belgium Seven groups of pigs with acute diarrhoea during the months February 
to March 1992 were investigated. Seven of them had seroconverted to 
PEDV.
Vet Rec. 1994 Dec 
17;135(25):594–
597 
1996 Hungary When faecal samples of 92 live diarrhoeal weaned pigs (representing 19 
farms) were tested, PEDV (5.5%) was detected.
Acta Vet Hung. 
1996; 44(1):9–19 
2000 Korea Between August 1997 and July 1999, a total of 1258 cases from 639 pig 
farms were examined. Three hundred and four (47.6%) of 639 herds 
were diagnosed with PEDV infection.
Vet Rec. 
2000 Nov 
18;147(21):606–
608 
2005 China PEDV LJB/03 was isolated from the faeces of piglets infected with PEDV 
on a pig farm, Heilongjiang province, China.
Virus Genes. 2005 
Jan;30(1):69–73 
2008 China Six PEDVs were isolated from the faecal samples of piglets infected with 
PEDV in 2006 in China.
Virus Genes. 2008 
Apr;36(2):355–
364. Epub 2008 
Jan 24
2008 Italy There was an epidemic of diarrhoea affecting pigs of all ages in Italy 
between May 2005 and June 2006. In 63 herds the cause was conﬁrmed 
as PEDV by EM, immune EM, PCR and serology.
Vet Rec. 
2008 Mar 
8;162(10):307–310 
2010 China Since early 2006, PEDV has been reemerging in immunized swine herds 
in China.
Arch Virol. 2010 
Sep;155(9):1471–
1476. Epub 2010 
Jun 11
2010 Thailand Since late 2007, several outbreaks of PEDV infection have emerged in 
Thailand.
Emerg Infect 
Dis. 2009 
Jul;15(7):1112–
1115 
2010 Thailand A PEDV outbreak was observed in March 2008 in a swine herd in 
Thailand. The disease was diagnosed by clinical symptoms, gross and 
histopathology and viral detection using RT-PCR.
AnimReprod Sci. 
2010 Oct;122(1–
2):42–51. Epub 
2010 Jul 27 
2011 China PEDV CH/S strain occurred in a swine breeding farm in Shanghai in 1986 
and was conﬁrmed as PEDV by EM, direct IF testing, and serum neutral-
ization testing.
J Virol. 2011 
Nov;85(21):11538–
11539 
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phosphoprotein associated with the genome [5, 16, 18, 46]. 
As such, it can be used as the target for the accurate and 
early diagnosis of PEDV infection. It has been suggested 
that N protein epitopes may be important for induction of 
cell-mediated immunity (CMI) [38].
Whereas the genes encoding the structural proteins have 
been thoroughly investigated for most coronaviruses, little 
is known about the functions of the accessory proteins, 
which are not generally required for virus replication in 
cultured cells [46–49]. On the contrary, their expression 
might lead to decreases of viral ﬁtness in vitro, and mutants 
with inactivated accessory genes are easily selected during 
serial passage through cell cultures [50–53]. In general, ac-
cessory genes are maintained in ﬁeld strains [50, 54], and 
their loss mainly results in attenuation in the natural host 
[55–57]. In the case of PEDV, the only accessory gene is 
ORF3, which is thought to inﬂuence virulence; cell culture 
adaptation has been used to alter the ORF3 gene in order to 
reduce virulence [52], as has been done for TGEV [53]. Dif-
ferentiation of ORF3 genes between the highly cell-adapted 
viruses and ﬁeld viruses could be a marker of adaptation to 
cell culture and attenuation of the virus [52, 58, 59]. Thus, 
measures of variation in ORF3 gene differentiation could 
be a valuable tool in molecular epidemiology studies of 
the PEDV [42, 45, 52, 59].
Molecular epidemiology of PEDV
Genetic and phylogenetic analyses based on the S, M, and 
ORF3 genes have been used to determine the relatedness 
of PEDV isolates, both within Korea and among various 
countries in which PEDV has surfaced. Research on part 
of the S gene, and on the entire M gene, have suggested 
that PEDVs can be separated into three groups (G1, G2, 
G3), which have three subgroups (G1–1, G1–2, G1–3) [32]. 
According to analysis of the partial S genes, the G1 PEDVs 
had 95.1–100% nucleotide sequence similarities with each 
other, and they had 93.5–96.7 and 88.7–91.5% sequence 
identities with the G2 and G3 PEDVs, respectively. The 
G2 PEDVs had 96.7–99.8% similarities with each other, 
and they had 91.8–93.0% similarities with the G3 PEDVs 
[32]. These results reﬂect the existence of genetic diversity 
among the Korean PEDV isolates (Figure 3).
The majority of the Korean PEDV isolates are closely 
related to Chinese strains [32]. The Chinese PEDV clade 
also contains all strains isolated from several outbreaks 
of PEDV that have occurred in Thailand since late 2007. 
These classiﬁcations have been based on the phylogenetic 
relationship of the S genes, and support the results of Park 
et al. [32]. Recently, after analyzing the full S gene-based 
phylogenetic tree [31] reported that all PEDVs can be 
separated into 2 clusters, and that Korean ﬁeld isolates 
are more closely related to each other.
In 2006, an analysis of the M gene of 6 PEDVs isolated 
from the faeces of Chinese piglets indicated that the 
isolates compose a separate cluster with Chinese strain 
JS-2004–02 [60]. These results demonstrated that there 
may be a new prevailing PEDV genotype in China [60]. 
Phylogenetic relationships of complete M gene nucleotide 
sequences indi-isolates have been found to be closely re-
lated to Chinese cate that recent Thai PEDV isolates are 
closely related to strains [45], and belong to the third of 
3 PEDV groups con-isolates from China [30]. Likewise, 
most Korean PEDV taining all PEDV isolates [45].
Investigations of the ORF3 gene have revealed the reemer-
gence of PEDV in immunised swine herds since early 
2006 [42]. ORF3 genes have been used to divide Chinese 
ﬁeld strains and PEDV reference strains into 3 groups; 
further, Chinese ﬁeld strains appear to be closely related 
to Korean strains, but genetically different from PEDV 
vaccine strains. Another report revealed that PEDV has 
caused enteric disease with devastating impact since the 
ﬁrst identiﬁcation of PEDV in 1992 in Korea, and recent, 
prevalent Korean PEDV ﬁeld isolates are closely related to 
Chinese ﬁeld strains but differ genetically from European 
strains and vaccine strains [45].
Figure 1: Photographic records of PEDV outbreaks. 
During a 2006 outbreak on a commercial farm in 
Kimpo. South Korean, piglets < 1 week of age died 
from severe watery diarrhoea after showing signs 
of dehydration. After the acute outbreak, piglets 
were anorectic, depressed, vomiting, and producing 
water faeces that did not contain any signs of blood. 
Necropsies of deceased piglets from the Kimpo out-
break uncovered gross lesions in the small intestines, 
which were typically ﬂuidic, distended, and yellow, 
containing a mass of curdled, undigested milk. Atro-
phy of the villi caused the walls of the small intestines 
to become thin and almost transparent.
2013 Allen D. Leman Swine Conference 7
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Figure 2: Schematic representation of the PEDV genome based on the CV777  
(GenBank accession No. AF353511) strain
Diagnosis
A diagnosis of PED cannot be made on the basis of clini-
cal signs and histopathological lesions [61–64]. Due to the 
similarities in causative agents of diarrhoea, differential 
diagnosis is necessary to identify the PEDV in the labo-
ratory [64, 65]. Many techniques have been used for the 
detection of PEDV, including immunoﬂuorescence (IF) 
tests, immunohistochemical techniques, direct electron 
microscopy, and enzyme-linked immunosorbent assays 
(ELISA). However, these techniques are time-consuming 
and are low in sensitivity and speciﬁcity [66]. Kim et al. 
[67] compared three techniques (RT-PCR, immunohisto-
chemistry and in situ hybridization) for the detection of 
PEDV. They concluded that although RT-PCR identiﬁed 
the presence of PEDV more frequently than the other 
methods, when only formalin-ﬁxed tissues are submitted, 
immunohistochemistry and in situ hybridization would be 
useful methods for the detection of PEDV Ag and nucleic 
acid. The PEDV leader sequence was used to develop a 
reverse transcriptase polymerase chain reaction (RT-PCR) 
diagnostic technique [68, 69] that has successfully been 
used to detect both laboratory and ﬁeld isolates [70, 71]. M 
gene-derived primers can be used in an RT-PCR system 
to obtain PEDV-speciﬁc fragments [69], and duplex RT-
PCR has been used to differentiate between TGEV and 
PEDV [66]. The past few years have seen several useful 
modiﬁcations of the basic RT-PCR method. For instance, 
it is possible to estimate the potential transmission of 
PEDV by comparing viral shedding load with a standard 
internal control DNA curve [72], as well as to perform 
multiplex RT-PCR to detect PEDV in the presence of vari-
ous viruses [73] – a technique that is particularly useful 
for rapid, sensitive, and cost-effective diagnosis of acute 
swine viral gastroenteritis). The commercial dual priming 
oligonucleotide (DPO) system (Seegene, Seoul, Korea) 
was also developed for the rapid differential detection of 
PEDV. It employs a single tube 1-step multiplex RT-PCR 
with two separate primer segments to block a non-speciﬁc 
priming [74].
Another useful reverse transcription-based diagnostic tool 
is RT loop-mediated isothermal ampliﬁcation (RTLAMP). 
This assay, which uses 4–6 primers that recognize 6–8 
regions of target DNA, is more sensitive than gel-based 
RT-PCR and ELISA, in large part because it produces a 
greater quantity of DNA [75]. Immunochromatographic 
assay kits can be used at farms in order to detect PEDV 
S proteins with 92% sensitivity and 98% speciﬁcity. 
This technique is less accurate than RT-PCR, but allows 
diagnosis within 10 min. Thus, it is particularly effective 
for quickly determining quarantine or slaughter policies 
in the ﬁeld. Especially, endemic situation of PED in-
fection brought the several commercialised PED virus 
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Figure 3: Relationships among PEDVs isolated from various countries based on the partial S gene including 
epitope region. The phylogenetic tree was constructed using the neighbor-joining method in MEGA ver-
sion 5.05 with pairwise distances [99]. Bootstrap values (based on 1,000 replicates) for each node are given 
if > 60%. The scale bar indicates nucleotide substitutions per site. Asterisk represents PEDV isolate whose 
sequence available in GenBank database was shorter as compared to that of other reference strains. PEDVs 
isolated from various countries were marked with various colors: Europe (black), Korea (blue), China (red), 
Japan (olive green), Thailand (green) and Viet Nam (purple) (Color ﬁgure online) 
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detection systems using diagnosis techniques including 
conventional duplex RT-PCR (iNtRON Biotechnology, 
Inc, Korea), real time RT-PCR (kogenebiotech, Kore), 
DPO based multiplex RT-PCR (Seegene, Seoul, Korea), 
and immunochromatography (Bionote, Korea) in Korea.
Recently, a protein-based ELISA was developed to detect 
PEDV. In this technique, a polyclonal antibody is produced 
by immunising rabbits with puriﬁed PEDV M gene after 
its expression in Escherichia coli. IF analysis with anti-
PEDV-M antibody is then able to detect PEDV-infected 
cells among other enteric viruses [76]. ELISA blocking 
and indirect IF have been used to detect PEDV antibodies 
at 7 and 10–13 days postinoculation, respectively [77]. For 
all tests, the second (convalescent) serum sample should 
be collected and examined no sooner than 2–3 weeks after 
the onset of diarrhoea. PEDV antibodies, detected by the 
ELISA-blocking and IF-blocking tests, have been found 
to persist for at least 1 year.
Due to the special features of the porcine mucosal immune 
system, the presence of serum antibodies against gastro-
enteric pathogens is not always correlated with protec-
tion; rather, detection of these antibodies only proves that 
individuals had contact with infectious microorganisms 
[78–80]. Additionally, Ha et al. [81] recently reported that 
colostrum IgA concentration is a better marker of protec-
tion from PEDV infection than serum neutralising (SN) 
titre from serum samples; however, SN titres may still be 
useful in determining herd infection status [81].
Vaccines
Until they are 4-to 13-day old, piglets are protected against 
PEDV by speciﬁc IgG antibodies from the colostrum and 
milk of immune sows [82]; the length of immunity de-
pends on the titre of the mother. After antigenic sensitisa-
tion in the gut, IgA immunocytes migrate to the mammary 
gland, where they localise and secrete IgA antibodies into 
colostrum and milk. This ‘gut-mammary’ immunologic 
axis is an important concept in designing optimal vac-
cines to provide effective lactogenic immunity [83]. Pigs 
that regularly suckle the immune mother are constantly 
inoculating their lumens with milk-bound IgA antibodies, 
a process that confers passive immunity. IgG accounts for 
more than 60% of colostrum immunoglobulin content. 
However, IgA is more effective at neutralising orally infec-
tious pathogens than either IgG or IgM because it is more 
resistant to proteolytic degradation in the intestinal tract 
and has a higher virus neutralising ability than IgG and 
IgM [84]. Therefore, only passive transfer of IgA from an 
immunised mother effectively induces immune responses 
in suckling piglets [85]. However, these antibodies do not 
protect against intestinal infection with PEDV.
Several PEDV vaccines, which differ in their genomic 
sequence, mode of delivery, and efﬁcacy, have been devel-
oped. A cell culture adaptation of the CV777 strain had a 
strikingly different genomic sequence [18], was associated 
with much lower virulence in new born caesarean-derived 
piglets, and caused much less severe histopathological 
changes. However, in Europe, the disease caused by PEDV 
was not of sufﬁcient economic importance to start the vac-
cine development. Therefore, the trial of vaccine develop-
ment was mainly accomplished in Asian countries where 
the PEDV outbreaks have been so severe that the mortality 
of the new born piglets was increased. An alternative vac-
cine for suckling piglets may be an attenuated form of the 
virus derived from serial passage (passage level: 93) of 
the PEDV [86]. In Japan, a commercial attenuated virus 
vaccine of cell culture-adapted PEDV (P-5V) has been 
administered to sows since 1997. Although these vaccines 
were considered efﬁcacious, not all sows developed solid 
lactogenic immunity [87].
Oral vaccination with attenuated PEDV DR13 (passage 
level: 100) has recently been proven to be more efﬁcacious 
than injectable vaccine. Further, this vaccine candidate 
remained safe even after three back passages in piglets 
[88]. Piglet mortality can be reduced by orally inoculat-
ing pregnant sows with the DR13 strain. The viral strain 
was licensed, and used as an oral vaccine in South Korea 
from 2004 (patent No. 0502008). And the oral vaccine was 
registered and commercialised in Philippine at 2011. De-
spite the documented beneﬁts of the DR13 vaccine, it does 
not signiﬁcantly alter the duration of virus shedding – an 
indication of immune protection [79, 89] in challenged pig-
lets. Shorter periods of virus shedding, as well as reduced 
severity and duration ofdiarrhoea in piglets, result from 
higher titres of serum antibodies; complete protection from 
PEDV infection prevents shedding after exposure to viral 
challenge [90]. Oral immunisation with highly attenuated 
PEDV confers partial protection against virulent challenge 
in conventional pigs, a result that is related to inoculation 
dose. At low doses of the attenuated PEDV, 25% of pigs 
are protected against PEDV challenge, but this proportion 
increased to 50% when pigs were inoculated with a dose 
20 times stronger [91]. However, viral shedding may be 
difﬁcult to measure accurately, as it is varies depending 
on viral strain and sensitivity of the detection tool [72].
Therefore, for the ideal and perfect development of vac-
cines, several criteria including the factors related the 
reduction of virus shedding in piglets, and the details 
of the mucosal immunity of PEDV should be focused in 
the course of development of next generation vaccines. 
Information on PEDV mucosal immunity has typically 
been limited. De Arriba et al. used the enzyme linked 
immunospot (ELISPOT) technique to characterise the 
isotype-speciﬁc antibody secreting cells in mucosal and 
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systemic-associated lymphoid tissues in pigs inoculated 
with PEDV. After infection with PEDV, levels of an-
tibody secreting cell (ASC) in the gut were similar to 
those observed in response to TGEV and rotavirus infec-
tion; IgG ASCs were more prevalent than IgA ASCs. In 
PEDV-infected pigs, a limited number of IgM ASCs were 
detected at post infection day (PID) 4, and memory B cells 
appeared at PID 21 in mesenteric lymph nodes, spleen, 
and blood. Finally, the authors noted correlations between 
protection and both serum isotype-speciﬁc antibody and 
ASC response in gut-associated lymph tissues and blood 
on the challenge day [90–92].
There have also been reports of immune responses by 
transgenic plants and lactic acid bacteria that express the 
PEDV antigen [85, 93, 94]. The transgenic tobacco plants 
that express the S protein corresponding to the neutralising 
epitope of PEDV was tested whether feeding the plants 
induced the immune response in murine model. And the 
efﬁcacy of orally administered antigen gene transgenic 
carrot and lettuce were tested after codon optimization and 
application of viral expression systems [85]. In mice, in-
duced antibodies have neutralising activity against PEDV. 
No neutralising antibodies were detected in either mice 
or pigs given mucosal immunizations with recombinant 
Lactobacillus casei expressing PEDV N (nucleoprotein) 
on its surface. However, this treatment elicited high levels 
of mucosal IgA and circulation IgG immune responses 
against the PEDV N protein. Before this vaccine can be 
commercialised, further studies are needed; for instance, 
it will be necessary to understand discrepancies between 
test results of the ﬁrst LAB scale vaccine and large-scale 
pilot vaccines.
Research into this and other potential vaccines should 
be made a priority, as PEDV-mediated diarrhoea causes 
signiﬁcant economic losses in the swine industry. How-
ever, there is also a potential drawback to the use of 
live-attenuated vaccines. Recently, a survey conducted in 
China indicated close phylogenetic relationships between 
a Chinese PEDV ﬁeld strain (CH/GSJIII/07) and two vac-
cine strains, suggesting that live vaccines can evolve into 
more infectious forms in the ﬁeld [42].  
Treatment
During the European outbreak of PEDV, pregnant sows 
were deliberately exposed to the intestinal contents of 
dead infected pigs, thus artiﬁcially stimulating lactogenic 
immunity and, hopefully, shortening the duration of out-
breaks at farms [12]. However, several complications arose 
from this treatment. Because the intestinal contents did not 
have homogenous titres of PEDV, the induction of immu-
nity – including solid lactogenic immunity – might not be 
expected. Diseases may be spread via contamination with 
viral agents, such as PRRSV and PCV2.
Immunoprophylactic agents may also be used to treat PEDV. 
For instance, anti-PEDV chicken egg yolk immunoglobulin 
(IgY) and colostrums from immunized cows have been 
found to increase survival rates of virally challenged 
piglets [95, 96]. Mouse monoclonal single chain variable 
fragment (scFv) antibodies to neutralised PEDV, which 
can be expressed in E. coli, are as potent as parental 
antibodies and block PEDV infection into target cells in 
vitro [97]. Thus, it is possible that recombinant E. coli cells 
expressing scFv can be used as prophylactic agents against 
PEDV infection. Epidermal growth factor (EGF), which 
stimulates the proliferation of intestinal crypt epithelial 
cells and promotes recovery from atrophic enteritis in 
PEDV-infected piglets [98], has also been proposed as 
a potential novel therapy to promote intestinal villous 
recovery in piglets with PEDV infections; it may also 
be useful in other species with viral atrophic enteritis. 
Drawbacks of this treatment include its high price and 
questionable safety.
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Livestock associated MRSA: Tiger or  Pussycat?
Peter Davies BVSc,  PhD
Department of Veterinary Population  Medicine, University of  Minnesota
“The larger the island of knowledge, the longer the shoreline of  wonder (doubt)”
Ralph  Sockman
The following comments are personal reflections on how 
the issue of “livestock associated methicillin resistant 
Staphylococcus aureus” (LA-MRSA) has evolved in the 
USA and globally. At the Leman conference, my presenta-
tion will emphasize details of recent research we have been 
conducting at the University of Minnesota to understand 
S. aureus ecology and the potential occupational risks for 
workers in the US swine industry. The comments below 
present a broader context of the epidemiology and sociol-
ogy of LA-MRSA as a foundation for interpreting these 
recent  observations.
Angst is born  (again)!
It is approaching a decade since July 2004 when the phe-
nomenon of LA-MRSA burst onto the scene in the Nether-
lands then echoed throughout the swine production world.1 
MRSA (deservedly) have high name recognition among 
the public as the flagship organism of a loosely defined 
fleet of “Superbugs” (or now more fashionably “nightmare 
bacteria”). Emergence of apparently novel pathogens 
rightly furrows the brows of infectious disease clinicians 
and epidemiologists. Will it be the ‘big one’ that wrecks 
an unprecedented toll on public and/or animal health and 
creates massive social and economic disruption? If there is 
a food animal reservoir, a few nanoseconds might expire 
before somebody asks what the industry has done wrong 
to deliver this evil upon  society.
As each new ship sails in (BSE; Salmonella Typhimurium 
DT104; vancomycin resistant enterococci; Nipah virus; 
Hepatitis E virus, H5N1 and novel H1N1 influenza vi-
ruses; SARS and MERS; NDM-1, ESBL E. coli, carbape-
nem-resistant Klebsiella,…and LA-MRSA…) uncertainty 
is usually the prevailing sentiment among the medically 
and epidemiologically literate. It takes time, often many 
years, to get a reasonable handle on the magnitude of a 
novel microbial threat, with the public interest arguably 
best served when guarded consternation drives system-
atic research that is enhanced by thoughtful inference. 
Much of this appropriate response has occurred with the 
LA-MRSA issue, particularly in the Netherlands. The 
island of knowledge of LA-MRSA is now fairly extensive, 
predictably bringing new questions and uncertainties, but 
also some time to gauge the likely public health impact. 
Unfortunately it is rarely the guarded consternation of the 
prudent and epidemiologically informed that drives the 
public  conversation.
Whipping up a  frenzy!
While discovery of apparently emerging pathogens rightly 
troubles most people, these events are the lifeblood of those 
who make their living by peddling panic to the public. If 
food animals are implicated, even remotely, as having 
any role in the threat du jour, the tone from the ‘science 
journalists’ will usually degenerate towards apocalyptic 
finger pointing. History tells us that journalistic hyper-
bole often misses the mark by many orders of magnitude 
with respect to actual public health impact. BSE (one 
case where animal feeding practices were responsible for 
the propagation of the agent) illustrates the discrepancy 
between predictions of carnage purveyed by journalists 
(often cherry picking the upper confidence interval from 
the most pessimistic projection among highly uncertain 
models), and the actual toll on public health. Estimates 
aired in the media of predicted human deaths from vari-
ant CJD reached hundreds of thousands, but the ultimate 
(and still tragic) global toll over 16 years is around 230 
– equivalent to about 2 days of road fatalities in the USA. 
SARS and H5N1 influenza are other examples where 
cumulative human deaths to date (respectively about 800 
and 400 globally over about a decade) are of Lilliputian 
dimensions relative to the doomsday predictions, and are 
dwarfed by the public health burdens from daily risks like 
road deaths, and even lightning strike.2 And just to place 
LA-MRSA in perspective, the global tally of fatal cases 
currently stands at ONE (more later), and in the USA the 
number of confirmed cases of clinical infection with LA-
MRSA currently stands at ZERO. The ritual of ‘crying 
wolf’ benefits nobody but the scaremongering authors, 
contributes nothing to addressing any concerns and, like 
in the fable, is probably counterproductive for that rare 
future moment when the real wolf appears. I in no way 
want to trivialize the valid concerns that accompany all 
events of disease and pathogen emergence, but point out 
that those who hawk sensation for a living have little in-
terest in the whole truth, or even reasonable perspective. 
Touting doomsday scenarios is a better business  model.
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I have written elsewhere of some myths and misinforma-
tion about LA-MRSA that was aired earlier in the course 
of the LA-MRSA ‘panic-demic.3 The romantic narrative 
of the swashbuckling journalists nobly fighting to inform 
a gullible public about the evils that are knowingly propa-
gated by unscrupulous and money-grubbing food (and 
particularly meat) industries who hide their secrets from 
the hapless consumers has, for me personally, passed from 
tiresome to nauseating. My dismay about the quality of US 
journalism about LA-MRSA is not simply fatigue from 
listening to a ‘broken record’. It is that the same refrain 
keeps repeating when they should be reading from a very 
different and more factual score. Recent exhibits of jour-
nalistic ineptitude on LA-MRSA4 rival the stratospheric 
levels set in 2009,5 when at least one could offer a defense 
of greater uncertainty. But as I have stated before, ‘given 
the level of politicization of discussions about food animal 
production in general, and intensive livestock production 
in particular, it is now quaint if not delusional to dream 
of rational and factual public discourse on these  issues.3
While the pedestrian standards of science journalism 
are dismaying, the media do not have a monopoly on hy-
perbole and overstatement. Science combines two basic 
processes: observation and inference. I contend that biased 
(or worse still deliberately hyperbolic) inference afflicts 
more than a small portion of the peer-reviewed literature 
published to date on LA-MRSA. Almost no studies refer 
to the fact that only one fatality in the world has been as-
sociated with LA-MRSA over 9 years and that the clinical 
burden of LA-MRSA to date has been very small. Another 
prevalent but misleading statement about the human health 
implications is that LA-MRSA represent a high proportion 
of ‘cases’ in countries such as the Netherlands, without 
pointing out that ‘cases’ in those countries include people 
who are colonized (i.e. culture positive nasal swabs) but 
do not have infections. A recent and well conducted Dan-
ish study concluded ‘we therefore face an infectious oc-
cupational exposure of huge quantitative dimensions but 
of unknown clinical importance.6 The statement per se is 
true, but the authors fail to point out that based even on 
their own data, not to mention the accumulated preceding 
studies, the real unknown is exactly how SMALL is the 
clinical impact of LA-MRSA. Current data are sufficient to 
conclude that the clinical importance of LA-MRSA (mean-
ing those organisms now known to occur in livestock in 
many countries) is ‘non-zero’ but very small. This is a 
mild example of insufficient context, but there are many 
more papers in which inferences drawn are questionable 
or even completely unjustified. The collective bias toward 
overstatement of the public health impact (real and pro-
jected) of LA-MRSA is pervasive, and the gatekeepers 
of quality (author responsibility and critical thinking, 
peer review and editorial standards) are inadequate. Two 
examples discussed below illustrate inferences that were 
so inappropriate (if not completely unjustified) that myself 
along with other colleagues submitted letters to the editor 
to document our  concerns.
The first was a tragic report from France of a fatal case of 
ST398 MSSA (i.e. methicillin sensitive) infection of a girl 
with no known contact with livestock. The isolate involved 
had multiple attributes that were uncommon among ST398 
MRSA isolates from pigs, yet the authors blithely inferred 
that ‘spread of S. aureus ST398 among livestock is a mat-
ter of increasing concern because strains of this sequence 
type were able to acquire PVL genes and cause necrotizing 
pneumonia in a young immunocompetent patient.’ Our 
response argued that apart from the different attributes of 
the organism (t571 MSSA) and the absence of any evidence 
of livestock involvement, there was substantial informa-
tion supporting the possibility that the organism derived 
from a human rather than animal reservoir.7 This has since 
been strongly endorsed by identification of distinct human 
and pig clades of that specific spa type (t571) of ST398 S. 
aureus that are likely epidemiologically independent.8,9 
Storm in an academic teacup, you say? But for the fact 
that the original paper immediately spawned considerable 
media and blogger interest, including a blog titled “News 
Break: PigMRSA involved in the death of a child” despite 
the fact that it was not MRSA, and there was no contact 
with pigs. The post remains alive and well at  http://www.
superbugtheblog.com/2010/07/news-break-pig-mrsa-
st398-involved-in.html.
The second study published in late 2012 concluded that 
risk from LA-MRSA in livestock dense regions extended 
to the general community and not just to people with 
livestock contact.10 We contend that this paper had seri-
ous flaws both in methodology and inference, and its final 
conclusion was unwarranted and contradicted by three 
much larger and methodologically superior studies (see 
below).11 Unfortunately, a press statement issued when the 
paper was published ensured that the unjustified inference 
was echoed through scaremonger community. After all, 
the amplifiers merely relay what the credentialed scientists 
were stating in a ‘peer reviewed journal’. In both cases, I 
believe that the authors of the papers we not sufficiently 
diligent (or perhaps just too busy) to consider alternative 
hypotheses before leaping to very questionable conclu-
sions. Worse still is that the review process of the journal 
was patently inadequate for ensuring even rudimentary 
standards of inference. However, the most frustrating issue 
was the constipated process we encountered in publishing 
our concerned response to these papers. In both cases, 
publication of the letters (just 500 words) required almost 
a year, most of it spent trapped in the bowels of the jour-
nal while the babble that had been generated continued 
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to cycle around the Internet. Probably not a functional 
model for how science can inform public debate! Now 
that I have vented that frustration, let’s get back to the 
Tiger and the  Pussycat.
LA-MRSA: Where are the  bodies?
I am emboldened to use this arguably tasteless subtitle 
by recalling an article I read as a graduate student over 
30 years ago. During the 1960s when oral contraceptives 
were unleashed on the western world, there was a little 
research and much speculation that this might have grave 
consequences for cardiovascular health and mortality in 
young women. Unsurprisingly, much of the doomsday 
predictions were propagated by entities with philosophi-
cal objections to contraception. A couple of decades later, 
‘where are the bodies’ was a rhetorical question pointing 
out that the wolf had not appeared. With LA-MRSA, where 
we confront concerns about an acute infectious process 
(rather than a chronic and metabolic process), a decade 
after the emergence of LA-MRSA is not too soon to pose 
this  question.
In 2011, with support from the National Pork Board, I 
reviewed published studies of ST398 S. aureus to cata-
logue reports of human clinical disease. The charge was 
to identify all published information related to clinical 
infections with ST398 organisms [both MRSA and MSSA 
(i.e. susceptible to methicillin)]. Eighty three papers or 
reports were identified to contain information on ST398 
associated with clinical cases in humans. Where available, 
information was recorded on country; numbers of isolates 
that were from screening swabs; numbers of isolates that 
were from clinical infections; clinical presentations (e.g., 
bacteremia; pneumonia; skin or soft tissue infection…); 
invasiveness (number of cases with invasive infections, 
i.e. not skin or soft tissue infections); history of animal 
contact; and number of fatalities. Using conservative cri-
teria of invasiveness (i.e., likely overstating invasiveness 
by including sputum and urine cultures) there were 2,213 
events of positive screening (isolates not linked to infec-
tion) and 495 isolates from humans with clinical infec-
tions. More than half of the specified presentations were 
skin or soft tissue infections, or infected wounds. There 
were 89 cases deemed invasive, and 5 fatalities (note 4 of 
these were MSSA and without association with livestock) 
documented globally over several years. Approximately 
30% of the 89 invasive cases involved the t571 spa type 
that is relatively uncommon in pigs. For context, in the 
USA alone, in 2005 the CDC estimated 94,600 invasive 
MRSA infections and 18,650 deaths every year.12 That 
is, if all the invasive and fatal cases of ST398 reported in 
the world from 2004 to 2011 had occurred in the USA in 
2005, they would have represented 0.09% and 0.03% of 
those cases  respectively.
As noted above, some European studies do not distinguish 
between events of colonization and clinical infection, and 
thus there is a lack of quantitative information about the 
actual clinical risks associated with livestock exposures 
and colonization with ST398 MRSA. The small number 
of reports of severe or fatal systemic infections with 
ST398 S. aureus have led to inferences that organisms of 
this lineage can be serious human pathogens. However, 
analysis of two years of data for a laboratory serving an 
estimated population of 800,000 people in a pig dense 
area in Holland identified 30 ‘clinical’ ST398 isolates, of 
which 6 were pneumonia or systemic infection (1 blood, 
3 sputum, 2 urine). These data suggest an annual risk of 
approximately 2 clinical infections (and 0.38 invasive 
infections) per 100,000 people.13 A more recent report 
from the hog dense region of Jutland in Denmark (where 
all MRSA infections are reportable) recorded 3 clinical 
infections with ST398MRSA (all pig farmers) over 2 years 
in a population of around 580,000 people.6 This implies 
an annual incidence around 0.25 clinical infections per 
100,000 people per year. The infections were two cases 
of impetigo (superficial skin infection) and one case of 
tonsillitis (where isolation of the organism alone does not 
prove causation). For context, widely cited estimates for 
MRSA infection in the USA are 31.8 invasive cases and 
6.3 fatalities per 100,000 people per  year.12
To date, there have been 5 reported fatalities associated 
with ST398 S. aureus. In 4 of these cases, the organisms 
were t571 MSSA with no known livestock contact, and 
therefore are more likely related to the human than the pig 
clade of t571.8 The other case was t011 ST398 MRSA (un-
like t571, common in pigs in Europe) and the patient had 
indirect contact with pigs. This 85 year old man suffered 
from lung carcinoma and chronic obstructive pulmonary 
disease, and the organism was isolated from pleural fluid.14 
Other than infected bite wounds, reports of medically 
significant ST398 MRSA infections in healthy livestock 
workers are remarkably scarce and livestock contact is a 
notably inconsistent feature of invasive ST398 infections. 
Some authors default to the assumption that lack of live-
stock contact constitutes evidence of indirect spread (e.g. 
via food and the ‘environment) putting the wider public 
at risk.10 However, this is a very questionable assumption 
unless the organisms are known not be belong to the t571 
human clade,8 which itself may prove not to be unique (i.e., 
other spa-types deemed LA-MRSA may be found to have 
distinct human-adapted  counterparts).
Information on human disease associated with ST398 
MRSA is sparse in North America than Europe. A retro-
spective assessment of 3,687 MRSA clinical isolates in 
Canada identified only 5 cases with ST398 MRSA, 4 of 
which presented with skin or soft tissue infections.15 The 
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CDC has examined over 12,000 US isolates and is yet to 
identify ST398 among human clinical isolates (Dr. Brandi 
Limbago, personal communication). Similarly, in the hog 
dense state of Minnesota, the MN Department of Health 
has tested over 7,000 clinical isolates of MRSA with sma1 
PFGE (inability to type isolates with sma1 is a characteris-
tic of ST398 lineage) and is yet to identify an ‘untypable’ 
isolate (Dr. Kirk Smith, personal communication). Given 
the known presence of ST398 in the North American swine 
industry, and the sporadic reports of clinical infections 
in swine workers in Europe, it is likely that some clinical 
infections may have occurred in occupationally exposed 
individuals in the USA. The absence of reported cases 
until now in the USA is likely attributable to both a low 
incidence and low severity of ST398 infections. On the 
other hand, t571 ST398 MSSA of the human clade has 
recently been identified as a relatively important source 
of human MSSA infection in New York, being identified 
in 5% of non-invasive MSSA cases and 2.5% of MSSA 
bacteremias.9. That is, the only documented cases of clini-
cal ST398 infections in the USA to date involve the human 
clade of t571 that is considered ‘animal  independent’.7
The larger island of knowledge – do we 
know what LA-MRSA  are?
In my experience around zoonotic pathogens over 20 
years, simple phenomena rarely stay that way. The initial 
discovery of ST398 in Netherlands provided a fairly clear 
and simple narrative. A novel lineage of MRSA had been 
discovered in livestock (particularly pigs) and constituted 
a new threat to public health. Possession is nine-tenths 
of the law and the term ‘livestock associated MRSA’ or 
‘livestock associated S. aureus’ understandably became 
synonymous with ST398-MRSA/S. aureus. However, this 
once reasonable terminology now causes more confusion 
than enlightenment. Firstly, we now know that at least 
one clade of ST398 is in not associated with livestock.8,9 
Secondly, ST398 S. aureus are not uniquely associated 
with pigs, a fact that is unsurprising both on the grounds 
of basic biology (assuming S. aureus is part of the normal 
flora of pigs) and from research conducted on isolates 
obtained before,16 and after, the Dutch revelation. There 
is now accumulating evidence that S. aureus belonging to 
several MLST lineages (particularly ST9 and ST5, but also 
others included ST97 and ST1) may be equally ‘pig associ-
ated’.17-20 MRSA isolates belonging to these lineages (par-
ticularly ST9 in Asia) are being increasingly documented 
in swine. As research continues, a better understanding 
of the diversity of S. aureus in swine populations will be 
achieved, and it is clearly much broader than  ST398.
‘ST398’ should no longer be seen as synonymous with 
‘livestock associated’. Its use as such should be elimi-
nated henceforth, particularly in titles of peer reviewed 
literature. Though once having some utility, this ter-
minology has been rendered inappropriate by recent 
research and contributes to misleading inferences21,22 
that can be carelessly cited as evidence of community 
spread of S. aureus from livestock sources, without any 
evidence that this was the case.10 The use of the term 
‘livestock associated’ with MSSA or MRSA should be 
reserved for isolates that have been directly obtained 
from or closely linked to livestock environments. Authors 
drawing inferences indirectly about livestock involve-
ment in the epidemiology of human MRSA cases should 
be held to a higher level of accountability than has been 
the case to  date.
Who are at risk of LA-MRSA  exposure?
To date there are insufficient data to make any judgments 
about swine associated MRSA other than ST398. There 
has yet to be a community based outbreak of ST398 MRSA 
infection reported from any country, and two reports 
of hospital associated “outbreaks” were of small scale 
and predominantly involved asymptomatic carriage and 
contamination of superficial wounds. Evidence to date 
indicates the health risks associated with ST398 organ-
isms of livestock origin are overwhelmingly restricted to 
people with direct animal contact and their immediate 
families.23-25 Across these 3 studies, LA-MRSA preva-
lence (44%) was > 180 times higher in 352 occupationally 
exposed persons than in 2,094 rural residents without 
farm exposure (0.24%). Prevalence in family members 
of livestock workers was intermediate (5.2%). The stud-
ies collectively confirm that in livestock dense regions 
where exposure to ST398 MRSA is a common occupa-
tional risk for livestock workers, it is a lesser risk to their 
family members, and a negligible risk to persons without 
livestock or farm  contact.11
MRSA myopia- what’s in a  gene?
MRSA are differentiated from MSSA based on the pres-
ence of a single gene (mecA). MRSA paranoia in the media 
creates the impression that MSSA have no importance as 
human pathogens, whereas MSSA contribute significantly 
to the burden of human S. aureus disease including fatali-
ties across the world. It is remarkable that given the volume 
of research conducted on ‘LA-MRSA’, the biology and 
ecology of the parent organism (S. aureus) remains largely 
overlooked. Much of this focus was justified initially by the 
effort to understand the extent of the ‘problem’ in the early 
period of great uncertainty. However, as the conversation 
in some sectors drifts towards ‘control and interventions’ 
(albeit unwarranted and probably ineffective), it is essential 
to understand the basic ecology of S. aureus in pigs. Some 
very recent studies in pigs and veterinarians have broken 
this barrier,26,27 and more are required if we are to obtain 
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any comprehensive understanding of the basic biology. At 
the University of Minnesota, we currently have ongoing 
studies of S. aureus epidemiology in pigs (funded by the 
National Pork Board) and swine veterinarians (funded by 
NIOSH through the Upper Midwest Agricultural Safety 
Center) in the USA, and some results will be presented at 
the Leman conference. This will include growing evidence 
that the prevalence of ‘LA-MRSA’ is lower in the USA 
than in many European countries, and that MSSA variants 
of most lineages of MRSA associated with pigs around the 
world are prevalent in the USA. Given that these organisms 
have likely been associated with pigs since well before 
the modern era of intensive swine production, the appar-
ent lack of any incremental risk of S. aureus infections 
recognized swine farmers suggests that their pathogenic 
potential in humans is probably negligible. Further re-
search into the virulence of livestock associated lineages 
will be required to explain the apparently minor risk of 
occupational S. aureus infections of swine farmers despite 
‘occupational exposure of huge quantitative  dimensions’.
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Increase the value of your diagnostics and your value as a 
 diagnostician
Marie Culhane, DVM,  PhD
University of Minnesota Veterinary Diagnostic  Laboratory, St. Paul,  Minnesota
Introduction
During lean financial times, all veterinary expenses in-
curred by the pork producer come under scrutiny. There-
fore, it is essential to properly invest time and effort into 
all diagnostic submissions to get meaningful answers 
worthy of the diagnostic costs. But what if, despite your 
best efforts, the results you receive from the diagnostic 
laboratory just do not make sense or seem worthless? This 
paper discusses the issues of proper sampling technique, 
submission and interpretation of results that will increase 
the value and benefit received from diagnostic work ups 
for your  clients.
Pig  selection
The selection of pigs for testing, whether for serology 
or necropsy, is the most important step in obtaining an 
accurate and timely diagnosis. The majority of the vet-
erinarian’s time should be spent observing pigs, taking 
temperatures, and obtaining complete histories prior to 
collecting samples or performing  euthanasia.
Sampling pigs that have been treated for days or weeks 
with antibiotics will be unrewarding if your goal is to 
isolate pathogenic bacteria. Likewise, sampling only pigs 
that are chronically ill will skew the diagnostic picture, 
resulting in isolation only of common secondary or op-
portunistic pathogens and finding histopathological le-
sions masked by scarring or regeneration rather than the 
inciting  lesion.
In some situations, sample selection is straightforward – 
such as in outbreaks of PEDV, TGEV or ileitis in naïve 
herds. In other, more complex situations such as porcine 
respiratory disease, many agents may be involved. Diag-
nostic sample selection may involve testing pigs at recur-
ring intervals in order to define all the agents involved. 
Sampling carefully to include acutely affected pigs will be 
the greatest help to the producer, the pathologist, and the 
veterinarian seeking treatment or prevention  strategies.
Consultation
For common disease situations, as mentioned above, your 
sample selection will be straightforward and you can rely 
on your experience and best judgment to collect samples. 
For more complex situations or emerging diseases, 
consultation with a trained diagnostic pathologist may 
bring immediate benefit to the disease investigation.1 
The discussion should be followed by careful animal ob-
servation free of time constraints and other distractions. 
By doing this, you should be able to determine what is 
actually occurring with the pigs, not what the producer 
says is occurring with the pigs. An excellent example of 
what can be gained by evaluating pigs for clinical signs 
personally occurs in situations of central nervous system 
disease. CNS disease can present in many forms and the 
clinical signs displayed can sometimes help localize the 
lesion to a particular area of the central nervous system. 
While it is true that discrete lesions of the central nervous 
system resulting in well-defined neurological signs are not 
as common in pigs as they are for dogs and cats, careful 
observation and recording of clinical signs can be very 
helpful. For example, pigs that are down or ataxic but 
alert are likely suffering from lesions in the spinal cord or 
perhaps musculoskeletal system. Pigs that are unaware of 
their surroundings or near comatose are likely suffering 
from lesions in the cerebral cortex, such as those due to 
bacterial meningoencephalitis and viral encephalitis, in 
cases of primary neurological disease.2
Once the clinical observations are made, the clinical in-
formation should be documented and submitted in detail 
because it is needed by the pathologist to generate a report 
that is correct and meaningful. At present, laboratory sub-
mission forms are sometimes completed by a lay person 
and are either useless or contain incorrect information. 
Important or relevant information is sometimes omitted 
or is indecipherable and occasionally no information is 
provided at all. Where possible, historical data and pro-
duction records should be submitted electronically therby 
enabling analysis using high speed computers to uncover 
biological information hidden in the mass of laboratory 
and epidemiologic data. Great care should be taken to 
avoid searching for a narrow list of infectious agents when 
faced with an unusual disease. It is precisely the wrong 
approach and sometimes leads to overconclusion and er-
roneous diagnostic endeavors. Instead, subroutines used 
for diagnostic investigations should be expanded to include 
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a complete physical examination and complete necropsy. 
Several animals displaying typical signs at various stages 
of disease should be necropsied and a full set of tissues 
collected for histopathology and other laboratory  testes.
Evaluation of diagnostic laboratory 
 results
Laboratory results should be evaluated with an “open mind” 
through a process of inductive and deductive reasoning. Di-
agnostic hypotheses should be developed, investigated, and 
continually refined while separating what you know from 
what you think you know. Avoid disbelieving or dismissing 
laboratory data if the results cannot be related to a specific 
disease entity because pre and post analytical errors are far 
more common than analytical errors. By studying a similar 
pattern of laboratory data in a large series of cases, confi-
dence in the existence of a new disease or syndrome will 
emerge and will increase as similar findings are reported 
by others. When the findings have been replicated several 
times, a disease or syndrome will assume and increasing 
degree of  believability.
Errors in laboratory  medicine
While it may be tempting to dismiss some findings as 
error, be cautious before doing so. An explanation on the 
types of errors that exist in laboratory medicine may help 
you determine why results seem to make no sense. So, to 
understand laboratory errors, it is important to think of the 
diagnostic investigation as a series of events. The interval 
between the time a patient’s sample is collected until the 
result is reported to the veterinarian can be divided into 
3 phases: the pre-analytical phase, the analytical phase, 
and the post-analytical  phase.
Pre-analytical phase  errors
The pre-analytical phase occurs in the clinic after visiting 
the farm. The analytical phase occurs in the laboratory. 
The post-analytical phase is a shared responsibility and 
occurs both in the client and laboratory’s environments. 
There are several errors that can occur in the pre-analytical 
phase. Errors regarding the patient status and information 
sharing include inaccuracies such as incorrect age listed, 
no age listed, or only a number listed as age and no units. 
A diagnostic investigation regarding diarrhea in a pig listed 
only with an age of “3” can result in several different test 
strategies on the fecal sample submitted. A 3 day old pig 
fecal sample will be tested for rotavirus, TGEV, Salmonella 
sp., E. coli, anaerobic bacteria such as Clostridium perfrin-
gens, and Clostridium difficile toxin. A 3 week old pig fecal 
sample will be tested for rotavirus, TGEV, aerobic bacteria, 
and protozoan parasites. A 3 year old pig fecal sample 
will be tested for TGEV, Salmonella sp., Brachyspira sp., 
Lawsonia intracellularis, Yersinia enterocolitica, and 
metazoan parasites. You can see that a pathogen may be 
missed or tested for extraneously if the age of the pig is 
not shared with the laboratory. Errors in specimen collec-
tion may also occur. For example, attempting to detect the 
red blood cell surface pathogen Mycoplasma haemosuis 
(formerly Eperythrozooan suis) in pale piglets by PCR 
requires the submission of whole blood in EDTA. If only 
serum is submitted, the PCR test cannot be performed and 
the serology test for M. haemosuis antibodies in piglets is 
uninterpretable as they may represent maternal antibod-
ies or may be false negative as antibody production to 
M. haemosuis occurs in waves.3 Even when the correct 
sample is collected, errors in specimen processing can 
occur. Centrifugation at high speeds for prolonged times 
and in the presence of high temperatures can destroy 
viral RNA making it undetectable by polymerase chain 
reaction assays. Specimen transport occur especially in 
places with extremes in seasonal temperatures. Accidental 
freezing of formalin-fixed tissues can result in freeze-thaw 
artifacts that destroy tissue integrity rendering samples 
useless for histopathology examinations. Improper insu-
lation and refrigeration of tissues or serum can result in 
high temperatures that destroy pathogen RNA or DNA or 
promote  decomposition.
Analytical phase  errors
All the steps involved in the actual analysis of the sample 
in the laboratory can be considered analytical phase er-
rors. These “lab errors” include such technical mistakes 
such as mis-pipetting, fibrin interference (from clotting), 
hemolysis (from clotting), equipment errors, tube number-
ing or numerical ordering errors, and transcription errors. 
Such mistakes can occur if there is a lack of sufficient 
quality assurance and quality control measures in place. 
A laboratory with an insufficient quality assurance and 
quality control program may have at their disposal a lack 
of validated assays. Additionally, the laboratory may have 
chosen the inappropriate method for the sample and situ-
ation if a specific method was not available or not clearly 
requested. The American Association of Veterinary Labo-
ratory Diagnosticians has in place an accreditation system 
that requires all accredited laboratories to have in place 
quality assurance programs, training records, calibration 
records, and validation of all tests used in each laboratory. 
The accreditation process is lengthy and taken seriously 
and repeated every 3 to 5 years. The accreditation process 
is in place to reduce the number of analytical phase errors 
and increase client  satisfaction.
Post-analytical phase  errors
Reviewing results for discordance, interpretation and utili-
zation of results, and appropriateness of reference intervals 
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are tasks shared by the laboratory and the client. Basically, 
the laboratory has a responsibility to report results that 
have been checked for accuracy and repeatability using 
only validated tests. The laboratory has the responsibil-
ity of providing reference ranges and test interpretations 
where appropriate. Regarding test interpretations provided 
by the laboratory, these include cut-off points for positives 
and negatives (such as the IDEXX Herd Check PRRSV 
ELISA test has a cut-off of 0.40 s/p ratio for positive) that 
come from the validation information. In some cases, 
interpretations are not possible from the laboratory either 
due to insufficient numbers of test values to analyze or 
running a new test on a different species. Some reference 
ranges are age specific. Liver iron levels in pigs very 
greatly by age and by supplementation or diet status. Since 
information on age, supplementation, and diet status is 
often not provided with the liver samples, an interpretation 
on adequate, low or toxic levels of iron often cannot be 
made with certainty. A post-analytical phase that is pri-
marily the responsibility of the laboratory is post analysis 
sample storage. Keep in mind sample storage is limited by 
space, time and money. Therefore, any precious, rare, or 
valuable samples should be archived by the submitter or 
special arrangements made with the  laboratory.
Which errors occur with the greatest 
 frequency?
According to a 2002 publication, “Errors in Laboratory 
Medicine” by Bonini, et al. from the Journal of Clini-
cal Chemistry in 2002, a large percentage of laboratory 
errors occur in the pre-and post-analytical phases, with 
fewer mistakes (13-32%) occurring during the analytical 
phase.4 They determined this by evaluating 8 years of 
literature (Medline and hand searches) and searching for 
“mistakes, blunders, errors, problem or defect associated 
with laboratory or medical laboratory.” They found that 
even when different study designs, patient numbers, and 
discovery techniques were used, the distribution of errors 
across the different phases of the entire testing process 
was very similar, and usually occurring in the pre-and 
post-analytical phases. Another study conducted in 1997 
analyzed the results of 40,490 “stat” results in a human 
clinical laboratory.5 This is especially important to con-
sider in our world of ever increasing needs for just-in-time 
testing and “RUSH” result reporting for such diseases of 
porcine veterinary importance like PRRSV. In this 1997 
study, 189 errors were found for an error rate of 0.47%. 
Of those 189 errors found, 68% were pre-analytical, 13% 
were analytical, and 18% were  post-analytical.
Reducing laboratory errors – a shared 
 responsibility.
It is important to remember that the client and laboratory 
share in the responsibility of reducing laboratory errors 
at the pre-analytical and post-analytical levels. To prevent 
pre-analytical errors, the submitter and the laboratory 
need to be conscious of sample labeling, tube type, tube 
fill level, pre-centrifugation intervals, post-centrifugation 
intervals, storage time and temperatures, transport time 
and temperatures, and the condition of the samples re-
ceived at the laboratory. The laboratory should serve as a 
reference for the client, providing the necessary submis-
sion information for optimal  results.
Conclusion
The contemporary swine diagnostician must have the ability 
to carefully observe and describe diseases; correlate his-
tory, physical examination, clinical signs, and production 
data; must know when, how, what type and to what extent 
of laboratory investigations to undertake; must understand 
and interpret the significance of the laboratory results 
obtained; must use knowledge of pathological principles 
to formulate possible diagnoses; must develop hypotheses 
about underlying mechanisms, and must be able to explain 
the basic mechanisms underlying the disease processes to 
the producer. Having the ability to incorporate these skills 
will make it easier to deal with results that don’t seem to 
make sense and increase the knowledge of all those involved 
in finding the correct  answers.
Acknowledgement
Dr. Rebecca Davies, Dr. Jim Collins, and Dr. Kurt Rossow 
are especially thanked for their significant contributions 
to this manuscript and to my value as a  diagnostician.
References
1. Collins JE. Pathogens as their role evolves: a view from the 
diagnostic laboratory. Proceedings of the Allen D. Leman Swine 
Conference, St. Paul, MN 2006; 33:  33–39.
2. Radostits OM, Gay CC, Blood DC, Hinchcliff KW. Diseases 
of the Nervous System, pp. 501–504. In Veterinary Medicine – 
A Textbook of the Diseases of Cattle, Sheep, Pigs, Goats, and 
Horses, 9th Ed. WB Saunders, London, UK.  2000.
3. Thacker EL. Mycoplasma Diseases, pp. 710–714. In Straw BE, 
et. al., Diseases of Swine, 9th Ed. Blackwell Publishing, Ames, 
IA.  2006.
4. Bonini P, et al. Errors in Laboratory Medicine:. Clin Chem 
48:5,  2002.
5. Plebani M et al. Mistakes in a stat laboratory: Types and fre-
quency. Clin Chem. 43,  1997.
26 2013 Allen D. Leman Swine Conference
D
is
ea
se
 C
as
es
D
isease Cases
Marie Culhane
2013 Allen D. Leman Swine Conference 27
D
is
ea
se
 C
as
es
D
isease Cases
Haemophilus parasuis: Infection, immunity and antibiotics
Nubia Macedo; Albert Rovira; Montserrat Torremorell
University of Minnesota, College of Veterinary Medicine
Introduction
H. parasuis is considered one of the most important 
bacterial pathogens affecting pigs. Vaccines and other 
management strategies have not always been successful 
in controlling the losses associated to H. parasuis. This 
bacterium frequently colonizes the mucosal of the swine 
upper respiratory tract. Oliveira et al., (2004) showed 
that exposure of young pigs to a low dose of virulent 
H. parasuis strain (controlled exposure) reduced mortality 
due to Glasser's disease and could induce the development 
of protective immunity. Under field conditions, factors 
that may disrupt colonization patterns of H. parasuis at 
weaning, such as antibiotic treatment, might result in delay 
of disease to late nursery phases, due to lack of immune 
response priming.
H. parasuis, as a gram-negative bacterium, interacts 
with the immune system at different levels, including the 
innate and the specific immune system. The literature 
offers a vast characterization of antibody-mediated im-
mune responses, whereas little information is currently 
available for innate immune and cell-mediated responses.2 
A recent study showed that H. parasuis susceptibility to 
phagocytosis by porcine alveolar macrophages (PAMs) 
correlates with the clinical origin of the strain.3 H. para-
suis strains isolated from systemic lesions (virulent) were 
resistant to phagocytosis, while nasal strains (non-virulent) 
were efficiently phagocytosed by PAMs in vitro, followed 
by subsequent bacterial death within the macrophage. 
Similarly, H. parasuis was able to stimulate the produc-
tion of IL-1 expression in lung of pigs undergoing severe 
disease following experimental infection, whereas IL-4, 
IL-10, tumor necrosis factor-alpha (TNF-α), and (IFN-γ) 
were expressed in significantly higher levels in spleen, 
pharyngeal lymph nodes, lung and brain of survivors, 
which suggests that these cytokines might contribute to 
protection against H. parasuis.4 Specific increases in the 
relative proportions of T and B lymphocytes isolated from 
peripheral blood mononuclear cells (PBMC) were also 
found in colostrum-deprived pigs after challenge with 
virulent H. parasuis strain, but not after immunizations.5,6
Most frequently, pigs exposed to H. parasuis live cultures 
or vaccinated with killed bacterins generate progressively 
increasing serum IgG antibody response. Pigs with high 
homologous titers are protected against challenge,7 while 
Glasser's disease has been associated with absence or low 
titers of serum antibodies.8,9 Likewise, pigs lacking mater-
nal immunity were susceptible to Glasser's disease upon 
inoculation with a virulent H. parasuis strain, whereas 
pigs that received maternal immunity were protected.10 
Cerda-Cuellar et al. (2010) further demonstrated that pig-
lets from vaccinated sows had significantly higher levels 
of antibodies earlier after birth and were colonized later 
and to a lower degree than piglets from non-vaccinated 
sows. Furthermore, the increase in colonization rate was 
associated with a decrease in H. parasuis serum antibod-
ies in piglets, which indicates that the level of maternal 
antibodies in piglets might be able to modulate the timing 
and level of colonization by H. parasuis.
According to Oliveira et al., (2004), the success of H. para-
suis controlled exposure in preventing mortality during 
the nursery stage suggests that H. parasuis might interact 
with the mucosal of the upper respiratory tract, possibly 
resulting in colonization, priming of the immune response 
and protection from disease. Therefore, the development of 
a protective immune response against H. parasuis might 
be delayed by factors that interfere with bacterial colo-
nization. Recent studies have shown that early antibiotic 
treatment not only prevented the development of an effec-
tive immune response against Chlamydia trachomatis and 
Salmonella sp., but also rendered the animals susceptible 
to challenge infection.12,13 In contrast, however, a recent 
study demonstrated that early antibiotic treatment with 
enrofloxacin against Salmonella typhimurium infection 
primed specific antibody response, which protected 
against secondary challenge.14 Enrofloxacin, the primary 
compound of Baytril (Bayer Animal Health), is considered 
efficacious against H. parasuis, but limited information 
is currently available on the effects of enrofloxacin on 
H. parasuis colonization and immunity. Therefore, a better 
understanding of H. parasuis colonization over time and 
the effect of antibiotics on colonization and the develop-
ment of an effective immune response requires further 
investigation in order to prevent and control disease.
The objective of our study was to evaluate the effect of 
enrofloxacin (Baytril 100) in H. parasuis colonization in 
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weaned pigs. Additionally, in order to recreate H. parasuis 
colonization under conditions representative of what oc-
curs in the field, a new experimental inoculation model 
was developed in conventional pigs to better understand 
dynamics of colonization and immune responses to viru-
lent H. parasuis.
Material and methods
Study 1: Effect of enrofloxacin on H. parasuis 
colonization
Forty five pigs were identified in a commercial herd and 
screened for H. parasuis using gel-based PCR.15 Twenty-
four of the weaned pigs that tested positive for H. parasuis 
were selected and moved to the University of Minnesota 
research isolation facility. Pigs were randomly divided 
into one treatment group of 12 pigs and one control group 
of 11 pigs and housed in two separated rooms (one pig in 
the control group died shortly after arrival). On arrival at 
the research facility, blood samples and nasal and tonsil 
swabs were collected from all the pigs. Pigs in the treat-
ment group were treated with a single dose of injectable 
enrofloxacin (0.034ml/lb / 7.5 mg/Kg Baytril) at 24 h 
post arrival. Pigs in the control group received saline 
solution intramuscularly but not antibiotics. Pigs were 
monitored for 15 days. Throughout the study pigs were 
sampled by tonsillar and nasal swabs and selected pigs 
were necropsied at 3, 8 and 14 days post-treatment (DPT). 
At necropsy, swabs from the nasal cavity, tonsil, trachea, 
lung, and peritoneal and pleural serosas were collected 
for diagnostic investigation. Nasal swabs were processed 
for qPCR testing. DNA from swabs were extracted using 
DNeasy Blood & Tissue Kit Qiagen kit and then tested 
individually by quantitative PCR (qPCR),16 with some 
modifications. Differences between the proportions of 
H. parasuis positive pigs in treated vs control groups at 
each sampling time point were calculated using Fisher’s 
Exact Probability Test. The Bonferroni correction was 
used to address multiple comparisons (α = 0.003).
Study 2: Colonization model
Sixteen conventional weaned pigs were divided into 3 
groups and placed into 3 different rooms at the University 
of Minnesota research isolation facility. At day 0 of the 
study, groups 1 and 2 (n = 6 each) and 3 (n = 4) received 
106 or 104 CFU/ml of highly virulent H. parasuis, strain 
Nagasaki, or saline, intranasally, respectively. Clinical 
evaluation and nasal swabs (for bacterial culture) were 
collected before and every day after inoculation (dpi) dur-
ing 7 days. Blood samples were collected on 1, 3 and 4 dpi 
for bacterial isolation. At 2 time points (4 and 7 dpi), half 
of the pigs were euthanized and assayed for the presence 
of H. parasuis in the respiratory tract and systemic sites. 
H. parasuis isolates obtained were genotyped by ERIC-
PCR17 in order to differentiate strain Nagasaki from any 
other H. parasuis strains that the pigs may carry.
Results
Study 1: Effect of enrofloxacin on H. parasuis 
colonization
Pigs tested positive by gel-based PCR15 at the herd of origin 
and on the day of arrival. Results from qPCR showed that 
twenty two out of twenty three pigs (95.7%) tested posi-
tive from tonsil swabs on arrival, while only 11 pigs (48%) 
tested positive from nasal swabs. All treated pigs tested H. 
parasuis negative by qPCR at 1 day post-treatment (DPT). 
Moreover, treatment effect persisted partially until 12 
DPT. The control pigs tested positive throughout most of 
the days of the study. Differences between the proportion 
of positives for control and treated pigs were statistically 
significant on days 1, 2, 3, 4, 5, 6 and 7 post-treatment for 
nasal swabs and on days 2, 4 and 5 post-treatment for tonsil 
swabs (P-value < 0.003). At necropsy, nine out of eleven 
control pigs were positive for H. parasuis in at least one of 
the five samples tested. One sample from the serosas was 
cultured positive and two isolates were recovered from the 
nasal cavity. In contrast, only 4 out of 12 pigs in the treat-
ment group tested positive at necropsy. Three pigs tested 
positive in the tonsil, 3 in the trachea, and one in the nasal 
cavity. None of the serosas were cultured positive and only 
one bacterial isolate could be cultured from the nasal cavity 
at necropsy. Interestingly, all isolates were recovered at 15 
DPT. No clinical signs or lesions of any kind were observed 
during the experiment.
Study 2: Colonization model
ERIC-PCR genotyping demonstrated that the H. parasuis 
strains isolated before inoculation were identical, and fre-
quently isolated from the nose of all the pigs throughout the 
study. The Nagasaki strain, also identified by ERIC-PCR, 
was recovered from the nose of 5 pigs after inoculation. 
Moreover, tracheal swabs collected at necropsy yielded 
only Nagasaki isolates in 10 pigs. Overall the Nagasaki 
strain was isolated at least once from all 12 inoculated pigs, 
but was never recovered from systemic sites of experimen-
tally inoculated pigs, control pigs or before inoculation. 
There were no differences in isolation of the Nagasaki 
strain based on inoculation doses. The absence of fever, 
clinical signs, lesions and bacteremia demonstrates that 
there was no systemic infection, even though the Nagasaki 
strain can be highly virulent. Trachea represents a less 
competitive niche for H. parasuis colonization, which 
may explain why tracheal swabs yielded higher number 
of Nagasaki isolates compared to nasal swabs.
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Conclusions
Under the conditions of this study, enrofloxacin treatment 
significantly reduced the number of pigs colonized with 
H. parasuis and this effect was mostly seen during the 
first week post treatment. In addition, enrofloxacin also 
reduced the presence of H. parasuis on the nasal cavity 
and the tonsils of naturally colonized pigs, but was unable 
to completely eliminate the organism. Nevertheless, the 
results showed that the effect of enrofloxacin was rapid and 
active for relatively long time against H. parasuis harbored 
on the nasal cavity and tonsils of weaned pigs, since all 
treated pigs tested negative at 1 DPT and continued to test 
negative during most of the study.
Reduction of H. parasuis in the nasal cavity and tonsils 
may help to control the disease during susceptible stages 
such as the weaning period, but further research is needed 
to evaluate the lasting effect of enrofloxacin in coloniza-
tion patterns and immune response. We intend to investi-
gate these findings further by using the H. parasuis colo-
nization model that we have established in conventional 
pigs to study the early events of H. parasuis infection and 
immune response in conventional pigs.
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Association of Brachyspira antibiograms with species and 
 source
N. Mirajkar; C.  Gebhart
Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine,  
University of Minnesota, Saint Paul, Minnesota
Introduction
Brachyspira hyodysenteriae is the etiological agent of 
swine dysentery, a mucohemorrhagic diarrheal disease of 
grower-finisher pigs. Recently, a novel pathogenic species, 
“B. hampsonii”, has been isolated from clinical cases of 
swine dysentery in North America. Other members of 
the genus Brachyspira cause varying degrees of clinical 
disease ranging from mild to mucoid diarrhea. Although 
these diseases continued to cause significant economic 
losses to swine rearing countries globally, they largely 
disappeared from the US in the 1990s. Recently however, 
Brachyspira species known to cause mucohemorragic, 
mucoid and mild diarrhea in grower-finisher pigs have 
been increasingly isolated in the US Limited information 
exists on the susceptibilities of pathogenic and commensal 
Brachyspira species towards commonly used antimicrobi-
als. In addition, no routine diagnostic method currently 
exists in the US for testing in vitro antimicrobial suscep-
tibilities of Brachyspira species. Therefore our aim was 
to identify the in vitro susceptibility patterns of various 
Brachyspira species towards commonly used antimicrobi-
als in the US A second objective was to validate a broth 
microdilution method for routine diagnostic testing of 
Brachyspira species.1
Materials and  methods
Bacterial isolates and antimicrobials: A sample set 
of 80 submissions made to the University of Minnesota 
Veterinary Diagnostic Laboratory (20 B. hyodysenteriae, 
20 “B. hampsonii”, 20 B. pilosicoli and 20 B. murdochii) 
originating from a variety of sites, companies and states 
across the US in 2009 to 2013 were tested. A set of 40 iso-
lates (10 each of four different species) were evaluated by 
both the agar and the broth microdilution methods to test 
for comparability. An additional set of 40 isolates (10 each 
of four different species) were evaluated in duplicate by the 
broth microdilution method to test for reproducibility. Sus-
ceptibility of Brachyspira species towards commonly used 
antimicrobials including tiamulin, valnemulin, lincomycin, 
tylosin, tylvalosin and carbadox (agar dilution method only) 
was evaluated. The B. hyodysenteriae type strain B78T 
(ATCC 27164) was used as an experimental  control.
Agar dilution method: Fresh sheep blood agar plates 
were prepared which contained two-fold serial dilutions 
of antimicrobials. A 5μl suspension of 1 × 108 Brachyspira 
per ml of BHI broth supplemented with 10% FBS was 
inoculated and a cut was made on the agar to observe the 
ring phenomenon. The plates were incubated anaerobically 
at 37°C for 4 days.2
Broth dilution method: A 500 µl suspension of 1 × 106 to 
5 × 106 Brachyspira per ml of BHI broth supplemented 
with 10% FBS was inoculated into each well of the broth 
antimicrobial susceptibility panel (VetMIC Brachy panel, 
SVA Sweden). The panels were anaerobically incubated at 
37°C for 4 days on a rotator. The internal growth controls 
for each isolate were checked microscopically to confirm 
purity.3
Analysis: The minimum inhibitory concentration (MIC) 
was identified as the lowest concentration of the tested 
antimicrobial that inhibited visible growth. The MIC
90
 and 
MIC
50
 values (in μg/ml) were calculated for each species 
evaluated. The association between isolates from sow/gilt 
sites (vs. finisher sites) and susceptibility towards tylosin 
and lincomycin was tested with an odds ratio and a z-test 
for two  proportions.
Results
The concentration at which the growth of 50% (MIC
50
) and 
90% (MIC
90
) of the isolates was inhibited is summarized 
in tables 1 and 2. Table 1 contains the comparative MIC
50 
and MIC
90 
results of the agar and broth microdilution 
methods categorized by species. In general, the results 
obtained by the broth dilution method were equal to or 
within two doubling dilutions of those obtained by the 
agar dilution method. In addition, the results of the broth 
dilution method showed good reproducibility. Table 2 
contains the MIC
50 
and MIC
90 
results by species using only 
the broth microdilution method for tiamulin, valnemulin, 
lincomycin, tylosin and tylvalosin, and only the agar 
dilution method for carbadox. These results were inter-
preted by using epidemiological cut-off values proposed 
by Pringle et al.4 In general, MICs for all species were 
high for lincomycin, tylosin and tylvalosin; and low for 
tiamulin, valnemulin and carbadox. MICs for B. pilosicoli 
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and B. murdochii were moderately higher for all tested 
antimicrobials than for other species. Several B. pilosicoli 
isolates with unexpectedly high MICs for tiamulin were 
identified. Table 3 shows the results of the odds ratio and 
the two-proportion z-test comparing high susceptibility 
to tylosin and lincomycin in sow/gilt sites as compared to 
finisher sites. The results indicate an approximately 13 and 
10 times higher odds of high susceptibility towards tylosin 
and lincomycin respectively, for isolates originating from 
sow/gilt sites as compared to that of isolates originating 
from finisher sites. In addition, the proportion of isolates 
originating from sow/gilt sites with a high susceptibility 
to tylosin and lincomycin was found to be statistically 
different from that of isolates originating from finisher 
sites (P <  0.0001).
Table 1: Comparison of the MIC50 and MIC90 (in µg/ml) results by species using the agar and the broth microdilution  methods
species method tiamulin valnemulin lincomycin tylosin tylvalosin
MIC50 MIC90 MIC50 MIC90 MIC50 MIC90 MIC50 MIC90 MIC50 MIC90
B. hyodysenteriae
agar ≤ 0.063 0.25 ≤ 0.031 0.063 32 64 128 > 128 8 32
broth 0.125 0.125 ≤ 0.031 0.125 32 64 > 128 > 128 2 8
“B. hampsonii”
agar ≤ 0.063 0.5 ≤ 0.031 0.125 1 > 64 4 > 128 0.5 16
broth ≤ 0.063 0.25 ≤ 0.031 ≤ 0.031 0.5 32 2 > 128 ≤ 0.25 8
B. pilosicoli
agar ≤ 0.063 > 8 ≤ 0.031 4 32 > 64 128 > 128 16 > 32
broth 0.125 > 8 0.063 1 32 32 > 128 > 128 16 > 32
B. murdochii
agar 0.5 1 1 4 8 32 > 128 > 128 16 > 32
broth 0.125 1 0.25 0.5 16 16 > 128 > 128 8 32
Table 2: MIC50 and MIC90 (in µg/ml) results by species using only the broth microdilution method (and only the agar dilution method for  carbadox).
“*” indicates values 
with low susceptibility 
to  an antimicrobial (4)
tiamulin valnemulin lincomycin tylosin tylvalosin carbadox
MIC50
B. hyodysenteriae ≤ 0.063 ≤ 0.031 16* > 128* 4* 0.0039
“B. hampsonii” ≤ 0.063 ≤ 0.031 ≤ 0.5 4 0.5 0.0039
B. pilosicoli 0.5* 0.5* 32* > 128* 32* 0.0078
B. murdochii 0.25 0.25 16* > 128* 8* 0.0039
MIC90
B. hyodysenteriae 0.5* 0.5* 32* > 128* 16* 0.0078
“B. hampsonii” 0.25 ≤ 0.031 16* > 128* 4* 0.0039
B. pilosicoli > 8* 2* 64* > 128* > 32* 0.0156
B. murdochii 1* 0.5* 16* > 128* 32* 0.0078
Table 3: Results of odds ratio comparing high susceptibility to tylosin and lincomycin from sow/gilt sites as com-
pared to finisher  sites
Antimicrobial Odds ratio (95% CI) Z – score (P – value)
Tylosin 12.68 (4.01 to 40.01) 4.7 (P < 0.0001)
Lincomycin 9.68 (3.2 to 29.3) 4.0 (P < 0.0001)
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Discussion
While most Brachyspira species isolates showed a pat-
tern of high susceptibility to tiamulin, valnemulin and 
carbadox, and low susceptibility to tylosin, lincomycin 
and tylvalosin; several isolates originating from sow/gilt 
sites with high susceptibility to all antimicrobials were de-
tected. In addition, B. pilosicoli showed low susceptibility 
towards most antimicrobials tested. This study indicates 
that different MIC patterns were generally associated with 
the species of Brachyspira evaluated as well as with the 
source of animals (sow/gilt site vs. finisher site). In addi-
tion, this study validates the use of a broth microdilution 
method for routine diagnostic  applications.
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Antibiotics and their role in Brachyspira elimination 
 programs
Aaron J. Lower,  DVM
Carthage Veterinary Service, Carthage,  Illinois
Introduction
With any bacterial elimination program, sanitation coupled 
with discontinuing contamination of the environment is 
fundamental to eradicating the organism from a premise. 
Site depopulation is the easiest way to discontinue contami-
nation of the environment and has led to all in all out pig 
flow or depopulation/repopulation strategies. The decision 
to depopulate involves a variety of considerations including 
feasibility, economics, and site biosecurity. In situations 
where the production economics of continuing to populate 
a facility with infected animals versus depopulation are 
advantageous, antibiotic interventions are employed to as-
sist with discontinuing contamination of the environment. 
This strategy increases the risk of failure in the elimination 
program and increases cost through antibiotic usage but 
is calculated to be offset by continued production and the 
economics of the situation. An increase in the laboratory di-
agnosis of strong beta hemolytic Brachyspira and associated 
lesions since 20061 coupled with the recent identification of 
B. hampsonii2 has reinvigorated the practitioners interest in 
this reemerging pathogen. Antibiotic selection and dosage 
play a key role in elimination of this  pathogen.
Program
In large sow herds that are not depopulated, a structured 
and rigorous program with quality assurance checks must 
be employed to eliminate Brachyspira. Due to the labor 
requirements of the program, external labor and twenty 
four hour washing crews are often times warranted due to 
the considerable work load and scope of the project. This 
program requires excellent sanitation of the following  areas:
1. Animal  areas
a. Presoak areas with a  detergent
b. Strict sanitation of flooring, side walls, ceiling, 
feed, and ventilation  systems
c. Inspection and certification by veterinarian or 
upper  management
d. Disinfection with quaternary/glutaraldehyde 
disinfectant with contact time of 10 minutes prior 
to moving  animals3
e. Removal of water nipples, cleaning and 
 disinfection
f. Prevention of backsplash – use of plastic and 
tarps during pressure washing between clean and 
dirty  areas
2. Animals
a. Washed prior to movement with particular atten-
tion to feet, legs and  underline
b. Animals disinfected with  iodine
3. Fomites
a. Danish changes between clean and dirty  areas
b. McREBEL during site sanitation. No use of hot 
boxes, processing carts,  etc.
4. Water  source
a. Inspection of holding tank, ensure no rodent or 
bird  exposure.
5. Rodent/pest  control
a. Bait stations every 50 feet around the perimeter, 
checked twice  weekly.
b. Bait stations installed in the barn attics, checked 
 weekly.
c. Grass and weeks mowed and sprayed around the 
barns. Intact rock barrier surrounds the perimeter 
of all  barns.
d. Implementation of The Rodent Index System 
(adapted from Penn State Cooperative Extension) 
to quantify rodent  activity4.
e. Boric acid applied to all electric boxes and areas 
where cockroaches congregate. Creep dividers in 
farrowing house filled with foam spray to elimi-
nate cockroach  habitat. (Table 1)
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Table 1: Example medication and sanitation  schedule
Timeline Stage Inclusion rate
Medication 
start date
Medication 
end date
Washing 
startdate
Washing 
end date
Week 1-2 Gestation 
Lactation 
GDU
Denagard 200g/ton & 60 ppm H20 
Denagard 200 g/ton 
Mecadox 50 g/ton
June 20 July 3 June 27 July 3
Week 3-6 Gestation 
Lactation 
GDU
Denagard 35 g/ton 
Denagard 35 g/ton 
Mecadox 25 g/ton
July 4 July 31
Week 7-8 Gestation 
Lactation 
GDU
Denagard 200g/ton & 60 ppm H20 
Denagard 200 g/ton 
Mecadox 50 g/ton
August 1 August 14 August 8 August 
14
Antibiotics commonly used for treatment of Brachyspira 
include tiamulin, carbadox, tylosin, lincomycin, gentami-
cin, valnemulin, and salinomycin.5,6 Of those tiamulin and 
carbadox are most commonly utilized in the United States. 
Brachyspira MIC values to tylosin are intermediate and 
high MIC values to lincomycin and gentamicin provide 
concern of resistance to these antibiotics.5 Valnemulin is 
not approved for use in the United States and salinomycin 
is not labeled for use in  swine.
MIC data for the pleuromutalin drugs, valnemulin and 
tiamulin, suggest that antibiotic resistance patterns in 
US isolates of Brachyspira are not developing as quickly 
as what has been described in other countries. Carbadox 
and salinomycin MIC levels are at the low end of the 
range tested and expected to be effective.5 The MIC90 of 
Brachyspira hyodysenteriae and spp is 0.03 and 0.015 
respectfully.5 Administration of carbadox at 50 g/ton 
provides colonic activity at 4 mg/g (Dwain Guggenbiller. 
personal communication. June  2012).
When a herd is infected with Brachyspira hampsonii, MIC 
patterns are generally elevated compared to Brachyspira 
hyodysenteriae. Susceptibility testing in 2011, examined 
MIC patterns of 11 North American sourced Brachyspira 
spp. isolates. 91% (9/11) of these isolates exhibited strong 
beta hemolysis. After the study was published, these 
isolates were sequenced and mostly identified to be B. 
hampsonii (Eric Burrough, personal communication, June 
2012). The median MIC values from B. hampsonii are 8 
time higher and the MIC90 4 times higher than isolates of 
B. hyodysenteriae tested in this study (n = 24).3 Tiamulin 
colonic contents activity is outlined in Figure C with the 
MIC90 setting a target of 2 for B. hampsonii.
 Ad libitum feed 
intake in lactation results in a calculated daily drug dose 
of 2.4 mg/lb (500 lb sow with 12 lb per day intake – 200 g/
ton tiamulin). This is slightly less than the published daily 
dosage of 3.0 mg/lb which supplies activity in colon 
contents at 2.84 mg/g7 but is estimated to supply tiamulin 
activity of > 2 mg/g (Keith Erlandson, personal commu-
nication, June 2012). Restricted feed intake in gestation 
results in a calculated daily drug dose of 0.9 mg/lb (500 
lb sow with 5 lb per day intake – 200 g/ton tiamulin) 
which results in colonic content concentrations below 
the limit of quantification (<1.62 mg/g)7. Since this is less 
than our target MIC value of 2, supplemental tiamulin 
must be administered via the drinking water. Additional 
dosage of tiamulin at 60 ppm provides a calculated daily 
drug dose of 2.27 mg/lb7 (500 lb sow with 5 gal per day 
intake). Total combined dosage is estimated to be ~3.27 
mg/lb which is estimated to provide tiamulin activity of 
>2 mg/g in the colon contents (Keith Erlandson, personal 
communication, June  2012). (Tables 2 and 3)
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7. Anderson, M.D.; Stroh, S.L.; Roger, S. 1994. Tiamulin 
(“Denagard”) in certain swine tissues following oral and intra-
muscular administration. Proc. Ann. Mtg. American Association 
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Table 2: MIC for Brachyspira hyodysenteriae and  spp.
Tiamulin MIC (µg/ml) Carbadox MIC (µg/ml)
B. hyodysenteriae (n = 24) Median 0.125 0.015
Mode 0.125 0.015
MIC90 0.5 0.03
Range 0.125 - 4 0.008 - 0.06
B. spp. (n=11) Median 1 0.008
Mode 1 0.015
MIC90 2 0.015
Range 0.125 - 4 0.004 - 0.03
Clothier K. 2011. J VET Diagn Invest. 23: 1140.
Table 3: Tiamulin  activity
Tiamulin activity, mg/g
Treatment group
Calculated  
daily drug 
dose,  mg/lb
Lung Tonsil Colon 
mucosa
Colon 
contents
I.  Feed medication (THF)
35 g/ton .9 a a a a
105 g/ton 3.0 1.46 (1) a a 2.84 (4)
200 g/ton 6.2 1.99 (3) a 1.57 (1) 8.05 (5)
II.  Water medication (THF)
60 mg/L 2.8 1.11 (1) a a 2.16 (2)
120 mg/L 6.0 4.26 (5) a 1.56 (3) 5.59 (5)
180 mg/L 9.5 8.50 (5) 2.50 (1) 3.39 (4) 18.58 (4)
Limit of quantitation (LOQ) 0.94 2.31 0.92 1.62
a   Below the Limit of Quantitation. Anderson, M.D. 1994.  AASP Annual Meeting. p. 115-117.
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Methodology to investigating CNS disease in pigs  
 post-weaning
Amber Stricker MS,  DVM
Suidae Health and  Production
Introduction
Central nervous system signs in nursery pigs are not 
uncommon and it doesn’t take long for someone new to 
the hog industry to experience their first “paddling pig” 
when frequenting young pigs. Often times this scenario is 
described as a ‘Strep’ pig and treatment with an antibiotic 
such as penicillin is successful. However, this scenario 
may not always be quite so simple and may require ad-
ditional intervention. What steps should be taken when 
investigating central nervous system signs in nursery pigs? 
What differentials should be considered? The discussion 
below outlines a practitioner’s methodology to diagnosing 
central nervous system disease in young growing  pigs.
Interviewing the eyewitness
The caretaker involved with the day to day care of the 
pigs can provide a great deal of insight when investigating 
disease events in a population of pigs. When a veterinar-
ian arrives on a sick call it is a point in time observation 
that may or may not be an accurate portrayal of what has 
been going on. Involving them in the investigation is key 
to understanding the big picture and will enhance the abil-
ity of the veterinarian to arrive at the correct  diagnosis.
Gathering  evidence
The next step in the investigation is to review pertinent 
records that may help to further narrow the scope of dif-
ferentials. Looking at mortality records and noting how 
many animals have died in the past 7 days is useful. Also 
it is helpful to know whether or not these pigs are sudden 
death pigs or chronic pigs. Records should also be avail-
able for treatments that have been occurring and should 
indicate how many pigs have been treated per day, with 
what, and how  much.
Observing the  scene
Quietly opening the door and observing the pigs in their 
environment will give clues as to whether or the pigs 
are comfortable in their environment. Next, physically 
entering the pens and walking through the pigs is essen-
tial to get a true picture of the condition of the pigs. Pigs 
displaying neurological signs should be observed closely 
for ataxia, head tilt and circling. Get all of the pigs up 
and observe them for tear staining, nasal secretions, skin 
lesions, lameness and activity level. Completely evaluate 
the entire population before coming to a conclusion on 
the diagnosis. Make a mental note of how many pigs are 
visually ill and estimate the percent of the population that 
is affected. Begin forming a list of  differentials.
Necropsy any dead pigs that are present and note gross 
lesions. If the diagnosis is still unclear euthanize 2-3 acute 
pigs for submission to the diagnostic  lab.
Developing a key suspect  list
Differentials vary depending on the distribution of disease. 
Primary differentials for diagnosing neurological signs 
affecting populations of pigs should  include:
• Infectious  causes
▶ Bacterial meningitis-commonly caused by Strep. 
 suis
▶ Edema disease caused by various types of  E.coli
▶ Meningoencephalitis caused by Haemophilus 
 parasuis
• Non infectious  causes:
▶ Salt poisoning (water  deprivation)
▶ Toxicities (i.e. organophosphates,  ionophores)
▶ Nutritional deficiencies (i.e. vitamin  A)
Other differentials exist but should be considered after 
ruling out the primary infectious  causes.
Gathering  samples
Necropsy of recent mortalities may be helpful when 
evaluating gross lesions but are not ideal for tissue submis-
sion due to level of autolysis that has likely taken place. 
When choosing pigs to sample it is important to choose 
at least 2-3 acutely affected pigs that are representative of 
the population. Euthanasia method should be taken into 
consideration and if possible done in a way that preserves 
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the brain from damage. A set of fresh and fixed tissues 
should be taken and should include a full sampling of 
both thoracic and abdominal tissues (lung, heart, lymph 
nodes, liver, spleen, kidney, small intestine, colon, and 
brain). Tissues should be placed on ice and fixed with 10% 
formalin as soon as possible to prevent further autolysis. 
Swabbing the lateral cerebral hemispheres and other parts 
of the brain may also be warranted in cases where bacterial 
meningitis is  suspected.
Treatments
Treatment for central nervous system disease in pigs 
should not only involve antibiotic use but should also in-
clude management related interventions such as reviewing 
ventilation and stocking density of the barn. Overcrowding 
and poor ventilation including high humidity, can lead to 
increased incidence of bacterial  meningitis.1
In infectious cases, antibiotic choices should include those 
antibiotics that are capable of crossing the blood brain 
barrier and may include an anti-inflammatory drug such 
as Predef. Common injectables, specifically for treatment 
of Strep. meningitis in post-weaning pigs, should include 
penicillin or cephalosporins. Oral antibiotic choices in-
clude a combination of chlorotetracycline and tiamulin.. 
Successful outcomes using potassium penicillin G via 
the water to treat Strep. suis have also been documented.2 
However, an effort should be made to obtain a sensitivity 
specific to the isolate obtained from the farm of  origin.
Case  1
A nursery located in MN was placing approximately 2000 
PRRS positive pigs every 9 weeks at a rate of 500 pigs per 
week. The pigs ranged in age from 17-21 days and were 
placed by delivery in 4 rooms housing 500 head  each.
At 10-14 days post-placement the grower would start to 
notice pigs displaying signs of ataxia with some progress-
ing to lateral recumbency and paddling movements of 
the front and rear limbs. Pigs in the affected room would 
rapidly deteriorate and sometimes as many as 25% of the 
pigs would be showing the clinical signs described includ-
ing head pressing and chomping at the mouth. Mortality 
rates were as high as 25% on a per room  basis.
Diagnostics revealed a highly resistant pathogenic he-
molytic E.coli. Genotyping revealed the presence of the 
StX2e toxin and F18 pilus. A combination of injectable 
and oral antibiotics was attempted with marginal response. 
This disease process was highly predictable and occurred 
at various severity levels for over a year despite numerous 
and extensive interventions. Interventions included venti-
lation adjustments, gating modifications, well treatments, 
downtime, oral inoculants etc. however clinical signs 
continued. The final intervention was to seal the concrete 
floors with two coats of a concrete sealer after which the 
E.coli related death loss  stopped.
Case  2
2400 PRRS negative pigs were being placed into a continu-
ous flow nursery site in MN every other week. Around 
4-7 days post-placement the caretaker reported finding 
several good pigs found dead and numerous others down 
and paddling. Death loss quickly approached 1% within 
3 days. Oral antibiotic intervention using a combination 
of chlorotetracycline and tiamulin was implemented to 
address the current disease issue and tissues were sent off. 
Diagnostics confirmed meningitis and septicemia due to 
Strep. suis serotype  1.
The following groups placed on feed also showed similar 
clinical signs so a decision was made to implement an 
autogenous bacterin on the pigs at the sow farm as well 
as to treat the pigs with ceftiofur upon  weaning.
References
1. Straw et. al. Disease of Swine 9th Edition. 2006. Blackwell 
Publishing, Ames,  IA.
2. Byra C, Gadbois P, Cox WR, Gottschalk M, Farzan V, 
Bauer SA, Wilson JB. Decreased mortality of weaned pigs with 
Streptococcus suis with the use of in-water potassium penicillin 
G. Can Vet J. 2011 Mar;  52(3):272–6.
2013 Allen D. Leman Swine Conference 41
D
is
ea
se
 C
as
es
D
isease Cases
CNS disease  diagnostics
Darin Madson
Iowa State  University
Introduction
Central nervous system (CNS) disease or like diseases 
can be frustrating circumstances in growing pigs, even if 
there are only a few animals affected. The challenges we 
as swine veterinarians face is accurately diagnosing these 
issues, mitigating, and then preventing future problems. 
The intent of presentation/proceedings to provide guid-
ance, understanding, and sample collection tips for CNS 
disease scenarios or disease presentations that may arise 
in nursery aged  pigs.
Disease diagnosis is different for each of us. It basically 
comes down to how each of us thinks followed by incor-
porating previous experiences. What you see, determine, 
or link together with a thorough investigation in the clini-
cal setting will hone in your diagnostics skills when it 
comes to particular pathogens or syndromes, but this will 
also guide proper sample submissions when CNS disease 
problems are not so clear cut from the  normal.
Bear in mind that not every condition with perceived 
neurological signs is infectious or is even related to the 
central nervous system. Too often we as veterinarians 
make broad assumptions on the cause of disease. There 
is nothing wrong with this. Experience usually lends our 
differentials to be true. However, not understanding poten-
tial differential will hinder finding the actually etiologic 
cause of the clinical  syndrome.
Oh, where to begin? Well, how about on a complete clinical 
examine of those pigs displaying signs of disease. Neurol-
ogy was maybe not your favorite during veterinary school, 
but that does not mean that we should forget about proper 
procedure. An exam can localize the issue or possibly 
disprove CNS involvement all together. Some clinical 
examples would include proprioceptive defects, varied 
coordinated movement, posture and mentation. A second 
key aspect of an investigation is gathering a detailed his-
tory including recent procedures such as vaccinations, feed 
changes, or mechanical issue within the facility affecting 
air, feed or  water.
Before we start listing conditions, a mini review of basic 
neurology may help. The cerebrum is responsible for 
behavior, voluntary movement and consciousness; it is 
the hub for normal thought. “Down paddling” and nys-
tagmus is a loss of voluntary movement of the limbs and 
ocular muscles and therefore would indicate cerebrum 
involvement. This is most commonly in the form a bacte-
rial meningitis, but viruses and toxins (i.e. salt), can also 
result in this clinical presentation. Seizures, tremors, and 
hyperesthesia are other clinical signs that would indicate 
the cerebrum is involved. If normal or perceived normal 
mention is apparent, the cerebrum is likely not  affected.
The cerebellum is responsible for coordinated movement, 
balance, and posture. Ataxia, proprioceptive deficits, and 
incoordination are typically present with defects in the 
cerebellum. However, spinal cord issues can also present 
with similar clinical problems as seen in with cerebellar 
disease, and can also include muscle rigidity or flaccidity. 
Table 1 summarizes clinical signs that can be seen with 
different segments of the  CNS.
I hope that you are not confused yet because we also have 
to rule out cardiovascular, muscle, bone and joint lesions 
that may appear as “CNS signs.” This is where your “rou-
tine” necropsy is important; don’t just drill down on CNS 
tissue for sample submission! Pain associated with trauma, 
broken or weak bones, or inflammation within the axial 
skeleton can cause incoordination, proprioceptive deficits, 
or recumbency. However, the pig’s awareness/mentation is 
typically not altered. Cardiovascular problems resulting in 
tissue hypoxia may also mimic CNS disease syndromes 
in certain  scenarios.
CNS  differentials
Swine medicine is population medicine at its finest. With 
that said, we are typically dealing with infectious patho-
gens when CNS disease issues within the nursery phase 
of production occur. This does not exclude metabolic 
conditions, toxin issues, or traumatic problems as the 
cause of clinical CNS disease. Below is a list of common 
differentials for CNS like diseases in nursery aged pigs. 
This list is not complete, but captures the vast majority 
of cases that are typically seen at diagnostic  laboratories.
1. Bacterial septicemia: Streptococcus suis,  
Haemophilus parasuis and Mycoplasma  hyorhinis
•	 Lesion: Meningitis, but otitis is  possible
•	 Clinical sign: Nystagmus, “down paddling,” head 
tilt, and  circling
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2. Viral diseases: Porcine Reproductive and respira-
tory syndrome virus, porcine circovirus type 2, and 
enteroviruses  (Teschoviruses)
• Lesion: Encephalitis or meningoencephalitis, 
typically perivascular. Lesions associated with 
teschoviruses are in the  brainstem
• Clinical sign: Dulled mentation, seizures, incoor-
dination, ataxia, recumbency and proprioceptive 
deficits. Knuckling-over and/or posterior paresis 
more common with Teschovirus  infection.
3. Toxin: Stx2e toxin (edema  disease)
• Lesion: Perivascular edema and neuronal necro-
sis. Lesions typically start within the brainstem, 
but cerebellar inflammation and edema is can 
also be present. Gastric and mesocolonic edema 
is sometimes  viewed.
• Clinical sign: Sudden death, eyelid edema, and 
diarrhea. Diarrhea is not a prerequisite for edema 
 disease
4. Nutritional: Water deprivation (salt toxicosis), 
Vitamin A toxicity or deficiency, Vitamin D and/or 
calcium deficiency, and tremorgenic  mycotoxins
• Lesion: Water deprivation is associated with 
eosinophilic perivascular encephalitis. Lesions 
associated with other nutritional issues are often 
not  apparent.
• Clinical sign: Dulled mentation, seizures, incoor-
dination, ataxia, recumbency and proprioceptive 
 deficits
5. Trauma: Improper vaccination technique and bro-
ken  bones
• Lesion: Dependent on the type of  insult
• Clinical sign: Ataxia, paresis and prolonged 
recumbency are  typical
Diagnostic  sampling
The old adage is collect samples from “acutely affected 
and non-treated” animals exhibiting clinical signs that 
predominate within the population. This is still true in 
CNS disease scenarios. It also advised to submit animals 
in the subacute stage as some lesions, both gross and 
microscopic, are not always apparent in the acute cases. 
Your routine, complete, and clean necropsy technique, ex-
amining all organ systems will assure a proper diagnosis. 
Don’t just focus on animal tissues is another important 
piece of advice, feed could be the issue as  well.
The below list is a guide to proper sampling when work-
ing up CNS  cases.
• Serum and whole blood from affected and non-
affected  pigs
▶ Reason: Serum can be useful for analyte evalu-
ation (sodium, calcium, etc), agent and antibody 
detection. Whole blood may be useful to deter-
mine if the process is infectious (white blood cell 
count) or if toxins are a  concern.
• Brain: Fresh and formalin fixed cerebrum, cerebel-
lum, and brainstem (PLEASE collect all, not just 
 cerebrum)
Table 1: Central nervous system clinical signs and insult  location
Location Clinical signs
Cerebrum
Altered mention, decreased awareness
Loss of consciousness
Loss of voluntary movement (nystagmus)
Seizures
Tremors
Cerebellum
Ataxia
Proprioceptive deficits
Incoordination
Spinal cord
Ataxia
Proprioceptive deficits, knuckling 
Incoordination
Rigidity 
Flaccidity
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▶ Advice: Please try not to use captive bolt or blunt 
force trauma euthanasia methods in pigs being 
evaluated for CNS  disease.
▶ Advice: Swab the brainstem prior to brain extrac-
tion for a “clean” bacteriology sample. Sending a 
fresh chilled intact head is better than not submit-
ting brain at  all
▶ Advice: Split brain longitudinally, putting the 
“best half” in formalin. Don’t cut into little 
pieces. “Bread-loafing” is  encouraged
▶ Advice: Collect proximal cervical cord as  possible
• Spinal cord: Fresh and formalin fixed 1” segments 
of cervical, thoracic, and lumbar  cord
▶ Reason: Pieces of spinal cord can be invalu-
able for diagnosis and it doesn’t need to be hard. 
Remove with a Barnes dehorner, cleaver, or saw. 
Sending intact vertebrae with the spinal cord 
inside is better than no spinal cord at  all
• Muscle and Heart: fresh and  fixed
▶ Reason: To rule out toxins or other diseases such 
as mulberry heart disease that may mimic CNS 
clinical  signs.
• Bone and  joints
▶ Advice: Routinely break ribs for bone strength; 
vitamin D, calcium or phosphorus issues. If weak 
or questionable, Collect rib bone which includes 
the costochondral  junction.
▶ Advice: Sample joint fluid, then open them (ver-
sus contaminating them first) by removing the 
overlying skin and using a syringe and  needle
▶ Advice: Open multiple joints, examine, and col-
lect synovium. Submitting intact, chilled joints is 
an  alternative.
• A complete set of tissue; other  organs
▶ Reason: Add strength to the diagnosis and rule 
in/or out other  issues
▶ Reason: Need intestine to confirm Escherichia 
coli isolation and genotyping (edema  disease)
• Feed and  water
▶ Reason: You are there, why not collect? It doesn’t 
cost anything to  collect
Diagnostic  testing
Diagnostic testing can be expensive with CNS like dis-
ease scenarios. The reasoning being there are numerous 
differentials to potentially rule out and there is not always 
a “PCR” for what we are trying to diagnose! Some testing 
modalities, especially when investing nutritional reasons, 
are not always clear cut with a yes or no answer either. An 
important aspect to bear in mind is that sample submission 
will drive testing; meaning that if the appropriate sample 
is not received, then the test will not be selected or run. 
Teschovirus testing is a prime example of this potential is-
sue. If the brainstem or cervical spinal cord is not received, 
the likelihood of diagnosing this pathogen as the etiologic 
agent involved in the clinical picture is almost  none.
At diagnostic laboratories, testing is highly driven off the 
clinical history. Yes, that means what you write on the 
submission form is important! This helps the diagnosti-
cian! Please be more specific that “CNS signs”. Take a 
moment and write something smart on the paper; if that 
is not an option,  call.
“Routine” testing of CNS disease in the nursery pig gener-
ally involves bacterial culture of the brain, small intestine, 
and other major organs, and combining these finding with 
microscopic lesions that would be compatible with bacte-
rial septicemia or edema disease. Microscopic evaluation 
would then potentially lend to further testing based on 
the findings. Examples include Teschovirus testing in the 
case of brainstem changes or vitamin D if bone lesions 
are viewed at the costochondral  junction.
On occasion there are cases that do not align; meaning 
testing may be negative but there are microscopic lesions 
indicating a particular etiology or vice versa. In these 
events, further submission is recommended, but ultimately 
the “diagnosis” is made by you incorporating all pieces 
of the  puzzle.
Take home  points
1. Diagnosis of “CNS signs” is multifaceted as differ-
entials can be vast for nursery-aged pigs and begins 
with a complete clinical examination. Clinical ex-
amination will aid in localizing a potentially insults 
or rule in/out other organ system  involvement.
2. CNS disease syndromes or like diseases require 
submission of multiple tissues including cerebrum, 
cerebellum, brainstem, and spinal cord to arrive 
at an accurate diagnosis. Sample collection meth-
ods and cleanliness add strength to the diagnostic 
 findings.
3. Diagnostic testing is driven by sample submission 
and reported clinical signs; Arriving to the correct 
etiology is based upon testing the appropriate tis-
sue or sample and combing these with the clinical 
 findings.
44 2013 Allen D. Leman Swine Conference
D
is
ea
se
 C
as
es
D
isease Cases
Darin Madson
2013 Allen D. Leman Swine Conference 45
D
is
ea
se
 C
as
es
D
isease Cases
Blood-brain barrier basics: A selective passageway for 
bacterial pathogens and antimicrobial  drugs
David R. Brown, PhD
Department of Veterinary and Biomedical Sciences, University of Minnesota College of Veterinary 
Medicine, St. Paul, Minnesota
Meningitis is a serious complication of Streptococcus 
suis bacteremia in young piglets. This microorganism is 
also an emerging human pathogen that has been recently 
implicated in a case of meningitis in a swine handler 
(Wertheim et al., 2009; Fowler et al., 2013). In order to 
access and infect the brain meninges, blood-borne S. suis 
must penetrate the blood-brain barrier of affected animals 
or humans. The purpose of this article is to briefly review 
some key aspects of the locations and protective functions 
of this important physical barrier in swine and other ani-
mals and summarize our current understanding of how 
S. suis breaches this  barrier.
There is more than one “blood-brain 
 barrier”
The blood-brain barrier plays several key roles in central 
nervous system (CNS) homeostasis in that it hinders the 
entry of microorganisms and potentially neuroactive or 
toxic substances into the brain, maintains concentrations 
of proteins and ions at levels optimal for neural activity, 
and orchestrates immune responses that incur a minimum 
of inflammation and cellular damage (that would disrupt 
barrier function, see below). There are in reality, three 
major barriers within the CNS, which include (1) the en-
dothelial cells lining continuous capillaries supplying the 
brain parenchyma, which encompasses the largest surface 
area for barrier function; (2) a less extensive blood-cere-
brospinal fluid (CSF) barrier consisting of CSF-secreting 
choroid plexus epithelial cells lying in close proximity to 
fenestrated capillaries; and (3) an arachnoid epithelium 
within the meninges (Saunders et al., 2012; Abbott, 2013). 
The microvascular endothelial cells of brain capillaries 
interact with closely apposed pericytes, and adjacent neu-
rons, astrocytes and microglia (the “macrophages of the 
brain”) to form a so-called neurovascular unit (Iadecola, 
2004). These cells act in a concerted manner to maintain 
barrier function. Compared with these three regions, the 
circumventricular organs possess a “leakier” barrier com-
posed of ventricular ependymal cells. This more permeant 
cellular structure permits brain chemosensors to monitor 
and respond appropriately to changes in serum osmolality 
or the presence of blood-borne  toxicants.
Tight junction and adherens junction 
proteins are the main contributors to 
blood-brain barrier  integrity
Brain microvascular endothelial cells (BMECs) and epi-
thelial cells of the choroid plexus and meninges are held 
together by a complex array of specialized membrane 
proteins to form tight junctions. Claudin-5, occludin, 
junctional adherens molecules (JAMs) and zona oc-
cludens adapter proteins are proteins in tight junctional 
complexes that are commonly expressed in BMECs and 
choroid plexus epithelial cells (CPECs) from pigs (Malina 
et al., 2009; Schroten et al., 2012). These tight junctions 
physically exclude proteins and other macromolecules as 
well as microbes present in the brain blood supply. Even 
blood-borne molecules that are essential for brain func-
tion are generally excluded by these intercellular junctions 
and normally cannot cross the barrier through a paracel-
lular pathway. Instead, these substances move across the 
blood-brain interface by means of selective carrier proteins 
(e.g. ion and water channels, glucose and amino acid 
transporters, transferrin receptors, efflux pumps). Many 
inflammatory, immune and neuroactive substances can 
regulate blood-brain barrier permeability (Liu et al., 2012). 
For example tumor necrosis factor-α, a pro-inflammatory 
cytokine, has been reported to increase paracellular per-
meability to both small and large molecules in neonatal 
pigs (Megyeri et al., 1992; Abraham et al., 1996). On 
the other hand, transforming growth factor-β, which is 
secreted by astrocytes and pericytes present in the neuro-
vascular unit, decreases blood-brain barrier permeability 
by increasing tight junction protein gene expression in 
BMECs (Takeshita and Ransohoff,  2012).
Streptococcus suis breaches blood-brain 
and blood-CSF  barriers
Streptococcus suis appears to migrate across the blood-
brain and blood-CSF barriers of piglets after adhering 
to and invading BMECs and CPECs respectively. This 
process appears to involve several Streptococcal proteins, 
including adhesins, invasins and cell wall components as 
well as bacterial interactions with serum components such 
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as fibronectin (Fittipaldi et al., 2012). The Streptococcal 
exotoxin suilysin may disrupt barrier function through 
cytotoxic effects on endothelial and epithelial cells, but 
it is not required for invasion. Capsular polysaccharide, 
which is otherwise considered a major virulence factor 
for this bacterium, may actually reduce S. suis invasion 
in BMECs and CPECs by covering up cell wall adhesins 
(Vanier et al., 2007,  2009a).
Interactions between Streptococcus suis serotype 2 and 
cultured porcine CPEC monolayers in a Transwell system 
have been the subject of recent investigations (Tenenbaum 
et al., 2009; Schroten et al., 2012). These have revealed 
that S. suis shuttles across the choroid plexus epithelium 
and enters the CSF in a polarized fashion. Bacteria cross 
the basolateral membranes of epithelial cells, are enclosed 
in endocytic vacuoles and trafficked to the apical mem-
brane, and the cocci are subsequently released intact into 
the CSF via exocytosis. This process, which involves 
virulence factors and direct bacterial-epithelial contacts, 
disrupts blood-CSF barrier function and enhances the 
entry of additional bacteria and white blood cells into the 
CSF (Fittipaldi et al., 2012). Administration of an anti-
inflammatory glucocorticoid (dexamethasone) inhibits S. 
suis-induced alterations in tight junction re-organization 
and breakdown in CPECs (Tenenbaum et al., 2008). 
Although the mechanistic aspects of S. suis migration 
across BMECs are less well-defined, it is known that this 
organism can reside within porcine BMECs for up to 7 
hours (Vanier et al.,  2004).
Host cells residing in the blood-brain 
barrier can detect and respond to 
pathogen  attack
Cells comprising the neurovascular unit that participate in 
first line defense against pathogenic microbes must have 
the ability to recognize conserved, pathogen-associated 
molecular patterns, such as the presence of lipopolysac-
charide or lipopeptides on bacterial surfaces. BMECs and 
neighboring cells express a number of pathogen recogni-
tion receptors, including Toll- and NOD-like receptors, 
and virus-detecting RIG helicases (Kristensson, 2011; 
van Sorge and Doran, 2012; Lampron et al., 2013). Strep-
tococcal cell wall components can activate these recep-
tors in BMECs and CPECs to produce pro-inflammatory 
responses, which can potentially degrade barrier function 
if unchecked (Schwerk et al., 2011; Fittipaldi et al. 2012). 
Inflammatory mediators, including cytokines, chemokines 
and arachidonic acid metabolites, facilitate the attachment 
of leukocytes to the basement membranes of BMECs and, 
by loosening tight junctions, allow the paracellular trans-
migration of these immunocytes into the CNS (Lampron 
et al., 2013). Neutrophils appear to move directly through 
porcine CPECs in response to inflammatory mediators 
formed during S. suis infection (Wewer et al., 2011). 
Streptococci can degrade the chemokine interleukin 8 
generated by porcine BMECs and thereby slow the ap-
pearance of neutrophils at sites of infection (Vanier et al., 
2009b). On the other hand, exposure of porcine CPECs 
to the inflammatory cytokine interferon-g increases the 
activity of epithelial indolamine dioxygenase, an enzyme 
that degrades tryptophan necessary for S. suis growth. 
CPECs can thus have a bacteriostatic effect on this organ-
ism (Adam et al.,  2004).
Drugs, including antimicrobials, and even 
large proteins can cross the blood-CSF 
barrier, especially in young  piglets
Although the blood-brain barrier function of BMECs and 
the overall neurovascular unit appears does not appear 
to mature with age, the blood-CSF barrier of neonates is 
generally more permeable than that of adults (Saunders et 
al., 2012). Relatively large proteins such as IgG from co-
lostrum or bilirubin can enter the CSF in suckling piglets 
(Lee et al., 1995; Harada et al., 2002). This barrier may 
be particularly vulnerable to S. suis infection in neonatal 
swine. However, it may likewise be more permeable to 
antimicrobial drugs, such as β-lactam antibiotics that are 
routinely used to treat Streptococcal infections in swine 
and humans and to which microbial resistance is currently 
low (Nau et al., 2010; Varela et al., 2013). Meningitis is as-
sociated with increased permeability to hydrophilic drugs 
(e.g. penicillin) that normally penetrate the blood-brain 
barrier poorly (Lutsar et al., 1998). Drug accumulation 
in the CSF to concentrations effective in arresting Strep-
tococcal meningeal infections may even be enhanced, 
based on studies in neonatal rodents reporting a reduced 
expression of drug efflux pumps such as P-glycoprotein 
(Tsai et al.,  2002).
Summary
Work with porcine experimental models, including BMEC 
and CPEC cell lines from swine, has provided significant 
insights into the mechanisms by which Streptococci inter-
act with cells of the blood-brain and blood-CSF barriers 
to produce meningitis in piglets. Many questions remain 
to be addressed, however. These include the following. 
What is the role of the blood-arachnoid barrier in Strep-
tococcal meningitis? What factors affect the achievement 
of effective antibacterial drug concentrations in the CSF 
of piglets? Can effective S. suis vaccine be produced? As 
S. suis has recently been recognized to be an emerging 
human pathogen, it is expected that this avenue of research 
with swine-based models will continue to yield new 
knowledge of benefit to both piglets and  people.
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Diagnostic  considerations
James A. Kober, DVM, MS, Diplomate  ABVP-SHM
Swine Veterinary Services of MI, LLC; 4 Star Veterinary  Services
How much should we spend on diagnostic examinations? 
This is a question that veterinarians and producers con-
tinue to struggle with. There are a number of questions 
that must be considered when making this decision. The 
most common question from producers is how much is the 
testing going to cost. Obviously this will depend on what 
tests are going to be requested. This is often decided by the 
veterinarian with some input from the producer. Occasional 
submissions are left to the “discretion of the pathologist”, 
but hopefully these are minimal. Testing “all tissues for 
everything” is not a sound financial diagnostic  plan.
The decision to conduct diagnostics will vary depending 
on the type of  producer:
Integrator:  budgeted
Managed herd:  budgeted
Large independent herd: as needed or budgeted. (May 
not be budgeted but it seems they know when they have 
spent too  much)
Small independent herd: as needed. Veterinary discretion 
if it is needed and/or what tests are  needed.
Backyard herds/ secondary income: as needed or “do it 
all”. (Profit/cost is not  considered)
Show pig: 4H vs. professional. (Cost may or may not be 
 considered)
For the past year (June 1, 2012 to June 1, 2013), the 4 
Star group submitted 308 tissue cases to the Iowa State 
University Veterinary Diagnostic lab. The total cost was 
$56,020 or $182 per case. For the sake of discussion, we 
will use $182 as an average cost for tissue diagnostics for 
the rest of this  article.
Diagnostic testing is divided into two broad categories: 
diagnosing the cause of sick pigs and disease  surveillance.
Let’s talk about diagnosing the cause of sick pigs  first.
A vast majority of the tissue cases submitted by the 4 
Star group were to diagnose the cause of sick pigs. Why? 
Because tissue submissions are not a cost effective plan 
for surveillance. It is not practical to submit tissues from 
enough pigs in a group or from a farm to make the find-
ings  significant.
It seems like an easy decision to spend money on diag-
nostics when pigs are sick. But even then, some producers 
are slow to make the call. As Dr. Tokach has pointed out 
some will call with the first sneeze and it’s difficult to see 
the problem, while others will not call until 15% are dead 
and “maybe you should come out when you get a  chance”.
As farms have evolved, many submit their own tissues 
and the veterinarian does know until the lab report. Then 
veterinarians may not even know the history or clinical 
signs. This may be the only contact veterinarians has with 
small  farms
It is nice to have a budget for diagnostics. It is difficult to 
know how much to set aside for diagnostics. Use previous 
year’s expenses at a guide? And how do you budget for 
new agents that show up in the industry? For  example:
In the late 80’s, there were no tests for mystery swine 
disease. MSD turned into PRRS and diagnostic tests were 
developed. Now a large portion of diagnostic testing on 
any farm is for  PRRS.
SIV is another example. Before 1998, there was only 
H1N1. Then H3N2 came into the picture. The next 10 
years saw an increase in testing sorting the new strain 
and other new strains out. Recently pandemic H1N1 and 
variant H3N2 have become prevalent and now take up 
portions of the diagnostic  budget.
Other examples include PCV2, Brachyospira and most 
recently PED. A few years ago these things were not tested 
for all. Now they are taking up a significant portion of the 
diagnostic  budget.
If we discover that the “post weaning failure to thrive” 
syndrome has an infectious cause, you will likely see a 
spike in diagnostics for that particular  agent.
Finally, FAD testing is not in anyone’s budget. If a FAD 
shows up in the USA, testing will exceed most diagnostic 
 budgets.
Surveillance testing is the other broad category for diag-
nostic  testing.It is important to be looking for something 
or to be answering a question. “Monitoring for the sake 
of doing something does not justify itself in all but the 
highest health  system.”
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For example, the testing a breeding herd pyramid is look-
ing for positives vs. negatives. In this case it is vitally 
important to understand the sensitivity and specificity of 
the particular test you are conducting. What is the rate of 
false positives vs. negatives? Will the results create more 
questions than  answers?
Looking back, the old SPF system looked at very few 
animals (10 sets of lungs per quarter) to determine My-
coplasma hyopneumoniae status of enrolled herds. This 
worked to a certain extent because most of these farms 
were small, one site, continuous flow farms. The theory 
was that if Mycoplasma was on the farm, at least one of 
these sets of lungs would show lesions. The big problem 
with this system was that if a herd failed, they would just 
continue to look at sets of 10 lungs until they all passed, 
then they kept their SPF  status.
Most commercial herds will be looking for infection levels 
or percentage positive vs. negative for a specific agent. 
In other words, may be trying to determine stability of 
a herd or if a herd is shedding a particular agent. They 
may also be checking for exposure to an agent after an 
intentional  exposure.
One thing that has come about with the PRRS area regional 
control projects is the concept of conducting surveillance 
across a wide geographical area instead of one farm. Is the 
area positive for PRRS? If yes, what strain? In the West 
Michigan ARC, we tested the entire area three times or 
every other year. We tracked results on a spreadsheet and 
created a dendogram for the area and even divided by 
year. We learned that the strains we had in our area did 
not change much over the six years (so far) of the project. 
With good communication, we would learn quickly if 
there was sick pigs in the area. We would then try to test 
in front of the outbreak and to warn producers downwind 
that something may be headed their  way.
This is a good time to talk about the diagnostic laboratory’s 
work. A few years ago, we were requesting IFA’s, SN’s, 
CF’s, and virus isolation. Many of those tests lacked good 
specificity or sensitivity. Now we have Immuo-histochem-
istry, PCR’s, and sequencing. PCR testing has become the 
most requested test at the ISU veterinary diagnostic lab. 
In the case of a new agent (PED for example), the first 
thing the laboratory network does is develop a PCR test. 
Producers can quickly determine if they have the agent or 
not, without waiting several days or weeks to  see.
The most significant change in the field of diagnostics 
and surveillance is oral fluid testing. Oral fluid testing has 
changed how samples are taken on the farm. Oral fluid 
or rope testing has several advantages including the fact 
it is easy and fast to collect, more animals can be tested 
per sample than serum, the sample can be tested by PCR 
as well as for antibodies (the sample can be used for di-
agnostic and surveillance purposes), and one sample can 
be used for multiple agents. Multiple studies have shown 
that oral fluid testing is as accurate as serum testing and 
can accurately show if and when a barn is exposed to a 
particular agent. This is amazing technology and I can’t 
wait to see what tests are developed for this technology 
in the  future.
As our industry continues to evolve, we undoubtedly will 
continue to conduct diagnostics for sick pigs and surveil-
lance to monitor exposure and disease levels. The tests 
we conduct will change as the older and better controlled 
diseases fade away and new agents show up. I trust our 
diagnostic labs will develop new testing methods and fine 
tune existing tests. The goal will be to use more sophisti-
cated surveillance tests to head off sick pigs and the need 
to true diagnostic  tests.
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Mycoplasma infection costs in a naïve swine  population
Tom Gillespie, DVM, Diplomate,  ABVP
Rensselaer Swine Services, Rensselaer, Indiana
Introduction
Mycoplasma hyopneumoniae (M hyo) remains a ubiqui-
tous pathogen in the worldwide swine population; espe-
cially in countries with a major swine industry.1 This paper 
estimates the economic effects of reduced performance 
due to M hyo infection in a naïve commercial grow/finish 
flow in the United  States.
Materials and  methods
A 2200 sow, M hyo naïve farrow to finish operation located 
in the eastern corn belt of the United States was diagnosed 
with M hyo in March 2010. Individual PCR’s performed on 
the nasal swabs for Mycoplasma hyopneumoniae; PRRSV 
and SIV were used to determine positive results for M hyo 
and negative results for SIV and PRRS  virus.
Production records were evaluated comparing performance 
prior to and after the M hyo break. Parameters included 
average daily gain (ADG) and feed efficiency (FE), and 
the economic value for extra days on feed (overhead  cost).
Economic analysis was made with the following evalua-
tion assumptions: average feed cost of USD $239.42/ MT; 
average market animal revenue of USD $130.00; overhead 
cost of days on feed of USD $0.10 per day and a main-
tenance cost for feed due to more days on feed of USD 
$2.49 kg per day. The average initial weight at placement 
was 22.7 kg and average market weight was 115.7 kg. For 
the three parameters measured, the data were normally 
distributed. Student’s T-test was used for the analysis and 
results considered significant if  P = 0.05.
Results
The M hyo outbreak significantly impacted ADG 
(P = 0.021). Average daily feed intake (P = 0.74) and FE 
(P = 0.07) was not numerically improved, but failed to 
reach significance based on the a set. (Table  1).
The economic analysis revealed a combined loss of 
USD$7.92 per market animal in the outbreak phase. 
The majority of the cost impact was due to slower gains 
(7.2 days longer to market weight). Treatment costs, mor-
tality rate and culls were not included in this  study.
Conclusions and  discussion
M hyo and the pneumonia associated with an infection 
remains a concern to the swine industry throughout the 
world. The clinical signs associated with a naïve popula-
tion infected with M hyo are expressed as a respiratory 
challenge. The clinical signs include but are not limited 
to coughing, gaunt appearance, fever, labored breath-
ing and an increase in mortality if timely treatments are 
not preformed.1,2 Co-infections with other primary and 
secondary pathogens will complicate the diagnosis and 
increase costs associated with  treatments.
In this M hyo and PRRS virus naïve production system, 
an acute outbreak occurred in March 2010 and was clini-
cally expressed as respiratory disease in the finishing age 
animals with reduced growth performance. Even though 
antibiotic therapies (using both individual animal and 
mass treatments) were utilized to control mortality and 
reduced under-valued animals at market time there still 
was a significant decrease in growth. This paper illustrates 
what a worldwide distributed pathogen costs when an 
infection occurs in a naïve swine population. Biosecurity 
programs can use this economic data to show why the 
effort is needed to limit entry of a major pathogen like 
M hyo. Calculations of how costs were evaluated will be 
discussed and illustrated during the  presentation.
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Table 1: Mean performance parameters pre and post 
M hyo  outbreak.
ADG FCR ADFI
Naive period 1.99a 2.58 5.11
Post-infection 1.86b 2.71 5.05
52 2013 Allen D. Leman Swine Conference
D
is
ea
se
 C
as
es
D
isease Cases
2013 Allen D. Leman Swine Conference 53
D
is
ea
se
 C
as
es
D
isease Cases
Valuing an increase in litter size
John Kolb
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What have we learned using load close expose to produce 
PRRSv-negative pigs from positive breeding  herds?
Daniel Linhares; Montserrat Torremorell; Robert  Morrison
Swine Disease Eradication Center, College of Veterinary Medicine, University of  Minnesota
Herd closure is a strategy widely used in the US swine 
industry to control and eliminate PRRSv from infected 
breeding herds. As part of the herd closure program some 
veterinarians expose the breeding herd with PRRSv in an 
effort to increase herd immunity (Desrosiers and Boutin, 
2002; Voglmayr et al., 2006). In conjunction with deliber-
ate exposure, the program often includes filling the facility 
with extra replacement pigs and then temporarily closing 
the breeding herd to any replacement pig introduction. 
Hence, the herd closure program for PRRSv is commonly 
thought of as having “load, close and expose” components. 
There are different immunogens that can be used for 
whole-herd exposure including the resident live virus and 
attenuated virus vaccine. Recently, our group conducted 
a series of studies to compare effectiveness of LCE using 
live virus inoculation (LVI) to that of using modified-live 
virus vaccine (MLV). Full details of the studies are avail-
able in the Ph.D thesis of Daniel Linhares at the University 
of Minnesota’s College of Veterinary  Medicine.
One study compared the LCE programs using LVI or MLV 
in regards to the time it takes to reach PRRSv stability 
(TTS) from infected breeding herds. Results showed that 
despite the great variability of TTS between enrolled 
herds, there were some variables associated with shorter 
TTS. Specifically, herds that used LVI as the method of 
whole-herd exposure reached TTS earlier than herds that 
used MLV vaccines. Moreover, herds with history of 
PRRSv infection in the 3 years prior to our study reached 
TTS sooner than herds without history of PRRSv in those 
same 3 years. Furthermore, herds assisted by a specific 
veterinary clinic reached TTS sooner than all other herds 
suggesting that there might be management practices as-
sociated with shorter TTS. Our results also showed that 
PRRSv-monitoring must be done repeatedly over time to 
increase confidence of PRRSv-negative status of weaned 
piglets. Altogether, those findings represent prove of 
concept that herds can reach PRRSv stability as soon as 
84 days from establishment of  LCE.
Another study evaluated the effect of attenuated PRRSv 
vaccine inoculation compared to the use of live-virulent 
virus inoculation on production performance in breeding 
herds. It was shown that herds that used MLV vaccine as 
part of load-close-expose herd closure programs recovered 
production levels and had a less severe production impact 
than herds that used LVI. Also, herds that reported previ-
ous PRRSv infection reached time to baseline production 
(TTBP) sooner than herds with no history of PRRSv 
infection in the previous 3 years. Interestingly, herds 
assisted by a specific veterinary clinic recovered produc-
tion faster than other herds, raising the hypothesis that 
specific management practices could be associated with 
herd closure  effectiveness.
Because results of TTS and TTBP studies pointed to 
different directions in regards to advantage of MLV com-
pared to that of LVI, we built economic models to assist 
veterinarians to make informed decisions between LVI 
and MLV as part of LCE program to eliminate PRRSv. 
Taking in consideration the future prices for market hogs 
and pig feed from January to December 2012, and $13.52 
loss per pig that is PRRSv-positive, the results suggested 
that MLV would be a better economical  choice.
Furthermore, the final study investigated herd-closure 
practices associated with successful PRRSv-elimination 
from breeding herds. It showed that the success rate of 
LCE programs was 76% and 92% for LVI and MLV herds, 
when failures associated with unrelated PRRSv were ex-
cluded from the analysis although these differences were 
not statistically significant. Moreover, one out of six herds 
that achieved 90 days of failure to detect PRRSv in due to 
wean piglets failed to achieve AASV category III, which 
indicates that more strict monitoring programs should be 
adopted in herds undergoing PRRSv elimination. Inter-
estingly, herds assisted by different veterinary clinics had 
different set of recommendations of management practices 
to be followed during LCE, indicating that there was no 
agreement between veterinarians on what is the relative 
importance of each management practice evaluated. The 
variables associated with failure to reach AASV category 
III were a) being infected with a PRRSv of RFLP pattern 
1-4-4 and b) holding back pigs at weaning for  quality.
Results from these studies provided science based infor-
mation on LCE with live PRRSv as a method to produce 
PRRSv-negative pigs from infected breeding herds. Fur-
ther studies are needed to compare herd closure without 
the “exposure” component on the c) effectiveness of 
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reaching TTS, b) total loss followed by the infection and 
intervention, and c) chance of program success. Also, 
further studies are needed to better understand specific 
factors associated with reaching short TTS and minimized 
total loss, such as farm layout, pig flow and actual imple-
mentation of specific management practices during the 
period of herd  closure.
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PRRS control and eradication options  for breed to wean 
 farms
Clayton Johnson,1 DVM; Jean-Paul Cano,2 DVM,  PhD
1The Maschhoffs, LLC, Carlyle, Illinois; 2Boehringer Ingelheim Vetmedica, Inc., St. Joseph,  Missouri
Introduction
The swine veterinarian is charged with delivering opti-
mal health management in a socially and economically 
sustainable manner. This expectation is complicated by 
the lack of available evidence for disease prevention, 
control and treatment forcing the swine veterinarian to 
regularly make decisions with less than ideal evidence. 
Never is this complication more evident than in the face 
of epidemic disease on a Breed to Wean (BTW) farm. 
A novel porcine reproductive and respiratory syndrome 
virus (PRRSV) introduction on a BTW farm results in 
dramatic performance losses that with or without interven-
tion threaten farm and producer viability. In the face of 
this challenge the swine veterinarian must craft a health 
management plan which optimizes the client’s biological 
and economic performance. To maximize BTW farm 
efficiency in the face of a novel PRRSV infection, the 
swine veterinarian must apply the best available evidence 
to their decision making process, and ultimately to their 
health management recommendations. This paper will 
communicate how The Maschhoffs health team has used 
best available evidence to control and eradicate PRRSV 
from BTW farms in our system, and specifically how we 
have applied learning’s from the Time to Negative Pig 
Study conducted by the University of Minnesota. PRRS 
control and eradication options presented below will fo-
cus on a Load, Close and Expose (LCE) model of PRRS 
management, with particular consideration given to two 
key decision points; the final goal of the PRRS manage-
ment plan (PRRS Control vs. PRRS Eradication), and the 
method of BTW herd exposure (Live Virus Inoculation 
vs. Modified Live Virus  Vaccination).
System PRRS management background
PRRS impact on a BTW farm is most noticeable dur-
ing the acute outbreak, and our system has historically 
modeled biologic and economic performance relative to 
growing pig losses, specifically post-weaning mortality. 
Accordingly, the health team’s recommendation for PRRS 
management following a novel PRRSV introduction has 
been based on PRRS elimination to most rapidly achieve 
PRRSV negative piglet production, described in the 
Time to Negative Pig Study as Time to PRRSV Stabil-
ity (TTS). Herds achieve “TTS status” when there is a 
failure to detect PRRSV RNA in serum of pre-weaning 
pigs by PCR over a 90-day period, following the AASV 
PRRSV-status criteria for a category IIB herd. The value 
of prior herd immunity (defined as decreased total pre-
weaning piglet losses and decreased TTS) has been harder 
to quantify and therefore not valued in previous PRRS 
control bio-economic models. The Time to Negative Pig 
Study provides quantified estimates of Time to Baseline 
Production (TTBP) and TTS associated with various 
PRRS management strategies as well as previous herd 
immunity to PRRSV. Adding this information to our 
model and therefore to our decision making process allows 
valuation of the PRRSV negative weaned pig in relation to 
total sow farm losses assuming the BTW herd has either 
previous immunity or no immunity to  PRRSV.
Updated PRRSV impact  estimates
Time to Negative Pig Study updates provided in No-
vember, 2012 supported the quantification of two critical 
decision making points in PRRS management, the method 
of exposure (Live Virus Inoculation vs. Modified Live 
Virus Vaccination) as well as the value of prior immunity 
(PRRSV antibody positive vs. PRRSV antibody negative) 
in the face of subsequent novel PRRSV infections. TTS 
and TTBP were quantified for each option using median 
results of reported data. The resulting model outputs have 
truly revolutionized our approach to PRRS management. It 
is important to note that like all studies, the Time to Nega-
tive Pig Study has limitations. Specifically, participant 
herds were not randomly allocated to treatment, there-
fore the comparison relies on observational analysis and 
association does not infer causation. There is high vari-
ability and low control of loading, exposure and sampling 
methods. The TTBP estimates make major assumptions 
and do not consider the impact of other infectious agents 
present within a BTW herd. Finally, genetics, nutrition, 
environmental factors and numerous other variables are 
not controlled. Despite these challenges, our team has 
identified this to be the “best available information” and 
in the spirit of evidence based medicine, we will utilize 
this resource until superior evidence is  presented.
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Our updated impact estimates can be most easily explained 
relative to biologic performance. When reviewing the as-
sociations with TTS, our group noted that consistent with 
The Maschhoffs experiences, tremendous variability in 
TTS existed throughout the industry. Regardless of the vari-
ability in TTS, two significant associations could be  made:
• BTW herds implementing Live Virus Inoculation 
(LVI) for exposure achieved TTS significantly faster 
than comparable herds achieving stabilization through 
Modified Live Virus  (MLV).
• BTW herds with prior immunity (defined as PRRSV 
antibody positive at the time of novel PRRSV intro-
duction) had achieved TTS significantly faster than 
comparable herds without prior immunity (defined as 
PRRSV antibody negative at the time of novel PRRSV 
 introduction).
When reviewing the associations with TTBP (defined as 
21 week performance of the affected farm prior to novel 
PRRSV outbreak), we noted several critical  findings:
• TTS was poorly correlated with  TTBP.
• TTBP was highly correlated with total pre-weaning 
production  losses.
• Prior herd immunity resulted in earlier TTBP, with 
a drastic increase in total weaned piglet production 
relative to PRRSV naïve herds and an apparent dose 
impact with herds exposed multiple times reaching 
TTBP sooner than herds exposed  once.
• BTW herds using MLV reached TTBP significantly 
faster than herds using  LVI.
The following tables (Table 1 and Table 2) reflect our 
updated assumptions used to evaluate the biologic and 
economic performance of BTW farms engaging in an 
LCE PRRS management strategy utilizing LVI or MLV 
as their exposure method. These models assume that the 
same minimum criteria defined for inclusion in the Time 
to Negative Pig Study are in place and that the BTW farm 
currently experiencing a novel PRRSV infection flawlessly 
implements MCREBEL practices throughout herd  closure.
These assumptions and associated economic impacts have 
resulted in two dramatic changes in PRRS management 
on BTW farms. We first changed our method of exposure 
from LVI to MLV on all BTW farms implementing an LCE 
PRRS management program. While our assumption that 
LVI would result in faster TTS was correct, the value of the 
increased PRRSV naïve weaned piglets was less than the 
value of faster TTBP and the associated increased weaned 
piglet production during herd closure. We continue to chal-
lenge the model as the value of a weaned pig changes, but 
the model is insensitive to weaned pig values, resulting in 
consistent PRRS management recommendations regard-
less of the current weaned pig price. Our second dramatic 
change was a transition from exclusive use of an “Eradica-
tion” approach to PRRS management to a decision making 
process that uses historical PRRS “outbreak frequency” 
to determine whether PRRS management attempts will 
result in Control (PRRSV vaccinated gilt introductions) 
or Eradication (PRRSV negative gilt introductions). Given 
that BTW herds regularly challenged by novel PRRSV 
introductions have inherently more value in being PRRSV 
antibody positive, we found the point of inflection in our 
model at which the benefits of decreased performance 
losses associated with each novel PRRSV introduction 
outweigh the cost of maintaining PRRS immunity in the 
BTW herd. For the purposes of our very basic model, 
this break frequency is approximately 1 novel PRRSV 
introduction every three years. Farms with a historic 
outbreak frequency of less than one outbreak every three 
years create more value by Eradicating PRRSV and farms 
with a historic outbreak frequency of more than one out-
break every three years create more value by Controlling 
PRRSV. This assumes that the historic outbreak frequency 
is an accurate predictor of future break frequency, an 
assumption that should be challenged regularly by the 
veterinarian working with the impacted  herd.
Historical vs. current  performance
While caution should be taken in comparing biological 
performance between historical and current PRRS man-
agement strategies, it is good practice to evaluate actual 
results in relation to model assumptions. Such information 
provides a quantitative “response to therapy” that can 
assist continuous improvement of PRRS management 
decision making and at a minimum, can point to specific 
model assumptions which need further validation. The 
performance data listed below represents the impact of 
novel PRRSV infection on a Maschhoffs BTW farm us-
ing an LCE PRRS management strategy utilizing LVI 
(Historical) vs. MLV (Current) as our exposure method. 
Results of biologic performance are presented specific 
to one BTW herd and include the herds TTS, TTBP and 
Post-Weaning Mortality. Definitions for these performance 
metrics are listed  below:
 TTS – Number of weeks from herd closure (date of 
exposure followed by no live animal introductions) 
until the achievement of PRRSV status category IIB. 
Category IIB represents the time at which pre-wean-
ing piglet testing for PRRSV has provided evidence of 
decreased PRRSV transmission to allow for negative 
(Eradication) or vaccinated (Control) gilt entry and 
subsequent sentinel  testing.
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 TTBP – Number of weeks from herd closure until 
weekly PSY has returned to baseline performance 
(defined as the average herd PSY during the 12 months 
prior to novel PRRSV  introduction).
 Post-Weaning Mortality Increase– Average weekly 
mortality increase for all pigs weaned in the first six 
months immediately following herd closure when com-
pared to the average weekly mortality during the six 
months immediately prior to novel PRRSV  diagnosis.
Given our recent adoption of PRRSV Control on farms 
with high historic PRRSV break frequencies, we do not 
yet have data available on actual impact of prior immu-
nity. We recognize the value in this data, and will monitor 
performance of PRRSV Control farms in the face of novel 
PRRSV introductions to challenge our model in a similar 
manner as our LCE-MLV vs. LCE-LVI  approach.
Conclusions
• While ideal evidence to support PRRS management 
decision making on a BTW farm does not exist, there 
is an ever growing body of information which should 
be consulted regularly by the swine veterinarian prior 
to implementing a PRRS management  plan.
• The Time to Negative Pig Study provides performance 
impact estimates of TTS and TTBP using either LVI 
or MLV for  exposure.
Table 1: Value of prior immunity – per 1000  sows
No immunity Prior immunity
Cost of an outbreak
Weaned pig value $40.00 $40.00
Lost weaned pigs 3,575 645
Value lost $143,000.00 $25,800.00
Cost of prior immunity
PSY drag from immunity 0 1
Cost of immunity per year $0.00 $40,000.00
Outbreak frequency to justify prior immunity
Value of immunity in an outbreak $0.00 $117,200.00
Outbreak frequency (years between outbreaks) to justify prior immunity 2.93
Table 2: MLV vs. LVI exposure – per 1000  sows
Weaned pig value $40.00
Improvement in pigs weaned from MLV 1,300
Value of increased weaned pigs $52,000.00
Pre infection pigs per week 519
Post infection pigs per week with MLV 487
Reduced value of pigs weaned with PRRSV (per pig weaned) $7.00
MLV TTS (weeks) 36
LVI TTS (weeks) 30
MLV PRRSV positive pigs weaned 17,532
LVI PRRSV positive pigs weaned 13,310
Lost value of MLV due to PRRSV positive weaned pigs $122,724.00
Lost value of LVI due to PRRSV positive weaned pigs $93,170.00
Increased cost of weaning PRRS positive pigs with MLV $29,554.00
MLV cost ($1.00 per dose, two doses per sow during exposure) $2,000.00
Net value of MLV for exposure $20,446.00
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• The Time to Negative Pig Study provides performance 
impact estimates of TTS and TTBP based on the pres-
ence of prior immunity in a BTW herd in the face of 
a novel PRRSV  introduction.
• TTS and TTBP estimates can be used to create bio-
logical and economic performance models to improve 
the quality of decision making prior to implementing 
a PRRS management  plan.
• Using TTS and TTBP estimates, homogenizing a 
BTW herd through MLV results in more value gen-
eration than exposure through LVI in spite of the fact 
that LVI results in a shorter  TTS.
• Using TTS and TTBP estimates, maintaining a 
PRRSV antibody positive status results in more value 
generation than eradication of PRRSV on a BTW farm 
that experiences a novel PRRSV introduction more 
frequently than once every three  years.
Table 3: Historical performance of BTW farms utilizing LCE-LVI for PRRS  management
Diagnosis 
date
Closure 
date
TTS 
(weeks)
TTBP 
(weeks)
Post-weaning mortality increase 
(per week)
Farm 1 2/7/2011 2/15/2011 36 24 0.02%
Farm 2 12/5/2011 12/12/2011 33 33 0.23%
Farm 3 12/19/2011 1/9/2012 32 28 0.38%
Farm 4 12/19/2011 1/9/2012 26 25 0.11%
Farm 5 3/19/2012 5/2/2012 43 22 0.01%
Average N/A N/A 34 26 0.15%
Table 4: Current performance of BTW farms utilizing LCE-MLV for PRRS  management
Diagnosis 
date
Closure 
date
TTS 
(weeks)
TTBP 
(weeks)
Post-weaning mortality increase  
(per week)
Farm 1 11/6/2012 1/9/2013 23 20 0.23%
Farm 2 11/26/2012 1/2/2013 26 26 0.11%
Farm 3 11/26/2012 1/2/2013 25 26 0.09%
Farm 4 11/26/2012 1/9/2013 23 25 0.06%
Average N/A N/A 24 24 0.12%
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Coordinated herd closures for PRRSv control and 
­elimination
Joel Nerem, DVM
Pipestone Veterinary Clinic, Pipestone,  Minnesota
PRRS virus infections in breed to wean farms has nega-
tive consequences for animal health, farm productivity, 
and financial performance. Elimination of endemic PRRS 
virus from infected breeding herds has been practiced with 
success. Through analysis of both successful and unsuc-
cessful PRRS elimination projects, Pipestone Veterinary 
Clinic (PVC) has developed a list of best practices. These 
best practices have been incorporated into a standardized 
protocol for PRRSv elimination projects implemented in 
the Pipestone  System.
Summary of PVC philosophy: Elimination of field virus 
(wild type virus) will be the goal for every farm following 
a new PRRS virus introduction. Principle of elimination 
is based  on
1. Exposure of all resident breeding animals to new 
PRRS virus for the development of neutralizing 
 immunity
2. Cessation in new breeding stock introductions to 
facilitate the “dying out” of the virus. Stopping gilt 
introductions removes the population of susceptible 
animals in which the virus could continue to  replicate.
Basics of PVC protocol  include:
• Written plan approved by Health  Director
• Whole herd “exposure” will be accomplished through 
 either:
▶ serum exposure/live virus injection,  or
▶ mass vaccination with commercially approved 
modified live PRRS  vaccine
• Gilt pool will always receive serum/field virus 
 exposure
• 250 day herd closure to gilt entries, beginning when 
gilts are exposed to field  virus
Requirements at closure (Weeks  1–16):
1. Close farm to replacement gilt  introductions
2. Virus  exposure/”homogenization”
a. Serum – expose all sows and  gilts
b. Vaccine  –
i. 2 doses vaccine to  sows
ii. Field virus exposure to non-pregnant gilts + 
PRRS  vaccine
3. No pigs/V-boars retained on  farm
4. Save serum samples used for gilt exposure for poten-
tial later  analysis
Requirements mid/late closure (Weeks  17–36):
1. Begin pig movement restrictions in  farrowing
a.  Block  sizing
b.  Viremic pigs  euthanized
2. Begin piglet testing no later than 16–18 weeks into 
 closure
a.  Oral fluids and  serum
b.  Fall behind pigs in oldest farrowing  rooms
3. Change needles and disinfect nippers between  litters
4. No partial washing of farrowing  rooms
5. Foam hallways with Synergize prior to power washing 
following weaning  events
6. No tubs or processing  carts
7. Discontinue all pre-farrow  feedback
8. Discard all serum retained on the  farm
9. Discard all frozen/refrigerated feedback material 
retained on the  farm
10. Defrost, clean, and disinfect all farm refrigerators 
and  freezers
11. Discard all open bottles, needles, syringes, oral 
dispensers,etc from refrigerator and med storage area 
– any open bottles or delivery devices that may have 
been used when animals were still viremic on  farm
12. Clean and disinfect all storage areas, hallways, water 
rooms, etc – good general farm  cleaning
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13. No manure pumping or agitation within 14 days 
from the end of herd closure (arrival of naïve gilts). 
All manure pumping following closure must be ap-
proved by Health  Director
14. Discontinue oral dosing of  piglets
15. GDU must be cleaned, disinfected, and inspected       
  by Health  Tech
Release from herd  closure:
1. Requires approval of Pipestone System Health Direc-
tor – make sure to contact before ordering  gilts.
2. Testing program for release of  closure:
a.  3 bleeds of 30 head @ 2 week intervals – 100% 
PCR  Neg
b. 3 bleeds of 60 head @ 2 week intervals – 100% 
PCR  Neg
c. Oral fluid testing of piglets – collect 6 ropes (12 
litters) on weeks opposite of serum  collection
Post-closure  testing
1. Monthly piglet PRRS PCR on OF or  serum
2. Monthly PRRS PCR on naïve replacement gilts that 
have entered the  G-barn
a. 10 hd  serum
b. Test for 6  months
Following the above protocol, PVC has documented ~90% 
success rate at elimination of resident PRRS  virus.
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An interesting case – deeper knowledge helps avoid 
jumping to  conclusions
Spencer Wayne1, DVM, PhD; Paul Yeske2, DVM, MS  
1Pipestone Veterinary Clinic, Pipestone, Minnesota; 2Swine Vet Center, St. Peter, Minnesota
ORF-5 sequence information is commonly used by vet-
erinarians in helping to understand the characteristics and 
dynamics of a client herds’ PRRS status. Primarily this 
information is used in an effort to answer the question, 
“Is this my old virus or is this a new infection?” In addi-
tion, ORF-5 sequences may be used in an epidemiologic 
comparison of viruses in a pigflow or neighborhood. In a 
recent case example, neighborhood, pigflow, and ORF-5 
sequences were used in elucidating a likely transmission 
pattern in lieu of an initially suspected  route.
In early 2012, a Company-A isowean sow unit experienced 
a new PRRS infection. The virus matched very closely 
with a strain of PRRS identified at a Company-A finishing 
site found in late 2011 (Figure 1). Both sites were part of 
the same production system (although not part of the same 
pig flow) and were 15.7 miles apart. Due to the similarity 
of the two viruses, a Company-A, “in-system” route of 
infection was suspected (transportation, personnel, equip-
ment,  etc…).
Concurrent communication with the veterinarian servicing 
other area farms (Company-B) revealed additional infor-
mation. Shortly after the initial Company-A finishing site 
became infected, a neighboring Company-B sow farm (1.9 
miles away) became infected with a nearly identical virus. 
Following infection at the Company-B sow unit, pigs were 
weaned to the downstream Company-B sites. Two of these 
sites were 3.1 miles away from the Company-A sow unit 
(Figure 2). The timing of infection at the different sites and 
the sequence of pig movements, now suggested a multi-
step route of transmission between Company-A’s finisher 
and sow unit. With this more complete information, both 
Figure 1: Figure 2:
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companies gained a deeper understanding of the sources 
and outcomes of their PRRS infections, and ultimately 
were able to avoid making false  assumptions.
This case illustrates the necessity of a thorough epide-
miologic investigation in understanding PRRS transmis-
sion events. Throughout most of the major pig producing 
areas in the US, the landscape is characterized by a broad 
and diffuse criss-crossing of pig flows. The possibility 
of aerosol transmission is amplified by movements of 
growing pigs (weaned pigs and feeder pigs) between 
sites in multisite production systems. Not appreciating 
the potential combination of infection routes may lead to 
erroneous conclusions and unwarranted actions. Effec-
tive communication methods and professional goodwill 
between producers and between their veterinarians is 
essential in completing the epidemiologic picture in a 
PRRS  investigation.
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Why we cannot just use  2%
Michael P.  Murtaugh
Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota
PRRSV ORF5 sequencing is widely used by producers 
and veterinarians to help interpret the source of outbreaks 
and the effectiveness of biosecurity procedures. Sequence 
comparisons by percent difference or percent similarity 
provide a crude estimate of relatedness, but frequently 
provide inadequate guidance to decide if a new sequence 
indicates re-isolation of an existing virus or discovery of 
a newly introduced virus. Expert opinion also may not be 
helpful since “experts” often express a wide range of opin-
ions. Some consider a 2% difference significant, whereas 
other consider 5% difference as still being  equivalent.
So what is a person to do? We know that the PRRSV that 
comes out of a pig is the same or nearly the same as the 
virus that went into a pig. In direct comparisons the differ-
ence is usually between zero and six mutations (6 changes 
in ORF5 equals 1%). Sequential passage of an isolate from 
one pig to another and another gives a more-or-less ad-
ditive increase in variation, so that a specific virus may 
change by 1% or more in a year’s time. When a producer 
or veterinarian is using percent similarity to determine 
if sequences in a herd are re-isolates of a herd-specific 
sequence or are a new viral introduction, the interpreta-
tion requires a thorough historical knowledge of previous 
isolates circulating in the herd and their rates of  variation.
A critical misinterpretation can occur in using percent 
similarity to judge the relatedness of field isolates. In 
ORF5 sequencing a 1% difference means that six bases are 
not the same due to mutation. Suppose you find PRRSV 
A in a herd. Six months later, virus B shows up, with six 
mutations. At 12 months, two new viruses are found. Vi-
rus C has the same 6 mutations as virus B plus six more. 
Virus C now is 2% different from virus A. Since it is 1% 
different from virus B, it is reasonable to conclude that A 
–> B –> C. The second virus at 12 months, virus D, also 
has 12 mutations compared to virus A, but they are all 
different from the mutations in viruses B and C. It could 
not have evolved from virus B, since the six mutations in 
B would have to revert to the virus A version, and then 
12 new mutations would need to occur. This is highly 
unlikely. It is probable that virus D is a new introduction 
into the  herd.
Since it is possible to get viruses that have the same per-
cent similarity but acquiring independent and unrelated 
mutations, using percent similarity alone is unreliable for 
determining relatedness. The same problem occurs in us-
ing RFLP type to characterize PRRSV. It is well known 
that viruses that are genetically completely unrelated may 
have the same RFLP pattern. For example, the highly 
virulent 1-4-4 family of viruses that appeared in 2010 is 
not related at all to 1-4-4 viruses that were circulating in 
the  1990’s.
The solution is to use phylogenetic trees (dendrograms) in 
addition to percent similarity for interpretation of PRRSV 
relatedness. Dendrograms show calculate the most simple 
path by which mutations in a group of isolates could have 
evolved. The value of a dendrogram and the resulting 
interpretation is enhanced by the regular monitoring to 
detect viruses that are present in the herd, awareness of 
clinical and production history of the herd, and knowledge 
of resident viruses in the region. We know that PRRSV 
is a difficult challenge, so it is important to have as much 
information as  possible.
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A decision tree to guide to answering the question, is this 
a new virus or not to the  farm?
Paul Yeske, DVM MS, Swine Vet Center, St. Peter, Minnesota
(Travis Clement, South Dakota State University; Scott Dee, Pipestone Veterinary Clinic; Joel Nerem, 
Pipestone Veterinary Clinic; Mike Murtaugh, University of Minnesota; Spencer Wayne, Pipestone 
Veterinary Clinic; Bob Morrison, University of Minnesota)
Introduction
One of the hardest questions to answer is, could this be 
a new virus to the herd or is it the resident virus that has 
been in the herd before. In herds that are negative it is an 
easy question but for herds that have had previous virus 
exposure it is a harder question. Sequencing is a valuable 
epidemiological tool but can be difficult to interpret once the 
results are completed. One of the most challenging things to 
do is to determine if a virus that is found from a diagnostic 
workup is a virus the herd has or is it new. The standard 
convention is if 2 viruses are more than 2% different then 
they are different viruses.1 The MJ classification system is 
another method to determine similarity of  viruses.2
In herds that are class IV (by AASV PRRS herd classifica-
tion system)3 negative. When a virus is identified in these 
herds it is easy to interpret because all viruses in the herd 
are considered  new.
Class III herds are similar to the class IV herds but need 
to make sure that it is not the resident virus that was be-
ing eliminated from the herd.3 These herds have sentinel 
animals entered after the break and herd closure and these 
can be help in interpretation of diagnostic  information.
The real problems in interpretation of sequencing results 
are in the class II and I herds.3 These herds are known to 
have a resident virus and then it is more difficult to make 
the  evaluation.
Determining if the virus is a resident virus or a new in-
troduction is particularly important if the herd is in a herd 
closure program and this may extend the time before gilts 
can be re-introduced. There are also pig flow considerations 
on where can the pigs go and do changes need to be  made.
Objectives
To develop a methodology that can be used to determine 
if 2 viruses with similar sequence patterns are the resident 
virus in the herd or a new introduction. A working group 
of the AASV PRRS task force was formed to define a way 
to make these  determinations.
Materials and  methods
The viruses that are more than 5% different are easy to 
determine that they are new introductions to the herd. 
The ones that are tough are the ones that are less than 2% 
different. The standard conventional wisdom is that less 
than 2% different is a similar virus and closely  related.1
In a poll of expert opinion viruses that are more than 4% 
different are considered to be clearly different. Anything 
less than this may or may not be related. This just adds to 
the confusion around the conventional wisdom determin-
ing if this is a resident virus or  not.
There are number of questions that need to be asked to 
help determine if the virus is a new introduction or not to 
use in conjunction with the sequencing information. The 
sequencing cannot be used as a standalone method to an-
swer this question. This algorithm is designed as decision 
tree type of structure using other herd information once 
the sequence is determined and how use this information 
in an organized manner to help answer the question is this 
the herd virus or is it a new  introduction.
Start with the sample collected and then work down the 
decision tree to determine if it is a resident or new  virus 
(See Figures 1-3).
Conclusions
There is still much to be understood about virulence and 
cross protection with the PRRS virus. Until this is better 
understood practitioners and producers have to use the 
best information available to answer the epidemiological 
question of could this be a resident herd virus or is this a 
new introduction. There is not a simple answer the hope 
is this decision tree type algorithm is helpful in giving a 
structured way to use clinical information about the herd 
and sequence information and determine the status of 
the  virus.
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Figure 1: The next step is to work through the Location/Biosecurity/Sequence  information.
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Figure 2: Biosecurity questions that need to be  answered.
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Comparison of various sample types for detection of 
Mycoplasma hyopneumoniae in recently infected  pigs
Maria Pieters, DVM, PhD; Albert Rovira, DVM, MSc,  PhD
Veterinary Population Medicine Department and Veterinary Diagnostic Laboratory,  
College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota
Introduction
Mycoplasma hyopneumoniae (M. hyopneumoniae) infec-
tions continue to be a major problem for the swine indus-
try worldwide. The detrimental effect of this bacterium 
in swine populations is not only due to the pneumonia 
and the associated decreased performance caused by the 
pathogen itself, but also by the animal’s predisposition 
to secondary respiratory infections of bacterial and viral 
origin. Therefore, M. hyopneumoniae infections cause 
significant losses to swine producers each  year.
Disease control, typically attempted through vaccination 
and/or medication of growing pigs, is expensive and does 
not consistently work in all herds. For these reasons, dur-
ing the last few years many veterinarians and producers 
have chosen to completely eliminate M. hyopneumoniae 
from their herds. This has resulted in an increased num-
ber of herds that are free of this pathogen. Continuous 
serological surveillance of free herds by serum ELISA 
is a good strategy that most negative herds have in place. 
However, these ELISA-based surveillance protocols have 
two main limitations: 1. Current ELISAs lack the ability 
to detect early infections. 2. Current ELISAs produce 
false positives and no good confirmatory test is available. 
Usually another ELISA is used as a confirmatory test, 
which does not completely clear the uncertainty created 
by false positives. In many instances, the question of 
whether the original positive result was a false positive 
or the true early manifestation of a recent infection of the 
herd remains unanswered. In replacement breeding stock 
populations confirmation of the status of a population fol-
lowing questionable positive ELISA results often requires 
costly euthanasia of high value animals for tissue submis-
sions. In addition, accurate detection of an early infection 
to prevent downstream spread is even more  important.
The lack of tools to efficiently detect M. hyopneumoniae 
early infections in live pigs further complicates this sce-
nario. M. hyopneumoniae diagnosis in live pigs, and espe-
cially during early stages of infection is very challenging. 
Therefore, there is a growing need for surveillance tools 
that complement ELISA tests to demonstrate that popu-
lations remain negative overtime or to accurately detect 
early infection to prevent further spread. In response to 
this need, several sampling and diagnostic tools to be used 
in live pigs have been proposed, for example, oral fluids, 
tracheal swabs, and tracheo-bronchial lavages. However, 
some of these techniques have not been properly evaluated 
and they have not been compared side by side. Therefore, 
we carried out an investigation by performing a side by 
side comparison of sampling and testing tools currently 
available for detection of M. hyopneumoniae during the 
early phase of infection, as well as the use of alternative 
 procedures.
Materials and  methods
Twenty three 8-week old conventional pigs were obtained 
from a source known to be negative to major swine patho-
gens, including M. hyopneumoniae and PRRSV. Pigs were 
housed in the Isolation Units at the St. Paul Campus of the 
University of  Minnesota.
Pigs were ear-tagged at arrival and divided in two groups 
of 21 and 2 animals. Each pig in the group of 21 was 
inoculated with M. hyopneumoniae 7 days after arrival, 
and all were housed in experimental rooms (3 rooms of 7 
pigs each). Pigs were intra-tracheally inoculated with M. 
hyopneumoniae strain 232. The remaining two pigs were 
mock inoculated with negative culture media and served 
as negative  controls.
Each pig was sampled at 0, 2, 5, 9, 14, 21 and 28 days 
post-inoculation (dpi). At each sampling time, blood, nasal 
swabs, laryngeal swabs, tracheo-bronchial lavage and 
oral fluids were collected. All animals were euthanized 
at 28 dpi and M. hyopneumoniae infection was assessed 
by gross and microscopical lesions and by bronchial swab 
real time  PCR.
Blood samples were separated to obtain serum, which was 
aliquoted and prepared for the following ELISA  testing:
• IDEXX
• Oxoid
• Biochek
All serum samples were processed straight after collection 
and aliquots were stored at -80°C until  analysis.
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Nasal, laryngeal and bronchial swabs, as well as tracheo-
bronchial lavage and oral fluids (by room) were submitted 
to the VDL for DNA extraction and M. hyopneumoniae 
real time PCR testing (VetMAX, Life  Technologies).
After euthanasia, macroscopic lung lesion evaluations 
were conducted as a single blind study. Microscopic lung 
lesion evaluation was done using the fixed lung tissues 
collected at  euthanasia.
The percentage of positive pigs for each diagnostic pro-
cedure was compared with McNemar tests for paired 
samples at each sampling  time.
Results
The two mock inoculated pigs in this study were negative 
for M. hyopneumoniae at all sampling times for all type of 
tests, ELISAs, real-time PCR and lung lesion  evaluation.
The detection of M. hyopneumoniae genetic material in 
the experimentally infected pigs was as follows: All pigs 
were negative to M. hyopneumoniae at 0 dpi (prior to 
inoculation). All samples from 2 dpi resulted negative for 
detection of M. hyopneumoniae DNA. First positive real 
time PCR results were obtained at 5 dpi, in either nasal 
or laryngeal swabs, or in tracheo-bronchial lavages. M. 
hyopneumoniae genetic material was detected in various 
sample types from various pigs in all rooms at 9, 14, 21 
and 28 dpi. The higher percentage of positive pigs was 
achieved with laryngeal swabs from 5 until 28 dpi. Propor-
tion of positive pigs, as tested by tracheo-bronchial lavage 
increased from 5 dpi until 21 dpi, decreasing at 28 dpi. 
DNA detection in nasal swabs was similarly low from 5 
until 21 dpi, increasing at 28  dpi.
Mycoplasma hyopneumoniae genetic material was de-
tected in oral fluids in 2/3 samples (2/3 rooms) obtained 
at 9 dpi and 28 dpi, and was negative at all other sampling 
 times.
Specific M. hyopneumoniae antibodies were detected in 
a proportion of experimentally infected pigs at 21 and 28 
dpi. Detection rates were similar among the three ELISA 
assays compared in this study  (P > 0.05).
Conclusions
Under the conditions of this study, laryngeal swabs 
showed the highest sensitivity for early detection of M. 
hyopneumoniae compared to other sample types. Tracheo-
bronchial lavages were more sensitive than nasal swabs 
during the first 21 dpi, while nasal swabs showed lower 
sensitivity during the first 3 weeks post-inoculation, com-
pared to laryngeal swabs and tracheo-bronchial lavage. 
Oral fluids showed low sensitivity for M. hyopneumoniae 
detection during the early stages of infection. Detection 
of M. hyopneumoniae-specific antibodies was similar by 
the 3 commercial kits used in this study. In summary, 
detecting pig exposure to M. hyopneumoniae was earlier 
achieved by real time PCR testing in laryngeal and nasal 
swabs, tracheo-bronchial lavage than by detection of 
antibodies by  ELISA.
Acknowledgements
This investigation was funded by the National Pork Board 
and the Pork Checkoff, and by Pig Improvement  Company.
References
1. Fablet C, Marois C, Kobisch M, Madec F, Rose N. 2010. 
Estimation of the sensitivity of four sampling methods for My-
coplasma hyopneumoniae detection in live pigs using a Bayesian 
approach. Vet Microbiol. Jul  14;143(2–4):238–45.
2. Maes, D., Segales, J., Meyns, T., Sibila, M., Pieters, M., Hae-
sebrouck, F. Control of Mycoplasma hyopneumoniae infections 
in pigs. Vet. Microbiol. 2008. Jan  5;126(4):297–309.
3. Marois, C., Le Carrou, J., Kobisch, M., Gautier-Bouchardon, 
A.V. 2007. Isolation of Mycoplasma hyopneumoniae from dif-
ferent sampling sites in experimentally infected and contact SPF 
piglets. Vet Microbiol.  120:96–104.
4. Pointon, A.M., Davies, P., and Bahnson, P.B. 1999. Disease 
Surveillance at Slaughter. In: Diseases of Swine. 8th Edition. B. 
Straw, S. D’Allaire, W. Mengeline, and D. Taylor (editors). Iowa 
State Press. p.  1118.
5. Sibila, M., Pieters, M., Molitor, T., Maes, D., Haesebrouck, 
F., Segales, J. 2009. Current perspectives on the diagnosis and 
epidemiology of Mycoplasma hyopneumoniae infection. Vet. J. 
 Sep:181(3):221–231.
6. Thacker, E.L. & C. Minion. 2012. Mycoplasmosis. In: Disease 
of Swine. Tenth Edition. Zimmerman, J (Editor). Hoboken, NY. 
 USA.
7. Woolley LK, Fell S, Gonsalves JR, Walker MJ, Djordjevic SP, 
Jenkins C, Eamens GJ. 2012. Evaluation of clinical, histological 
and immunological changes and qPCR detection of Mycoplasma 
hyopneumoniae in tissues during the early stages of mycoplas-
mal pneumonia in pigs after experimental challenge with two 
field isolates. Vet Microbiol. Dec  28;161(1–2):186–95.
2013 Allen D. Leman Swine Conference 77
D
is
ea
se
s 
Re
se
ar
ch
D
iseases Research
Molecular characterization of Mycoplasma hyorhinis field 
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Introduction
Since late 2008 Mycoplasma hyorhinis associated dis-
ease has been one of the main concerns of the US pork 
industry.1 It appears that differences in virulence of the 
infecting M. hyorhinis strain, the host immune response, 
and concomitant infections may play a role on disease 
manifestation. Antigenic differences between different 
M. hyorhinis isolates have been shown by seroreactivity 
to specific antisera.2 A few experimental challenge stud-
ies have shown differences in virulence in vivo.3 While 
detection of the bacterium in polyserositis and arthritis 
cases can be easily achieved through bacterial isolation 
and PCR, there are currently no genotyping tools available 
for the characterization M. hyorhinis isolates circulating 
amongst swine populations. The molecular typing of 
M. hyorhinis would aid in better understanding transmis-
sion routes, in assessing sources of infection and also in 
evaluating interventions such as vaccination and use of 
antibiotics. MLST is considered a rapid, reproducible 
and inexpensive technique that can identify phylogenetic 
relationships amongst diverse organisms.4,5 The objective 
of this study was to develop and validate a multi-locus 
sequence typing (MLST) protocol for the characterization 
of M. hyorhinis field  isolates.
Materials and  methods
Thirty-nine M. hyorhinis isolates from different geograph-
ic regions obtained from pigs with polyserositis and a clini-
cal history suggestive of M. hyorhinis infection, together 
with one reference ATCC strain (17981D) were utilized in 
this study. Modified Hayflick’s medium was used to grow 
all M. hyorhinis isolates. Purified, genomic DNA was 
obtained using the DNeasy Blood & Tissue Kit (Qiagen, 
Hilden, Germany). The completed genome sequences 
of four M. hyorhinis isolates available in Genbank were 
utilized to identify potential target genes. Primers were 
designed with MEGA 5.2.1 (version 5; www.megasoftware.
net) and Primer 3 software. Primers targeted different 
housekeeping and outer membrane protein gene segments 
dispersed throughout the M. hyorhinis genome. PCR was 
performed using an initial denaturating step at 95°C for 
15 min, followed by 35 cycles of 94°C for 1 min, 43.5°C 
for 1 min 30 sec. Agarose electrophoresis was performed 
on the amplified products and bands were observed under 
ultraviolet light in the presence of ethidium bromide. PCR 
products were purified using the QIAquick PCR Purifica-
tion Kit (Qiagen, Hilden, Germany) and bidirectionally 
sequenced by standard Sanger sequencing on an ABI 
3730xl genetic analyzer (Applied Biosystems). Quality 
of the generated sequencing data was evaluated and se-
quences were aligned utilizing ClustalW and trimmed to 
equal sizes. Phylogenetic analysis mas carried out using 
MEGA  5.2.1.
Results
A total of 25 genes were evaluated as potential target 
genes. These included housekeeping genes: pgmB, fusA, 
gyrB, lepA, metS, gltX, dnaA and pdhB, as well as surface 
proteins: p3, p95, p37, hexosephosphate transport protein 
(hexo), ribonucleoside-diphosphate reductase (nrdf ), 
uracil-DNA glycosylase (ung), mannitol-1-phosphate 
5-dehydrogenase (mtlD), lipoprotein Signal peptidase II 
(lspA) and variable lipoproteins (vlp) A,B,C,D,E,F and G. 
The majority of the housekeeping genes and a few surface 
protein genes were found to be identical in all four an-
notated genomes, therefore were not included for further 
testing. On the contrary, the gene sequences for vlpF and 
B genes were found to be highly divergent among the four 
available genomes, with no conserved flanking regions 
hindering the possibility of primer placement. Primers 
for the remaining vlp genes were designed, however, an 
amplicon was not obtained for vlpA, C, D and E gene 
when testing 6 of the 39 available M. hyorhinis isolates. 
Although and amplicon was generated for the vlpG gene, 
the generated product had low quality and was not repro-
ducible. Finally, a total of 7 target genes were included in 
the MLST protocol: ung, pdhB, mtlD, hexo, p3, p95 and 
p37. Preliminary data suggests that there is variation at 
the nucleotide level amongst the 39 isolates tested, with 
varying degrees of nucleotide difference between isolates 
within each gene. Further analysis will be performed on 
the concatenated sequence data and sequence types will 
be assigned. The data will be evaluated to potentially 
identify epidemiological patterns, i.e, clustering of isolates 
by tissue, system, state and  year.
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Discussion and  conclusions
Currently swine producers and veterinarian are faced with 
the challenge of controlling M. hyorhinis disease in affect-
ed post-weaning pigs. The development of a genotyping 
tool will result in a better understanding of the diversity of 
M. hyorhinis field isolates circulating in US swine herds. 
This tool will allow to study the epidemiology and dynam-
ics of infection for this pathogen. Furthermore, this tool 
will be extremely useful for veterinarians and producers 
to understand disease outbreaks, to select isolates for vac-
cine production, and to perform epidemiological studies 
on the potential origin of a specific isolate. Therefore, the 
US swine industry will be better positioned to control a 
pathogen that is responsible for an important part of the 
mortality observed in the  nursery.
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Mycoplasma hyosynoviae A Case Study: Quantitative 
assessment of incidence and severity across time 
alongside a diagnostic monitoring plan and  intervention
Co-authored by Sarah Probst Miller (SPM), AgCreate Solutions; and Alejandro Ramirez (AR), Iowa 
State University (IS-CVM; Original case pathology and histology photographs by Kuldeep Singh (KS), 
University of Illinois (UICVM); Diagnostic plan coordinated with Paul Knoernschild and Everett Rosey 
from Zoetis, Monitoring diagnostics sponsored by Zoetis via STOMP and completed by  IS-CVM
Review of Mycoplasma hyosynoviae as a 
pathogen  (SPM)
Mycoplasma hyosynoviae is one of several agents capable 
of instigating arthritis in growing swine. This arthritis is 
typically noted as inflammation of the intra-articular tissue 
of one of more joints accompanied by an increased volume 
of intra-articular fluid along with other descriptors such 
as serous, fibrinous, purulent, macrophagic, lymphoplas-
macytic, etc1. An increase in M. hyosynoviae instigated 
diagnosis has been noted by Iowa State University Veteri-
nary Diagnostic Laboratory (ISU-VDL) in the Midwestern 
United States. From 2003 to 2010 Mycoplasma species 
accounted for 17% of cases at ISU-VDL while in 2010 
Mycoplasma species accounted for up to 37% of cases.1 
While the majority of animal afflicted with infectious 
arthritis may make it to commercial markets, the concern 
lies in the welfare of afflicted animals as well as potential 
impact on pig profitability.1 If a swine operation is involved 
in the business of raising and developing replacement 
females, the concern is threefold: 1) Reduction in percent 
sold from the gilt herd 2) Potential contagiousness of the 
disease to the sow farm 3) Effect of the infectious arthritis 
on the females’ longevity in the sow herd. This case study 
reports the process of diagnosing and treating a gilt herd 
afflicted with aesthetic and clinical  lameness.
Background  (SPM)
In September of 2013 a wean to market gilts site of 7200 
gilts sourced from an 1800 multiplication unit complained 
of reduced selects sold due to “lameness.” Gilts are nega-
tive to PRRS, Mycoplasma hyopneumoniae, and APP. The 
reported “lameness” was purely aesthetic (Image 1) in many 
cases and clinical in others (Image Groups 2 and 3). Most 
females appeared to recover and not suffer lameness in the 
sow herd if they were in the aesthetic lameness category. 
Those farms receiving clinical lameness cases (Image 
Groups 2 and 3) reported improvement in some females 
and deterioration in others. An effort was made to weed 
out all clinical lameness cases during the selection  process.
Past percent sold on the select market had ranged from 
66 to 79% sold per group over the previous 6 months 
(Table 8 and 9). At the time of first assessment, the herd 
had reduced the percent sold per group to 51.9% in August 
2012 followed by 38.6% in September 2012 of opportunity 
females (Table 8). This reduction was not due to demand 
but was due to true reduction in ability to select because 
of this  condition.
Maternal barrows in a variety of wean-to market barns 
from this parent source also went through this “lameness.” 
However, the “lameness” did not impact pigs sold at the 
commercial level nor did it appear to impact growth. In 
fact, at the commercial level, the “lameness” was not 
considered problematic just purely incidental. At the gilt 
grow out however, the height of the swelling and associ-
ated lameness occurred at the time when the majority of 
females were sold, 230 to 250 pounds, hence the strong 
impact on percent  sold.
Clinical observations at first visit 
09/19/2012  (SPM)
Clinically at the time of first visit, the observing veteri-
narian noted various levels of swelling surrounding the 
hock and/or shoulder region (See Image Groups 1, 2 and 
3). Many females had one limb affected, however other 
females had two, three or all legs affected. Original inci-
dence by age is shown in Table 1. Varying levels of lame-
ness was observed ranging from no effect on mobility, to 
mild aversion to weight on the affected limb, to pigs with 
muscular tremors walking in an eggshell-like fashion and 
going down in back. Initially two females were delivered 
live to the University of Illinois Veterinary Diagnostic 
 Laboratory.
Diagnostics (SPM and  KS)
Diagnostics on sacrificed females by UICVM pathologist 
on call reported the  following:
Morphologic  diagnosis:
1. Moderate bilateral subacute to chronic tibiotarsal and 
hock joints  tenosynovitis
2. Marked chronic tenosynovitis of the left carpal and 
right tibiotarsal  region
3. Moderate acute synovitis of the left stifle  joint
80 2013 Allen D. Leman Swine Conference
D
is
ea
se
s 
Re
se
ar
ch
D
iseases Research
Sarah Probst Miller; Alejandro Ramirez
Microscopic  report:
 Tendon sheaths were markedly thickened and expanded 
by mature fibrous connective tissue, as well as multiple, 
variably sized, occasionally coalescing foci with small 
to moderate numbers of reactive fibroblasts, newly 
formed blood vessels and small to moderate numbers 
of lymphocytes, plasma cells, and rare eosinophils 
and neutrophils. The synovial lining is multifocally 
thickened, eroded and partially replaced by protein-
aceous fibrillar material fibrin. The underlying areas 
are multifocally to locally extensively infiltrated by 
small to moderate numbers of lymphocytes, plasma 
cells, few eosinophils and rare neutrophils. In other 
areas the synovial lining is multifocally thickened 
(hyperplastic). The tendon sheath lumen contains vari-
ably sized clumps of fibrin with minimal amounts of 
necrotic cellular debris. The synovial membrane lining 
is multifocally minimally thickened, forms rare, small 
papillary projections, and the underlying soft tissues 
are infiltrated a few aggregates of small numbers of 
lymphocytes, plasma cells, and rare  eosinophils.
Microscopic  summary:
1. A moderate to marked diffuse chronic lymphoplasma-
cytic tenosynovitis with fibrin formation and granula-
tion tissue proliferation (Image Groups 3 and  4)
2. Minimal to mild multifocal chronic lymphoplasma-
cytic synovitis (Image Group  5)
3. Moderate to severe reactive lymphadenopathy with 
lymphoid hyperplasia. (Image Group  6)
In regards to long bone articular cartilage, the patholo-
gist noted some lesions within the articular cartilage and 
physis, but said that gross lesions and histopathology did 
not support OCD. He also reported that the observed le-
sions on the cartilage were likely secondary to expansion 
of inflammation centered on tendons and that nutritional 
disease seemed  unlikely.
M. hyosynoviae was isolated from Pig B’s right tarsal 
tendon. Other affected tendons in Pig A were not positive 
but the pathologist said that lesions were typical of M. 
hyosynoviae. At a later date from subsequent diagnostic 
submissions, M. hyorhinis was isolated from affected 
pigs (lungs) but not from leg lesion sites. Post treatment 
implementation there were no non-treated females on site. 
No further isolates occurred on subsequent submissions 
(6) likely do to treatment impact or efficacy. All lesions on 
submitted females looked the same on morphologic and 
microscopic examination and remained consistent with 
findings in the original case  submitted.
After these diagnostics, the veterinarian was tasked with 
development of a diagnostic, treatment, preventative and 
monitoring plan. The goal was to reduce lesion incidence 
and severity and increase the number of selects sold and 
to measure the effectiveness of the treatment/preventa-
tive  plan.
First plan of action and results  (SPM)
The first treatment program implemented had a dual 
preventative and treatment purpose. To accomplish this, 
a feed medication chlortetracycline (10 mg/lb.) pulsing 
program was initially instigated. Shortly after implementa-
tion the treatment/preventative plan, diagnostics showed 
the isolated M. hyosynoviae resistant to chlortetracycline, 
but sensitive to lincomycin. Lincomix is not labeled for 
reduction or control of Mycoplasma hyosynoviae however 
it is labeled for control of ileitis.2 This herd also needed 
a control plan for ileitis. Switching the treatment plan to 
Lincomix achieved this end goal as well and also had 
a secondary benefit of assisting with the Mycoplasma 
hyosynoviae prevention and treatment plan. Details of 
the plan implemented in late November of 2012 involved 
concentration of Lincomix therapy at 100 g per ton from 
3 to 8 weeks post entry, with pulses of Lincomix starting 
at 11 weeks and again at 15 weeks post entry. Table 1 a 
and 1 b show the incidence results of lameness (Table 1) 
and diarrhea (Table 2) and Fallouts (Table 3) per age per 
monthly visit as we monitored the quantitative impact of 
this prevention/treatment program on diarrhea and fallout 
incidence as well as  lameness.
Simultaneously, our isolate was forwarded to laborato-
ries to be poised for potential production of autogenous 
 vaccine.
Case communication to customers  (SPM)
The goal with preventative and treatment implementation 
was not to hide the situation, but rather be transparent and 
clear regarding our diagnostic findings and preventative/
treatment approach. As the plan was implemented, vet-to-
vets were completed with all customers and diagnostics 
and preventative/treatment plan discussed. During the 
vet-to-vet’s communication, we made it clear that this herd 
remained negative to Mycoplasma hyopneumoniae, but 
like many herds was positive to Mycoplasma hyosynoviae, 
and to the best of our knowledge was now experiencing 
clinical expression of Mycoplasma hyosynoviae. Vet-to-
vet’s information gathered reported that most of gilts 
merged well with the sow herds that were negative to 
PRRS and Mycoplasma hyopneumoniae, however if the 
herd converted to PRRS or Mycoplasma hyopneumoniae 
during acclimation, the severity of the lameness would 
increase vs. decrease. When Lincomix2 was implemented 
at the time of PRRS and Mycoplasma hyopneumonaie 
conversion, this increase in severity was mitigated or 
2013 Allen D. Leman Swine Conference 81
D
is
ea
se
s 
Re
se
ar
ch
D
iseases Research
Mycoplasma hyosynoviae A Case Study: Quantitative assessment of incidence and  severity across time...
eliminated. During and post communication customers 
were concerned, but expressed desire to remain on the 
same gilt source. They reported good performance of gilts 
in spite of the situation we were  addressing.
Further diagnostics plan started  (SPM)
A diagnostic and monitoring plan was implemented to 
further work to evaluate the impact of the prevention/
treatment program and impact on M. hyosynoviae and to 
evaluate whether M. hyorhinis was impacting the signs 
as well. The veterinarian in charge, Sarah Probst Miller, 
coordinated with the Zoetis representatives, Drs. Paul 
Knoernschild and Everett Rosey from Zoetis as well as 
Drs. Alex Ramirez and Phil Gauger at  ISU-CVM.
Background summary of diagnostic 
capabilities at the time of the plan 
development  (AR)
Unfortunately not all swine diseases have well established 
validated diagnostic tools available. Such is the case for M. 
hyorhinis and M. hyosynoviae. Culture for Mycoplasma 
spp is not easy and is usually time consuming. Mycoplas-
mas tend to be overgrown by contaminants quite easily. 
There are several PCR assays available for both of these 
mycoplasmas. These PCRs are quite sensitive and specific 
but unfortunately difficult to quantify the amount of DNA 
present in the sample; especially for M. hyosynoviae. As 
such, sometimes we can rely on CT values as close proxy 
to help us compare amount of mycoplasma DNA between 
two samples. This is not a perfect science, especially 
when comparing CT values from different days, but with 
caution, CT values can provide some insight into possible 
pathogen load until quantitative PCR assays are developed 
and  validated.
These PCR assays can be used on blood, tonsil scrapings 
as well as oral fluids. Past experience and research by ISU 
has shown that tonsil scrapings and oral fluids are the best 
samples for detecting M.  hyosynoviae.
Serologically we still have the problem on having a 
validated assay. Currently the ISU-VDL has a Tween-20 
ELISA assay for both M. hyorhinis and M. hyosynoviae 
that is still under research development. Although cutoff 
values have not been well established for these assays, the 
trend in increased in corrected optical density (OD) values 
can be used to demonstrate exposure through increased 
values. As a test under research development, OD values 
between dates can vary. Currently, based on past experi-
ence, we believe that the immune response detected by 
this Tween-20 ELISA assay occurs much later than the 
traditional 2 weeks post exposure we are used to with 
many other  pathogens.
Diagnostic plan created  (SPM)
The following diagnostic plan was  created:
1. Quantitative assessments of incidence and severity 
 levels:
a. To monitor the incidence rate and severity (ABCE 
ranking levels described in b.), whole barns of gilts 
were monitored monthly by choosing 4 pens of gilts 
per barn and assessing all gilts per pen for signs of 
lameness and associated  severity.
b. In each pen, 4 gilts were tagged and their level of 
lameness was monitored over time. Gilts were given 
a severity ranking of A, B, C or E. (See Images 4, 
5, 6 and  7),
i. A pigs showed aesthetic swelling but would likely 
sell as sound due full mobility (Image  4).
ii. B pigs also showed swelling on limbs but it was 
more advanced. These hogs if sound might sell 
and if not fully weight bearing on all limbs would 
not sell as selects (Image  5).
iii. C pigs would for sure end up a market hog vs. a 
select due to level of swelling and clinical lame-
ness (Image  6).
iv.E pigs were severely lame hogs that would either 
go on the cull/lite truck or be euthanized (Im-
age  7).
2. To further assess presence and intensity of M. hyo-
synoviae and M. hyorhinis in the population, the 
following sampling methodology was  completed:
a. Every month rope sampling was done in the selected 
 pens
b. Every month serum sampling and tonsilar swabbing 
was done on the tagged  gilts
Results (SPM and  AR)
Quantitative results showing incidence per symptoms of 
concern per month are reported in Tables 1, 2, and 3. Total 
incidence does not reduce over time. In fact, it appears to 
increase. At first, only total incidence of each symptom 
was assessed. We implemented ranking by severity in 
February. We believe by inclusion of the aesthetic lame-
ness category of A where these animals had mild visual 
signs, but no actual mobility lameness; we were more will-
ing to put females into this category thus increasing our 
incidence totals. At this same time, as we started to have 
females sold that had been through the entire treatment 
program; our percent selects sold started to go up (Table 8 
and 9). April 9, 2013 had our first group that had received 
80% of the preventative treatment plan and gilts sold on 
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5/9/2013 through 7/9/2013 had received 90 to 100% of the 
preventative/treatment plan. Once females receiving the 
preventative/treatment plan for most of their life started 
to be sold the range of percent sold moved from 38 to 55% 
sold to 58 to 75%  sold.
Quantitative results reporting the severity breakdown per 
incidence are shown in Tables 4a and b through Tables 7a 
and b. These charts show the percentage of A, B, C and E 
pigs in the total incidence reported. Since A pigs could be 
sold as selects, we also created a Linear Forecast Trend line 
showing the total pigs with symptoms minus the A pigs. 
Most of these forecasts in every age group are trending 
down indicating a trend towards more saleable females, 
except for the 15 to 18 week trend. We believe this 15 to 
18 week trend may be skewed by potentially aberrant July 
results. At the time of the presentation we will have August 
quantitative numbers in and will be able to understand if 
this July spike is artifact or real. Of importance is that the 
trend line is headed in the right direction for animals in 
the 19 to 22 week range as this is the age that the majority 
of females are sold (Table  7b).
Serology results April, May and June 
2013 testing  results
In April, Tween 20 testing showed presence of both M. 
hyosynoviae and M. hyorhinis. Table 10a shows the aver-
age S/P ratio of M. hyosynoviae across age groups. Both 
pathogens peaked at 22 and 17 weeks respectively. Initial 
exposure Table 11 shows the average S/P ratios for pigs 
ranked as A,B or C and Normal (labeled as blank in table) 
pigs. Normal pigs had lowest S/P ratios while B (subacute) 
and C (chronic) had the  highest.
In May and June we focused on just M. hyosynoviae to 
reduce total testing cost as M. hyorhinis was never isolated 
from a leg lesion and only from lung tissue. Also the height 
of symptoms matched better with the timing of typical M. 
hyosynoviae infections. May had similar results to April 
and June’s Tween 20 results are be redone to check test 
accuracy due to unexpected variation from April and  May.
Rope PCR  results
Rope PCR results are reported in Chart 1a-c. By pen fe-
males appear to arrive with some pens positive. As they 
start Lincomix treatment, the majority of pens are nega-
tive. As pigs move to non-medicated feed, pens start to 
move back positive again. This test lets us know that the 
Lincomix program does appear to reduce the presence 
of the pathogen when under full treatment; but it does 
show that in any given pen, the pathogen does reappear 
over time once treatment is discontinued. This would be 
discouraging if not for the results from the tonsilar swabs 
from the individual  females.
Tonsilar swabs of individual  females
In Chart 2a and b we have M. hyosynoviae results from 
tagged females. Results show a reduction in the number 
of pigs who are individually positive in those females 
who had received a more complete preventative/treatment 
course. With this test we speculate that by continuing the 
preventative/treatment Lincomix plan we appear to be 
reducing pathogen load over  time.
Next  steps
Based on these results, a decision has been made to hold 
the current preventative/treatment course and work to 
move the Lincomix program as close to arrival as pos-
sible. With this plan we hope to continue to reduce the 
pathogen load at this site. Due to a K88 diarrhea at arrival 
the herd is currently reluctant to move their Mecadox pro-
gram in the first two weeks post arrival. Lincomixwill go 
in the feed 2 weeks post entry for most  females.
At this time the herd is poised for potential autogenous 
production, but does not have immediate intentions of 
starting autogenous  production.
This report will be communicated to the sow farm and 
a possible pathogen reduction program at the sow farm 
level will be  discussed.
Discussion and significance of the case 
 study
M. hyosynoviae is hard to diagnose and prove correlation 
with lameness in certain circumstances. The novel rope 
tests for M. hyosynoviae involved in this case showed 
promise as a diagnostic tool for the industry to use in 
the future to help diagnose presence of M. hyosynoviae 
and treatment efficacy. In addition, tonsilar swabs of 
individual animals allowed us to better understand re-
duction in pathogen presence. When diagnostic testing is 
paired with regular intervals of quantitative assessment 
of incidence and severity of symptom, the presence and 
absence of clinical signs during therapeutic intervention 
can be potentially assist with diagnostics interpretation. 
This quantitative and diagnostic approach allowed us to 
achieve an early understanding of trends to know if we 
were on the right  track.
Summary of what we learned about 
diagnostic capabilities from this case 
 (AR)
One of the key points we have learned from this case study 
is that in working up a case like this using multiple diag-
nostic tools is essential; especially since we are dealing 
with tools that we are still learning how to use for this 
2013 Allen D. Leman Swine Conference 83
D
is
ea
se
s 
Re
se
ar
ch
D
iseases Research
Mycoplasma hyosynoviae A Case Study: Quantitative assessment of incidence and  severity across time...
particular pathogens. If we just take one individual test, 
say tonsil scraping PCR vs. oral fluid PCR, we would ar-
rive at different conclusions based on which test we would 
have chosen. In this flow, tonsil scrapings were more likely 
to be positive in younger animals while oral fluids tended 
to be more positive in older animals. Using multiple tools 
has allowed us to have a better picture on what may be go-
ing on in this flow. Also incorporating be big overall clini-
cal picture as well as having a keen understanding of when 
and how pigs are being medicated is a critical skill that 
attending herd veterinarians are able to bring to the table 
to help interpret diagnostic results. This re-emphasizes the 
importance of the clinical perspective and understanding 
necessary to interpret any diagnostic  results.
Images 1-7:
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7
Table 1: Lameness incidence per age per month.
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Table 2: Diarrhea incidence per age per month.
Table 3: Fallout incidence per age per month.
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Table 4a:
Table 4b:
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Table 5a:
Table 5b:
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Table 6a:
Table 6b:
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Table 7a:
Table 7b:
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Table 8: Percent sold in categories over per sell group date.
Table 9: Percent selects sold with a moving average trend line. 
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Table 10a: April Testing of M. hyosynoviae Tween 20 
results average of S/P
Table 10b: May Testing of M. hyosynoviae Tween 20 
results average of S/P
Table 10c: June testing results of M. hyosynoviae 
Tween 20 average of S/P
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Table 11: S/P ratios of A, B, C and Normal (blank) pigs.
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Chart 1a: April Rope PCR M. hyosynoviae
Count of 
R-s-R04 Column labels
Row  
labels Neg Pos
Grand 
total
4 3 1 4
7 2 2 4
11 3 1 4
17 1 3 4
22  4 4
Grand 
total 9 11 20
Chart 1b: May Rope PCR M. hyosynoviae
Count of 
R-s-R05 Column labels
Row  
labels Neg Pos
Grand 
total
4  2 2
8 4  4
11 2 2 4
15  4 4
21  4 4
Grand 
total 6 12 18
Chart 1c: June Rope PCR M. hyosynoviae
Count of 
R-s-R06 Column labels
Row 
 labels Neg Pos
Grand 
total
4 3 1 4
13 1  1
14 3  3
17 3 1 4
21  4 4
26    
3 3  3
Grand 
total 13 6 19
Chart 2a: April Tonsilar swabs on individual tagged 
pigs
Tonsilar  
swabs 
April
 Exposure appears to be higher. 
These pigs received a partial 
preventative/treatment therapy in 
their lifetime.
Count of 
s-R04 Column labels
Row  
labels Neg Pos Sus
Grand 
total
4 6  2 8
7 14 1 1 16
11 16   16
17 10 3 3 16
22 8 7 1 16
Grand  
total 54 11 7 72
Chart 2b: June Tonsilar swabs on individual tagged 
pigs
Tonsilar 
swabs  
June
 Exposure appears to be less than 
in April. These pigs have received 
more of the preventative/treatment 
therapy in their lifetime.
Count 
of s-R06 Column labels
Row 
 labels Neg Pos (blank)
Grand 
total
4     
13 4   4
14 12   12
17 15   15
21 13 3  16
26     
Grand  
total 44 3  47
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Influenza virus prevalence and risk factors  
in weaning-age  pigs
M. Allerson; M.  Torremorell
College of Veterinary Medicine, University of Minnesota, St. Paul,  Minnesota
Introduction
Influenza virus continues to be a major respiratory patho-
gen in pigs. A recent active surveillance study identified 
91% of enrolled growing pig farms as influenza virus 
positive during a 12 to 24 month study (Corzo et al., 2013). 
While many herd level risk factors have been described for 
influenza virus infection based on serologic surveillance, 
little information is available regarding influenza virus 
epidemiology in sow herds. Weaning age pigs have been 
identified as an important subpopulation for influenza 
virus infection, but little is known regarding factors influ-
encing influenza virus prevalence in sow herds (Allerson 
et al., 2013). The objectives of this study were to assess 
the prevalence and temporal patterns of influenza virus 
infection in weaning-age pigs and to evaluate the asso-
ciation between sow herd attributes (including influenza 
vaccination) and the prevalence of influenza virus positive 
weaning-age  pigs.
Materials and  methods
Sow herds (breed to wean) from across the United States 
were invited to participate in this study. Sow herds with 
a previous history of influenza virus infection were pref-
erentially enrolled. Each sow herd collected 30 individual 
nasal swab samples from weaning-age pigs each month for 
a six month period. All samples were tested for influenza 
virus RNA via a matrix gene based RRT-PCR in pools 
of 3 nasal  swabs.
Results
Fifty-two sow herds were enrolled from 5 different states 
and 8 different swine production systems. To date, ap-
proximately 5,160 nasal swabs (1,720 pools) have been 
collected and tested via RRT-PCR. Of the 1,720 pools 
(pools of 3 nasal swabs) tested, 22% were positive or 
suspect. Of the 172 sampling events (30 nasal swabs from 
a sow herd), 30% have contained at least one positive or 
suspect pool. Finally, of the 52 sow herds tested to date, 
42% have tested positive at least once for influenza  virus.
Discussion
The common use of multi-site production systems in the 
United States has allowed for the strategic segregation of 
pigs in order to reduce disease pressure on a particular 
site. This also allows for the elimination of certain patho-
gens once the infection dynamics of those pathogens are 
understood. This large scale study has identified weaning 
age pigs as a significant subpopulation for influenza virus 
infection and transmission. This knowledge will better 
inform control strategies and herd elimination strategies. 
Further risk factor analyses will add to the understanding 
of influenza virus at the sow herd  level.
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Dynamics of influenza in a wean-finish  population
Andres Diaz; Montserrat  Torremorell
College of Veterinary Medicine, University of  Minnesota
Introduction
Influenza A virus (IAV) infection is endemic in pigs 
worldwide. The epidemiology of IAV within and between 
species is extremely complex and not completely under-
stood. The virus has a segmented genome, negative sense 
RNA, with 8 gene segments that translate up to 12 differ-
ent proteins. The pig has been blamed to be the mixing 
vessel for IAV, but little is known of IAV virus evolution 
within swine populations. The objective of this study is to 
characterize IAV transmission in pigs after weaning, and 
to determine which factors allow IAV to persist in swine 
populations for prolonged  periods.
Materials and methods
One hundred and thirty two pigs out of two thousand and 
two hundred 3 week old pigs were randomly selected, 
and ear tagged, at arrival to a commercial wean to finish 
facility. The swine herd selected for the study was previ-
ously diagnosed as IAV positive, and received piglets 
from a single infected breeding herd. Nasal swabs were 
collected from each pig at arrival, and on a weekly basis 
for 15 weeks. Each swab was tested for IAV by RT-PCR 
targeting the M gene, and positive swabs were tested by 
RT-PCR to determine the subtype of IAV circulating 
within the population. The proportion of positive to nega-
tive pigs by RT-PCR were compared between weeks, and 
PCR results from individual animals were compared to 
assess the risk of re-infection with IAV over time. Serum 
samples were collected at arrival and every 4 weeks there 
after, and tested for antibodies to IAV by ELISA. The mean 
of the sample to negative ratios, (S/N) from the ELISA 
test, were compared between weeks using a paired t-test, 
and considered significant at  0.05.
Results and  conclusions
Positive pigs were identified at arrival to the barn by RT-
PCR indicating that weaned pigs can be a source of IAV 
to other swine populations. Additionally several animals 
tested positive after weaning. At least one animal tested 
positive to IAV for most of the weeks, (except for week 
10 after weaning). There were 2 infection waves identi-
fied throughout the study period (Fig. 1). There were 
significant differences on the ELISA S/N result between 
weeks. Overall our results indicate that IAV in endemi-
cally infected growing pigs is very dynamic, that wean 
pigs can be a source of IAV to other pigs after weaning 
and that the levels of maternal antibodies may play a role 
on the maintenance and development of new  infections.
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Figure 1: Frequency distribution of the number of animals that tested positive to IAV by RRT-PCR
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Getting a closer look at USDA swine influenza A 
surveillance: What can we learn from the genetic data that 
can help us on the  farm?
Tavis K. Anderson; Pravina Kitikoon; Amy L.  Vincent
Virus and Prion Research Unit, National Animal Disease Center, USDA-ARS, Ames,  Iowa
Introduction
Among the influenza A viruses (IAV) circulating in the 
US swine population from 1930 to present are at least ten 
genetically and antigenically distinct hemagglutinin (HA) 
lineages: three classical swine lineages H1α, H1β, H1γ; two 
lineages derived from human seasonal H1 viruses H1δ1, 
H1δ2; the H1pdm09; and H3 cluster I-IV viruses.1,2 The 
primary implication of these antigenic differences is that 
controlling infection and transmission via vaccination may 
not be optimal. Current swine IAV vaccines use multivalent 
formulations of field-sourced virus, each component repre-
senting one of the different lineages, but not all lineages are 
included.3 These vaccines elicit antibodies with a relatively 
narrow range of protection, and efficacy is equivocal for 
drifted  strains.
Our best option in controlling disease is the development 
and appropriate application of effective vaccines. It is es-
sential that these vaccine strains match viruses circulating 
in the swine population, and achieving this is predicated on 
availability of robust viral surveillance data. As a model, 
the global surveillance program administered by the World 
Health Organization for human influenza vaccine design 
conducts large-scale phylogenetic and antigenic analyses 
of thousands of HA1 sequences and hemagglutination 
inhibition (HI) results collected from >100 countries 
on a semi-annual basis to inform selection of strains for 
multivalent vaccine compositions.4 Although vaccine mis-
matches occasionally occur, a robust surveillance system 
has resulted in vaccines that tend to protect well against 
circulating viruses, reducing morbidity and mortality in 
the human population.5 Prior to 2009 such an approach 
would not have been feasible in the swine IAV system; 
however, capacity building efforts in North America, led 
by the United States Department of Agriculture (USDA) 
and implemented through the voluntary National Animal 
Health Laboratory Network (NAHLN) has redressed 
concerns about the insufficient quantity of virological and 
molecular surveillance of IAV in swine.6 Consequently, it 
is now possible to provide insight into the patterns of swine 
IAV spread, genetic diversity throughout the year, and 
the dynamics of IAV evolution in North America. These 
data allow for the identification of intervention strategies 
such as timely vaccine and diagnostic updates, as well as 
providing insight into determinants of transmission that 
could be mitigated by changes in production practices or 
facility  management.
Methods
 From 2009-2013 samples were collected from swine across 
the US and processed upon: a) observation of swine with 
influenza-like illness (ILI); b) observation of swine epi-
demiologically linked to a human case of novel IAV; or 
c) observation of swine with signs of ILI at “comingling 
points.” Up to 10 samples per laboratory accession, either 
from nasal swabs, lung tissues or oral fluids, were sent to 
a participating NAHLN laboratory and screened with a 
matrix (M) gene PCR assay specific for IAV. For those 
submissions positive for IAV, up to 2 positive samples were 
subjected to subtyping by PCR assays (H1 or H3, N1 or 
N2, and/or undetermined), and virus isolation. Successful 
virus isolations were further characterized by sequencing 
of the HA, neuraminidase (NA), and M genes and sub-
sequently deposited into the Influenza Virus Resource, 
National Center for Biotechnology Information’s online 
sequence repository.7
Nucleotide sequences from 1210 HA segments, 1175 NA 
segments, and 1197 M segments were analyzed from 
IAV from US swine during 2009-2013. Viruses were col-
lected from swine in 25 US states (Arkansas, Colorado, 
Iowa, Illinois, Indiana, Kentucky, Michigan, Minnesota, 
Missouri, Mississippi, Montana, North Carolina, North 
Dakota, Nebraska, New York, Ohio, Oklahoma, Oregon, 
Pennsylvania, South Dakota, Tennessee, Texas, Virginia, 
Wisconsin, and  Wyoming).
From these data, five sequence alignments were construct-
ed using MUSCLE v.3.8.31:8 an alignment of H3 and H1 
HA sequences, an alignment of N1 and N2 neuraminidase 
sequences, and an alignment of the M sequences. Based 
upon the H1 phylogeny, H1N1 and H1N2 isolates were 
assigned to one of six previously described H1 antigenic 
lineages, H1α, H1β, H1γ, H1δ1, H1δ2, H1pdm09.9,10 H3N2 
isolates were assigned to one of four main clusters based 
upon the H3 phylogeny,2 and H3 Cluster IV isolates to one 
of 6 recently designated “clades”.2 Within and between 
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clade nucleotide distances were calculated using MEGA.11 
To clarify the evolutionary history of the H3N2 viruses, 
sequences from randomly selected H3 Cluster I, II and 
III viruses in Genbank were included in addition to the 
USDA system H3N2 isolates. For each of the alignments 
a maximum likelihood tree was inferred using RAxML 
(v7.4.2;)12 employing a general time-reversible (GTR) 
model of nucleotide substitution with G-distributed rate 
variation among sites. The starting tree was generated 
under parsimony methods, with the best-scoring tree and 
statistical support values obtained with the rapid bootstrap 
algorithm (1,000  replications).
 To study the seasonal patterns of swine IAV in the US, 
we conducted statistical analyses using the number of in-
fluenza isolates aggregated by month from 2009 to 2013. 
Frequencies of monthly isolates were analyzed through 
decomposition of the time series into seasonal, trend and 
irregular components using Loess.13 Swine population 
estimates were sourced from the Quarterly Hogs and Pigs 
report produced by the National Agricultural Statistics 
Service (USDA: http://usda.mannlib.cornell.edu/). 
In addition, using a Lotka–Euler framework, we relate 
observed growth rate in the number of swine IAV cases 
in the surveillance system to the reproductive number.14 
In this way the reproductive number, which represents 
generation intervals and seasonal epidemic growth, pro-
vides insight into the strategies and efforts required to 
control swine  IAV.
Results and  discussion
 The three IAV subtypes (H1N1, H1N2, and H3N2) en-
demic in the US swine population were detected every year 
during our study period. The H1N1 and H1N2 subtypes 
were detected at similar frequencies across the 4 years, 
representing 37.4% and 36.8% of all isolates respectively. 
Although the H3N2 represented less than 25% of the 
identified viruses during the total time period, this sub-
type represented an increasing proportion of sequenced 
isolates, from 25% in 2010 to 33% in 2012. Among the 
H1N1 and H1N2 subtype viruses in our study, 1.1% were 
H1α, 3.4% were H1β, 32.8% were H1γ, 43.3% were H1δ1, 
3.9% were H1δ2, and 13.9% were H1pdm09. Of note, is 
the rapid increase in the occurrence of H1δ1 in samples 
submitted, with a concurrent decrease in H1pdm09 since 
2009. These data reveal year round circulation with a 
primary peak of sequenced isolates in October-November; 
and in H1N1 and H1N2, a secondary peak in March. We 
find that the reproductive number of H1N1, H1N2 and 
H3N2 across each year is larger than R = 1: in 2010 H1N1 = 
2.31 (1.7-2.9); H1N2 = 3.14 (1.3-5.7); H3N2 = 3.55 (1.6-6.8) 
and in 2012 H1N1 = 2.75 (2.6-2.9); H1N2 = 2.67 (2.5-2.8); 
H3N2 = 6.05  (1.1-14.8).
We also detected a seasonal trend in clinical swine IAV 
within the US We observe a primary seasonal peak that 
starts in September and peaks during November, and a 
secondary peak that begins in February and peaks in 
March. These peaks are coincident with changes in farm 
management. In the fall of each year when temperatures 
drop and daylight hours decrease, farms move from 
open-ventilation to closed-ventilation systems, with a 
concomitant change in indoor environmental conditions 
(i.e., reduced air exchange, decreased relative humidity). It 
is likely these factors facilitate transmission by exposing 
pigs to different climatic, airflow, and/or behavioral stress 
conditions; and management and control of transmission 
should take this into  consideration.
Swine IAV is commonly identified in diagnostic in-
vestigations of respiratory disease; these outbreaks and 
endemic infections likely cause significant economic 
burden on producers given the loss in growth potential 
following infection.15 Vaccines that do not sufficiently 
cover or match the observed diversity of IAV in the swine 
population and, in relation, poorly timed vaccine use (i.e., 
when pigs have circulating maternal antibodies16) likely 
contributes to the difficulty in controlling IAV in swine. 
Given that we document seven genetically and antigeni-
cally distinct hemagglutinin lineages (H1α, H1β, H1γ, 
H1δ1, H1δ2, H1pdm09 and H3 cluster IV) circulating, 
it is essential that we reconsider our approach to vaccine 
updates and/or technology. Surveillance of IAV in US 
swine has progressed substantially since 2009, providing 
timely insight into co-circulating viral diversity. These 
data should be used to inform intervention strategies of 
vaccine and diagnostic updates and potential changes 
swine health  management.
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Managing risk with employee safety and animal  welfare
Kevin  Wulf
Riverview  LLP
Animal agriculture is a risky place to be. Machines, 
humans, and animals are busy at all hours of the day 
and night. Therefore, personal safety and good animal-
handling techniques are pivotal pieces in managing risk 
in a sustainable  operation.
Perhaps risk can be best understood by using the analogy 
of driving or riding in a car. All of us have done that in 
our lifetimes, probably as recently as today, even though 
we know it has the potential to cause significant injury 
or death. Yet, we are willing to take that risk in order to 
achieve the end result of arriving at our destination. We 
also want to be efficient with our time while driving. Have 
you ever seen someone talking on his/her cell phone? Or 
texting? Or reading? Or shaving? Or applying make-up? 
Or various other activities? Of course, we all have. When 
drivers are occupying their minds in ways other than 
paying attention to their driving, the risk of having an 
accident increases dramatically. There are laws against 
texting while driving, but millions of people still text 
while behind the wheel, which brings up the unanswerable 
question: How safe is safe  enough?
This speaks to the point of effective safety programs and 
animal handling programs. Most employees on your farms 
know what is safe and what is not. They know what proper 
animal handling looks like and what is not appropriate. 
The programs with the most “thou shalt nots” are not the 
most effective. Those programs which touch the hearts 
of your employees are. Effective safety programs help 
people change their behaviors because they want to, not 
just because they have to. An effective program must also 
have a measurable goal and be very simple and easy to 
 understand.
Naturally, the most important part of any program is 
communication. First, the specific, measureable goals 
and expectations must be communicated to all employ-
ees. But one safety meeting per year is not enough. The 
communication must be ongoing and consistent. Warning 
signs and safety reminders ought to be posted in visible 
areas, safety discussions should happen on a daily basis 
and a culture of candor and openness should be nurtured 
in order to hold one another accountable. The same can 
be said of animal handling. Open communication about 
the expectations, protocols, procedures and consequences 
must be continually  cultivated.
Perhaps you only visit the operation once per month as an 
on-call veterinarian. What can you do? You can encourage 
the owner/manager to have employee safety and animal 
handling conversations with his/her employees. You may 
share ideas you have seen on other farms. You may visit 
with employees to help them see the importance of good 
animal handling techniques and safety protocols. You are 
part of the problem if you sit back and passively watch 
things happen that you know are not  right.
As business owners/operators and veterinarians we have 
an obligation to our employees and animals. We must 
provide a work environment which promotes employee 
safety and the well treatment of animals. We must have 
measures in place to encourage good performance and 
discipline misbehavior. And we must ensure that all em-
ployees are aware of the expectations and  consequences.
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Injury prevention in swine  production
Luis Torres
For the most part, safety hazards and injury types in a hog 
farm are similar to those found in other agricultural pro-
duction units. Animal contact, operation of specialized and 
general equipment, tractors and other vehicles, electrical 
hazards, unsafe walking and working surfaces, chemical 
exposure, confined spaces, and extreme temperatures can 
result in injuries of various types. These include caught 
in or between two objects, animal etc.; slips, trips, and 
falls; electrocution; hit by or against and object, animal, 
etc.; chemical and fire burns; eye injuries; and oxygen 
deprivation, to mention some of the most common. The 
severity of these injuries also varies from minor abrasions 
and bruises to loss of limbs and lives. With that said, this 
document will review these risks and hazards specifically 
from the perspective of the people working in pig produc-
tion  environments.
Hazard ID and risk  assessments
“A hazard is any existing or potential workplace condition 
that, by itself or by interacting with other variables, can 
result in death, injury, property damage, or other loss.”1
The first step in understanding hazards and risks specific 
to the swine production industry is to review every one of 
the procedures performed by each individual production 
employee Currently, pig production is divided in three 
stages, and therefore into three different types of pro-
duction units: sow production, boar studs, nurseries, and 
finishers (wean to finish). Although these types of units 
share the same general hazards and risks, there are differ-
ences between them in the potential frequency, likelihood, 
and severity of the resulting injuries. The differences are 
primarily due to the differences in the size of the pigs at 
each stage, but it is also due to the different processes 
and procedures performed by the workers. Because of 
those differences, it’s recommended to perform hazard 
identification and risk assessment for each production 
stage. Hazard assessments should be conducted anytime 
a change is made to the workplace (processes, equipment, 
materials, construction modification,  etc.).
The purpose of formal hazard identification is (1) to find 
patterns of unsafe conditions or behaviors; (2) to determine 
which of these hazards have a significant impact on the 
frequency, likelihood, and severity of workplace incidents; 
and (3) to use that information to prioritize the order in 
which potential hazards should be addressed. The hazards 
on that short list are deemed to be significant  risks.
Significant risks in a swine production  unit
• Animal  contact
 Examples of farm tasks that present this  risk:
▶ Moving boars, sows, gilts, feeder pigs, and finish-
ing hogs between and inside  barns
▶ Loading and unloading animals from live-haul 
 trucks
▶ Heat  detection
▶ Pregnancy checking in gestation  barns
▶ Vaccination or blood  collection
▶ Assisting sows during  parturition
▶ Tagging/tattooing
▶ Euthanizing heavy hogs or breeding  stock
• Walking/working surfaces  (slips/trips/falls)
 Examples of farm tasks that present this  risk:
▶ Every task performed inside the  barns
▶ Climbing feed bins, flush tanks, and  pens
▶ Loading/unloading animals using loading  chutes
▶ Showering in and out of the  farm
▶ Any area of the farm with deficient  housekeeping
▶ Any area outside the barns with slippery condi-
tions due to weather or  spills
• Operating tractors and other farm  vehicle
 Examples of farm tasks that present this  risk:
▶ Grass  mowing
▶ Dead pig  disposal
1    National Safety Council. Advance H&S certification  manual.
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▶ Weed  spraying
▶ Cleaning feed or waste water  spills
Other risks that have shown to produce incident patterns 
 are:
• Electrical hazards due to exposed wires or defi-
cient repairs and maintenance or lock-out tag-out 
 programs.
 Examples of farm tasks that present this  risk:
▶ Pressure  washing
▶ Replacing feed  motors
▶ Operating fans, heaters, heat pads, curtain sys-
tems, and  lights
▶ Working around electric fences outside  barns
• Exposure to Chemicals due to deficient Hazard 
Communication and personal protection equipment 
(PPE)  programs
 Examples of farm tasks that present this  risk:
▶ Disinfecting farrowing  rooms
▶ Pesticide  application
▶ Reproductive hormone  injections
• Caught in or between two objects, animal etc. due to 
deficient Training and Machine Guarding  programs
 Examples of farm tasks that present this  risk:
▶ Operation of fans, feed motors, or tractor  PTO
▶ Dead cart  operation
▶ Hand feeding using feed  carts
◆ Composter and incinerator  operation
• Injuries incurred during non-routine tasks due to 
deficient Hazard ID and Risk Assessment  programs
 Examples of farm tasks that present this  risk:
▶ Cleaning waste-water recycle  lines
▶ Construction and building  modifications
▶ Live haul vehicle accident  response
▶ Any task performed less than once a  month
Operational  controls
Once the hazards existing in the work areas have been 
identified, analyzed, and prioritized, the next step is 
to implement controls to minimize them or eliminate 
them. This process should consider the specifics of each 
hazard, including the frequency of employee exposure 
and the availability of mitigating technology, materials, 
and human resources. Control methods can be based on 
engineering, administrative, or PPE  processes.
Ideally, the solution to prevent injuries should result from 
enhanced engineering controls. This integrates safety 
protocols into the design of a work procedure before 
the workers are involved by modifying, substituting, or 
eliminating materials, processes, and equipment; or by 
installing barriers between areas of hazard exposure and 
the  workers.
If engineering based solutions are not feasible, the next 
best thing to do is to eliminate or reduce risks using an 
administrative control. This category of controls eliminate 
or minimize worker’s exposure to hazards by establish-
ing a comprehensive program for housekeeping, workers 
training, job rotation, adequate rest periods, tools, equip-
ment, and facility compliance audits and  inspections.
Use of PPE should always be the last option of operational 
control to be considered. The reason is that control using 
PPE does not eliminate or even reduce workplace hazards. 
PPE provides only an immediate barrier between the 
worker and the hazard, and too many variables (quality, 
comfort, training, commitment, supervision) could affect 
the efficiency of the protection achieved using  PPE.
Safety included in all training and 
development  activities
Besides being an OSHA requirement and part of the ad-
ministrative control category, including safety in all worker 
training is a crucial component of any effort to eliminate and 
prevent workplace injuries. Too many sectors of agriculture 
industry still train their workers on the most efficient way 
to perform a task and leave the worker the responsibility to 
figure out the safest way to do it. In a true safety culture, the 
best way to perform a task is also the safest  one.
When workers receive training on the best and safest way 
to do a job simultaneously, they perceive the expectation 
from their supervisor is to fulfill the requirement as a 
whole, and not to ignore safety for the sake of efficiency. 
This ensures that the workers will learn the safety aspects 
for the specific tasks they are performing; nothing more, 
but most importantly, nothing  less.
Finally, conducting appropriate safety training does not 
guarantee the elimination or reduction of incidents. A 
follow-up and compliance monitoring program that in-
cludes strict but fair and consistent disciplinary actions as 
well as meaningful acknowledgement of positive safety 
practices is an equally critical element for maintaining an 
appropriately safe workplace  environment.
2013 Allen D. Leman Swine Conference 111
Pr
od
uc

on
Produc
on
Injury prevention in swine  production
Near  misses
Unfortunately, not even the best hazard identification pro-
gram is 100% effective. There will always be unidentified 
hazards that result in close calls that almost lead to inju-
ries, especially with non-routine tasks. Because it’s pain-
less and inexpensive, the investigation of near misses is 
the best way to prevent injuries in the workplace. However, 
this is only effective if the workers involved in the inci-
dents take the time to report it; supervisors and workers 
conduct a thorough investigation that results in appropriate 
corrective action; those measures are communicated to all 
workers and recorded; and a timely follow-up is conducted 
to verify effectiveness and  compliance.
Conclusion
Safety works, try it  first
When it comes to safety, prevention is always better than 
reaction. A good safety program must include strong hazard 
identification and risk assessment protocol; an up-to-date 
and comprehensive set of hazard-reducing operational con-
trols through the application of engineering, administrative 
and protective equipment solutions; a training program 
that includes safety in all standard operating procedures; 
an efficient tracking and investigating system for all work-
place incidents that includes immediate and appropriate 
corrective action; a versatile communication system to 
maintain universal workplace awareness of the safety pro-
gram; and production of simple but meaningful incentives 
to recognize and reward employee  participation.
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The Upper Midwest Agricultural Safety and Health  Center: 
Worker health and safety in animal  agriculture
Bruce H. Alexander, PhD; Jeffery B. Bender, DVM,MS,  DACVP
The challenge of providing a consistent, affordable, and 
safe food supply for a growing population has lead to 
considerable change in how food is produced in the United 
States and globally. The agriculture industry continually 
evolves in response to economic conditions, social driv-
ers, such as environmental and animal welfare concerns, 
and globalization. As the industry changes there can be 
both positive and negative consequences for the health 
of agriculture producers, workers, and their families. To 
ensure the health and well-being of agricultural popula-
tions is maintained, innovative approaches using multi-
disciplinary partnerships are  required.
The Upper Midwest Agricultural Safety and Health Cen-
ter (UMASH) was formed to develop multidisciplinary 
approaches to address existing and emerging workplace 
health and safety issues in agriculture. UMASH is dedi-
cated to improving the health, safety, and well being of 
agricultural workers and their families by building part-
nerships to improve knowledge about safety and health in 
agriculture and to inform industry practices and policy. 
UMASH has adopted three guiding principles to address 
its  mission.
•	 All	people,	organizations,	and	diverse	perspectives	
are important to the work of  UMASH.
•	 UMASH	embraces	and	promotes	a	One	Health	phi-
losophy that emphasizes the connections between 
human health, animal, and plant health and the 
health of the  environment.
•	 UMASH	partners	seek	to	understand	how	changes	
in agriculture, to meet an increasing global demand 
for	food	and	fiber	at	affordable	prices	and	produced	
in a sustainable manner, can impact agricultural 
workers and their  families.
The Upper Midwest produces more hogs than any other 
region in the country, thus the health and safety in swine 
production is a priority for the UMASH center. Some of 
the Center’s work is directly related to health and safety in 
swine production, while other work may provide tangential 
information on health and  safety.
Agriculture is recognized as a dangerous profession with 
some of the highest rates of fatal and non-fatal injuries. 
The type of agriculture and production methods largely 
determines	the	specific	health	risks	related	to	agriculture.	
All types of animal agriculture production can create 
potentially hazardous environments. Exposure to organic 
dusts, bioaerosols gases, and injury hazards are common. 
In the pork industry there is a recognized potential for 
exposure to dusts, toxic gases, and endotoxin at levels 
sufficient	 to	 affect	 respiratory	 health	 (Charavaryamath	
et al. 2005; Dosman et al. 2006; Heederik et al. 2007; Mc 
Donnell et al. 2008; Von Essen and Donham 1999; Von 
Essen et al. 2010; Von Essen and Auvermann 2005; Wyatt 
et	al.	2008).	These	exposures	are	modified	by	production	
practices,	particularly	confinement	operations	that	bring	
many animals into a smaller space. Though the potential 
for exposure is well characterized, the impact on the 
production practice is not clear. Injury risk is another 
recognized hazard in agriculture and contact with animals 
is considered one of the major risk factors (Boyle et al. 
1997;	Erkal	et	al.	2008;	Hard	et	al.	2002).	Animal	confine-
ment operations, including pork, dairy, beef, and pork are 
known to be high injury risk work places in contrast to 
other agriculture (Kaustell et al. 2007; Mitloehner and 
Calvo 2008; Gordon and Rhodes  1993).
The trend toward fewer, larger and more specialized 
pork production enterprises has been accompanied by a 
continual rise in the pig inventory (National Pork Board 
2010) and a greater percent of the labor force working 
for larger operations (Kliebenstein et al. 2005). By 2005 
nearly 30 percent of employees worked on operations 
that produced more than 100,000 pigs, where as less than 
9 percent of operations produced 10,000 or more pigs in 
1990. Despite the trend toward the use of larger production 
facilities, there are still a substantial number of producers 
with smaller enterprises. A review of the industry in 2006 
reported that 85 percent of swine come from operations 
marketing at least 10,000 hogs per year, while 86.1 percent 
of the operations marketed fewer than 1,000 hogs annually 
(Grimes and Lawrence 2006). The trends in employment 
also track the specialization occurring in the pork indus-
try.	There	is	a	movement	away	from	the	farrow-to-finish	
operations where all phases of pork production occurs on 
one site toward specialization; 83.1% to 43.7% of producers 
(Kliebenstein et al. 2005). Specialization may impact the 
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potential for various exposures or injury such as repetitive 
motion injuries. In the past workers may have spent only a 
part of each day in barns caring for animals, but in special-
ized swine farms the workers are employed full-time in the 
pork enterprise. In the 2005 survey of pork producers and 
employees, employees indicated that they worked an aver-
age of 45.3 hours (Kliebenstein et al. 2005). With every 
other weekend or partial Saturdays and Sundays off, it is 
common for pork production workers to put in a 50-hour 
work week and 11.3% of employees indicate that they 
do not have any weekends off (Kliebenstein et al.  2005).
As	the	industry	has	moved	toward	greater	intensification	
and specialization in pork production there has been an 
increase in consumer interest in, and concern about, food 
production, which has been described as “consumer driven 
agriculture” (Martinez and Davis 2002). The concern 
over animal welfare has lead toward changes in practices 
demanded by consumers and the food retail industry. 
For example, several states are following suit with the 
European Union and considering a ban on gestation stalls 
(Harper 2006). The EU is also planning to ban piglet 
castration by 2018 (PigProgress.net 2010). These trends 
are also being observed in the United States as several 
states have banned gestation stalls, and the largest pork 
producer in the United States agreed to voluntarily move 
their sows from stalls to penned housing (Harper 2006). 
Potential impacts on the workplace are possible from these 
production changes, such as more frequent interaction of 
workers with loose animals as well as contact with intact 
males that may be more aggressive than castrated  males.
The type of facility or practice employed in the industry 
may	reflect	the	economic	and	social	influences.	The	con-
finement	facilities	are	under	scrutiny	for	environmental	
exposures and some efforts have been made to character-
ize the impact of production methods on workplace and 
environmental health. The modest efforts to date suggest 
potential differences in exposure by season (Kim et al. 
2007;	O’Shaughnessy	et	al.	2010).	The	influence	of	con-
finement	facility	type	is	not	well	characterized,	and	the	
studies that have explored the issue have been limited 
(Diefenbach et al. 2007; Lavoie et al. 2009; Letourneau 
et al.  2010).
The UMASH center has currently funded projects related 
to health and safety in the pork production industry, 
methicillin-resistant Staphylococcus aureus (MRSA) 
colonization and infection in swine veterinarians, surveil-
lance of disease and injury in dairy farmers, surveillance 
of zoonotic diseases in agriculture workers, immigrant 
dairy worker health and safety, facilitating return to work 
in ill and injured workers, and establishing a multidisci-
plinary network to address agriculture worker health and 
safety issues. The center is also building partnerships to 
engage producers in conversations about health and safety 
of their employees as the workforce and other drivers such 
as animal welfare, economics and emerging pathogens 
influence	their		operations.
In this conference we will discuss the characterization of 
risks to pork production workers for injuries and airborne 
exposures in the working environment in a study compar-
ing concentrations of airborne contaminants and potential 
injury risk in operations using gestation crates or gesta-
tion pens. We will also summarize information related to 
the risk of needlestick injuries in livestock workers and 
potential methods for  prevention.
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Introduction
Escalating costs of typical swine feed ingredients such as 
corn and soybean meal has created a demand for producers 
to consider feeding diets containing higher levels of by-
products to nursery and finishing pigs to reduce feed cost. 
However, these alternative feed ingredients are generally 
higher in fiber and lower in dietary energy compared to the 
cereal grains normally utilized. This decrease in energy 
along with increased fiber and decreased bulk density can 
lead to decreased performance and an increase in the time 
needed for hogs to reach target market  weights.
In light of these circumstances, more emphasis is being 
placed on feed processing technologies to improve utiliza-
tion of the higher fiber diets. Fine grinding and pelleting 
are the two primary feed processing technologies that exist 
that will improve feed efficiency. First, reducing particle 
size of individual ingredients or whole diets is commonly 
understood to improve their digestibility and consequently 
feed efficiency, but little research has explored the effects 
of fine-grinding high fiber alternative ingredients or the 
entire diet containing these high fiber ingredients. Second-
ly, pelleting high by-product diets will improve diet bulk 
density, reduce feed wastage, and potentially improve diet 
digestibility. When used in tandem, reducing particle size 
of ingredients or complete diets and then pelleting could 
potentially be useful strategies to improve feed efficiency 
and subsequently reduce the cost per pound of  gain.
Adding the necessary infrastructure to fine grind and pel-
let diets has a high initial cost and necessitates increased 
energy usage, which leads to a higher cost of production of 
the feed. However, these extra costs should provide more 
economic return through improved feed utilization and 
growth performance. Thus, the economics associated with 
the increased production costs of grinding and pelleting 
need to be studied and compared with pig performance 
 benefits.
In this paper we briefly review recent studies conducted 
at Kansas State University investigating the effects of fine 
grinding high fiber ingredients such as dried distillers 
grains with solubles (DDGS), wheat middlings (midds), 
and soybean hulls as well as the interactive effects of fine 
grinding and pelleting on both nursery and finishing pig 
growth  performance.
Nursery  pigs
Recently, four studies were conducted to investigate the 
effects of fine grinding high-fiber ingredients and/or 
complete diets as well as the effects of pelleting on growth 
performance of nursery  pigs.
Experiment 1 – Pelleting and particle  size
De Jong et al. (2013a) used a total of 675 nursery pigs in 
a 21-d study to evaluate the effects of varying ingredi-
ent particle size and diet form on nursery pig growth 
performance and caloric efficiency. Pigs were fed 1 of 8 
experimental diets including 3 corn-soybean meal–based 
diets consisting of: (1) corn fraction ground to an average 
of 620 µ and fed in meal form, (2) corn fraction ground 
to an average of 352 µ and fed in meal form, and (3) corn 
ground as in diet 2 but fed in pellet form. The remaining 
5 diets were high by-product diets containing 20% midds 
and 30% DDGS. Diets 4 to 8 consisted of: (4) corn fraction 
ground to an average of 620 µ, midds and DDGS unground 
(as received from the supplier) with an average particle 
size of 534 µ and 701 µ, respectively, and fed in meal form; 
(5) diet 4 but corn fraction ground to an average of 352 µ 
and fed in meal form; (6) diet 5 but fed in pellet form; (7) 
corn, soybean meal, DDGS, and midds ground to average 
particle sizes of 352 µ, 421 µ, 377 µ, and 357 µ, respectively, 
fed in meal form; and (8) diet 7 but fed in pellet form. The 
diets were not balanced for dietary energy, thus energy 
was lower for treatments 4 to 8 than for treatments 1 to  3.
Overall, pelleting diets improved ADG and G:F as expected, 
but reducing corn particle size reduced ADG as a result 
of decreased ADFI. Pigs fed the high-by-product diet had 
reduced ADG, ADFI, and final BW and poorer G:F, but 
caloric efficiency (defined as the amount of calories needed 
to produce one unit of gain) was similar to pigs fed the corn-
soybean meal–based diet. Finally, grinding the by-products 
to a smaller particle size further reduced ADG, ADFI, and 
final BW and did not influence feed  efficiency.
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Experiment 2 – Particle size pelleting and 
grinding  DDGS
In the second experiment De Jong et al. (2013b) used 687 
nursery pigs in a 21-d study to evaluate the effects of fine 
grinding corn or DDGS in diets fed in meal or pellet form 
on nursery pig performance. The 10 experimental diets 
fed included 4 corn-soybean meal-based diets consisting 
of: (1) corn ground to ~638 µ in meal form, (2) treatment 
2 in pellet form, (3) corn ground to ~325 µ in meal form, 
and (4) treatment 3 in pellet form. The remaining 6 diets 
contained 30% DDGS. Diets 5 to 10 consisted of: (5) corn 
and DDGS ground to ~638 and 580 µ, in meal form, (6) 
diet 5 in pellet form, (7) corn and DDGS ground to ~638 
and 391 µ, in meal form, (8) diet 7 in pellet form, (9) corn 
and DDGS ground to ~325 and 391 µ, in meal form, and 
(10) diet 9 in pellet  form.
A corn particle size (regardless of DDGS addition) × diet 
form interaction was observed as a result of increased 
ADFI when corn was ground and fed in pellet form but 
decreased intake when corn was finely ground and fed in 
meal form. Pelleting the diets decreased ADG, ADFI, and 
final BW and increased G:F and caloric efficiency on both 
an ME and NE basis. Fine grinding corn decreased ADG 
as a result of numerically decreased ADFI. Also, feeding 
30% DDGS decreased ADG, ADFI, and NE caloric ef-
ficiency, and tended to decrease final  BW.
Experiment 3 – Corn particle size, complete diet 
grinding and  pelleting
A third trial conducted in a commercial setting was com-
pleted to evaluate the corn particle size results found in 
the first two experiments. De Jong et al. (2013c) used 996 
nursery pigs in a 21-d study to evaluate the effects of corn 
particle size, complete diet grinding, and diet form on 
nursery pig growth performance. The same corn-soybean 
meal-based diet containing 30% DDGS and 10% midds 
were used for all treatments. The 6 treatments were: 1) 
roller-mill ground corn (737 µ) fed in meal form; 2) treat-
ment 1 fed in pellet form; 3) hammer-mill ground corn 
(324 µ) fed in meal form; 4) treatment 3 fed in pellet form; 
5) complete mixed diet reground through a hammer-mill 
(541 µ fed in meal form; and 6) treatment 5 in pellet form. 
All diets contained 2% added fat prior to  pelleting.
Overall ADG and ADFI decreased when corn was finely 
ground and fed in meal form, but increased when fed in 
pelleted form. Pelleting diets improved ADG, G:F, ME and 
NE caloric efficiencies, and final BW. The interaction of diet 
form × corn µ and numerical decreases in intake of pigs 
fed fine ground complete diet, suggests that finely ground 
feed fed in meal form may reduce palatability of the diet; 
however, improved performance from fine grinding may be 
realized if the diet is fed in pelleted form. Thus data from 
this trial shows that pelleting diets significantly improved 
performance and fine grinding corn numerically improved 
performance when fed in pelleted form. No additional 
improvements were found when the complete mixed diet 
was finely ground compared to only grinding corn, which 
agrees with earlier nursery  studies.
Results from these three studies suggest that reducing 
the particle size of either corn or high fiber ingredients in 
complete feed when fed in meal form decreases perfor-
mance in nursery pigs. While previous research has shown 
improvements in reduced particle size, most of this work 
only showed a response to approximately 500 µ and no ad-
ditional benefit by grinding to a smaller particle size. The 
available research is consistent with our findings where 
fine grinding corn did not result in further improvements 
and in fact negatively impacted feed intake and gain when 
fed in meal form. Interestingly, as all major ingredients 
were ground in the high-by-product diet and fed in meal 
form, feed intake for these pigs was reduced even further, 
which suggests that feeding a finely ground complete diet 
may negatively influence  palatability.
The varying response to pelleting on nursery pig perfor-
mance in these three trials supports previous research 
where not all, but the majority of trials have shown a 
positive effect on growth  performance.
Medel et al. (2004) showed inconsistent results when pigs 
fed diets that were pelleted had improved G:F from d 22 to 
42 post-weaning but had no differences in ADG. Traylor et 
al. (1996) conducted an experiment feeding meal and pel-
leted diets to nursery pigs. They also observed improved 
G:F when pigs were fed pelleted feed; however, there 
were no differences in ADG. Hansen et al. (1992) also 
showed improved G:F of nursery pigs when fed a pelleted 
diet compared to the same diet in meal form immediately 
following weaning with no changes in ADG. This trend 
held true in our current nursery experiments as there was 
an improvement in G:F for all three experiments, but pigs 
in the first experiment had improved ADG and pigs in the 
second and third experiments had decreased  ADG.
We believe the reduction in ADG from feeding pellets that 
was associated with a similar decrease in ADFI may be 
a result of increased pellet hardness. We observed a high 
pellet durability index which is an indicator of a hard pel-
let. Mavromichalis et al. (2002) conducted 2 experiments 
to determine the effects of pellet hardness on nursery pig 
growth performance. In the first experiment they showed 
that harder pellets decreased ADFI and ADG but had no 
effect on G:F and in a second experiment, ADFI tended 
to decrease leading to numerically decreased  ADG.
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Experiment 4 – Grinding and pelleting soy hull 
 diets
A fourth experiment was conducted in a commercial set-
ting to determine the effects of fine grinding or pelleting 
diets containing soybean hulls. Goehring et al. (2013a) 
used a total of 1,100 nursery pigs in a 42-d growth trial 
to determine the effects of increasing soybean hulls (10 or 
20%) and soybean hull particle size (unground or ground) 
in nursery pig diets fed in both meal and pelleted forms. 
The average particle size of the unground and ground 
soybean hulls were 617 and 398 µ,  respectively.
Soybean hulls worsened G:F when fed at 20% compared 
with 10%;  however, pelleting these diets resulted in little 
change in G:F compared with the 20%  inclusion fed in 
meal form. Pelleting diets resulted in improved ADG, but 
also increased feed intake, which resulted in no change in 
feed efficiency compared with pigs fed a meal diet. The 
increased feed intake could be the result of providing a 
more dense feed, because soybean hulls in a meal diets 
reduced diet bulk density. For fine grinding soybean hulls, 
ADG and ADFI were reduced which resulted in no change 
in feed  efficiency.
Nursery  summary
Pelleting and fine grinding had few positive and even some 
negative effects on nursery pig performance. Possible 
reasons include decreased palatability of finely ground 
ingredients, limited or no benefit to grinding grain finer 
than 600 µ for nursery pigs, or limited biological benefits 
of fine grinding other ingredients for nursery pigs. We 
speculate that the lack of improvement to pelleting in the 
second experiment may have been a result of increased 
pellet hardness. It is clear; however, that more research 
needs to be conducted to determine the optimum particle 
size of cereal grains and complete diets when fed to 
nursery pigs as well as the effects of pellet hardness on 
nursery pig  performance.
Finishing  pigs
Two studies were conducted to investigate the effects 
of feed processing technologies on high fiber diets for 
finishing  pigs.
Experiment 1 – Processing techniques for diets 
with high fiber  ingredients
The first trial was conducted in a commercial setting in-
vestigating the effects of corn particle size, complete diet 
grinding, and diet form of high fiber diets on finishing pig 
growth performance. De Jong et al. (2013d) used a total of 
855 finishing pigs in a 111-d trial. All pigs were fed the same 
corn-soybean meal–based diet containing 30% DDGS and 
20% midds. Different processing techniques were used to 
achieve the 5 dietary treatments: (1) roller-mill ground 
corn to approximately 650 µ with the diet fed in meal form; 
(2) hammer-mill ground corn to approximately 320 µ with 
the diet fed in meal form; (3) treatment 2 pelleted; (4) corn 
initially roller-mill ground to approximately 650 µ, then 
the complete mixed diet reground through a hammer-mill 
to approximately 360 µ with the diet fed in meal form; and 
(5) treatment 4 fed in pellet  form.
Overall diet form × portion ground interactions were 
observed for ADG, ADFI, final BW, percentage of pigs 
removed per pen, and HCW. These interactions occurred 
because fine grinding the complete diet reduced each vari-
able when fed in meal form, whereas pigs fed that same 
diet in pellet form had increased responses for each of the 
measurements. Reducing particle size of the corn from 650 
to 320 µ did not affect ADG or ADFI but improved G:F 
and caloric efficiency. Pelleting the diet improved ADG, 
G:F, caloric efficiency, final BW, HCW, and loin depth but 
tended to increase  BF.
Particle size reduction improved G:F and caloric ef-
ficiency; however, fine grinding the complete diet was 
actually detrimental to performance when fed in meal 
form. Particle size reduction of corn has been consistently 
shown to improve performance in finishing pigs. Hedde 
et al. (1985) observed that pigs fed finer particle corn 
compared to simple cracked corn had improved ADG and 
G:F. Wondra et al. (1995 a,b) found that reducing particle 
size from 1,000 to 400 or 800 to 400 µ improved G:F and 
apparent digestibility of  diets.
It is commonly understood that fine grinding will influence 
feed mill production parameters. Wu et al. (1985) found 
that decreasing particle size increased the total particle 
surface area but worsened mill production rate and grinding 
efficiency. Thus, feed mill operators and producers must 
balance decreased mill efficiency with growth  benefits.
We hypothesized that grinding the corn, complete diet, 
and pelleting would have allowed for more calories to be 
available to the pig, thus improving caloric efficiency. 
However, only grinding the corn portion and pelleting the 
diets improved caloric efficiency. Interestingly, grinding 
the entire diet post-mix did not improve caloric efficiency 
over that of the diet containing fine ground corn. This 
means that fine grinding the other major ingredients (soy-
bean meal, DDGS and midds) did not create additional 
dietary energy for the pig regardless of feed form. In ad-
dition, this study showed that ADFI decreased when the 
complete diet was finely ground. The decrease in ADFI 
may have been a result of decreased palatability of the diet 
when finely ground. Work by Mavromichalis et al. (2000) 
and Wondra et al. (1995a) both showed that finely ground 
ingredients in diets decreased  ADFI.
Ulceration of the pig’s esophageal region of the stomach 
is a concern when feeding finely ground ingredients or 
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diets. There were increased removals off test for pigs fed 
the diet that was post-mix ground and pelleted. However, 
no clear link was found between the removals and feed 
processing in this study. Most removals reported during 
the study appeared to be caused by reasons other than 
experimental treatment effects. More research needs to be 
conducted to evaluate whether this effect was  diet-related.
Fine grinding ingredients and complete diets can also 
potentially lead to feed handling issues. In the current 
experiment, angle of repose was used as an indicator of 
the flow ability of the diet. Angle of repose is the measure 
of the internal angle created by feed allowed to flow freely 
onto a horizontal surface. As the angle increases (becomes 
steeper) the feedstuff is associated with having decreased 
flow ability. Fine grinding only the corn fraction of the 
diet didn’t affect angle of repose when compared to the 
control and this was most likely caused by the limited 
concentration of corn (30-40%) in the diet. However, when 
the complete diet was reground there was an increase in 
the angle of repose when compared to the control or the 
meal diet with finely ground  corn.
In conclusion, fine grinding corn and pelleting the diet 
improved performance and carcass characteristics, as well 
as caloric efficiency of finishing pigs. However, grinding 
the complete diet and feeding it in meal form had detri-
mental effects on all criteria measured which may be due 
to reduced palatability of a finely ground diet presented 
in meal form. Finally, post-grinding a complete diet did 
not provide any advantage in growth performance to that 
of a diet with only finely ground corn. This indicates that 
fine grinding DDGS, midds and soybean meal does not 
provide an additional  benefit.
Experiment 2 – Particle size and inclusion rate 
of soy  hulls
In the second experiment Goehring et al. (2013b) used 
1,235 finishing pigs in a 118 d growth trial to determine 
the effects of 7.5 and 15% ground or unground soybean 
hulls on growth performance and carcass characteristics 
of pigs raised in a commercial environment. Treatments 
were arranged in a 2 × 2 factorial with a positive control. 
Main effects were soybean hull particle size (unground 
or ground, 787 and 370 µ, respectively) and amount of 
soybean hulls (7.5 or 15%) in corn-soybean meal–based 
diets. The fifth treatment was a positive control, corn-
soybean meal–based diet with no added soy hulls. Diets 
were fed in meal form and were formulated to a constant 
SID lysine  level.
Overall, increasing dietary soybean hulls did not impact 
ADG, ADFI, or final live BW; however, G:F decreased. 
Caloric efficiency improved on an ME and NE basis as 
soybean hulls were added. Feeding pigs diets with the 
ground soybean hulls did not influence ADG or ADFI, 
but resulted in poorer G:F and caloric efficiency on an 
ME and NE basis compared to pigs fed the diets with 
unground  hulls.
A study in South America conducted by Moreira et al. 
(2009) observed an improvement in DE and ME when 
soybean hulls were ground through a 2.5 mm screen as 
compared to a screen size up to 3.5 mm. However, soy-
beans are processed differently in South America than in 
the United States. In South America the soybean hulls are 
separated before roasting and trypsin inhibitors may still 
be present in the hull. The improvement in digestibility 
observed by Moreira et al. (2009) could be the result of 
reducing the negative effects of trypsin inhibitors and 
not improving digestibility of soybean hulls. In our study 
grinding soybean hulls resulted in no difference in ADG 
or ADFI but feed efficiency and caloric efficiency were 
worsened with soybean hull grinding. These results imply 
that grinding soybean hulls did not improve pig perfor-
mance by means of improving digestibility and in fact, 
the opposite may have occurred. It has been observed that 
increasing the amounts of fiber in the diet will increase the 
rate of passage of digesta (Ehle et al., 1982; Stanogias and 
Pearce, 1985). It could be possible that an increased rate 
of passage caused by smaller particles of fiber occurred 
which resulted in decreased digestibility of the feed and 
consequently poorer caloric  efficiency.
In summary, increasing soybean hulls reduced G:F as ex-
pected due to lowering diet energy density. The hypothesis 
of reducing the particle size of soybean hulls to improve 
their energy value was proven false. Grinding soybean 
hulls reduced ADG and ADFI, but pelleting improved 
ADG and ADFI regardless of particle size. It appears 
that fine grinding soybean hulls when fed in meal form 
is detrimental to performance but performance can be 
restored if the diets are  pelleted.
Overall  summary
• Grinding ingredients other than corn or complete 
diets resulted in little or no improvements in feed 
efficiency (Table  2).
• Fine grinding ingredients to resulted in no improve-
ments and even negative effects on growth perfor-
mance in nursery  pigs.
• In nursery pigs some variability exists, but our data 
combined with that available in the data base sug-
gests a positive response to pelleting (Table  1).
• In finishing pigs, pelleting appears to elicit a more 
consistent positive feed efficiency  response.
• Pelleting diets for finishing pigs appears to 
mitigate any negative effects of the finely ground 
 ingredients.
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Table 1: Effects of diet form on nursery and finishing pig growth  performance.
Item: ADG, g ADFI, g G:F
 Meal Pellet Meal Pellet Meal Pellet
Nursery
  Exp. 1 578 597 914 916 0.633 0.652
  Exp. 2 594 560 952 864 0.626 0.648
  Exp. 3 413 445 641 643 0.645 0.692
  Exp. 4 470 491 707 737 0.665 0.667
Finishing
  Exp. 1 920 970 2,510 2,520 0.370 0.390
Table 2: Effects of particle size on nursery and finishing pig growth  performance.
Item: Diet µ ADG, g ADFI, g G:F Research notes
Nursery
  Exp. 1 696 648 1001 0.648 620 µ corn, corn-soy formulation
517 621 963 0.647 352 µ corn, corn-soy formulation
679 585 935 0.626 620 µ corn, high fiber formulation
551 564 917 0.615 352 µ corn, high fiber formulation
397 548 861 0.637 397 µ complete diet, high fiber formulation
  Exp. 2 724 621 989 0.631 638 µ corn, corn-soy formulation
619 589 932 0.633 325 µ corn, corn-soy formulation
709 588 958 0.616 638 µ corn, high fiber formulation
703 595 955 0.625 391 µ DDGS, high fiber formulation
550 576 926 0.620 325 µ corn and 391 µ DDGS, high fiber formulation
  Exp. 3 656 421 650 0.649 742 µ corn, high fiber formulation
425 402 632 0.636 335 µ corn, high fiber formulation
540 416 641 0.650 540 µ complete diet, high fiber formulation
  Exp. 4 436 487 731 0.667 617 µ soy hulls
412 474 713 0.666 398 µ soy hulls
Finishing
  Exp. 1 596 920 2,580 0.355 647 µ corn, high fiber formulation
487 930 2,530 0.369 322 µ corn, high fiber formulation
365 900 2,480 0.365 365 µ complete diet, high fiber formulation
  Exp. 2 573 840 2,150 0.387 787 µ soy hulls, 7.5% inclusion
595 850 2,180 0.384 787 µ soy hulls, 15% inclusion
546 840 2,210 0.381 370 µ soy hulls, 7.5% inclusion
543 820 2,180 0.375 370 µ soy hulls, 15% inclusion
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Introduction
Pelleting is a technology that is widely used in southeast-
ern US feed mills and gaining popularity in the Midwest 
as it offers economic, physical and nutritional benefits. 
The physical benefits of pelleting include improved ease 
of handling, reduced ingredient segregation, less feed 
wastage and increased bulk density. Nutritional benefits 
of pelleting, as measured through feeding trials, are in-
creased growth rate and increased nutrient utilization, 
resulting in improved feed efficiency. Pelleting research 
has tended to focus mainly on the benefits of pelleted 
diets in comparison to mash. However, pellet quality has 
become more important as people recognize the economic 
benefits of  pelleting.
Stark (2011) reported the factors affecting pellet quality are 
diet composition (40%), particle size (20%), conditioning 
temperature (20%), die specification (15%) and cooling 
(5%). Recently, production throughput has been added to 
the list of factors that impact pellet quality (Stark, 2011). 
Therefore, the current study chose to focus on two of the 
most important factors that explain variation in pellet 
quality, diet composition and particle  size.
Diet composition has been demonstrated by several stud-
ies to impact pellet quality. Wheat based diets have been 
reported to have greater pellet durability index (PDI) in 
comparison to corn diets (Stevens, 1987; Winowiski, 1988; 
Abdollahi, 2011). Inclusion of dried distillers grains with 
solubles (DDGS) has been shown to both increase (Feoli, 
2008) and decrease (Stender et al., 2008; Fahrenholz et al., 
2013; Loar et al., 2010) PDI. Briggs et al. (1999) reported 
increasing the protein content of the diet increased PDI. 
Similarly, Buchanan and Moritz (2009) reported the inclu-
sion of small amounts of soy protein isolate or soybean 
meal improved PDI. The same authors showed adding 
small amounts of fiber (cellulose) resulted in greater pel-
let  durability.
Reducing particle size has been shown to improve PDI. 
In corn-soy diets, Wondra et al. (1995) reported PDI 
improved from 79% to 86% as corn particle size was 
reduced from 1000 to 400 microns. Also using corn-soy 
diets, Stark (1994) reported PDI improved from 97% to 
99% when the entire diet was ground from 543 to 233 
microns. In diets containing DDGS, Fahrenholz et al. 
(2013) reported modified PDI improved 1% to 3% when 
DDGS particle size was reduced from 692 to 508 microns 
in diets containing 10 to 30%  DDGS.
Pelleting is well known to improve swine feed conversion 
in comparison to mash diets (Stark, 1994; Wondra et al., 
1995). Yet, little public information exists associating 
pellet quality characteristics and pig performance. Schell 
and van Heugten (1998) showed feed efficiency improved 
from 2.10 to 2.01 as the level of fines decreased from 
37% to 3% in grower pigs. In finishing pigs, Stark (1994) 
reported feed conversion improved from 2.82 to 2.65 as 
percent fines decreased from 60% to 0%. Also in finishing 
pigs, Nemechek et al. (2013) reported feed efficiency was 
2.67 to 2.55 for pigs fed 50% and 0% fines, respectively. 
Collectively, these results suggest improving pellet quality 
by increasing pellet durability and reducing percent fines 
has economic value. Therefore, the objective of the cur-
rent study was to evaluate the effect of regrinding major 
feed ingredients on pellet quality and pig  performance.
Methods and  materials
Experiment 1. The effect of regrinding major 
feed ingredients on pellet  quality
Feed was produced at the North Carolina State University 
Feed Mill Educational Unit (Raleigh, NC) June 11 and 
12, 2013. Grow-finish diet formulations (Table 1) were 
provided by Murphy-Brown, LLC. Treatments consisted 
of two levels of DDGS (0% & 30%), two particle sizes 
of DDGS (650 & 450 microns) and two particle sizes of 
soybean meal (1000 & 450). Corn was ground to 400 
microns in all diets. Particle size was measured using the 
approved method by ANSI/ASAE (ASABE, 2009) using 
sieve agitators and 0.5 g dispersing agent. Each treatment 
was replicated 4 times, with each batch being 909 kg 
and representing an experimental unit. Treatments were 
randomly ordered within replication. A 30 HP California 
Pellet Mill (Crawfordsville, IN) model 1112-2 pellet mill 
equipped with a 4.4 mm (11/64”) × 31.75 mm (1 1/4”) pellet 
die. Feed was steam conditioned prior to pelleting using 
a 30.5 cm (12”) by 121.9 cm (48”) steam conditioner. All 
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treatments were steam conditioned with the same reten-
tion time and set to the same temperature of 82°C (180°F). 
Production rate, conditioning temperature and hot pellet 
temperature were monitored during pelleting. A represen-
tative sample from each batch was reserved for determi-
nation of pellet quality, as measured by pellet durability 
index and modified pellet durability index. Pellet quality 
was assessed on the day of manufacture via a tumbling 
box according to ASAE standard S269.4 (ASAE, 1997). 
Modified PDI was determined by the addition of three 19.1 
mm hexagonal nuts to each chamber of the tumbler box to 
simulate movement of feed from the feed mill to the barn. 
Data were analyzed by analysis of variance using Proc 
GLM in SAS (SAS Institute, Inc, Cary, North Carolina). 
Contrast comparisons were used to evaluate the impact 
of regrinding soybean meal and DDGS on pellet quality. 
Models for PDI and modified PDI included diet and time 
of day as fixed effects. A value of P < 0.05 was considered 
statistically significant in all tests. Summary statistics for 
experiment 1 are shown in Table  2.
Experiment 2. The effect of regrinding DDGS on 
finishing pig  performance
Pigs (n = 760) will be housed at Murphy-Brown’s research 
facility near Rose Hill, NC starting August 2013. The test 
period will be from 27 to 123 kg. Pigs will be weighed at 
the start of the trial and at the end of each dietary phase. 
The formulation for experiment 2 will consist of a corn-soy 
diet with 30% DDGS. Four treatments will be randomly 
assigned to pens with 10 replicates per treatment. A 2 × 2 
factorial will be used, with two particle sizes of DDGS 
(450 vs. 650 microns) and two levels of removing fines 
after pelleting (yes & no). Data collection will include 
feed milling characteristics, growth rate, feed intake, feed 
efficiency and carcass  weights.
Results
Pellet durability index and modified PDI differed (P ≤ 0.05 
and P ≤ 0.01, respectively) between treatments in experi-
ment 1 (Table 3). Corn-soy diets had 1.6% lower (P < 0.05) 
PDI and 9.5% lower modified PDI (P < 0.01) in comparison 
to diets containing 30% DDGS. Regrinding soybean meal 
in corn-soy diets tended (P = 0.07) to improve PDI by 2.3% 
and tended (P = 0.06) to improve modified PDI by 5.8%. 
Within DDGS diets, regrinding soybean meal did not im-
prove (P = 0.19) PDI, but improved (P ≤ 0.05) modified PDI 
by 4.3%. Across all treatments, regrinding soybean meal 
improved (P < 0.05) PDI by 1.5% and improved (P < 0.05) 
modified PDI by 4.7%. Regrinding DDGS had no effect 
(P > 0.05) on PDI or modified PDI. In fact, regrinding 
DDGS numerically reduced both PDI and modified  PDI.
 Time of day impacted both PDI and modified PDI. Batches 
pelleted in the morning had greater (P < 0.01) PDI and 
greater (P < 0.05) modified PDI in comparison to those 
pelleted in the afternoon (91.4 vs. 89.4 and 70.5 vs. 65.9, 
 respectively).
Results for experiment 2 will be available fall of  2013.
Summary
• Diets containing 30% DDGS improved PDI and 
modified PDI by 1.6 and 9.5%, respectively in com-
parison to corn-soy based  diets
• Regrinding soybean meal from 1000 to 450 mi-
crons improved PDI and modified PDI by 1.5% and 
4.7%,  respectively
• Regrinding DDGS from 650 to 450 microns did not 
impact PDI or modified  PDI
Table 1: Diet formulations used in experiment 1, the effect of regrinding major feed ingredients on pellet  quality.
Diets
Ingredient Corn-soy Corn-soy with DDGS
Corn, % 69.4 53.0
DDGS, % - 30.0
Soybean meal, % 22.3 8.0
Poultry fat, % 6.5 6.5
Limestone, % 0.9 1.7
Deflourinated phosphate, % 0.5 -
Premix1, % 0.4 0.8
1   Premix contains synthetic amino acids, salt, trace minerals, selenium, vitamins and phytase.
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Table 2: Descriptive statistics from experiment 1, the effect of regrinding major feed ingredients on pellet  quality.
Trait Mean Standard deviation
Production rate, kg per hour 849 10.0
Conditioning temperature, °C 82.2 0.90
Hot pellet temperature, °C 85.8 1.07
Standard pellet durability index, % 90.4 2.1
Modified pellet durability index, % 68.2 6.8
Table 3: The impact of regrinding DDGS and soybean meal on pellet  quality.
Treatment
1 2 3 4 5 6 SE P-value
Level of DDGS, % 0 0 30 30 30 30
DDGS particle size, microns – – 650 650 450 450
Soybean meal particle size, microns 1000 450 1000 450 1000 450
Pellet durability index, % 88.3a 90.5abc 91.3bc 92.0c 89.5ab 91.0bc 1.16 0.05
Modified pellet durability index, % 59.0a 64.8ab 71.5cd 73.5d 67.0bc 73.5d 2.28 < 0.01
abcd   Means within a row with different subscripts differ (P < 0.05).
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Introduction
Grinding of feed ingredients is used to reduce the particle 
size and increase energy and nutrient digestibility (Won-
dra et al., 1995d; Laurinen et al., 2000; Mavromichalis et 
al., 2000; Kim et al., 2002) and it is usually accomplished 
with the use of either roller mills, hammer mills, or a 
combination of roller and hammer mills. It is currently 
recommended that corn grain be milled to an average 
particle size of approximately 640 - 650 µm (Wondra et al., 
1995b; Kim et al., 2002), but it has also been documented 
that the apparent total tract digestibility (ATTD) of energy, 
DM, and N in corn fed to finishing pigs or sows increases 
as the particle size of the grain is reduced (Healy et al., 
1994; Wondra et al., 1995a-d). It was also reported that 
there is a tendency for an increase in the SID of AA in 
soybean meal as particle size is reduced (Fastinger and 
Mahan, 2003), but there is no effect of particle size on the 
ATTD of P in distillers dried grain with solubles (DDGS; 
Liu et al., 2012). However, there are no data that demon-
strate the effects of particle size on the standardized ileal 
digestibility (SID) of AA, the apparent ileal digestibility 
(AID) of starch and GE, or the standardized total tract 
digestibility (STTD) of P in corn  grain.
Therefore, the objectives of the present experiments were 
to determine the concentration of DE and ME, the STTD 
of P, the AID of starch and GE, and the SID of AA and 
CP in corn grain that was ground to different particle 
sizes and fed to growing pigs. The hypothesis that there 
is a linear increase in the concentration of DE and ME 
and in the digestibility of AA, starch, GE, and P in corn, 
as particle size is reduced was  tested.
Materials and methods
Four experiments were conducted. The same batch of corn 
(Pioneer P0528) was used in all diets in both experiments 
and the corn was grown in IA in 2011. The corn grain was 
1  Financial support for this research was provided by the National Pork Board (Des Moines, IA). Appreciation is also extended 
to Pioneer Hi-Bred ( Johnston, IA) for donation of the corn grain used in these experiments and for grinding the grain to the 
specified particle  sizes.
2  Corresponding author:  hstein@illinois.edu
first rolled using an automatic roller mill (Model CSU 
500, 2 stage; Automatic Equipment Mfg. Co., Pender, 
NE). The rolled grain was then divided into 4 batches that 
were ground using a hammer mill (Model #EL-9506-TF; 
Bliss Industries, Ponca City, OK) with 3, 10, 24, or 40 mm 
screens to obtain average final particle sizes of 339, 485, 
677, and 865 µm, respectively. The grain was milled at the 
Pioneer Hi-Bred Feed Mill in Johnston, IA, and stored at 
15ºC until used (Table  1).
Exp. 1: Ileal digestibility of CP and  AA
Ten growing barrows (initial BW: 29.2 ± 1.35 kg) were 
equipped with a T-cannula in the distal ileum according 
to procedures adapted from Stein et al. (1998). Pigs were 
allotted to a replicated 5 × 5 Latin square design with 5 
diets and 5 periods in each square. Pigs were housed in 
individual pens (1.2 × 1.5 m) in an environmentally con-
trolled room. A feeder and a nipple drinker were installed 
in each pen. Five diets were formulated (Tables 2 and 3). 
Four of the diets each contained one of the 4 batches of 
corn (96.55%, as-fed basis) and corn was the only ingre-
dient contributing AA, CP, starch, and GE to the diet. 
The last diet was a N-free diet that was used to measure 
basal endogenous losses of AA and CP. Ileal digesta were 
collected on d 6 and 7 of each period following standard 
procedures and values for the standardized ileal digest-
ibility of CP and all AA were calculated (Stein et al.,  2007).
Exp. 2: Total tract digestibility of GE and  P
Experiment 2 was designed to determine the concentra-
tion of DE and ME, the ATTD of GE, and the ATTD and 
STTD of P in the 4 batches of corn that were used in Exp. 
1. Forty barrows (initial BW 22.8 ± 2.13 kg) were allotted 
to a randomized complete block design with 4 diets and 
10 replicate pigs per diet and placed in metabolism cages 
that were equipped with a feeder and a nipple drinker, 
fully slatted floors, a screen floor, and urine trays, which 
allowed for the total, but separate, collection of urine and 
fecal materials from each  pig.
128 2013 Allen D. Leman Swine Conference
Pr
od
uc

on
Produc
on
O. J. Rojas; H. H.  Stein
Table 1: Chemical and physical composition of corn with different particle sizes, as-fed basis
Corn particle size
Item 339 µm 485 µm 677 µm 865 µm
 GE, kcal/kg 3,870 3,914 3,900 3,920
 DM, % 86.30 86.71 86.40 86.54
 CP, % 7.00 7.25 7.23 7.08
 Ash, % 1.10 1.23 1.39 1.15
 AEE1, % 3.57 3.53 3.51 3.45
 NDF, % 9.25 9.29 10.01 11.06
 ADF, % 1.91 2.24 2.27 2.41
 Starch, % 64.42 62.73 61.19 62.90
 P, % 0.29 0.30 0.34 0.31
 Ca, % 0.03 0.03 0.03 0.03
Indispensable, AA %
 Arg 0.35 0.35 0.37 0.35
 His 0.20 0.20 0.21 0.20
 Ile 0.24 0.25 0.26 0.24
 Leu 0.83 0.83 0.84 0.85
 Lys 0.25 0.25 0.26 0.25
 Met 0.14 0.13 0.14 0.14
 Phe 0.35 0.35 0.35 0.35
 Thr 0.25 0.25 0.24 0.25
 Trp 0.05 0.05 0.05 0.06
 Val 0.35 0.36 0.38 0.35
Dispensable, AA %
 Ala 0.51 0.51 0.52 0.51
 Asp 0.49 0.49 0.50 0.49
 Cys 0.15 0.14 0.15 0.15
 Glu 1.26 1.26 1.25 1.28
 Gly 0.30 0.30 0.30 0.30
 Pro 0.63 0.64 0.62 0.64
 Ser 0.31 0.30 0.30 0.32
 Tyr 0.21 0.20 0.22 0.20
Total AA 6.87 6.86 6.96 6.93
Physical characteristics
 Standard deviation of particle size 1.89 2.92 3.20 3.15
 Surface area (cm^2)/gram 164.5 166.6 132.1 101.4
 Angle of repose, ° 57.4 54.9 50.7 46.8
 Bulk density, g/L 564.5 601.4 631.5 650.6
 Water binding capacity, g/g 2.3 2.3 2.2 2.2
1    AEE = acid hydrolyzed ether extract.
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Four corn-based diets that contained 97.7% corn were for-
mulated. The 4 diets were similar with the exception that 
the corn used in each diet was ground to a different mean 
particle size (i.e., 339, 485, 677, and 865 µm) as explained 
for Exp. 1. The experimental diets were fed to pigs for 12 
d. The initial 5 d were considered an adaptation period 
to the diet, while urine and fecal samples were collected 
during the following 5 d according to standard procedures 
using the marker to marker approach (Adeola, 2001). Feces 
were collecting twice daily and stored at -20°C immedi-
ately after collection. Urine buckets were placed under the 
metabolism cages to permit total collection. They were 
emptied in the morning and afternoon and a preservative 
of 50 mL of 6N HCL was added to each bucket when they 
were emptied. The collected urine was weighed and a 20% 
subsample was stored at -20°C. Samples were analyzed for 
energy and P and the DE and ME in each source of corn 
was calculated according to Adeola (2001) and the STTD 
of P was calculated as described by Rojas and Stein  (2013).
Exp. 3: Growth performance of growing finishing  pigs
Experiment 3 was conducted to confirm that the increase 
in the ME of corn that was observed in Exp. 2 can be 
used in practical diet formulation. A total of 36 gilts and 
36 barrows with an average initial BW of 32.00 ± 1.58 
kg were used. All pigs were housed individually in pens 
(0.9 × 1.8 m) with fully slatted concrete floors. A feeder 
and a nipple drinker were provided in each pen. Feed and 
water were provided on an ad libitum basis throughout the 
experiment. Pigs were fed a 3 phase program (Table 2) 
with phase 1 diets being offered from 30 to 65 kg, phase 
2 diets from 65 to 100 kg, and phase 3 diets from 100 to 
135 kg. Within each phase, 4 corn-SBM based diets were 
formulated to meet or exceed current nutrient require-
ments (NRC, 2012). The same batch of corn and SBM 
was used in all diets. The only difference among diets 
within each phase was that the corn that was used was 
ground to a different particle size (i.e., 339, 485, 677, and 
865 µm) and diets were formulated using values for ME, 
standardized total tract digestibility of P, and standardized 
ileal digestibility of CP and AA in corn with different 
particle size that were determined in Exp. 1 and 2. Diets 
were formulated to contain the same ME and addition of 
soybean oil was adjusted to compensate for the reduction 
of ME as particle size of corn increased. Diets contain-
ing corn ground to the larger particle sizes, therefore, 
contained more fat than diets containing corn with the 
reduced particle sizes. The inclusion of soybean oil was 
2.00% in phase 1, 2, and 3 diets containing corn ground 
to 339 microns; 2.78, 2.85, and 2.92% in diets containing 
corn ground to 485 micorns; 3.12, 3.23, and 3.30% in diets 
containing corn ground to 677 microns; and 3.60, 3.74, and 
3.87% in diets containing corn ground to 865 microns. Pigs 
were randomly allotted to the 4 dietary treatments in a 
2 × 4 factorial design with sex (gilts and barrows) and diet 
as factors. There were 9 gilts and 9 barrows allotted to 
each diet. Pigs were allowed ad libitum access to feed and 
water throughout the experiment. When pigs reached an 
average BW of 135 kg, they were harvested and carcass 
measurements were  recorded.
Results and discussion
Exp. 1: Ileal digestibility of CP and  AA
The SID of CP and all indispensable and dispensable AA 
was not affected by the particle size of corn (Table 2). 
The average SID of indispensable AA was also not dif-
ferent, among diets, but the average SID of dispensable 
AA decreased linearly (P < 0.05) as particle size of corn 
 increased.
The fact that particle size of corn did not influence the 
SID of AA concurs with observations by Fastinger and 
Mahan (2003) who reported that a reduction in particle 
size of soybean meal from 949 to 185 µm has no effect 
on the SID of indispensable AA. The implication of this 
observation is that the same values for digestibility of AA 
can be used for corn regardless of particle  size.
Exp. 2: Total tract digestibility of GE and  P
The ATTD of GE was reduced (linear and quadratic, 
P < 0.01) as the particle size increased from 339 to 865 
μm, respectively (Table 3). The concentration of DE (as-fed 
and DM basis) decreased (linear and quadratic, P < 0.05) 
as the particle increased from 339 to 865 µm. Likewise, 
the ME concentration, calculated on an as-fed or on a DM 
basis, decreased from 3,432 to 3,311 kcal/kg and from 
3,964 to 3,826 kcal/kg, respectively, when corn particle 
size increased from 339 to 865 μm.
The increase in DE and ME that was observed as the par-
ticle size was reduced is less than the increase reported by 
Wondra et al. (1994c), when grain with different particle 
sizes were fed to sows, but in agreement with data reported 
by Oryschak et al. (2002). The reason for this difference 
is most likely that sows have a greater ability to ferment 
fiber and nutrients compared with growing pigs (Noblet 
and Shi, 1993). However, the fact that the ME increased 
as particle size was reduced indicates that dietary energy 
concentration will be increased if particle size of corn is 
 reduced.
There were no differences in ADFI and P intake among 
pigs fed the 4 experimental diets. The concentration of 
P in feces decreased linearly (P < 0.01) as corn particle 
size increased from 339 to 865 μm. However, there were 
no differences in P output and absorbed P among diets. 
Likewise, the ATTD and STTD of P did not change as 
particle size of corn changed. This observation concurs 
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with observations by Liu et al. (2012), who reported that 
reduction of particle size in distillers dried grains with 
solubles did not influence the ATTD of P. Thus, it appears 
that reduction in particle size or increases in surface area 
are not effective in improving P digestibility in  pigs.
Exp. 3: Growth performance of growing finishing  pigs
The overall G:F was increased (liner, P < 0.05) as the par-
ticle size increased from 339 to 865 μm (Table 4), but there 
were no differences (linear, P > 0.05) in the starting weight 
or in final weight among dietary treatments. Likewise, no 
differences (linear, P > 0.05) among treatments were ob-
served for overall ADG and ADFI. The observation that 
no differences in growth performance among treatments 
were observed confirms that the differences in ME among 
the 4 batches of corn that were observed in Exp. 2 are of 
practical importance and can be used in diet  formulations.
There were no differences (linear, P > 0.05) in live BW, 
carcass fat-free lean (FFL), and HCW among dietary 
treatments (Table 5). However, the dressing percentage 
was reduced (linear, P < 0.01) for pigs fed the diet corn 
ground to the greatest particle size compared with pigs 
fed the diet with corn ground to the least particle size. The 
back fat, LEA, and pH of LEA were not different (linear, 
P > 0.05) among dietary  treatments.
Table 2: Standardized ileal digestibility (SID) of CP and AA (%) in corn that was ground to different particle sizes 
and fed to growing pigs, Exp. 11
Corn particle size P-value
Item 339 µm 485 µm 677 µm 865 µm Pooled 
SEM
Linear Quadratic
 CP, % 75.5 77.2 73.7 72.8 5.63 0.28 0.83
Indispensable AA, %
 Arg 89.2 93.3 94.9 92.0 2.69 0.33 0.07
His 80.9 83.2 84.3 82.3 2.73 0.47 0.17
Ile 73.9 76.3 77.7 76.4 4.85 0.68 0.38
Leu 84.1 85.1 86.3 83.0 2.45 0.63 0.14
Lys 74.8 75.8 73.6 74.3 6.53 0.60 0.98
Met 82.7 82.9 83.1 81.5 3.04 0.47 0.76
Phe 80.6 82.7 82.8 81.6 3.33 0.97 0.34
Thr 66.9 70.7 74.5 66.4 7.19 0.99 0.15
Trp 70.6 78.2 80.4 71.7 6.78 0.86 0.03
Val 74.1 77.4 79.8 78.9 4.73 0.22 0.29
Mean 77.8 80.6 82.0 78.6 4.06 0.79 0.36
Indispensable AA, %
Ala 82.5 81.6 81.6 80.0 3.62 0.23 0.91
Asp 77.5 77.6 79.0 78.1 4.67 0.95 0.79
Cys 74.0 76.1 79.3 76.6 3.95 0.25 0.25
Glu 84.3 84.8 85.5 82.7 2.65 0.42 0.30
Gly 84.8 95.5 98.1 87.2 9.04 0.75 0.08
Ser 81.7 82.5 85.4 79.6 3.69 0.68 0.15
Tyr 76.6 78.3 78.2 76.4 4.63 0.56 0.44
Mean 80.2 82.3 83.9 80.1 3.87 0.01 0.43
All AA 78.8 81.3 82.8 79.2 3.72 0.33 0.47
1       Data are least squares means of 10 observations.
2        Values for SID were calculated by correcting the values for AID for basal ileal endogenous losses. Basal ileal endogenous losses 
were determined (g/kg of DMI) as CP, 21.50; Arg, 0.84; His, 0.18; Ile, 0.37; Leu, 0.60; Lys, 0.56; Met, 0.09; Phe, 0.37; Thr, 0.59; 
Trp, 0.13; Val, 0.51; Ala, 0.77; Asp, 0.86; Cys, 0.18; Glu, 1.06; Gly, 2.20; Ser, 0.51; and Tyr, 0.32.  
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Table 3: Concentration of digestible and metabolizable energy, and apparent total tract digestibility (ATTD) 
of energy and P and standardized total tract digestibility (STTD) of P that was ground to different particle sizes, 
as-fed basis, Exp. 21
Item Corn particle size P-value
339 µm 485 µm 677 µm 865 µm Pooled 
SEM
Linear Quadratic
 ATTD of GE, % 91.6 90.3 89.2 88.7 0.51 < 0.01 < 0.01
 DE, kcal/kg 3,547 3,492 3,441 3,402 24.58  0.01  0.01
 DE, kcal/kg DM 4,097 4,035 3,978 3,932 28.40 0.02 0.02
 ME, kcal/kg 3,432 3,371 3,346 3,311 19.54 < 0.01 < 0.01
 ME, kcal/kg DM 3,964 3,895 3,868 3,826 22.58 < 0.01 < 0.01
 ATTD of P, % 29.6 31.0 31.1 31.3 3.32 0.67 0.81
 STTD of P2, % 37.8 37.1 37.3 37.4 2.99 0.99 0.87
1   Data are means of 10 observations per treatment.
Table 4: Growth performance of pigs fed diets containing corn ground to different particle sizes1
 Item
Corn particle size, µm P-value Sex
339 485 677 865 Pooled 
SEM
Linear Quadratic Barrows Gilts Pooled 
SEM
P-value
BW, kg
 Day 0 32.00 32.19 31.93 31.97 0.44 0.47 0.64 32.57 31.49 0.27 0.01
 Day 29 61.86 62.33 62.07 62.81 1.18 0.40 0.84 64.87 59.67 0.58 < 0. 01
 Day 58 93.72 93.83 94.10 94.72 2.16 0.53 0.85 99.38 88.80 0.98 < 0. 01
 Day 93 129.81 130.25 128.58 129.97 2.90 0.88 0.75 136.24 122.98 1.41 < 0. 01
ADG, kg/d
 Day 0 - 29 0.99 1.00 1.01 1.03 0.03 0.30 0.79 1.07 0.94 0.01 < 0. 01
 Day 29 - 58 1.06 1.05 1.07 1.06 0.04 0.80 0.93 1.15 0.97 0.02 < 0. 01
 Day 58 - 93 1.03 1.04 0.98 1.01 0.17 0.29 0.71 1.05 0.98 0.02 < 0. 01
 Day 0 to 93 1.03 1.03 1.02 1.03 0.03 0.97 0.76 1.09 0.96 0.01 < 0. 01
ADFI, kg/d
 Day 0 - 29 2.15 2.13 2.13 2.11 0.07 0.50 0.98 2.29 1.97 0.03 < 0. 01
 Day 29 - 58 3.11 3.05 3.03 3.01 0.12 0.27 0.70 3.35 2.74 0.05 < 0. 01
 Day 58 - 93 3.47 3.44 3.32 3.24 0.12 0.04 0.85 3.63 3.10 0.06 < 0. 01
 Day 0 to 93 2.94 2.90 2.85 2.81 0.10 0.09 0.98 3.12 2.63 0.04 < 0. 01
G:F
 Day 0 - 29 0.46 0.47 0.47 0.49 0.01 0.03 0.52 0.47 0.48 0.01 0.38
 Day 29 - 58 0.34 0.35 0.36 0.35 0.01 0.12 0.54 0.34 0.35 0.01 0.12
 Day 58 - 93 0.30 0.30 0.30 0.31 0.01 0.19 0.31 0.29 0.32 0.01 < 0. 01
 Day 0 to 93 0.35 0.36 0.36 0.37 0.01 0.02 0.56 0.35 0.37 0.01 < 0. 01
1       Data are means of 18 observations per treatment, except for the treatment with corn particle size of 677 μm, which had only 
17 observations.
2      There was not interaction effect between diet and sex for all the variables except for ADFI d 0 to 29, G:F d 29 to 58, and G:F d 
0 to 93.
132 2013 Allen D. Leman Swine Conference
Pr
od
uc

on
Produc
on
O. J. Rojas; H. H.  Stein
The reduction in dressing percentage that was observed for 
pigs fed diet containing corn ground to a greater particle 
size is mainly due to the increase in the intestinal weight 
for pigs fed the diet with the greatest particle size com-
pared with pigs fed the other diets. This observation is in 
agreement with data published by Wondra et al.  (1995a).
Overall, results of the growth performance experiment 
confirmed that the values for ME that were determined in 
Exp. 2 can be used in practical diet formulations without 
negatively impacting pig performance or carcass quality. 
Thus, there were no indications that the reduced inclusion 
of soybean oil in the diets had any negative influence on 
pig performance. The savings in diet formulations that are 
achieved by reducing the amount of added fat in the diets, 
therefore, will result in increased profit form the  pigs.
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Nutrition and health interactions: A practitioner’s 
 perspective
Mark FitzSimmons,  DVM
MAF Veterinary  Services, Mapleton,  Minnesota
Historically, diets for growing pigs have been formulated 
for optimal lean tissue accretion. Since the 1970’s many 
trials have been done to establish levels for amino acids, 
energy, macro-nutrients and micro-nutrients to optimize 
growth. Some of these trials would include whole body 
tissue analysis which involved grinding the complete pig 
up in order to measure all the building block pieces. These 
values with the known or assumed absorption and losses 
(via urine, fecal and etc.) would be used to determine the 
feeding requirements for each of these nutrients. The in-
crease capability of measurement techniques has increased 
our ability to get these assumed requirements down to 
very precise levels. Many nutritionists have been willing 
to narrow the margins of error because of the perceived 
accuracy of our knowledge. The inherit problem with these 
trials is that they did not always account for the increase 
requirements for other issues the pig may encounter in its 
life in the “real world” such as environmental stressors or 
disease  challenges.
It has long been known that the stimulation of the im-
mune system has growth implications. These have been 
believed to be a combination of decrease intakes and likely 
an increase in nutrient reallocation but the exact process 
was not completely understood. These effects were seen 
and measured as decreases in growth, feed efficiency and 
lean tissue accretion. These effects were seen whether the 
immunological challenge was disease or vaccination in 
origin. The level and duration of the changes were nor-
mally longer during the disease challenges but we would 
expect the response to be organism specific. The specific 
immunological by-products released that decrease appetite 
are assumed to be there for some protective reason but the 
effect on either the digestibility or absorption of nutrients 
during these health challenges may be reversible. The trials 
done to determine growth requirements may easily have 
missed these survival requirements due to the nature of most 
research facilities conducting these trials would have had 
very clean pigs. The decrease performance was accepted as 
normal and we just tried to make them all  healthy.
In the Midwest we have spent most of our lives feeding 
diets to pigs that were comprised mainly of corn and soy-
bean meal. Crude protein levels were always consider high 
due to formulating primarily for lysine needs for optimal 
growth, feed efficiency and lean tissue accretion. Years 
ago technology brought us products (synthetic AA’s) that 
gave us the ability to decrease SBM in pig diets. Lysine, 
Methionine, Threonine and Tryptophan along with the use 
of dried distiller grains allowed diets to be formulated with 
SBM completely out. It was during a research trial using 
synthetic AA’s that while experiencing a disease challenge 
the pigs on the highest SBM were the least affected for 
growth rate and feed efficiency. At first the data looked 
like it may not be useable due to the health challenge but 
then the fact that there was such a difference in the clinical 
response prompted us to ask some questions. The experts 
we spoke with looked at the data and then went back in 
some of their own work and found similar results that had 
been unexplained. Many others gave their opinions as to 
what may actually be present SBM that would help support 
the beneficial immunological response these pigs appeared 
to express. This prompted some controlled studies to be 
done in an effort to validate the hypothesis. We all have 
seen groups of pigs that have suffered 15–20% yet there 
are pigs present in the population that appear to have not 
been affected.  Why?
Gene Gourley and I decided to put together a group of 
experts that could try and explain what was really going 
on in these pigs. The mission was to find out what may 
be happening in these pigs that might be helping them 
through these challenges, was it a missing nutrient, AA 
or something else that when SBM was too low they did 
not possess. This required the development of a disease 
challenge model that would consistently create a consistent 
clinical response every time so that possible solutions 
could be applied and tested. Different disease challenges 
were discussed and a PRRS challenge model was decided 
upon. We approached the process looking at multiple 
physiological parameters and the differences between the 
top performers of a challenge group and the bottom ones. 
I will leave the discussion of these first trials to the lead 
researchers in this session. Once the model is established 
and specific parameters are defined we should be able 
to apply possible solutions to see if we can eliminate or 
minimize the negative effects of the disease  challenges.
The issue with trying to determine if we should or can 
feed pigs differently during health challenges is still being 
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debated but without the ability to measure the differences 
we will get nowhere. There are defensive reasons why pigs 
react they way they do to certain health challenges that 
we may not what to decrease or divert. The reduction in 
appetite may be a way to restrict the growth of organisms 
in the animal thus protecting it. But if part of the growth 
performance reduction is due to inadequate availability of 
a specific nutrient, the inability to absorb a nutrient or the 
lack of ability to digest the source of that nutrient maybe 
we can formulate diets that provide a solution to one or 
more of these or maybe we should just feed very basic 
diets and save the money? The answer here may help us 
prepare animals better for the immunological response 
required during a vaccination. Maybe less adjuvant can 
be used to get the same protection? The answers to this 
immunological response question is becoming more and 
more pertinent as we are put under more and more pressure 
to reduce the use of antibiotics in food animal  production.
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The impact of PRRSV on feed efficiency, digestibility and 
tissue accretion in grow-finisher  pigs
Nicholas K. Gabler1; Wes Schweer1; John F. Patience1; Locke Karriker1; Chris Sparks2;  
Gene Gourley3; Mark FitzSimmons4; Kent Schwartz1; Thomas E.  Burkey5
1Iowa State University, Ames, Iowa; 2Choice Genetic, Des Moines, Iowa; 3Swine Graphics Enterprises, 
Webster City, Iowa; MAF Veterinary Services Inc., Mapleton, Minnesota; 5University of Nebraska, 
Lincoln,  Nebraska
The economic losses caused by Porcine Reproductive 
and Respiratory Syndrome Virus (PRRSV) infection 
are estimated to cost the US swine industry more than 
$640 million annually (USDA, 2008). While significant 
advances have been made through research efforts to 
enhance our understanding of PRRSV at the animal 
health, immunological and genomic level, this disease 
still remains a significant issue in the US swine industry. 
Although we clearly know that PRRSV attenuates ADG 
of production pigs, its direct impact on feed efficiency, 
nutrient and energy digestibility, and whole body lean and 
fat accretion in grow finisher pigs has been poorly char-
acterized. Therefore, the overall objective of this project 
was to characterize the impact PRRSV challenge has on 
grow-finisher pig feed efficiency, energy and nutrient 
digestibility, and tissue accretion  rates.
To achieve this objective, 60 Choice Genetic maternal 
line gilts (33 ± 3 kg BW) where selected. These gilts 
came from 30 sows and consisted of live weight matched 
littermate pairs. After a nursery period, the litter mates 
were then split into two separate barns and placed into 
five pens (n = 6 pigs/pen). Pigs in both barns were fed 
corn-soybean-DDGS diets containing the non-digestible 
marker titanium dioxide. All pigs had ad libitum feed 
and free access to water. Pigs were of high health status 
and PRRSV naïve. One barn was then inoculated intra-
muscularly with a live field strain of PRRSV (PRRVS+) 
and the other barn with saline (PRRSV-). Blood samples 
were collected for PRRSV titers and feed intake and body 
weight gains were recorded for each pen over a 70-80 day 
performance period. At 19-21 days post inoculation (dpi), 
total tract fecal samples were collected for nitrogen and 
energy digestibility analysis. To longitudinally assess the 
impact of PRRSV on tissue accretion, at -1 and 80 dpi, 
all 60 pigs were sedated and scanned using a dual X-ray 
absorptometry machine (DXA). The DXA scan enabled 
us to measure whole body fat, lean, protein, water, and 
bone mineral content in a non-destructive way. DXA scan 
data was then corrected to account for gut and bladder fill 
using regression  equations.
All pigs were PRRSV naïve before the study started and 
the 30 PRRSV- pigs remained PRRSV negative throughout 
the study. Within the first seven dpi, the PRRSV+ gilts had 
a log adjusted PRRSV genomic titer of 4.6 and as expected 
they had all seroconverted by 35 dpi. No mortalities or sec-
ondary infections were reported in the study. The impact 
of PRRSV challenge on pig performance is shown in Table 
1. As expected, body weights where negatively affected 
by the virus challenge and growth rates were reduced by 
20% compared to the PRRSV- pigs (P < 0.01). PRRSV+ 
gilts also had significantly (P < 0.05) reduced ADFI and 
G:F compared to their healthy counterparts over the test 
period (-7% and -15%, respectively, Table 1). This was 
especially apparent over the first 28 dpi (data not shown). 
Proximate analysis of feed and fecal grab samples high-
light that apparent total tract digestibility of dry matter, 
nitrogen and energy were all significantly reduced at 19-
22 dpi (P < 0.001). The digestibility coefficients for dry 
matter (81.5 vs. 79.8), nitrogen (80.1 vs. 78.0) and energy 
(78.1 vs. 76.3) were all reduced by 3-5% for PPRSV- vs. 
PRRSV+ pigs, respectively. Knowing that PRRSV infec-
tion alters ADG, we wanted to know if the composition 
of gain was affected. Longitudinal DXA scan analysis 
showed that PRRSV+ gilts had significantly lower lean, 
protein, fat and bone accretion rates compared to their 
PRRSV- counterparts (Table  1).
In summary, this ongoing project is clearly demonstrating 
that PRRSV infection reduces not only ADG, but also 
ADFI, coefficients of apparent total tract digestibility, and 
feed efficiency in grow-finisher gilts. Furthermore, lean/
protein and fat accretion rates all appear to be affected to a 
similar extent. Additional blood analysis and carcass data 
from this project will allow us to better understand the 
metabolic impact of PRRSV in pigs and to calculate the 
economic impact of this health challenge in a grow-finisher 
production setting. This work has been supported by the 
National Pork Board grant #12-163 and Choice  Genetics.
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Parameter PRRSv- PRRSv+ SE P-value
Start BW1, kg 33.0 34.2 0.15   0.66
End BW1, kg 94.8 85.7 0.02 < 0.05
ADG1, kg/d 0.90 0.72 0.07 < 0.01
ADFI1, kg/d 1.98 1.84   0.046 < 0.01
G:F1 0.46 0.39   0.021 < 0.05
Lean2, g/d1 633 547 13.5     0.001
Protein2,3, g/d 126 109 2.53     0.001
Fat2, g/d 205 169 7.05     0.001
Bone mineral2, g/d 12.0 11.0 0.35     0.006
1  n = 5 pens/trt, 6 pigs/pen 
2  n = 30 gilts/trt
3  Predicted based on DXA lean (Chemical protein = DXA Lean x 0.2006 - 0.6611)
Table 1: Overall growth performance and whole body accretion rates of gilts challenged with  PRRSV
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Don Giesting
Introduction
The challenge of keeping young pigs healthy and grow-
ing after weaning can be complex and bewildering. Pigs 
are quite naïve in terms of digestive and immunological 
development, at the same time they are being stressed by 
removal from the sow, mixing with other pigs, traveling, 
changes in feed source and form, and exposure to new 
organisms in their environment. The common problems 
of delayed and low feed intake, diarrhea, and short or 
longer term disruptions in growth are commonly recog-
nized. There remains much debate about which aspects 
of the challenges to address, and how best to do so. This 
presentation will seek to provide some review and some 
perspectives on how pig health and performance in the 
starter period might be  improved.
The pig at 2½ to 4 weeks of  age
Pigs are born quite naïve and have evolved to develop 
immunity, intake, and digestive capacity over the first 
8-10 weeks of their lives, while still benefiting from 
maternal protection and nutrient supplementation. Com-
mercial production does not afford these options, as we 
try to optimize efficiency of the overall enterprise. Thus, 
we try to support the early-weaned pig with an artificial 
rearing system that is warm, sanitary, and able to provide 
all required nutrients in palatable and digestible forms, 
balanced to meet the pig’s rapidly changing requirements. 
Unfortunately, pigs vary in their adaptability to the rigors 
of weaning, unfamiliar and less digestible nutrient sources, 
and microbial challenges in their new environment. Failure 
to strive is apparent, when diarrhea hits, pigs fail to eat, 
uniformity of the group is destroyed, and morbidity and 
mortality  spike.
What we  control
Weaning age is a crucial fundamental factor establish-
ing the degree of challenge for us to meet the needs of 
young pigs. Weaning generally causes loss of mucosal 
integrity and tight junctions that increase gut permeability 
and reduce nutrient absorption and reduce brush-border 
enzymes. In general, the younger the pig, the more vul-
nerable they are to these changes after weaning. Recent 
research shows that younger pigs not only are more 
affected by weaning, including lower barrier function, 
more inflammation, and gut mucosa atrophy, but that the 
insults of weaning persist longer in earlier weaned pigs. 
Increasingly, producers are determining that pushing back 
weaning to avoid weaning pigs less than three weeks of 
age, improves outcome in many  systems.
Creep feed exposure has been viewed from many direc-
tions, as a terrible waste of money and nutrients, to a 
crucial tool to introduce pigs to dry feed as a necessary 
source of nutrients when the sow is removed. While pigs 
consume very low amounts of creep feed prior to about 
18 days of age, studies suggest that the learning value and 
the stimulation of digestive and immune functions in the 
pig may well over-ride the cost and labor challenges of 
providing creep feed before weaning. Of course, as wean-
ing age increases beyond 21 days, the importance of creep 
feeding to provide supplemental nutrients to support the 
rapidly increasing appetite and digestive capacity of the 
unweaned pig becomes more  apparent.
Group size, handling, sorting practices, feeder and water 
design all affect the stress experienced by young pigs. 
From the pig’s point of view, weaning is a bewildering 
experience. The loss of maternal security, the need to learn 
not only the location of food and water, but the necessity 
to consume dry feed and water in reasonable meal sizes 
and proportions are not learned until after weaning, dur-
ing a highly stressful period. Not surprisingly, the time it 
takes for pigs to consume feed after weaning, the pattern of 
meal size, and the time between meals is seen to be highly 
variable among pigs. Delays in food and water intake have 
been shown to increase the severity of gut damage, lower 
the rate of gain, destroy feed efficiency, and increase the 
risk of disease. Any adjustments in management that can 
limit stress and delay in feed and water intake can be 
expected to help commercial success of the  enterprise.
Assuming we have made the best choices we can to limit 
stress (social and environmental), to allow pigs’ easy ac-
cess to feed and water, and that we are weaning at the 
oldest practical age for our system, we now need to grapple 
with the feed  itself.
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Customizing diets to enhance pig  success
As with other aspects of post-weaning management, feed 
design is a continuous effort to strike the balance among 
numerous variables that affect pig performance, health, 
and cost of production. When we venture too far from 
optimal nutritional balance and high digestibility, we in-
crease risks of digestive and performance disruption and 
poor efficiency. If we recognize the risks and the options, 
we can better determine the solution we should  pursue.
In simple terms, pigs need proper levels of digestible 
and absorbable amino acids and energy to match their 
digestive development. Anti-nutritional factors, including 
mycotoxins, antigenic proteins, protease inhibitors, and 
some types of poorly digested carbohydrates and proteins 
that may be of little consequence to older pigs, can disrupt 
newly weaned pigs. Proteins that are not digested in the 
stomach and small intestine can be fermented in the lower 
bowel, producing ammonia, amines, phenols, and indoles 
that cause looseness and poorer  efficiency.
Some amino acids which are not considered essential 
for older pigs, may be essential during the post-weaning 
period. Glutamate and glutamine are important energy 
sources for the gut, enhancing gut wall integrity and repair. 
They may also have roles as precursors for glutathione, a 
crucial endogenous antioxidant molecule. They also seem 
to stimulate both innate and adaptive immunity. Alanine, 
glycine, and arginine sometimes show benefits during 
post-weaning recovery from gut  damage.
Protein sources are more critical to young pigs, whose 
digestive enzyme levels are limited and who have rapid 
digesta passage rate compared with older pigs. Dried 
animal plasma has been shown to greatly enhance the 
intake and gain, and often gut health, of young pigs. The 
benefit goes beyond provision of digestible nutrients or 
simply passive immunity from antibodies in the plasma. 
Recent research suggests that cytokines and factors that 
limit inflammation support better gut integrity. Properly 
processed milk or other animal proteins or specially pro-
cessed soy products have shown benefits in the first 2 
weeks, or so, after  weaning.
Some fiber sources, including some relatively purified 
soluble fibers may support increased and more stable com-
mensal bacterial populations that help reduce overgrowth 
of pathogens. They produce increased volatile fatty acids, 
especially butyrate that may help repair the mucosa of 
the intestine. Modest levels of insoluble fiber may help 
adaptation to dry diets by stimulating intake and gain, 
increasing brush border enzymes responsible for diges-
tion of partially digested peptides and starches to allow 
them to be absorbed, and reducing E. coli attachment and 
proliferation in the small intestine. On the other hand, 
some partially digested starches and fibers, especially 
from small grains, may inhibit digestion of proteins, and 
favor gas production in the lower  tract.
Starch is commonly the primary energy source in young 
pig diets, but some starch, including corn starch is not 
rapidly digested by young pigs and may arrive in the 
lower tract where it is fermented. The value of processing 
starches by pelleting or other method to increase rate of 
digestion, especially by a gut hindered by post-weaning 
damage, generally, is most clearly beneficial to perfor-
mance, in young  pigs.
Additives to support young pig 
 performance
Additives of many types have been shown to improve 
health, gain, and efficiency in young pigs. However, it is 
not always straight-forward to determine which additives 
to use, which additives are complementary to each other, 
or to know which additives may be only effective in un-
usual situations. A great effort is ongoing to understand 
more about the physiological and immunological effects 
of different additives for young pigs. Newer methods are 
helping to elucidate the many impact points additives 
can  provide.
Traditional application of antibiotics and pharmacologi-
cal levels of zinc oxide and copper have generally been 
credited with controlling deleterious bacteria. While these 
effects are clear, the modes of action are still being un-
tangled and vary among these compounds. Some impacts 
appear to be direct impacts on the gut or the immune sys-
tem. Recent research shows zinc oxide increases immune 
system development and improves gut barrier function in 
young  pigs.
Prebiotics are an additive type providing conditions that 
directly or indirectly reduce the opportunity for patho-
genic bacteria to become established, especially gram 
negative species of E. coli and salmonella. Perhaps, the 
most effective prebiotic for pigs is an ingredient com-
monly viewed not as a prebiotic, but as an energy source. 
Shortly after weaning, most diets contain lactose (milk 
sugar). At least part of dietary lactose is fermented by 
lactic acid bacteria to produce lactic acid and other 
metabolites that favor commensal bacteria populations 
and inhibit pathogens. Probiotics may populate the gut 
(Enterococci, Lactobacilli) or in the case of some bacilli, 
may favor lactic acid bacteria, and produce enzymes, or 
other useful metabolites. Organic acids used individually 
or more often in combinations, exert antimicrobial effects 
on pathogens, but may not impede favorable commensal 
bacteria, thus enhancing the stability and health of the 
pig’s digestive  tract.
2013 Allen D. Leman Swine Conference 139
Pr
od
uc

on
Produc
on
Feeding options to fit pig  health
Plant derived additives, including essential oils or other 
extracts, are being studied and showing promise to ad-
dress some of the fundamental challenges in the gut of 
early weaned pigs. Plant-based antioxidants may help pigs 
overcome losses of antioxidant function, at the gut level, 
that occur with weaning and bacterial overgrowth. Other 
plant extracts have been shown to reduce inflammatory 
responses by reducing cytokines that stimulate cascade 
effects, resulting in gut damage. Some plant extracts show 
promise in the face of PRRS or other viral challenges, not 
as a primary treatment, but to enhance the ability of the 
pig to cope with the effects of virus and limit immune 
system over  response.
On-going research using newer techniques, supported by 
practical feeding experiments and field validations will 
continue to help us clarify not only the modes of action, 
but the relative importance of additives and nutritional 
sources to help young pigs through the rigors of post-
weaning growth. The day may come, when this informa-
tion is well-enough defined that young pig models can be 
advanced and applied and allow us to predict the effect 
of a change in production condition on the pig, and to 
compensate with an appropriate nutritional adjustment to 
maintain or improve enterprise  profitability.
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What we are seeing at the diagnostic  lab
Darin Madson
Iowa State  University
Introduction
Swine diets are tailored for maximum growth and not neces-
sarily for optimal bone strength. Complicating this potential 
issue, that can result in clinical lameness, is ingredient cost, 
alternative feed sources and variability in feedstuffs. Not to 
mention NRC values for bone composition maybe outdated 
with today’s industry practices or  genetics.
Bone is a dynamic organ and continues to remodel after 
growth is complete. Besides mechanical strength, bone is 
crucial to body calcium homeostasis. Over 99% of body 
calcium is stored within bone.1 Following extracellular 
depletion of calcium for numerous cellular functions; a 
symphony of intricate events allows calcium to be pulled 
from existing bone. This finely regulated system will ulti-
mately result in increased calcium absorption from the diet 
if adequate vitamin D is available. Phosphate, also a large 
component of bone matrix, is required for mineralization 
and is released when body demands  increase.
In the not so distant past, metabolic bone disease issues 
arose within the swine industry resulting in clinical lame-
ness and even increased mortality. Metabolic bone disease 
broadly categorizes disturbances related to bone formation 
and remodeling.2 Disease can be gradual or abrupt and is 
associated with inadequate calcium, phosphorus, vitamin 
D, or hormonal problems related to parathyroid  hormone.
Mechanisms of metabolic bone  disease
1. Inadequate dietary supplementation of vitamin  D3
2. Inadequate absorption of phosphorus due to low 
phosphorus in diet, phosphorus bound to phytate 
and therefore unavailable, and inadequate or inef-
fective phytase  usage
3. Inadequate dietary  calcium
4. Imbalance of feed calcium to phosphorus ratio; 
improper formulation of Ca:P ratio in diet (should 
be roughly  1.2:1)1
Terminology
Rickets and osteomalacia are the disease names associ-
ated with metabolic bone disease in growing animals and 
adult animals, respectively. The cause and pathogenesis 
of these two diseases are similar; rickets involves grow-
ing bones while osteomalacia occurs with mature bone 
(remodeling  issues).2
Osteoporosis is disorder of bone that is classified under 
the umbrella of metabolic bone disease as well. This 
term is a lesion rather than a process as in rickets or 
osteomalacia, and denotes overall decreased bone mass. 
Bones are structurally normal, but become increasingly 
brittle (easily snap). Osteoporosis results from decreased 
caloric intake, decreased dietary calcium, lactation, or 
from increased  stress.2
Fibrous osteodystrophy (FOD) is a consequential lesion 
that is common in pigs with bone disorders. Primary 
FOD is caused by excessive production of parathyroid 
hormone. Parathyroid hormone is responsible from 
initiating the release of calcium from bone. Secondary 
FOD is associated with dietary or renal problems which 
result from inadequate dietary calcium or loss of calcium 
through the kidney. Secondary FOD is usually what is 
occurring in pigs with metabolic bone disease. In short, 
bone is replaced by fibrous connective in a response to 
add structural  support.
What was  seen?
Clinical  presentation
Clinical signs of swine metabolic bone disease depend 
on the age of pigs, the specific mechanism involved, and 
the magnitude and the duration of the insult. Growing 
pigs with classic rickets will have weak bones that bend 
before they break, clinical lameness, and enlarged growth 
plates that can give the appearance of swollen joints. Limb 
conformation may be abnormal because of bending or 
bowing of bones, but this was not typical in swine cases. 
Of note, long hair and decreased appetite have also been 
reported for vitamin D deficient pigs and there is sub-
stantial evidence suggesting “humpback” formation is a 
manifestation of  rickets.3
Gross abnormalities can take up to 4-6 months to develop 
in swine that are feed vitamin D deficient diets. The onset 
of disease is dependent on how severe the deficiency is. 
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However, chronic nutrient imbalances can have acute 
clinical manifestations other than pathologic fractures or 
rubbery or weak bones. Somewhat more unusual is the 
rather abrupt onset of clinical signs associated with acute 
hypocalcemia. Clinical signs of swine hypocalcemia in-
clude: tremors, tetany, seizure-like muscle fasciculations, 
weakness, lameness, painful gait with reluctance to move, 
and bone fractures (macroscopic and/or  microscopic).
Gross  lesions
Gross lesions, as with clinical signs, are highly variable. 
Gross lesions are often not detected. Bone fractures, 
rib calluses from previous fractures, rachitic lesions in 
growth plates may be apparent in other cases. Rachitic 
rosary lesions on rib bones are widened at the distal 
growth plate. Caudal ribs typically have more pronounced 
rachitic changes because these ribs are growing faster 
than cranial ribs.2 Widened growth plates can be seen in 
few or multiple bones, and frequently there are no grossly 
widened plates. The most useful post-mortem finding is 
measured by accessing bone strength by breaking ribs. In 
the absence of overt lesions, spending time to assessing 
rib strength is  recommended
Diagnosis
Diagnosing hypovitaminosis D or metabolic bone disease 
in swine is not difficult if disease is suspected clinically. It 
is difficult to diagnose if one is not aware or unintention-
ally excludes metabolic disease from the differential list. 
Serum levels of calcium, phosphorus, and vitamin D are a 
vital diagnostic inquiry in disease scenarios. Low values 
of calcium and/or phosphorus are often diagnostic, but 
normal values do not exclude the disease process. Low, 
reliably measured, serum levels of vitamin D are diag-
nostic for vitamin D deficiency (Table 1). Liver analyses 
for calcium or phosphorus do not reflect blood levels and 
are not a good estimate of overall calcium or phosphorus 
status since bone is the reservoir  organ.
Microscopic examination of bone growth plates in grow-
ing animals can confirm and/or add confidence to the 
diagnosis of rickets. Microscopic changes in bone can take 
weeks to months to develop. Rickets lesions will resolve 
in 1-3 months after the deficiency is corrected. Bone can 
be used post clinically to indicate previous metabolic dis-
turbance because microscopic changes take time to return 
to normal and/or remodel. In acute cases, bones changes 
may not be seen or location  dependent.
Bone density and total bone ash are very useful diagnostic 
tools for confirmation of deficiency. Bone ash and density 
are abnormally low in clinical cases of rickets, osteomala-
cia and osteoporosis. Abnormal ash and density may take 
several weeks to develop during a deficient state and will 
gradually return to normal after dietary correction and 
restoration. This is similar to microscopic  lesions.
For laboratory submission of bone for both histopathol-
ogy and bone analysis, it is recommended that the entire 
2nd rib be used for these analyses. Analysis of consistent 
specimen (e.g. 2nd rib) is essential to interpreting bone ash 
and density (Table 2). However, it is always recommended 
to submit lesions (rachitic rosaries) if visually present. 
Disarticulate the rib at its insertion to the vertebral body 
and make sure the costochondral junction and growth 
plate are included from the ventral attachment to  sternum.
When metabolic bone disease is demonstrated, dietary 
factors are implicated as causal irrespective of infectious 
diseases present in the population. A problematic caveat 
to feed testing is that the feed associated with a clinical 
problem is seldom the feed that is on-site during an inves-
tigation. Routinely saving a feed sample from each feed 
delivery in the freezer is recommended. Retained samples 
can be evaluated, depending on results of initial testing of 
tissue or serum samples. The important point is that there 
is feed retained for  testing.
Vitamin D  research
Recently, Iowa State University Veterinary Diagnostic 
Laboratory (ISU-VDL) broadly surveyed serum vitamin 
D levels in 3-4 week-old pigs, 10-12 week-old pigs, late 
finishing, sows, and boars in Iowa and adjacent Midwest-
ern states to try and determine if hypovitaminosis D is an 
industry wide problem. From each age group, 15 farms were 
identified on serum submission to the ISU-VDL. Serum 
Table 1: Suggested serum vitamin D levels for by 
pig  age.
Normal reference range for serum vitamin D
Age of animal 25-OH-D3 (ng/ml)
Neonate 5-15
10 days 8-23
Finishing pigs 30-35
Mature 35-70
At parturition 35-100
Table 2: Normal reference intervals for bone ash, 
bone density, bone calcium and bone phosphorus 
in  swine
Swine; bone
Bone ash 58-62%
Bone density 1.4-1.5 g/ml.  
Bone ash calcium 32-39%
Bone ash phosphorus 13-22%
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from 8 pigs per farm were assayed for serum vitamin D. 
Samples were collected from pigs that had no history of 
metabolic bone disease. A total of 600 serum samples 
were tested in January 2011 during the short photoperiod 
time of year. Another 600 samples were randomly tested 
in June of 2011. In addition, serum samples were col-
lected from groups of outdoor pigs in June of 2011as a 
non-confinement raised comparison. Ten samples from 
nursery, grower, finisher and sows were  collected.
Mean serum vitamin D results were lower than both refer-
ence values (Table 1), and outdoor pig samples in all age 
categories (Table 3). Trends in both January and June con-
firm mature animals having greater vitamin D levels than 
younger animals. Results from both time periods indicate 
that nursery pigs, as a group, have a lower than expected 
serum vitamin D compared to reference values. There was 
considerable variation in all age groups, with individual pigs 
within groups deemed deficient. When January submissions 
were compared to June submissions, there was a significant 
increase in serum 25, (OH) D levels in both nursery and 
boar age categories (P < 0.01). When June submissions were 
compared to outdoor submissions, all age categories (with 
the exclusion of boars) had significantly lower serum 25, 
(OH)D levels than outdoor animals (P  < 0.01).
Interpretation is more difficult because this is only a 
survey. Besides calcium absorption of the small intestine, 
vitamin D has been shown to have anticancer properties, 
reduce the risk of heart disease, and more importantly 
vitamin D is known to have a role in immunity. How this 
translates to swine is  unknown.
Following the serum vitamin D survey, a bulk source vi-
tamin D assessment was conducted through collaboration 
with feed suppliers. Bulk source vitamin D supplement 
samples were collected monthly from November 2011 
through July 2012. Information recorded for each sample in-
cluded: date of collection, date of manufacturing, expected 
concentration, manufacturer name, manufacturer country, 
lot number and supplier name. Each sample was then split, 
and sent to two separate laboratories (DSM and Heartland 
Assays, LLC) for vitamin D assays. A total of 45 supplement 
samples were collected, resulting in 90 assays  completed.
The bulk source vitamin D assessment results showed no 
difference between manufactures or country of origin. 
No samples were found to be statistically lower than the 
expected concentration of 500,000 IU/lb. However, a 
month effect was revealed indicating vitamin D degrada-
tion during extended  storage.
Confounding  problems
Metabolic bone disease has heightened the sensitivity of 
lameness issues within the industry. But obviously not all 
lameness cases in grow-finish pigs are related to the above. 
In the past 18 months, the ISU-VDL has seen a slight 
percentage increase in the numbers of cases compared to 
before the “metabolic bone disease rise”. Submitted cases 
run the gamut from acute clinical outbreaks of infectious 
disease to varied surveillance of the issue. The two etiolo-
gies that occur most frequently in these submissions to the 
ISU-VDL are osteochondrosis/osteochondrosis dissecans 
and Mycoplasma  hyosynoviae.
Osteochondrosis is a common growth cartilage disorder 
in pigs and can affect both articular or physeal cartilage. 
The exact pathogenesis is sketchy, but multiple risk fac-
tors including rapid growth, heredity, trauma, and dietary 
factors are often implicated. Common lesion locations in 
swine are the distal humerus and femur, but can be seen 
 elsewhere.4
Table 3: Combined serum 25, (OH) D results by age and month. Comparison of outdoor pig serum 25, (OH) D 
is also  included.
Serum 25, (OH)D levels (ng/ml)
January June January vs. June Outdoor June vs. Outdoor
Age 
category Min Avg Max Min Avg Max (P-values) Avg (P-values)
Nursery
(2-4wks)
2.1 8.42 56.2 3.0 13.75 62.4 < 0.01 58.54 < 0.01
Grower
(10-14wks)
3.4 21.80 54.1 5.3 18.04 50.5 0.013 61.03 < 0.01
Finisher  
(6-8mon)
3.7 27.66 77.9 66.6 28.18 68.5 0.048 85.98 < 0.01
Sows 8.6 35.70 83.4 4.7 36.33 94.5 0.792 57.17 < 0.01
Boars 8.9 31.56 64.5 17.3 45.42 93.8 < 0.01 n/a n/a
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Mycoplasma hyosynoviae is vertically transmitted for dam 
to offspring and subsequently transmitted horizontally 
in the grow-finish phase of production. The bacteria can 
localize in one or multiple joints resulting in proliferative 
synovitis with excessive red-tinged and watery synovial 
fluid. In my experience, the stifle and elbow are common 
joints that are affected. In addition, PCR detection of 
Mycoplasma hyosynoviae is common practice, yet caution 
in the diagnosis is advised; detection does automatically 
yield  cause.
Thoughts to ponder and diagnostic  advice
1. A common diagnostic sampling mistake is submit-
ting only rear legs without a clinical examine for 
localization purposes. Lame pigs lying on concrete 
with often form hygromas lateral to the hock. This 
is often misinterpreted as a swollen hock. The ac-
tual cause of lameness is  elsewhere.
2. Mycoplasma hyosynoviae can be a primary etio-
logic agent for lameness; however, it can also be 
secondary to joint instability. It is sometimes dif-
ficult to determine which process occurred fist. It is 
like the old saying, “which came first the chicken or 
the  egg”?
3. Would bone strength issues result in osteochondro-
sis? In other words, if a pig has subclinical nutri-
tional issues with calcium, phosphorus, or vitamin 
D in the growing phase, would this lead to late 
clinical osteochondrosis issues? A similar thought 
could be made for Mycoplasma hyosynoviae. If 
there is reduced bone strength causing joint insta-
bility, would this be an advantage for Mycoplasma 
hyosynoviae replication and  disease?
With the last thought above, I can’t help but believe that 
there is an intricate web or etiology associated with bone 
strength, infectious disease, and  osteochondrosis.
Conclusion
As of late, the number of metabolic bone disease case 
submissions has been declining. The decline is suspected 
do be related to awareness within the swine industry 
while improving quality control methods related feed 
ingredients, changes in diet formulations to enhance bone 
formation, and prophylactically treating with commercial 
supplements (i.e. oral vitamin D). However, there are still 
periodic cases or instances where metabolic bone disease 
issues are causing reduced profitability in the barn  today.
When working through lameness cases, a good clinical 
examination followed by a complete diagnostic submission 
will aid in determining the pertinent etiology for the issue. 
Bear in mind though, that other lameness disorders may be 
a consequence of previous nutritional issues arising from 
decreased bone strength at some point during  grow-out.
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Introduction
Lameness and mortality issues in the swine industry have 
escalated in recent years (Madson et al., 2012). Many of 
the recent cases were attributed to hypovitaminosis D. The 
issues have spurred interest and questions about bone com-
position and the methods used to accurately assess skeletal 
integrity. Necropsy reports that describe fractures, callous 
ribs, and “rubbery” bones may reflect extreme conditions 
of a nutrient deficiency, but more definitive descriptors are 
needed to establish guidelines that are useful for the es-
tablishment of a balance between nutrient inputs required 
for animal well-being and the environmental issues that 
often pressure nutrient formulation strategies. The goal 
is to prevent deficiencies without contributing to excess 
nutrient supplementation. This review briefly summarizes 
basic principles involved in bone composition, the impact 
of dietary nutrients on bone composition, and critically 
assesses methods used to quantify bone integrity in clini-
cal and research  settings.
Bone tissue  composition
As a wet tissue, bone is composed of 45% water, 10% fat, 
20% organic matrix, and 25% inorganic mineral (Cren-
shaw, 2001). The water and fat content of bone varies with 
age, type of bone, and nutrient input. Thus, the mineral 
content expressed as a percentage of the dry, fat-free 
weight describes the extent to which the organic matrix 
has become saturated with mineral. On a dry, fat-free 
basis, approximately 56% of the entire skeleton is ash. 
However, the percent ash varies from 62 to 72% in corti-
cal bone from mature sows (Crenshaw et al., 2012), but 
in young pigs the percent ash may be only 44 to 46% in 
bones that are mostly trabecular such as ribs (Rortvedt et 
al., 2012a) or vertebrae (45% in pigs at birth, 35% at day 25, 
Vanderwerff et al., 2013). Thus, the selected bone sample 
and animal age are critical determinants if percentage ash 
is used for diagnostic assessment of the mineral  adequacy.
Despite the range in percent ash, the Ca and P content of 
bone remains constant. The inorganic ash contains Ca (38 
to 40%) and P (17 to 19%) in a 2.1:1 ratio. The amount of 
inorganic material and the extent of mineralization of the 
organic matrix (percent ash) may vary, but the Ca and P 
composition of ash will not change (Crenshaw, 2001). If 
molar corrections of phosphorus for phosphate are cal-
culated, approximately 90% of the inorganic material in 
bone can be attributed to Ca and P. The remaining minerals 
include Mg, Na, K, Cl, and trace  minerals.
Roles for trace minerals in  bone
As discussed by Crenshaw et al., 2012, trace minerals are 
integral nutrients involved in bone and connective tissue. 
In skeletal tissues, the roles of these nutrients are mostly 
associated with roles as cofactors for proteins involved 
in the synthesis and maintenance of the organic matrix 
rather than a role in the formation of mineral crystals per 
se. Primary roles for trace minerals include: Cu, a cofactor 
for lysyl oxidase and formation of collagen cross-links; 
Mn, glycosyltransferases involved in the formation of 
glycosaminoglycans that are structural components of the 
extracellular matrix; Zn, a cofactor for alkaline phospha-
tase and collagenases, with more recent identification of 
a role as an antagonist to the RANK and RANKL ligands 
involved in the coupling of osteoblast and osteoclast func-
tion to balance bone formation with resorption; and Fe, a 
co-factor lysine and proline hydroxylase enzymes involved 
in collagen  cross-links.
Trace mineral deficiencies, excesses, or imbalances will 
result in bone integrity issues, but homeostatic mecha-
nisms allow animals to adjust to a relatively wide range of 
trace mineral nutrient inputs. Bone integrity issues in com-
mercial production animals are not commonly associated 
with trace mineral deficiencies. Over-supplementation or 
an imbalance of trace minerals are more common issues 
with trace minerals. With exception of Fe, the best method 
to clinically assess trace mineral status involves measure-
ments of the trace mineral composition of bone ash. The 
trace minerals should be expressed as a percentage of the 
bone ash to remove variable concentrations relative to 
water, fat, and organic matrix  content.
Which bone to  sample?
Decisions on the selection of a single bone to represent 
the entire animal have been speculative and were based 
on which bone responded to dietary treatments (Crenshaw 
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et al., 1981), or whether the fibulae were easier to collect 
than femurs or metacarpal bones (Biehl and Baker, 1996). 
With development of techniques, such as dual energy x-
ray absorpitometry (DXA), to accurately measure the ash 
content of the entire growing pig (Schneider et al., 2005) 
or feet (Hoffman et al., 2007), different inferences about 
responses to dietary treatments were identified if infer-
ences were based on the fibula vs the femur of young pigs 
(Crenshaw et al., 2009). The conclusion that more accurate 
inferences were obtained with assessments of the femur 
was based on observations that the femur ash content 
provided a better fit to dietary P inputs than the fibula 
ash content relative to responses in the entire pig. The 
fibula tended to overestimate whole body bone mineral 
content (BMC) at low P intakes, but underestimated BMC 
at high intakes. As the entire pig, not the femur or fibula, 
consumed the diet, the bone which reliably predicted the 
entire pig seemed to be a reasonable  choice.
In older pigs (40 to 120 kg) differences among bones 
(femur, front feet, or hind feet) were not dramatically 
different in their fit as predictors of whole body BMC 
(Table 1), but predictions based on fibulas over-estimated 
the whole body bone mineral content. Thus, selection of 
limb bones from pigs at market weight (120 kg) are not 
as critical as the bone selected at younger ages (< 40 kg), 
consistent with earlier conclusions (Crenshaw et al.,  1981).
Bone growth and maintenance - 
synthesis and  accumulation
Bone integrity (soundness) is affected by both the organic 
and inorganic materials that compose the tissue. Bone 
tissue is a composite material which requires synthesis 
of an organic matrix by osteoblast cells that are eventu-
ally embedded in an extra-cellular matrix. The matrix is 
composed primarily of collagen fibrils arranged in heli-
cal strands with proteoglycan polymers inter-dispersed 
within the matrix. With time, hydroxyapaptite-like 
[(Ca3(PO4)2)3·Ca(OH)2] mineral crystals form within the 
collagen helical matrix. Systemic hormones and local-
ized growth factors stimulate osteoblast proliferation 
and differentiation with consequences that affect the rate 
and accumulation of the organic matrix, but do not act 
directly to drive mineral crystal formation. Attempts to 
increase mineralization by over-supplementation of diets 
will down-regulate homeostatic mechanisms and decrease 
the efficiency of nutrient  use.
The combination of the organic matrix and mineral crys-
tals define the material strength properties of bone. The 
combination of collagen fibers, which contribute primarily 
tensile (resistance to stretching) properties, and mineral 
crystals, which contribute primarily compressive (resis-
tance to compression) properties produces an anisotropic 
material with properties that cannot be explained by the 
summation of the individual components. Normal loads 
imposed on a bone are not singularly a tensile or compres-
sion load. Rather, most forces imposed on live animals 
involve a combination of the two loads to produce a bend-
ing load. One surface of the bone is compressed while 
the other surface is under tension. Thus, the combination 
of materials, collagen and mineral crystals, provide a 
cumulative response to forces that cannot be explained 
by a single  material.
Guidelines to identify bone strength properties that reflect 
an acceptable range have not been defined. Results from 
mechanical tests of individual bones have been used to de-
scribe animal responses to nutrient inputs. The amount of 
nutrients required to maximize bone strength exceeds the 
amount required to maximize bone ash (Crenshaw, 1986). 
Thus, the ash content of bone is not directly proportional 
to the strength properties. Additionally, procedures used 
to measure bone mechanical traits are not standardized 
across laboratories. The time required for mechanical 
Table 1: Regression equations for the use of individual standardized a bone traits as predictors of whole body 
bone mineral content of pigs (rPBMC) from 40 to 120 kg.
Regression equations
rPBMC = -0.057 + 1.018*Femur rBMC R2  = 0.966
rPBMC = 0.133 + 0.846*Fibula rBMC R2  = 0.910
rPBMC = -0.089 + 0.994*Front Foot rBMC R2  = 0.906
rPBMC = -0.076 + 0.971*Hind Foot rBMC R2  = 0.797
rPBMC = 0.266 + 0.663*Yield Bending Moment R2  = 0.620
rPBMC = 0.455 + 0.201*Yield Stress R2 = 0.966
*   All values (n=78 total pigs with 6, 24, and 48 each at 40, 80 and 110 kg weight groups respectively) were standardized to the 
relative values for each trait based on the pig with the largest amount of bone mineral content.
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test procedures and requirements of specialized equip-
ment often preclude the routine use of these procedures 
as a clinical diagnostic method. Thus, bone mechanical 
tests are not recommended for use in clinical assessment 
of lameness issues, rather such test methods remain as a 
research technique for assessment of hypothesis-driven 
research  projects.
Nutrient inputs alter bone ash and 
 integrity
A discussion of concepts related to the effects that dietary 
concentrations of Ca and P have on the accumulation of 
bone mineral (ash) in pigs is beyond the scope of this 
review. Deficiencies of these nutrients lead to an under-
mineralized bone matrix, deformed limbs (rickets), and 
spontaneous fractures (mechanical failures). Numerous 
research papers, reviews and texts have focused on these 
topics. Guidelines for the amounts of Ca and P supplied 
and the ratio of Ca to P, especially under conditions of 
marginal P intake, were relatively well-established until 
the introduction of phytase supplements as a common feed 
ingredient. Development of recommendations related to 
dietary Ca and P supplements in diets that incorporate 
various phytase products are on-going. Variant feed 
formulations based on phytase inclusions may contribute 
to some of the escalated lameness issues, but quality 
control issues in feed management that affect phytase 
stability are more likely an issue. However, the focus of 
this paper is to address guidelines for the assessment of 
bone to establish if animals have been fed diets within an 
acceptable safe  range.
The recent escalated lameness issues associated with 
vitamin D have highlighted concerns for quality control 
issues in diet formulations (Madson, 2013). Failures in 
quality control procedures for feed management may 
contribute to delivery of diets with un-intentional deficien-
cies. In recent studies we have focused on the ability of 
growing pigs to recover skeletal mineral content after a 
brief period of mineral deficiency. Within 4 wk, a 61.6% 
reduction in whole body BMC was induced in young pigs 
fed a diet with 70 vs 150% of Ca and P requirements based 
on NRC, 1998 guidelines. Whole body DXA scans of the 
same animals at repeated intervals revealed that BMC 
was not recovered over a subsequent 8 wk period, even 
if the pigs were fed diets with 150% of Ca and P require-
ments (Aiyangar et al., 2010). However, femurs collected 
after the 8-wk recovery period had apparently regained 
equal strength properties as those in pigs fed control diets 
throughout the entire trial. Recovery of femur strength, but 
not whole body bone mineral content can be attributed to 
either preferential partitioning of mineral reserves to load-
bearing bones, potentially at the determent of non-load 
bearing bones, or to a shift in the distribution of mineral 
reserves within bone to align the limited resources with 
the direction of applied  loads.
These results further illustrate the discrepancy between 
assessments based on bone mineral (ash) measurements 
and bone mechanical test properties. Similar results have 
also been reported in nursery pigs (Rortvedt et al., 2012b, 
growing-finishing pigs (Iwicki et al., 2011) and to an extent 
by other researchers (Létourneau-Montminy et al.,  2011).
Which method to assess mineral 
 adequacy?
The results about the selection of a bone specimen and 
the depletion-repletion studies illustrated differences in 
conclusions based on methods used. Traditional methods 
used to assess skeletal tissue integrity can be broadly clas-
sified into 3 approaches (Table 2) which include histology, 
gravimetric, and mechanical procedures. All three proce-
dures, with exception to DXA scans, require a terminal 
approach and each provide unique, and often different 
conclusions with regards to nutrient inputs. Each method 
also has limitations and pitfalls that must be considered in 
a decision to employ the method or interpret the results for 
a final diagnosis. Clinical applications often require rapid 
turn-around diagnosis to deal with acute issues. Simple, 
rapid methods, such as visual appraisals, quantifying the 
incidence of occurrences and a terminal assessment of the 
bone ash content are the first-line approaches to deal with 
acute cases. Long-term, chronic issues can potentially be 
resolved with additional samples, such as the front foot, 
collected from marketed animals and submitted for DXA 
scans to determine mineral content. Use of histology and 
mechanical test require a longer turn-around time for 
results and are more  expensive.
Conclusions
Clinical cases that involve lameness issues often lead to 
questions about the adequacy of nutrient formulations, 
especially dietary Ca and P, and more recently vitamin 
D concentrations. Attempts to correct the increased inci-
dence of lameness by over-supplementation of nutrients 
most often do not resolve the problems and may contribute 
further complications. Over-supplementation of nutrients, 
particularly Ca and P, does not necessarily allow pigs to 
recover from skeletal integrity challenges that may have 
been imposed by brief periods of deficiency. Accurate 
diagnosis of nutrient deficiencies require standardized 
sampling and analysis procedures. Use of DXA technolo-
gies offer accurate and rapid turn-around for specimen 
analysis of bone mineral  content.
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Table 2: Methods used to assess skeletal tissues in response to nutrient inputs
Method Test Prospects Pitfall
Histology Terminal Dynamic Sample size/time
Gravimetric
   DXA 
Terminal
Non-invasive
Standard
Whole animal
Accuracy
Ash ≠ Strength
Mechanical Terminal Structural integrity Irregular shape & Composite material
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Introduction
The objective of this manuscript is to review recent re-
search information related to dietary requirements and 
utilization of calcium (Ca), phosphorus (P), and vitamin 
D (VitD) to optimize bone health, pig growth, farm profit-
ability, and minimize environmental pollution. Nutritional 
programs for swine must take into account the essential 
roles of Ca, P, and VitD in: 1) metabolism and overall lean 
tissue and bone growth, 2) contributions to total diet cost, 
and 3) managing excess concentrations of P in manure 
to minimize environmental pollution (Crenshaw, 2001). 
Calcium and P are required for optimal bone mineraliza-
tion, while VitD is required for proper Ca absorption 
and potentially pig health. Phosphorus is the third most 
expensive nutritional component of swine diets after en-
ergy and amino acids, and excess P in runoff manure may 
account for 33% of the P load into fresh water resources 
(UN-FAO,  2006).
The dietary requirements of nutrients for pigs has evolved 
from a static value expected to match all production cir-
cumstances to a dynamic value that accounts for multiple 
factors affecting the physiological processes related to 
maintenance, growth, and efficiency of nutrient utiliza-
tion. Animal growth and subsequent nutrient requirements 
are affected by multiple factors such as growth rate, feed 
intake, and type of diet. Therefore, it is not correct to as-
sume that nutritional recommendations will fit all animals 
in all production  conditions.
Several published references provide a review of current 
nutrient requirement recommendations based on the re-
vised “Nutrient Requirements of Swine” from the National 
Research Council (NRC, 2012). The NRC, 2012 along with 
newer mechanistic models of the fate of dietary P in the 
gastrointestinal tract and metabolic pathways in pigs allow 
for more precise estimates of dietary concentration and 
requirements of P for pigs (Schulin-Zeuthen et al., 2007; 
Létourneau-Montminy et al., 2011; Létourneau-Montminy 
et al., 2012a,b). The NRC (2012) and the newer mechanistic 
models are guidelines for nutritional recommendations 
and are useful to illustrate the variety of options that nu-
tritionists use to meet requirements for Ca, P, and VitD 
in diets for growing pigs and  sows.
Physiological functions of Ca, P, and 
Vitamin  D
Despite their high concentrations in skeletal tissue (>90% 
of Ca, and > 60% of P), Ca and P also have important roles 
not only on bone structure, but also in nutrient metabolism, 
cell signaling, blood clotting, among others (Crenshaw, 
2001). Calcium is deposited in skeletal tissue as hydroxy-
apatite, Ca5(PO4)3(OH), which may constitute about 50% 
of dry weight of bones. Deposition of both elements is nec-
essary for proper bone formation and one mineral will not 
be deposited without the other (Crenshaw, 2001). Calcium 
also has metabolic regulatory properties. For example, 
Ca forms complexes with proteins allowing for revers-
ible conformational changes and regulating the function 
of proteins. Phosphorus has structural functions in bone 
mineralization, is an intrinsic part of hydroxyapatite, and it 
is also constituent of phospholipids (Ewing and Charlton, 
2007). Phosphorus also functions to regulate metabolism. 
Phosphorylation activates and deactivates enzymes, and 
energy transfer requires formation of P  bonds.
The main link of VitD to Ca, P, and bone health is the role 
of VitD on intestinal absorption of Ca. Calcium is absorbed 
in the small intestine by active-transcellular and passive-
paracellular pathway and VitD causes formation of Ca 
binding proteins for the active absorption of Ca (Wasser-
man and Taylor, 1966; Crystakos et al., 2011). The role 
of VitD in Ca absorption is key for bone mineralization. 
However, VitD has other non-structural roles in regula-
tion of immune cells (Figure 1). Therefore, the nutritional 
requirements of these 3 nutrients depend on the balance 
and utilization of Ca, P, and VitD in all  functions.
Concentration, utilization, and 
measures of Ca, P, and Vitamin D in feed 
 ingredients
The concentration of Ca and P in feed ingredients, con-
centrates, and complete diets can be expressed on the 
basis of: 1) total dietary concentration, 2) availability, or 3) 
digestibility (Joengbloed et al., 1991; Carlson et al., 2008, 
Richert, 2012). It is well establish that total concentration 
of Ca and P is not a reliable measurement of the potential 
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use of the nutrient in feed ingredients and diets (Jongbloed 
et al., 1991). The reason for the unreliable use of total Ca 
and P as measure of requirement is that these minerals 
can be found bound to phytic acid in most plant raw ma-
terials (Table 1). The standardized total tract digestibility 
(STTD) of P bound to phytic acid in plant raw materials 
is only about 20% compared with 80% in most sources 
of inorganic P. Only transgenic pigs producing salivary 
phytase are capable of utilizing Ca and P bound to phytic 
acid (Goloban et al.,  2001).
The differences in digestibility and utilization of P among 
raw materials can be calculated by measuring the avail-
ability of P and Ca in raw materials. The availability of Ca 
and P are expressed as a value relative to a reference raw 
material (typically monocalcium or dicalcium phosphate). 
The inorganic standard raw material is assumed to be 100% 
bioavailable for metabolic functions and bone mineraliza-
tion. Therefore, bone strength and bone ash are the major 
outcomes of measuring bioavailability of Ca and P in feed 
ingredients. The availability system is a major improve-
ment over formulating diets for pigs, especially when using 
alternative feed ingredients (Hanson et al.,  2012).
The major problem with the bioavailability system is that 
digestibility and subsequent availability of “a standard 
feed ingredient” varies between and within ingredients 
(Table 2). This results P availability values not being ad-
ditive, and will cause errors in nutrient concentration in 
the final diet (Pedersen et al., 2011). In addition, expression 
of nutrient concentration of feed ingredients on digestible 
basis allows for calculations of nutrient excretion and use 
of digestibility values to determine necessary amounts of 
phytase enzymes to be added to the diet. Diets can also 
be formulated to minimize indigestible P concentrations, 
which is an advantage of digestibility system over other 
 methods.
The digestibility of P can be expressed on apparent, stan-
dardized, or true total tract digestibility (NRC, 2012). There-
fore, the concentration of P in diets for pigs can be calculated 
using a digestibility estimate times the concentration of 
total P. The recent NRC (2012) adopted the nomenclature 
and methodology of standardized total tract digestibility 
(STTD). The value of STTD represents the concentration 
of digestible P in a diet or feed ingredient after has been 
corrected for basal endogenous losses, which is the same 
concept comparable to that used for amino acids (Stein et 
al., 2007). Basal endogenous P loss is the amount of P that 
pigs excrete daily consuming a diet devoid of P (Petersen et 
al., 2012). It is assumed that an adjustment of digestibility 
values for endogenous losses of P will make diet formulation 
for P more additive because it corrects for losses of similar 
amounts across all feed ingredients, which is an advantage 
over the availability  system.
The concentration of vitamins can also be expressed on 
their total concentration usually in international units/
kg. The international unit is a measurement based on the 
biological activity of the specific chemical form of the 
vitamin (Baker and Stein, 2012). Given that there are many 
chemical forms, preparations, and sources of VitD, it is 
necessary to express their concentration on IU. The IU of 
VitD is the equivalent of the biological activity of 0.025 
µg of cholecalciferol (VitD3) a main form of the vitamin 
found in animals (NRC, 2012). The other prominent form 
is ergocalciferol (vitamin D2) found in plant materials. Pigs 
can synthetize VitD by isomerication of 7-dehydrocho-
lesterol (7-DHC) in the skin to VitD3 following exposure 
to sun light or from ingestion of vitamin D2 or D3 in the 
diet. There are numerous factors that affect the synthesis 
of VitD such as availability of precursors and amount of 
exposure to sun light. Once formed, VitD undergoes 2 
hydroxylations steps in liver in kidney at the 1 and 25th 
positions to form  1,25(OH)2D3.
The nutritional concentration of vitamins for requirements 
for vitamins has been expressed on the basis of their bio-
availability in a similar manner that used to express P bio-
availability relative to a standard source (Baker and Stein, 
2012). The bioavailability of vitamins in cereal grains and 
most ingredients is disregarded when formulating diets for 
pigs, while all requirements are met by vitamins supplied 
in the form of a premix added to the final diet. There are 
many factors that affect the bioavailability and degrada-
tion of VitD in premixes such as humidity, sun light ex-
posure, heat, pH, presence of oxidative agents, and type 
Ergocalciferol or Cholecalciferol
25-hydroxy-D3
1, 25-hydroxy-D3
Immune functions
Bone 
mineralization
Calcium 
absorption
Phosphorus 
absorption
Intestine Skeletal
Figure 1: Schematic presentation of systems and 
functions affected by vitamin D
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of inorganic trace minerals (Shurson et al., 2011; NRC, 
2012). Therefore, for many practical applications, vitamin 
concentrations provided by premixes are at levels several 
times greater than recommended levels in the final diet to 
account for these uncertainties while ensuring adequate 
vitamin nutrition (Richert,  2012).
Models to determine Ca, P, and VitD 
 requirements
Nutritional requirements for Ca and P of growing pigs, 
gestating and lactating sows can be obtained from pub-
lished values or from newer predictive models. In the 
newest nutritional recommendations from NRC (2012), 
the P requirement for growing pigs is calculated using a 
modeling approach of factorial and dynamic estimations. It 
is difficult to quantify each physiological function of these 
nutrients to determine a dietary requirement. Therefore, 
an alternative approach is to partition the animal’s nutri-
tional requirement into the functions that P has on basal 
metabolism and production (growth or lactation). Main-
tenance requirements for P are based on the amount of P 
that would need to be consumed to keep basal metabolic 
functions and replace those amounts lost in feces and urine 
(Jongbloed et al., 1991). The requirement for production 
purposes are the amount of P needed to support growth 
or milk production (Jongbloed et al., 1991; NRC, 2012). 
The sum of maintenance and production requirements 
are additive and account for all P intake required per day 
(Baker and Stein, 2012; NRC,  2012).
For growing pigs and sows, the main determinants of P 
requirements are: 1) maximum rate of retention (calculated 
from whole body P mass), 2) P retention in products of 
conceptus, 3) P output in milk, 4) basal endogenous loses 
of P, 5) minimum urinary losses of P, and 6) marginal ef-
ficiency of using STTD P intake for P retention. In addition, 
for growing pigs, the NRC estimates that the P requirement 
for maximum growth performance is 85% of the P require-
ment for maximum P retention. This suggests that optimal 
Table 1: Concentration of total calcium, total phosphorus, and phytate bound phosphorus in common raw  
materials fed to growing pigs
Calcium, % Phosphorus, % Phytate, % Avail. of P, %1 STTD of P2, %
Corn 0.02 0.26 0.21 – 34.0
Soybean meal 0.33 0.71 0.38 – 48.0
DDGS, 10% oil 0.12 0.73 0.26 – 65.0
Dicalcium phosphate 24.8 18.8 – 49.5 81.4
Monocalcium phosphate, 70 16.9 21.5 – 68.9 53.4
Monocalcium phosphate, 85 – – – 66.3 –
Monocalcium phosphate, 100 – – – 84.9 –
1    Availability of phosphorus, values modified from Pedersen et al. (2011).
2    Standardized total tract digestible phosphorus.
Table 2: Example of diets formulated with variable concentrations of total phosphorus but a similar concentration 
of standardized total tract digestible (STTD) phosphorus (P)
Item Diet 1 Diet 2 STTD of P, %
Ingredient composition, %
  Corn, yellow dent 64.5 43.7 26
  Soybean meal 32.6 13.2 39
  Distillers dried grains with solubles – 40 65
  Monocalcium phosphate 1.07 0.4 83
Nutrient composition
  Total phosphorus, % 0.61 0.64 51
  STTD of P, % 0.31 0.31 48
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pig growth can be achieved by feeding diets containing 
85% of the P that would be required for optimal bone 
mineralization. The requirement of P on a STTD basis 
can be calculated as  follows:
STTD P req (g/day)=0.85 ×[ (max WB P reten-
tion)/0.77+0.19 ×DMI+0.007 ×BW]
Where 0.85 is the maximum P required for growth as a 
proportion from the maximum requirement for P reten-
tion, Max WB P retention is the maximum whole body P 
retention, DMI is the dry matter intake of pigs, and BW 
is the body weight of pigs that is dynamically changed 
with phase of feeding. From the above requirement model 
it is implied that pigs require less dietary intake of P for 
optimal growth that for optimal bone mineralization. The 
optimal level of P for maximal profitability is then based 
on animal growth at 0.85 of the requirement for optimal 
bone mineralization (Cromwell et al., 1970). Under com-
mercial conditions, pigs are generally fed greater dietary 
levels of P than actually required for optimal growth to 
avoid the risk for rickets in young or osteomalacia in adult 
pigs. Therefore, a 5-10% safety margin is generally applied 
to calculated dietary requirements to account for variation 
in requirements and feed intake among the population 
of pigs. The other solution is to formulate diets using 
stochastic models (Pomar et al., 2011). Stochastic models 
of nutrient requirements take into account growth and P 
requirements of individual pigs, but they are rarely use 
under commercial conditions at this  moment.
The requirements for Ca, are expressed on total concentra-
tion of dietary Ca and are not expressed on STTD basis in 
NRC (2012). Therefore, the current NRC (2012) calculates 
the requirement of Ca as a linear function of the require-
ments for STTD P as 2.15. It is expected that new values 
for endogenous losses of Ca will be available to recalculate 
nutrient concentration of feed ingredients on STTD of Ca 
in the future (Gonzalez-Vega, 2012). A ratio of 0.9:1 for 
true total tract digestible Ca to true total tract digestible 
P was calculated, but not included in the current models 
of NRC (Fan and Archbold,  2012).
The nutritional recommendations for the concentration of 
VitD in diets of pigs between 5 and 25 kg in NRC (2012) 
remained the same at 220 IU/kg (Table 3) compared with 
previous revisions of the requirements since 1968 (NRC, 
2012). Despite the fact that pig’s genetics, feed intake, 
and environment has changed since 1968, the NRC 2012 
has kept requirements similar because very few studies 
have been conducted to establish a new requirement. 
Furthermore, most of the studies suggesting a benefit 
from increasing dietary VitD concentrations have con-
sidered only a few dietary levels (Jang et al., 2012). Ex-
perimentally, using only a few dietary levels to measure 
responses makes impossible to establish an objective 
rather subjective requirement for nutrients (Baker, 1986). 
It is also necessary to use the most appropriate response 
criteria for experiments designed to establish a nutritional 
recommended level of VitD, and in general, any essential 
nutrient (Baker, 1986). Common response criteria used to 
establish VitD requirements are measurements of bone 
health, as well as incidence and severity of rickets in young 
animals and osteomalacia and in adult animals that are 
fed increasing levels of VitD under experimental condi-
tions (Combs et al., 1966). These types of experiments are 
usually conducted under clean farm environments with 
minimal pathogen load. However, under field conditions it 
is possible that greater nutritional requirements are needed 
when animals are exposed to pathogens (Figure  1).
What is the role of the immune system 
on Vitamin D requirements? New areas 
of  utilization
Vitamin D has being demonstrated to have a modulatory 
role in the immune system of pigs (Tougsignant et al., 
2013). These modulatory effects of the immune system 
suggest that pigs may benefit from greater dietary levels 
of VitD. However, the dietary levels of VitD that are nec-
essary for improving immune function or improving pig 
growth under disease challenge conditions are not well 
defined for several reasons. First, as mentioned above most 
studies have used limited dietary or supplemental levels 
of VitD, which makes impossible to establish a correct 
dietary requirement (Baker, 1986). Second, most studies 
have measure only a few physiologic responses, either 
immune parameter or growth, but none has tested the bal-
ance among all functions for VitD (Figure 1). The optimal 
supplement or dietary concentration of VitD will depend 
on the most profitable balance between all  variables.
In conclusion, dietary requirements for Ca, P, and VitD are 
dynamic requirements that need constant monitoring and 
adjustment in diet formulations to optimize animal growth 
and minimize environmental impact of pork production. 
Nutritional models are a useful tool for determining ob-
jective and dynamic requirements, but new parameters in 
to account for differences in animal health may need to 
be included in these models to increase the precision of 
estimating  requirements.
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Rise up:  2013
Paul  McKellips
“Rise Up” is an inspiring and powerful multimedia pre-
sentation that traces the evolution of the extreme animal 
rights movement and reveals the impact it’s having today 
on the biomedical research community worldwide. McKel-
lips uses a litany of animal rights videos to uncover and 
identify the real agenda; it’s not about the animals – it’s 
about  anarchy.
When animal rights extremists conduct direct action vio-
lence or hold public protests with non-traditional stunts, 
they receive “earned media” coverage from news outlets, 
bloggers, radio and newspapers. Often times the animal 
rights claims are so outrageous that the research com-
munity doesn’t respond. Many voices fall silent because 
no one wants to put a target on their  back.
This presentation identifies how the Foundation for Bio-
medical Research has used the mass market, international 
media reach of the Bench to Bedside television series, 
national TV ads, a magazine, and mass market commer-
cial novels, to increase public support for the humane and 
responsible use of animals in  research.
“Rise Up” ends with a motivational component that’s 
guaranteed to leave every audience – at all levels of re-
search and support staff – feeling empowered, energized 
and proud of their  work.
About the Speaker:
McKellips has written, directed and produced three mo-
tion pictures and numerous television shows. He covered 
the Pentagon and State Department as national TV news 
correspondent and the Middle East desk at Voice of 
America before serving in Iraq and Afghanistan as a media 
trainer. McKellips has been the EVP at the Foundation for 
Biomedical Research since 2007 where he has earned eight 
Emmy nominations and 28 Telly Awards for the Bench to 
Bedside series and he has written two biomedical thrill-
ers, UNCAGED and JERICHO 3. His third novel will be 
released in 2013 through the Penguin  Group.
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The growing diversity of H3N2 influenza A virus in swine 
and the impact on control in swine and at the human 
animal  interface
Amy L. Vincent; Pravina Kitikoon; Tavis K. Anderson; Crystal L.  Loving
Virus and Prion Research Unit, National Animal Disease Center, USDA-ARS, Ames, Iowa
Introduction
H3N2 influenza A viruses (IAV) were recognized as 
endemic infections in the USA swine population follow-
ing the 1997-98 incursion of the triple reassortant viruses 
with gene segments from human- (HA, NA, and PB1), 
swine- (NP, M, and NS) and avian- (PB2 and PA) adapted 
viruses (reviewed in).1 The significance of the constella-
tion of triple reassortant internal genes (TRIG) would 
be realized from that critical turning point into the pres-
ent day, during which time we have observed the TRIG 
viruses reassort numerous times to acquire new surface 
genes (β-, γ-, δ1-, and δ2-H1N1 and H1N2; H2N3) in the 
USA, to be exported to new regions (China and South 
Korea for example), as well as to donate genes to the first 
human pandemic virus of the 21st century, H1N1pdm09.2 
Concurrent with frequent reassortment has been a dramatic 
evolution of IAV in swine in the USA, resulting in multiple 
antigenic variants that co-circulate and severely challenge 
our control measures. Recently, efforts within the public 
and animal health sectors to increase monitoring of IAV 
in populations of interest have been implemented, with the 
ultimate goals of improved detection and control interven-
tions. The public health efforts are linked to a mandate 
instituted in 2005, requiring all human cases of infection 
with novel influenza viruses be reported to the World Health 
Organization under the International Health Regulations. 
Consequently, investment in resources for domestic detec-
tion and reporting mechanisms for novel IAV in humans has 
increased. This includes all zoonotic infections of humans 
with swine IAV, termed “variant” IAV and denoted by a 
lower case “v” following the subtype. On the animal health 
side, the USDA implemented a swine influenza surveillance 
system in 2009 in response to the growing concern over 
endemic swine IAV and the emergence of the H1N1pdm09 
and subsequent spillover from humans to pigs in the USA. 
Data from both sectors have provided invaluable insights 
into the nature of IAV adapted to swine and the implications 
of spillover that occurs in both directions between humans 
and pigs. Although sporadic infection of humans with H1N1 
and H1N2 swine IAV were reported since 2005, none have 
occurred with the magnitude of the recent H3N2v cases,3 
thus H3N2 in swine and H3N2v in humans will be the 
primary focus of this  presentation.
Evolution of IAV in  swine
Recent improvements in influenza surveillance in swine 
populations in the USA allow for timely epidemiologic, 
phylogenetic, and virologic analyses that monitor emer-
gence of novel viruses and assess changes in viral popu-
lation dynamics. A phylogenetic analysis was conducted 
on sequences from IAV isolated from US swine during 
2009-2012 through voluntary and anonymous submissions 
into the USDA IAV swine surveillance system (T. K. 
Anderson, submitted). These analyses revealed changes 
in population dynamics among multiple clades of H1N1, 
H3N2, and H1N2 co-circulating in US swine populations 
during 2009-2012. Viral isolates were categorized into one 
of seven genetically and antigenically distinct hemaggluti-
nin (HA) lineages: H1α, H1β, H1γ, H1δ1, H1δ2, H1pdm09 
and H3 cluster IV. Over this period there was a dramatic 
increase in occurrence of H1d1 in samples submitted, 
with a concurrent decrease in H1pdm09. H3 cluster-IV 
exhibited increasing diversification, with multiple distinct 
phylogenetic branches emerging and being sustained since 
2010.4,5 Although H3N2 represented 25% of identified 
viruses, this subtype was reported in increasing propor-
tion of sequenced isolates since late 2011. In addition to the 
phylogenetic clusters of H3, at least 10 distinct reassorted 
H3N2/H1N1pdm09 (rH3N2p) genotypes were identified in 
studies at NADC5 and by others.6,7 Nearly all of the H3N2 
reassortants characterized in the USA contain the matrix 
gene from the H1N1pdm09 virus (pM) alone (genotype 1) 
or in combination with other H1N1pdm09 gene segments 
(genotypes 2-9). Genotype 1 was most frequently detected 
in swine and all human H3N2v viruses clustered within 
a single genotype 1 and HA clade. These data suggested 
that the genetic requirements for transmission of H3N2 to 
humans might be restricted to a specific subset of swine 
viruses. Mutations at putative antigenic sites as well as re-
duced serologic cross-reactivity among the H3 sub-clusters 
suggested antigenic drift of these contemporary viruses in 
swine that may impair currently available  vaccines.
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Phenotypes of H3N2v and contemporary 
swine H3N2 in pig challenge  studies
The pathogenic, transmission, genetic, and antigenic 
properties of a human H3N2v isolate and two swine H3N2 
isolates, H3N2-TRIG and rH3N2p, were compared.8 Our 
in vivo study demonstrated no increased virulence in the 
H3N2v- or rH3N2p-infected pigs. On the contrary, all of 
the rH3N2p we assessed caused relatively mild clinical 
disease and pathology compared to H3N2 with the TRIG 
backbone. However, the rH3N2p isolates were as efficient 
as the H3N2-TRIG in nasal replication and transmission 
to contact pigs. Two additional rH3N2p isolates with high 
sequence identity to the human H3N2v were used in sub-
sequent vaccine studies with similarly low pathogenicity 
phenotypes (P. Kitikoon, submitted and).9 Initial studies 
characterizing antigenic phenotypes of contemporary 
H3N2 by hemagglutinin-inhibition (HI) assays indicated 
that although antibodies to a 2010 H3N2-TRIG virus 
cross-reacted to rH3N2p viruses, the H3N2v virus had 
reduced cross-reactivity to other H3N2 antisera tested. 
These results prompted broader studies into antigenic 
properties of additional representative H3N2 viruses and 
vaccine efficacy  experiments.
Efficacy of vaccines to control H3N2 in 
 swine
Vaccines against IAV in swine provide a primary means 
to limit disease but may not be effective at neutralizing 
infection or transmission. Populations with variations in im-
mune status, such as pigs with waning maternal antibodies 
or varying levels of heterologous cross-reactivity, provide 
continual reservoirs for endemic infections with IAV as 
well as repeated outbreaks in naïve pigs. Antisera from 
3 commercial vaccines were tested in HI assays against 
contemporary H3N2 viruses. Since HI cross-reactivity 
demonstrated that contemporary swine rH3N2p viruses 
had drifted from viruses in current swine IAV vaccines, a 
series of in vivo vaccine efficacy studies were performed 
to assess commercial swine IAV vaccine efficacy against 
rH3N2p similar to H3N2v from a human cases in 2011-12. 
Vaccine 1, with the highest HI cross-reactivity, was selected 
to test for efficacy against rH3N2p virus infection in pigs 
with or without maternally derived antibodies (MDA) (P. 
Kitikoon, submitted). In addition, efficacy of vaccines de-
rived from a monovalent whole inactivated virus (WIV) was 
compared to experimental live attenuated influenza virus 
(LAIV) against rH3N2p. Vaccine 1 with the highest level 
of HI cross-reactivity significantly protected pigs without 
MDA. However, the presence of MDA at vaccination 
completely blocked vaccine efficacy. The performance of 
WIV and LAIV was comparable in the absence of MDA. 
LAIV was not tested in the face of MDA in this particular 
rH3N2p study, but previous studies have shown superior 
performance over WIV the presence of MDA.10 A critical 
review of the use of WIV in sows is required in the con-
text of the current IAV ecology and vaccine application 
in pigs with  MDA.
A second study was completed to evaluate the efficacy of 
commercial inactivated swine IAV vaccines and LAIV 
vaccines against infection with H3N2 virus and subse-
quent indirect transmission to naïve pigs.9 The rH3N2p 
virus evaluated was similar to the H3N2v detected in 
humans in 2012. Commercial vaccine 1 again provided 
significant partial protection in MDA negative pigs as 
in the other study, measured by reduced nasal shedding; 
however, indirect naïve contacts became infected, indi-
cating the reduction in nasal shedding did not prevent 
aerosol transmission. An LAIV vaccine with a 2004-era 
HA and NA provided complete protection and none of the 
indirect contact pigs became infected. Clinical disease 
was not observed in any group including non-vaccinated 
animals, a consistent observation in pigs infected with 
contemporary rH3N2p swine viruses. Serum HI titers 
against the challenge virus were not predictive of efficacy: 
titers following vaccination with the LAIV that provided 
sterilizing immunity were below the level considered pro-
tective; yet titers in a commercial vaccine group that was 
not protective were above the cut-off. While vaccination 
with currently approved commercial inactivated products 
did not fully prevent transmission, vaccines tested and 
proven against contemporary rH3N2p may provide benefit 
for reducing shedding, transmission and zoonotic spillover 
of antigenically similar viruses at agriculture fairs, when 
administered in the absence of MDA. Vaccine application 
in growing pigs should be monitored for appropriate ob-
servation of label recommendations, but it is also critical 
to monitor the response in pigs against the targeted IAV 
strains for an indication of expected efficacy. Expectations 
for WIV must be realistic, placed in the right context, and 
used in conjunction with additional control  measures.
H3N2v in humans during  2011-13
Of the approximate 360 detections of variant viruses of 
swine lineage in humans in the USA since 2005, 333 have 
been H3N2v: 12 in 2011, 309 in 2012, and 12 so far in 2013 
(http://www.cdc.gov/flu/swineflu/variant-cases-us.
htm). Many factors in the swine and human populations 
are likely to have impacted the increase in frequency 
of H3N2v detections in humans, but the precise factors 
have been difficult to discern with current epidemiologic 
information from exhibited swine. Certainly, the increase 
in monitoring and attention on H3N2v in the fair setting 
has played a role in the detection of new cases. However, 
difficulty in control of contemporary IAV in swine and 
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overall viral burden of IAV in swine is likely an important 
contributor. Although there has been an increase in detec-
tion of H3N2 in swine with the same genetic signature as 
the H3N2v in humans, this cannot be the sole explanation 
since there have also been increases in other genetically 
dissimilar H3N2 as well as in subsets of H1 viruses in the 
USDA surveillance data set. There may be specific virus 
properties that confer a better fit for the H3N2v to infect 
humans, and indeed the H3N2v was capable of airborne 
transmission in ferrets,11 the standard laboratory model 
for human IAV. However, other variant human isolates 
and swine IAV were also shown to successfully infect and 
transmit in ferrets. An additional and very likely major 
factor is the lack of human population immunity against 
subtypes of IAV that have evolved independently in swine 
away from their respective human seasonal precursor 
viruses and the strains used in contemporary human 
seasonal vaccines. A substantial proportion of adoles-
cents and young adults were shown to have cross-reactive 
antibodies against H3N2v; however, children and older 
adults lacked such protective antibodies.12,13 The current 
human seasonal vaccines containing H3N2 do not appear 
to protect against the H3N2v.13,14 Since the vast majority of 
cases of H3N2v have been in children with close contact 
and long periods of exposure time at agricultural fairs, all 
of these factors point to a unique set of circumstances that 
collectively increase the odds for H3N2v in these spillover 
events. This does not necessarily diminish the epidemic 
or pandemic risk of these viruses to humans if H3N2v 
gained the ability to efficiently transmit from human to 
human, allowing the virus further opportunity to mutate 
and adapt back to the human  host.
Sustained collaborative efforts from all facets of human 
and animal health, research, and regulatory entities are 
required to define and intervene against the problem of 
IAV in swine and humans in the USA and globally.15 To 
exemplify this type of cross-sector partnership, a national 
working group met in January 2013 and drafted guidelines 
aimed to minimize influenza transmission at agricultural 
fairs and swine exhibits in the USA (http://nasphv.
org/Documents/NASAHO-NASPHV-InfluenzaTransmis-
sionAtSwineExhibitions2013.pdf). The focus of the 
group’s guidance document is beyond the scope of this 
presentation and will be discussed by others. The cur-
rent situation of IAV in swine and spillover into humans 
highlights yet again the need for continuation of the USDA 
surveillance system in swine, improvements in swine vac-
cine technology and systematic updates, and expansion 
of research efforts to control this economically important 
and zoonotic virus in  swine.
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Management and challenges of dealing with swine 
­influenza
Joseph F. Connor, DVM, MS; Dyneah M. Classen, DVM; Aaron Lower,  DVM
Carthage Veterinary Service, Ltd., Carthage,  Illinois
Introduction
Swine influenza continues to present a health challenge of 
pigs. Recent active surveillance project of growing pigs in 
the Midwest identified 90.6 percent of the rural farms as 
influenza A positive at least once based on monthly testing 
for 12-24 consecutive months.1 Neonatal pigs play a key 
role in transmission of the virus. The approach to eliminat-
ing endemic influenza in a breed-to-wean population lacks 
standardization. Strategies include natural virus circula-
tion, mass vaccination of breed-to-wean population, pre-
farrow group vaccination, and combinations of all these 
strategies. Research suggests that piglets with maternally 
derived antibodies and challenged with homologous or 
heterologous influenza strains may have reduced clinical 
signs but viral shedding may still occur.2 The strategies 
are frequently changed based on empirical data. Because 
of the potential for reintroduction of the virus through 
human-to-pig contact, aerosol transmission, or endemic 
circulation, the cost of influenza is highly variable. Of-
tentimes, even though the cost of influenza is low in sow 
populations in herds that transfer wean pigs to multiple 
owners or to different owners, the frequency of even a low 
prevalence influenza cough is frequently not appreciated. 
With the perceived variability in weaning weights caused 
by influenza infection and with frequent co-infections of 
PRRS, producers frequently request that aggressive steps 
be taken to eliminate influenza from suckling  pigs.
This paper discusses a multi-herd approach to reducing 
and/or eliminating endemic influenza from suckling pigs 
in a geographical area of the  Midwest.
Background
A production system in the Midwest has experienced in-
fluenza viruses within the system over the past three years. 
Over that time period, various strategies from pre-farrow 
vaccination through mass vaccination have been imple-
mented in an effort to decrease the endemic transmission. 
These herds vary from 1800 to 6400 sows. Each herd has 
replacement facilities adjacent to and connected to gesta-
tion. Replacement gilts are received every 28 days from a 
designated multiplier within the system at 21 days of age. 
Gilts are quarantined in an isolation nursery facility for 
54 days during which time they are statistically sampled 
twice for PRRS and before movement to continuous flow 
gilt developer facility from 11-27 weeks of age. Entry 
population is sampled for influenza either by nasal swabs 
or oral fluid collection only if the source herd is active for 
influenza or there are clinical signs within the  population.
Our historical strategy for this system was to mass vac-
cinate the breed-to-wean populations with commercial 
vaccines quarterly during the flu season. Populations 
were vaccinated in late August, December, and March. 
Vaccination was skipped during the summer months. 
Developing gilts were administered commercial flu vac-
cine after selection at 151 days of age with a second dose 
administered at 165 days of age. In herds that had clinical 
increased flu activity or were endemic within the suckling 
pigs, the developing gilts were also vaccinated at 63 and 
84 days of  age.
Description
In the summer of 2012, discussion led to implementing 
various vaccines within herds of the system (15 herds 
were enrolled and two influenza negative herds were 
not vaccinated). Each herd was allotted to one of three 
strategies based on influenza strains within the herd and 
the genetic source herd. Vaccines administered were 
Newport Monovalent H1N2, Sirrah Monovalent H1N2, 
and FluSure  XP. (Table 1)
Protocol
Mass vaccination of the entire herd with assigned product. 
This includes the sows and gilts on breed row to preg 
check. Mass vaccination will be repeated. Gilts will be 
vaccinated every three weeks. Depending on age, some 
gilts may receive a fourth  vaccination.
• Newport Monovalent  H1N2
▶ Week 35: Mass  vaccinate
◆ Sows and  gilts
• Week 44: Vaccinate gilts in  GDU
▶ This includes gilts in  isolation
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Table 1: Source farms
▶ Week 41: Surveillance  begins
▶ Week 41: Mass  vaccinate
◆ Sows and  gilts
• Sirrah Monovalent H1N2 and Sirrah  Quadvalent
▶ Week 35: Mass  vaccinate
◆ Sows and  gilts
▶ Week 37: Surveillance  begins
▶ Week 38: Mass  vaccinate
◆ Sows and  gilts
▶ Week 41: Vaccinate gilts in the  GDU
• FluSure  XP
▶ Week 35: Mass  vaccinate
◆ Sows and  gilts
▶ Week 37: Surveillance  begins
▶ Week 38: Mass  vaccinate
◆ Sows and  gilts
▶ Week 41: Vaccinate gilts in the  GDU
Flow 3 Newport Monovalent H1N2
   Herd 1 Sirrah Monovalent H1N2
   Herd 2 FluSure XP
   Herd 3 Newport Monovalent H1N2
Flow 2 Sirrah Monovalent
   Herd 1 FluSure XP
   Herd 2 Newport Monovalent H1N2
   Herd 3 Newport Monovalent H1N2
   Herd 4 Sirrah Monovalent H1N2
   Herd 5 FluSure XP
Flow 1 FluSure XP
   Herd 1 Sirrah Quadvalent
   Herd 2 FluSure XP
   Herd 3 Newport Monovalent H1N2
   Herd 4 FluSure XP
   Herd 5 Sirrah Monovalent H1N2
Monitoring
• Start two weeks after second vaccination is completed 
(week  41).
• Repeat every two  weeks.
▶ Ten nasal swabs from due to wean  piglets.
◆ Sample five pigs per  swab.
▶ Seven oral fluid (rope) samples from the  GDU.
◆ Hang one rope per  lot.
◆ The rope should be shared between two pens of 
the same  lot.
◆ Label the tubes with the lot  number.
• Any clinical signs of flu in the sows or gilts in an off 
test week will be  tested.
▶ The farms should contact the PM and vet team if 
clinical signs  develop.
◆ i.e., off feed sows, deep barking cough, nasal 
discharge,  lethargy.
Summary
The results of the three interventions will be reported. Two 
mass vaccinations were beneficial in reducing influenza 
circulation in herds that were positive for H1N2 but not 
successful in eliminating the virus in 100 percent of the 
 herds.
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Using the Myers-Briggs Type Indicator to improve your 
own communication  skills
The Myers-Briggs Type Indicator (MBTI) is a useful 
method of understanding people by looking at eight dif-
ferent personality preferences that people use in everyday 
life. There are many personality profiling tools available 
to those who work in human resources. Some are just for 
fun, some are downright silly, but several are scientifically 
researched to prove their predictability and accuracy. Our 
office has used MBTI since 1991 as a tool to improve 
communication, help in conflict resolution, and improve 
teamwork skills. Other valuable tools are certainly out 
there such as TKI (Thomas-Kilmann Conflict Mode In-
strument), FIRO (Fundamental Interpersonal Relations 
Orientation), KTS (Keirsey Temperament Sorter), and 
DiSC (Dominance, Influence, Steadiness and Consci-
entiousness). Certainly each one offers insight into how 
people think and react. The MBTI has proven to be a 
relatively easy to understand model that participants can 
learn and hopefully apply to their everyday lives in order 
to understand and improve their communication  skills.
When applied correctly, use of the MBTI in an organiza-
tion can help individuals and teams  to:
1. Understand themselves better first, why they act and 
react the way they  do.
2. Appreciate the skills of others so that they can be 
applied in constructive  ways.
3. Approach problems in a different way so as to avoid 
the same chronic conflict  issues.
What MBTI does not  do:
1. Label people as a certain “type” that indicates skills 
they either have or don’t  have
2. Fix underlying health issues such as depression, 
anxiety, alcoholism, extreme OCD or the  like
3. Reveal deep, dark secrets of the people taking the 
inventory and reveal them to a  group
4. Cause everyone on your team to join hands and sing 
 “Kumbaya”.
MBTI works by having the participants take a 96 question 
survey that helps to sort them into one of two preferences 
in four different categories. Through a variety of ques-
tions, MBTI asks: where you get your energy, how you 
take in information, how you make decisions, and how 
you deal with the outer world. This gives 16 different 
four letter combinations, one of which is your MBTI  type.
Ideally, a person who takes the MBTI, learns and under-
stands their type can use that information to modify their 
communication to others, planning, and conflict resolution 
to make their own work environment have less conflict. 
Regardless of your MBTI type, everyone agrees that less 
conflict is  better.
The goal of this session is to demonstrate the four dichoto-
mies of MBTI and the two preferences of each. We will 
use some group exercises with those who have willingly 
agreed to take the MBTI in advance to demonstrate the 
differences. We will then give real life examples of how 
these differences can work together in an organization or 
how they can tear it apart depending on how we use  them.
Lisa Tokach
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A MAJOR GENE FOR HOST RESPONSE TO PRRSV INFECTION 
NJ Boddicker1, JK Lunney2, RRR Rowland3, JM Reecy1, N Serao1, and JCM Dekkers1
1Department of Animal Science, Iowa State University, 2USDA, ARS, BARC, 3College of 
Veterinary Medicine, Kansas State University  
Host genetics is an additional tool for controlling 
the costly disease of Porcine Reproductive and 
Respiratory Syndrome (PRRS). The objective of 
this work was to discover the genetic basis of 
host response to PRRS virus infection by 
estimating genetic parameters and conducting a 
genome-wide association study.  
Eight groups of ~200 commercial crossbred pigs 
were infected between 25 and 35 days of age 
with virus isolate NVSL 97-7985. Breeds 
represented in the crosses included Large White, 
Landrace, Yorkshire, Duroc, and Pietrain. Blood 
samples and body weights were collected up to 
42 days post infection (dpi). Experimental pigs 
and their parents were genotyped for 60,000 
single nucleotide polymorphisms (SNPs) across 
the genome with Illumina’s Porcine 60k 
Beadchip. Phenotypes analyzed were viral load 
(VL = area under the curve for log-transformed 
qRT-PCR based serum virus from 0-21 dpi) and 
weight gain from 0-42 dpi (WG). 
Heritabilities estimated using pedigree were 
moderate at 0.44 for VL and 0.29 for WG. 
Genomic regions associated with VL were 
identified on chromosomes 1, 4, and X, and on 
chromosomes 4, 5, and 7 with WG. Apart from 
the SSC4 region, the other regions explained 
less than 3% of the genetic variance. The 1 Mb 
region on chromosome 4 (SSC4) explained 
14.6% of the genetic variance for VL and 9.1% 
for WG. Effects of the most significant SNP in 
the region, WUR10000125 (WUR), acted in a 
dominant manner, with the favorable allele 
estimated to decrease VL by 4 units (0.53 
phenotypic sd) and increase WG by 2 kg (0.49 
phenotypic sd). The effect was present 
irrespective of parental breeds involved in the 
crosses.  
In conclusion, the 1 Mb region on SSC4 
explained a sizable proportion of genetic 
variation in response to experimental challenge 
with a specific strain of the PPRS virus. 
Heritability estimates were moderate and, with a 
frequency of 0.15 for the favorable allele at the 
WUR SNP on chromosome 4, genetic 
improvement of host response to PRRSv 
infection appears possible. However, additional 
research on the effect of the identified genomic 
regions during the reproductive phase and in the 
field is needed before selection can be 
implemented. This research is underway, with 
support from Genome Canada, Genome Alberta 
and USDA-NIFA grant number 2013-68004-
20362.  
The work presented here was supported by 
PRRS CAP, USDA ARS and NIFA Award 
2008-55620-19132, NRSP-8 Swine Genome and 
Bioinformatics projects, National Pork Board 
and the breeding companies of the PRRS Host 
Genetics Consortium. 
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EVALUATION OF FOSTERATM PRRS VACCINE SHEDDING IN GROWING PIGS 
FOLLOWING VACCINATION 
J Zhang, PC Gauger, MK Berkland, Q Chen, DM Haney, JT Thomas 
Iowa State University, Ames, IA 
 
Introduction: Porcine reproductive and 
respiratory syndrome (PRRS) is the most 
economically important disease affecting the US 
swine industry. Modified live vaccines have the 
ability to replicate in the animal after 
administration with subsequent shedding of the 
virus into the environment and to naïve swine in 
contact with vaccinates. In this study, we 
evaluated the magnitude and duration of shedding 
of the modified live FosteraTM PRRS vaccine 
virus in growing pigs following vaccination. 
 
Materials and methods: Twenty (3-week-old) 
pigs confirmed free of PRRS virus (PRRSV) 
were divided into a Vaccinate group (n=10) and a 
Sham control group (n=10), each group 
occupying a separate room. Pigs in the Vaccinate 
group were vaccinated with 2 mL FosteraTM 
PRRS intramuscularly and pigs in the Sham 
control group were intramuscularly administered 
2 mL of the vaccine diluent. Pigs were observed 
for clinical signs throughout the trial. Rectal 
temperature was recorded daily for 1 week and 
every-other-day for 1 additional week. Serum and 
feces were collected from individual pigs, and 
oral fluids were collected per pen, at 0, 3, 7, 10, 
14, 21, 28, 35, 42, 49, 56 and 63 days post 
vaccination (DPV). Pigs were necropsied at 63 
DPV. A quantitative PRRSV PCR (Life 
Technologies) was conducted on the lung and 
tonsil at necropsy and serum, oral fluids and feces 
collected throughout the trial. Virus isolation (VI) 
was attempted on selected serum, oral fluids, lung 
and tonsil on Marc-145 cells. Selected samples 
were sequenced for PRRSV ORF5 to confirm the 
virus identity. Serum and oral fluid samples were 
tested for anti-PRRSV antibody using PRRSX3 
ELISA (IDEXX). Neutralizing antibodies in 
serum against the FosteraTM PRRS vaccine virus 
was determined. Rectal temperature data were 
analyzed by a repeated measure ANOVA. A P-
value ≤ 0.05 was considered significant. 
 
Results: Neither the Vaccinate nor the Sham 
control pigs demonstrated clinical signs of 
systemic disease, anorexia or lethargy after 
vaccination. Body temperatures were within the 
normal range of growing pigs (102-105°F) during 
0-13 DPV and there were no significant 
differences between the two groups. As tested by 
quantitative PRRSV PCR, all 10 Vaccinate pigs 
became viremic at 3 DPV. All pigs remained 
virus positive in serum through 35 DPV. Viremia 
was detected in sera of 7/10, 2/10, 1/10 and 5/10 
pigs at 42, 49, 56 and 63 DPV, respectively. 
Virus levels peaked at 21 DPV in serum with a 
mean titer of 4.4 log10 genomic copies per ml of 
serum and quickly declined thereafter. All oral 
fluids collected from Vaccinate pigs were 
PRRSV PCR positive throughout the study 3-63 
DPV. One pig feces at 3 DPV and four pig feces 
at 7 DPV from the Vaccinate group were positive 
by PRRSV PCR. The lungs and tonsils were 
PRRSV PCR positive for vaccine virus at 
necropsy from 2/10 and 10/10 Vaccinate pigs, 
respectively. The vaccine virus was isolated from 
most sera of Vaccinate pigs at 3-7 DPV and from 
some sera till 21 DPV. VI was negative from oral 
fluids, lungs and tonsils. Anti-PRRSV ELISA 
antibodies were detected in serum of 5/10 
Vaccinate pigs at 10 DPV and 10/10 pigs from 
14-63 DPV, and in oral fluids from 7-63 DPV. 
Neutralizing antibodies were detected in serum of 
2/10 at 10 DPV, 6/10 at 14 DPV and 10/10 
Vaccinate pigs from 21-63 DPV. Virus was not 
detected in any sera, oral fluids, feces, lungs, or 
tonsils of Sham control pigs throughout the study. 
PRRSV-specific antibody was not detected from 
any Sham control pigs throughout the study. 
 
Conclusions and Discussion: Fostera™ PRRS 
vaccine did not result in clinical disease or febrile 
responses in vaccinated growing pigs. The 
vaccine virus can be shed at low levels and short 
periods in feces but can be shed in serum and oral 
fluids for longer than 63 DPV in spite of the 
presence of neutralizing antibodies in serum. 
These data emphasize the importance of 
implementing proper biosecurity programs to 
prevent the spread of PRRS vaccine to naïve 
populations at risk, such as pregnant females and 
regional nursery and finisher swine. 
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FACTORS ASSOCIATED WITH  
N-SPECIFIC IgG RESPONSE IN PIGLETS EXPERIMENTALLY INFECTED WITH PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
AS Hess1, BR Trible2, Y Wang2, NJ Boddicker1, RRR Rowland2, JK Lunney3, JCM Dekkers1
Iowa State University, Ames, IA, United States1, Kansas State University, Manhattan, KS, United States2,
USDA, ARS, BARC, APDL, Beltsville, MD, United States3
Porcine reproductive and respiratory syndrome 
(PRRS) costs the U.S. pork industry $664 million 
per year, affecting all stages of production 
(Holtkamp et al 2013).  Vaccines, biosecurity 
measures, and proposed methods for eradication 
have only been partially successful. Our emphasis 
is on identification of genomic markers and 
pathways associated with host response. These 
markers could potentially be used for genetic 
selection of pigs for increased resistance or 
reduced susceptibility. The objective of this study 
was to identify factors associated with total 
antibody (tAb) response, determine whether a 
heritable genetic component was present, and 
subsequently perform a genome wide association 
study (GWAS) to find QTL associated with tAb 
response following experimental infection with 
PRRS virus (PRRSV). The data were from 464 
Large White-Landrace crossbred piglets from 
three separate experimental infection trials of the 
PRRS Host Genetics Consortium. All piglets were 
experimentally challenged with PRRSV isolate 
NVSL-97-7895 at 28-35 days of age.  Serum 
samples were periodically collected until 42 days 
post infection (dpi) and viremia determined by 
qPCR assays. Serum samples collected at 42 dpi 
were assayed for tAb response using the 
fluorescence microsphere immunoassay to detect 
virus N protein-specific Immunoglobulin G, 
whereby a negative control was included to adjust 
for background during analysis. Results, reported 
as the mean fluorescence intensity (MFI), were 
obtained from MAGPIX. Viral load was defined 
as the area under the curve of Log viremia from 0-
21 dpi. A piglet was classified as having a virus 
rebound based on statistical evidence of a 
secondary viremia peak after 21 dpi. Weight gain 
from 28 to 42 dpi was assessed. Neutralizing 
antibody activity (nAb) was defined as the last 1:2 
serial dilution of serum incubated with 200 50% 
tissue culture infectious doses of PRRSV without 
cytopathic effects in MARC-145 cells (titer). All 
piglets were genotyped using the 60k SNP chip. 
Heritability of tAb response was estimated at 
18±14%. Pigs that did not experience virus 
rebound had a 1216±573 lower MFI (p=0.036), 
and each additional nAb titer was associated with 
a 360±132 unit increase in MFI (p=0.007). A one 
standard deviation increase in viral load was also 
associated with a 719±260 unit decrease in MFI 
(p=0.006). Additionally, a one kg increase in 
weight gained 28-42 dpi was associated with 
250±101 less MFI (p=0.014). The GWAS 
discovered SNPs in the MHC class I antigen gene 
region on chromosome 7 to be associated with tAb 
response. This 1 Mb region was estimated to 
explain 30.5% of genetic variation, indicating the 
presence of a major QTL associated with IgG anti-
N levels. An intronic SNP in the DHX16 gene 
explained all genetic variance observed in this 
window. Heterozygotes (AB) for this SNP had 
4315±604 lower MFI (p<0.001) and gained 
0.81±0.29 more kg between 28 and 42 dpi 
(p=0.005), as compared to AA individuals. These 
results suggest that AB individuals may be less 
susceptible to the effects of the virus. This SNP 
did not have a significant effect on viral load, virus 
rebound, or nAb, suggesting that this may be a 
QTL for general anti-PRRSV antibody response.  
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FOSTERA™ PRRSV EXPOSURE IN GESTATING SWINE AND CONGENITAL INFECTION 
PC Gauger1; J Zhang1; MK Berkland1; PA Arruda1; DM Madson1 
1Iowa State University, Ames, IA 
 
Introduction: Porcine reproductive and 
respiratory syndrome (PRRS) is the most 
economically important disease affecting the US 
swine industry1. Modified live virus PRRS 
vaccine can behave similar to field virus 
regarding horizontal or transplacental 
transmission and congenital infection2. The 
safety of Fostera™ PRRS accidental exposure in 
naive pregnant swine and piglets born to 
exposed dams has not been reported. 
Materials and methods: Fifteen pregnant dams 
confirmed free of PRRS virus (PRRSV) were 
divided into the following: Group 1 (N=10) 
dams were vaccinated with 2ml Fostera™ PRRS 
intramuscularly at 90 days of gestation. Group 2 
(N=5) dams served as sham vaccinated controls. 
Dams were monitored daily for anorexia and 
lethargy post-vaccination. Rectal temperatures 
were recorded daily for 1 week and every-other-
day for 1 additional week. At farrowing, total 
born, born alive, stillborn, mummified and 
nonviable piglets were recorded with piglet birth 
weight. Dams were necropsied at 46 days post 
vaccination (DPV). Pre-suckling serum was 
collected from the umbilicus or by venipuncture 
of 96 piglets and tested for PRRS specific 
antibodies by PRRSX3 ELISA (IDEXX) and 
viremia by a commercial PRRSV quantitative 
PCR assay (Life technologies). Piglet mortality 
data, weaning weight, weight gain and average 
daily gain were recorded from 5 litters in each 
group. Reproductive and piglet production and 
mortality data were analyzed using the student’s 
t test (JMP, SAS institute). A P-value ≤ 0.05 
was considered significant. 
Results: Group 1 (G1) and Group 2 (G2) dams 
did not demonstrate clinical signs of illness, 
anorexia or lethargy post-vaccination. 
Significant differences in rectal temperatures 
were not observed. One G2 dam aborted nine 
PRRSV negative piglets at ninety-eight days of 
gestation. Significant differences between G1 
and G2 (N=4) mean gestation length, total born, 
total born alive, birth weight, stillborn, 
mummified and non-viable piglets were not 
observed. Lung and tonsil from 4/10 and 10/10 
G1 dams, respectively, were PRRSV PCR 
positive for vaccine virus at necropsy confirmed 
by ORF5 sequencing. Eighty-four percent 
(81/96) of presuckle piglets demonstrated 
PRRSV viremia at birth ranging from 0.7 – 7.2 
Log10 genomic copies/ml of serum and anti-
PRRSV presuckle antibodies were detected in 
11.5% (11/96) of the piglets. Significant 
differences between G1 and G2 average weaned 
and percent pre-weaning mortality were not 
detected. In contrast, average weaning weight 
was significantly lower in G1 piglets (Table 1). 
Overall weight gain and average daily gain 
recorded for 5 G1 and 4 G2 litters was also 
significantly lower in G1 piglets from 
vaccinated dams. Clinical disease was observed 
in G1 piglets starting at 10 days post-farrowing. 
Conclusions and Discussion: Fostera™ PRRS 
did not cause clinical signs or affect 
reproductive performance between 90 and 117 
days of gestation under the conditions of this 
study. Dam lung and tonsil may remain PRRSV 
PCR positive for longer than 46 DPV. Fostera™ 
PRRS vaccinated sows give birth to viable 
piglets with variable levels of vaccine virus in 
piglet serum. Pre-wean mortality was unaffected 
by congenital vaccine viremia. In contrast, a 
significant reduction in growth performance and 
ADG was detected at weaning in congenitally 
infected piglets compared to the non-vaccinated 
controls. 
Table 1. Mean weaning weight, weight gain and 
average daily gain per piglet at weaning. 
Average/pig at weaning± standard error of the mean 
Group N Wean wgt*   N Wgt gain* ADG* 
G1 92 11.2±0.29a  50   7.6±0.31
a 0.36±0.01a 
G2 41 13.8±0.47b   41 10.2±0.40b 0.47±0.02b 
*Significant difference at P < 0.0001. 
  
References:  
1. Holtkamp DJ et al.: 2013, J Swine health 
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GWAS FOR REPRODUCTION TRAITS AND ANTIBODY RESPONSE IN PRRS 
INFECTED SOWS 
 
NVL Serão1, O Matika2, RA Kemp3, J Harding4, SC Bishop2, GS Plastow5, and JCM Dekkers1 
 
1Department of Animal Science, Iowa State University, Ames, USA, 2The Roslin Institute and 
R(D)SVS, University of Edinburgh, Scotland, 3Genesus, Oakville, Canada, 4Department of Large 
Animal Clinical Sciences, University of Saskatchewan, Saskatoon, Canada, 5Department of 
Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada 
 
Porcine Reproductive and Respiratory 
Syndrome (PRRS) causes increased 
abortions, stillbirths and mummies in 
reproductive sows, and chronic respiratory 
problems in pigs at all stages of production. 
The objective of this work was to study the 
genetic architecture underling a PRRS 
outbreak in a commercial pig herd. 
 
Data available for the study included 
reproductive data on ~2,500 purebred sows 
from a fully pedigreed herd. The first day of 
herd PRRS exposure was estimated based on 
rolling averages of farrowing traits (Lewis et 
al., 2009) and used to split the data in a Pre- 
and a Post-PRRS outbreak phase. A total of 
646 sows were in the herd during the PRRS 
outbreak and all had blood samples collected 
46 days after the estimated outbreak for 
ELISA, allowing semi-quantification of 
PRRSV IgG antibody levels (reported as 
sample-to-positive (SP) ratio). The available 
phenotypic data for each sow included parity 
and numbers of piglets born alive, stillborn, 
mummified, and alive at 24 hours of age. 
Genetic parameters were estimated 
separately for the Pre- and Post-PRRS data 
sets. All 646 sows were genotyped for the 
PorcineSNP60 BeadChip. The genotype 
data was used to perform GWAS for all 
traits using the BayesB method with 
π=0.995, and a model with the fixed effects 
of parity, the genotype at a SNP (WUR) on 
SSC4 that has been found to be associated 
with PRRS response in growing pigs 
(Boddicker et al., 2012), and the rolling 
average for the trait being analyzed (except 
for SP ratio). 
 
Pre-PRRS heritabilities for the farrowing 
traits ranged from 3% (number of 
mummified piglets) to 18% (number born 
alive). In the Post-PRRS data, estimates 
tended to be lower, ranging from 6% 
(number stillborn) to 10% (number alive at 
24 hours). SP ratio showed the highest 
heritability (53%) and genetic correlations 
with farrowing traits, ranging from -0.75 
(number mummified) to 0.74 (number born 
alive and alive at 24 hours). The GWAS 
detected several genomic regions associated 
with number stillborn and SP ratio. For 
number stillborn, two regions on SSC1 
explained ~4.5% of the genetic variance. For 
SP ratio, one region on SSC2 and six 
regions on SSC7 were found to be 
associated. The six regions on SSC7 jointly 
accounted for 25% of the genetic variance. 
One region close to the Major 
Histocompatibility Complex (MHC) region 
explained 11.4% of the genetic variance. 
Another region at the end of SSC7, 
harboring several candidate genes and in 
high linkage disequilibrium, explained 7.8% 
of the genetic variance. These results 
indicate that there is a significant genomic 
component associated with PRRS antibody 
response in this PRRS outbreak sow herd, 
and that antibody response is genetically 
correlated with reproductive traits in pigs 
during the outbreak. Additional research is 
necessary to better refine the genomic 
regions for SP ratio identified here. 
 
The work presented here was supported by a 
grant from Genome Canada, the Canadian 
Swine Health Board, and PigGen Canada. 
 
1. Boddicker NJ et at.: 2012, J Anim Sci 
60:1733. 
2. Lewis CRG et al.: 2009, J Anim Sci 
87:876. 
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PIGS SELECTED FOR INCREASED FEED EFFICIENCY ARE LESS AFFECTED BY 
EXPERIMENTAL INFECTION WITH THE PRRS VIRUS 
JR Dunkelberger1, NJ Boddicker1, JM Young1, RRR Rowland2, and JCM Dekkers1
1Department of Animal Science, Iowa State University, Ames, USA 2College of Veterinary Medicine, 
Kansas State University, Manhattan, USA 
Feed efficiency is of great importance to 
the swine industry, yet little research has been 
performed to evaluate the robustness of pigs 
selected for increased feed efficiency to disease. 
Recent resource allocation theories suggest that 
such animals may be more susceptible to disease 
as a result of having less available energy to 
mount an immune response. Since Porcine 
Reproductive and Respiratory Syndrome 
(PRRS) is the most economically devastating 
disease to the US swine industry, the objective 
of this study was to analyze the effect of PRRS 
on lines of pigs divergently selected for low and 
high residual feed intake (RFI), a measure of 
feed efficiency. We hypothesized that the 
efficient low RFI pigs will have a greater 
reduction in average daily gain (ADG) and 
higher serum viremia upon infection with the 
PRRS virus, compared to pigs selected for high 
RFI (reduced feed efficiency).  
One hundred piglets, each from the first 
parity of the 8th generation of the ISU high and 
low RFI selection lines, were shipped to Kansas 
State University upon weaning (between 18 and 
28 days of age) and received an intranasal/oral 
dose of the NVSL 97-7985 PRRS strain one 
week post-arrival. Serum samples were collected 
on days 0, 4, 7, 11, and 14 post-infection and 
weekly thereafter. Body weights were collected 
weekly and used to calculate ADG as the 
regression of weight on day. For comparison, 
body weights were also collected on 489 non-
challenged pigs, which were from parity two of 
generation 8 and were either full or half siblings 
of the pigs in the PRRS challenged data set. The 
non-challenged pigs were housed at the Iowa 
State Swine breeding farm throughout the 
duration of the data collection period. At least 
two weights (in addition to a weaning weight) 
were collected for each piglet before leaving the 
nursery and weights were estimated using linear 
regression for days that weight was not 
recorded. ADG was then calculated as the 
regression of these estimated weights on age. 
Viremia was quantified as viral load (VL) as 
area under the curve for 0-21 days post-infection 
of the log of PRC-based serum viremia.  
In the challenged pigs, VL tended to be 
slightly lower and ADG slightly higher for the 
more efficient low RFI line (p=0.11 and 0.08, 
respectively). In contrast, for the non-challenged 
pigs, ADG was slightly lower for the low RFI 
line but again not significantly (p=0.09). A joint 
analysis of challenged and non-challenged pigs 
showed a significant interaction between RFI 
line and challenge status (p=0.02), 
demonstrating that growth of the low RFI line 
was less affected by PRRS challenge than 
growth of the high RFI line.  
These findings demonstrate that 
selection for increased feed efficiency based on 
RFI does not increase the impact of PRRS 
infection on serum viremia and weight gain. In 
fact, our evidence shows that growth of the more 
efficient pigs was less affected by PRRS 
infection than that of the inefficient line. These 
findings may provide commercial farmers with 
additional incentives to invest in feed-efficient 
pigs. The work presented here was supported by 
USDA ARS and NIFA Awards 2012-38420-
19286 and 2011-68004-30336 and the breeding 
companies of the PRRS Host Genetics 
Consortium. 
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BROADLY NEUTRALIZING ANTIBODIES TO PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS 
BR Trible1, LN Popescu1, J Dekkers2, J Lunney3 and RRR Rowland1
1College of Veterinary Medicine, Kansas State University, Manhattan; 2Department of Animal Science, 
Iowa State University, Ames; 3ARS USDA, Beltsville, Maryland
Introduction 
Following infection with PRRSV, the 
neutralizing antibody (nAb) response is 
generally described as weak and delayed. 
Moreover, the nAb response is primarily 
directed against genetically related PRRSV 
isolates. The limited ability to produce nAb to 
genetically diverse isolates is a major 
impediment for the development of broadly 
effective PRRSV vaccines. A unique class of 
antibodies have been described for several 
viruses that are capable of neutralizing a broad 
range of genetically diverse isolates. These 
antibodies are known as broadly neutralizing 
antibodies (bnAb). Based on these observations, 
we hypothesize that bnAb exist for PRRSV. 
Methods 
This work was conducted as part of the PRRS 
Host Genetics Consortium (PHGC). Serum 
samples were obtained from 1,211 pigs 
challenged with either the Type II isolates 
NVSL (854 pigs) or KS06 (357 pigs). Serum 
samples, collected 42 days after infection, were 
analyzed for virus neutralizing activity using a 
standard PRRSV serum neutralization assay 
(NA) against the homologous (challenge) 
isolate, and three genetically diverse isolates. 
Briefly, NA involved incubation of 1:2 sera 
dilutions with 200 50% tissue culture infectious 
doses of PRRSV in 96-well plates. Following 
one hour incubation, contents were transferred to 
confluent MARC-145 cells and incubated for 
four days. The neutralizing titer was determined 
as the last dilution without PRRSV CPE. 
Measurements of NA activity incorporated four 
genetically diverse PRRSV isolates, which 
possessed 5 to 11% nucleotide level identity in 
ORF5. Based on the results, samples were 
placed into one of four groups: Grp1, no nAb; 
Grp2, homologous nAb (reactivity against only 
the homologous virus); Grp3, heterologous nAb 
(reactivity against 1 or 2 additional isolates); and 
Grp4, bnAb (reactivity against all isolates). 
Selected serum samples from Grp1 and Grp4 
were tested against 7 additional PRRSV isolates, 
including a Type I virus. 
Results 
The results show the percentage of pigs in each 
group: Grp1, NVSL-8.9%, KS06-24.9%; Grp2, 
NVSL-57.3%, KS06-46.5%; Grp3, NVSL-
29.6%, KS06-24.1%; and Grp4, NVSL-4.3%, 
KS06-4.5%. Four Grp1 samples with high 
homologous neutralizing titers showed no 
neutralizing activity against seven additional 
isolates, which confirmed the strict homologous 
nature of the nAb response. Assays 
incorporating four Grp4 serum samples showed 
that two samples neutralized all eleven viruses 
isolates, including a genetically diverse Type I 
virus.  
Conclusions and Discussion 
These results demonstrate that all neutralizing 
antibodies are not equal. Furthermore, within a 
population, there exists a subgroup of pigs with 
the capacity to produce a response against 
multiple isolates, which we term a broadly 
neutralizing antibody response. Future work is 
directed at investigating the unique properties of 
bnAb, including the contribution of host 
genetics. We predict that epitopes recognized by 
bnAb are highly conserved. The results create 
the opportunity to design new vaccines and 
breed animals that favor a bnAb response. 
This work was supported by National Pork 
Board Grant #12-120 and the PHGC
188 2013 Allen D. Leman Swine Conference
A
bs
tr
ac
ts
A
bstracts
CHARACTERIZATION OF AGE-RELATED SUSCEPTIBILITY OF MACROPHAGES TO 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
A Hoybook1, D Ngo, S Robinson1, MP Murtaugh1.
1 Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of 
Minnesota, St. Paul, MN, USA
Introduction
Porcine Reproductive and Respiratory 
Syndrome (PRRS) is the most economically 
important disease affecting swine production in 
the United States today. Age dependent 
resistance to Porcine Reproductive and 
Respiratory Syndrome Virus (PRRSV) has been 
observed, with young pigs experiencing longer 
periods and higher levels of viremia compared to 
older pigs.1 PRRSV targets pulmonary alveolar 
macrophages (PAMs) and cellular surface 
receptors CD163 and CD169 have been 
identified as important for infection.2 However, 
mechanisms underlying age-related differences 
as well as the specifics of the immune response 
to PRRSV remain unclear. Preliminary evidence 
suggests PAMs belonging to older pigs are more 
resistant to PRRSV compared to those from 
younger pigs (Li, 2010, unpublished data). We 
hypothesized that age-related resistance to PAM 
infection results from decreased infection of 
cells due to differential expression of surface 
receptors for PRRSV. 
Materials and Methods 
PAMs isolated from six pigs of different age 
groups (3 days old, 10-12 weeks, and adult) 
were infected with PRRSV. Level of PRRSV 
infection and expression of CD163 and CD169 
were analyzed by flow cytometry at 12 hours 
post-infection (HPI). Viral replication was 
compared at 12, 24, and 48 HPI by qRT-PCR. 
Results 
A higher percentage of PAMs from younger pigs 
were infected and yielded greater amounts of 
virus compared to those from older pigs. Level 
of infection for PAMs from 10-12 week old pigs 
was more similar to that of PAMs from the 
adults. CD163 and CD169 expression was not 
different between age groups.  
Conclusions
PAMs isolated from older pigs are more 
resistant to PRRSV infection compared to those 
from younger pigs. This age-related PAM 
resistance to PRRSV infection is not due to 
differential levels of CD163 and CD169 
expression. In the future, we hope to identify 
differences responsible for the age-related 
resistance. These may include cellular receptor 
polymorphisms, innate anti-viral gene response, 
and differential macrophage polarization.  
Acknowledgements 
Funding was supplied in part by the University 
of Minnesota College of Veterinary Medicine 
and the Merial Veterinary Scholars Program. 
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INFLUENCE OF PIG AGE ON THE NEUTRALIZING ANTIBODY RESPONSE TO PRRSV 
SR Robinson, MP Murtaugh 
Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, USA 
Introduction: There are inconsistencies in our 
understanding of the role of neutralizing 
antibodies in immune protection to Porcine 
reproductive and respiratory syndrome virus 
(PRRSV). After initial exposure to the virus, 
neutralizing antibodies are produced, but not until 
after peak viremia has abated. This suggests they 
are not the primary immunologic mechanism for 
viral clearance from the circulation; however the 
role these neutralizing antibodies play in 
protection against subsequent exposure to PRRSV 
is unclear. 
Age-dependent resistance to PRRSV has been 
observed, whereby younger pigs exhibit higher 
levels and longer duration of viremia compared to 
older pigs despite similar timing and magnitude of 
antibody production against the virus1. Most 
research investigating neutralizing antibodies to 
PRRSV has been conducted in young pigs, 
however in this study, we observed that older 
sows show high neutralizing antibody titers.  
Materials and Methods: Using a high-
throughput ELISA-based assay to examine the 
neutralizing antibody response to PRRSV, we 
sought to distinguish whether these high titers are 
a function of age at which pigs are first infected 
with PRRSV or a response to cumulative 
exposure to multiple PRRS viruses over time.  
Results: Sows exposed to multiple field viruses 
over time have high neutralizing antibody titers 
against PRRSV VR2332, whereas sows from the 
experimental inoculation study had lower 
neutralizing titers. 
Unexpectedly, sows experimentally infected with 
PRRSV JA142 had lower neutralizing titers 
compared with younger pigs (Figure 1). 
Figure 1: Sows have lower neutralizing titers on 
first exposure to PRRSV compared with younger 
pigs. 
Conclusions and Discussion: Findings suggests 
high titers observed in field sows may be more 
related to cumulative exposure, possibly to 
differing strains than to age at first exposure. 
Though the underlying factors responsible are not 
known, the importance of high neutralizing titers 
for protection against diverse PRRS viruses in 
older pigs can now be investigated. 
Acknowledgements: Thanks to Dr. Paul Yeske 
and Dr. Mark Wagner for providing field sow 
serum samples and to Diem Ngo for technical 
assistance with serum neutralization assays. 
Serum samples for age comparisons were 
originally collected as part of the Klinge et al. 
study1.
References: 1. Klinge KL et al.: 2009, Virology 
Journal 6:177
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THE EFFECT OF INGELVAC PRRS® ATP VACCINATION OF GROWING PIGS ON 
SEVERITY OF RESPIRATORY DISEASE CAUSED BY CO-INFECTION OF PRRSV AND SIV 
B. Leuwerke 
Swine Vet Center, St. Peter, Minnesota 
Introduction
Respiratory disease caused by porcine 
reproductive and respiratory syndrome virus 
(PRRSV) and swine influenza virus (SIV) 
causes dramatic losses for swine producers 
every year.  Conditions that favor the 
transmission of these viruses are similar; 
therefore, simultaneous infection within herds is 
common.  Vaccination of growing pigs with a 
modified-live PRRSV vaccine is performed to 
reduce the effects of PRRSV infection.  This 
practice reduces mortality, culls and increases 
performance in herds that become infected with 
PRRSV.1 Vaccination for SIV is less common 
due in part to timing constraints brought on by 
maternal immunity and limitted cross-protective 
immunity.  The objective of this study was to 
assess whether vaccination with a modified-live 
PRRSV vaccine could reduce respiratory disease 
in pigs co-infected with both PRRSV and SIV.  
Materials and methods 
An experimental study was performed on 30, 
ten-week-old pigs that were PRRS and 
Mycoplasma hyopneumoniae negative. The 
study consisted of three groups.  Group 1 (n=6) 
served as unvaccinated/unchallenged control.  
Group 2 (n=12) remained unvaccinated and was 
challenged with PRRSV and SIV. Group 3 
(n=12) was vaccinated on day 1 and challenged 
with PRRSV and SIV.  Pigs were ramdomly 
allocated to groups 2 and 3 and inoculated on 
day 32, via the intranasal route with 4ml of 
H1N2 SIV (TCID50=1.33x106/ml) and PRRSV 
RFLP pattern 1-4-4 (TCID50=1x104/ml).  
Weights were taken at days 1 and 39.  Serum 
and nasal swabs were collected at 7 days post-
inoculation (DPI) and rectal temperature was 
measured at 7 DPI. All pigs were necropsied at 
day 39 of the study. Lung lesions were scored as 
a percent of total lung affected for each pig 
individually. Parameters were compared using 
the non-parametric Mann-Whitney U Test. 
Results 
Fever and respiratory disease was identified by 2 
DPI in groups 2 and 3.  Temperature at 7 DPI 
was significantly higher in group 2.  Although 
numerical differences were observed in favor of 
group 3 in average lung lesion score and average 
daily gain (ADG), no statistical significant 
differences were detected for these parameters 
between groups 2 and 3 (Table 1). 
Table 1 Comparison of measured variables 
 GP1 GP2 GP3 Diff 2vs3 
P-value
2vs3 
ADG 1-39 
days 1.66
a 1.57a 1.63a 0.06 0.58 
Lung
Score (%) 0.0
a 10.2b 8.1b 2.10 0.40 
Temp (F)
7 DPI NA 105.6
a 104b 1.60 0.002 
Different superscripts within row indicate statistical 
significant difference between groups. 
Conclusions and discussion 
In this study there was a significant reduction in 
fever at 7 DPI for the group receiving Ingelvac 
PRRS ATP vaccination.  All pigs in group 2 and 
3 were PRRS PCR positive at 7 DPI.  Group 3 
had 6 pigs SIV positive at 7 DPI compared to 
group 2 having 3 remaining SIV PCR positive.  
Although not statistically significant, vaccinates 
had a numerical reduction in lung lesions and 
greater ADG indicating a potential performance 
benefit to PRRS vaccination for those pigs 
challenged with PRRSV and SIV that should be 
evaluated in a follow up study with higher 
statistical power. 
References 
1. Waddell J. Proc Am Assoc Swine Vet.  2008, 
257-260.  
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EVALUATION OF AIRBORNE SHEDDING OF FOSTERA PRRS MLV VACCINE FROM 
GROWING PIGS RAISED UNDER COMMERCIAL CONDITIONS 
Paul Yeske DVM MS 
 Swine Vet Center, St Peter MN 
Current Status of the Problem  
Herds have been successful at PRRS elimination 
and the ability to generate negative pigs. These 
negative pigs in high pig density regions are 
being vaccinated with PRRS MLV vaccines. 
Vaccinating these pigs has shown to improve 
performance when challenged with field 
virus1,,2. Even though previous studies 
demonstrated limited airborne shedding3 there is 
still concern with the use of PRRS MLV that it 
will shed and spread to other herds  
Project Objectives 
Identify the amount and duration of aerosol 
shedding of Fostera PRRS MLV inside a 
commercial wean to finish barn, outside the barn 
directly outside the pit fan and 1 mile down 
wind of the barn. 
Procedures to achieve Objectives 
1. 3600 PRRS negative pigs were housed in a 
tunnel ventilated double-sided wean-to-finish 
barn and split in 2 rooms with separated air 
spaces and entries.  
2. Pigs in room one were vaccinated with 
Fostera PRRS MLV labeled dose at 4 weeks 
of age. Pigs in the other room were not 
vaccinated.
3. Air samples were tested for PRRS PCR. 
4. Liquid cyclonic collectors were used to 
collect daily air samples for 28 days.  
5. 30 sentinel pigs per room were tested 
periodically by PRRS PCR and ELISA. Six 
oral fluid samples were also collected per 
room from the pens where the sentinel pigs 
were located and tested by PRRS PCR and 
ELISA.
Results 
No virus was detected in any of the air samples 
collected either in the barn, outside the pit fan or 
1 mile in the down wind direction.  
Viremia was detected in vaccinated pigs. PRRS 
virus was detected in oral fluids post-
vaccination.
PRRS virus RNA and ELISA antibody were 
detected in serum or oral fluids in the non-
vaccinated pigs following pit pumping and there 
is no evidence of a biosecurity breech in the 
system during this same time.  Sequencing was 
completed and was 99.7% homology to vaccine 
virus. A limited number of air samples were 
collected when the control side seroconverted 
and these were negative as well. 
Discussion 
Vaccine virus was not found in air samples at all 
3 collection sites. There was no spread via 
aerosol that can be detected. The non-vaccinated 
control room turned positive following pit 
pumping. Implication would be less likely to 
have virus spread following vaccination pigs in 
wean to finish sites. 
References 
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NO INDICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS (PRRSV) INFECTION IN BRAZILIAN SWINE HERDS 
JR Ciacci-Zanella1, D Gava1, R Schaefer1, CS Klein1, VS Silva1, L Caron1
1Embrapa Swine and Poultry Research Center, Animal Health Laboratory, Concordia -SC, Brazil; 
janice.zanella@embrapa.br
Introduction  
Porcine reproductive and respiratory syndrome 
virus (PRRSV) is a globally important 
pathogen of economic and veterinary concern. 
Recent studies estimate a cost of US$664m 
yearly to United States swine industry 3. PRRS 
is present throughout the world, with the 
exception of Australia, New Zealand, Finland, 
Norway, Sweden and Switzerland 5. Although 
Brazilian swine production is expressive 
(fourth pork producer and exporter), there has 
been no evidence of PRRSV infection in those 
herds 1. Most of the analysis used serology by 
commercial ELISA tests in breeding herds to 
perform prevalence surveys. The objective of 
this work was to detect PRRSV in samples of 
sera, plasma or oral fluids (OF) from swine 
herds, quarantined imported boars and feral 
pigs from 2008 – 2012. 
Material and Methods 
A total of 113 commercial pigs herds with a 
history of respiratory problems from 8 
Brazilian states (SC, RS, PR, MG, SP, MS, MT 
and GO) were included. Farms were divided in 
51 farrow to finish farms (1000 plasma and 257 
OF samples) collected between 2008-2009; 62 
commercial nursery farms (1860 sera and 232 
OF paired samples from 8-12 week old pigs) 
collected between 2009-2012. Moreover, 
quarantined imported pigs (471 sera and 52 OF 
paired samples) collected in 2011 and 148 feral 
pigs serum samples collected from captured 
pigs in 5 farms in the sub-regions of 
Nhecolândia and Abobral, in the Pantanal of 
MS. This serum sample collection was done in 
two periods, from August to September 2009 
and from January to August 2010. Thus, a total 
of 2479 serum samples, 1000 plasma samples 
and 541 OF samples were collected from 2008 
to 2012 and were sent to Embrapa Swine and 
Poultry for processing. All samples were tested 
using IDEXX HerdChek* PRRS Antibody Test 
Kit. Positive samples were processed for viral 
RNA extraction by MagMAX® 1836-5 
(Applied Biosystems). Real-time RT-PCR 
reactions were performed using specific 
primers targeting the ORF7 gene sequences of 
North-American PRRSV as described 4.
Positive control RNA was in vitro transcribed 
using RiboMAX™ (Promega), provided by 
NADC/ARS/USDA (Ames, USA) 2.
Results 
4020 samples (serum, plasma and OF) from 
domestic or feral pigs from eight Brazilian 
states and quarantined imported boars were 
tested by IDEXX HerdChek* PRRS Antibody 
Test Kit. All OF samples resulted negative, 
1/1000 plasma samples and 3/2479 sera 
samples resulted positives. Both sera and 
plasma samples were submitted to real-time 
RT-PCR and resulted negative as well. Real-
time RT-PCR was able to detect 2.6x103
molecules/uL of PRRSV positive control 2.
Discussion and Conclusion 
Herein are presented different categories of 
sampling aiming to detect PRRSV infection in 
Brazilian pig herds. Although this does not 
characterize a surveillance study, it 
demonstrates the absence of PRRSV antibodies 
or RNA at analyzed samples. The main route in 
which PRRSV has been introduced into 
previously free countries is undoubtedly via pig 
movements 6. Semen imports have also played 
a part, in some cases 6. Thus, no evidence of 
PRRSV infection in those pigs was observed, 
indicating the importance to implement 
diagnostic tools and a monitory program to 
prevent the entry and further distribution of 
PRRSV in Brazil. 
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EVALUATION OF LATE-GESTATION GILTS FOLLOWING ACCIDENTAL 
EXPOSURE TO FOSTERATM PRRS VACCINE VIRUS  
A Schelkopf 1, S Dee, 1, J Nerem 1, R Swalla 2, and B Cowles 2 
1Pipestone Veterinary Clinic, Pipestone MN USA  2Zoetis LLC, Florham Park NJ USA 
Introduction
Modified-live Porcine Reproductive & 
Respiratory Syndrome viruses (PRRSV) have 
the ability to replicate in the animal after 
administration with subsequent shedding of 
virus to the environment and to naïve swine in 
contact with previously vaccinated animals. 
Natural exposure of PRRSV in pregnant swine 
can be devastating depending on the virulence of 
the strain. It is vital to understand how 
accidental exposure with Fostera PRRS 
modified-live vaccine virus, may affect 
pregnancy and/or piglet viability and production 
if naïve, gestating gilts were exposed to the 
vaccine virus. 
Materials and Methods
The study involved 76 healthy pregnant gilts at 
90 days of gestation that were purchased from a 
SPF herd in Minnesota.  All animals were 
confirmed free of PRRSV and PCV2, and were 
Mycoplasma hyopneumoniae positive but stable 
(ELISA or PCR).  Animals were housed in a 
commercial farrowing unit with separate 
airspaces. Gilts were randomly allocated to 1 
block of 3 animals each, and within blocks each 
animal was then randomly assigned either 
control or exposed groups in a 1:2 ratio, 
respectively (randomized complete block 
design).  One day later, animals in each 
treatment group received the following 
injections (study day 0):  Fostera PRRS: 2 mL 
IM (n=51); Control: 2 mL vaccine diluent IM 
(n=25).  Data collected during the study 
included gilt morbidity and mortality, PRRSV 
serology, and litter productivity parameters 
(abortions, mummified/still-born piglets, live 
births, birth weights, pre-weaning mortality, 
weaning weights, birth-to-weaning daily gains). 
Serum samples collected from gilts (days -7, 0, 
7, 48) and liveborn piglets were evaluated for 
anti-PRRSV antibody using a commercial 
ELISA test. Piglets that died were necropsied 
and were tested by PCR for detection of 
PRRSV.  Air samples were also collected at the 
exhaust fans daily during the experiment.   
Results and Discussion 
Serology results showed that gilts in the Fostera 
PRRS vaccine virus group generated higher (P ≤ 
0.0075) PRRSV antibody titers on days 7 and 48 
compared to control animals.  All exposed gilts 
demonstrated PRRSV at 7 days post-exposure 
with PCR.  PCR cycle times (CT) ranged from 
23.9 to 33.0 with an average of 27.34 ± 1.9.  
These data indicate that administration of 
Fostera PRRS was successful in challenging 
gilts with the vaccine virus for the purpose of 
evaluating safety responses.  None of the gilts 
injected with Fostera PRRS vaccine virus 
demonstrated any clinical signs of systemic 
disease associated with PRRSV, anorexia, or 
lethargy, nor did any control animals. Most 
notably, no abortions occurred in any of the 51 
gilts that received the Fostera PRRS vaccine 
virus. In addition, no differences (P > 0.56) were 
observed between treatment groups in the 
average number of pigs born/litter or pigs born 
live/litter. Similar rates of mummies occurred in 
each group, but a higher rate of still births was 
noted in the Fostera PRRS vaccine virus group. 
A higher rate of pre-weaning mortality was also 
observed in the Fostera PRRS vaccine virus 
group. During the trial there were only two days 
that air samples from the exhaust fans were 
positive and this was after 98% of the 
farrowings had occured.  The PCR cycle times 
were both greater than 35.  
Though piglets born to gilts exposed to the 
vaccine virus 53% were viremic at birth 
(evidence of transplacental virus transmission), 
they appeared clinically unaffected. Dyspnea 
was noted in some animals at 7 to 10 days of 
age, and some were thin, gaunt, and rough-
haired. Average daily gain (ADG) during the 
birth-to-weaning period was reduced (P ≤ 
0.0001) compared to piglets born to control gilts. 
In summary, this trial demonstrated that 
inadvertent exposure of Fostera PRRS vaccine 
virus to naïve gilts at 90 days of gestation posed 
no threat to farrowing success, with the most 
notable observation being the absence of 
abortions that often result from PRRSV field 
infections. 
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MODIFIED LIVE PRRSV VACCINATION IS EFFICACIOUS FOLLOWING CHALLENGE 
WITH EIGHT GENETICALLY DIVERSE PRRSV ISOLATES 
A Patterson, J Victoria, D Jordan, E Vaughn, M Roof, R Philips 
Boehringer Ingelheim Vetmedica, Inc., Ames, USA 
Introduction
Modified-live vaccine (MLV) can significantly reduce 
lung lesions following a heterologous PRRSV challenge.1
It is necessary for PRRS MLV vaccines to be effective 
against newly emerging PRRSV field isolates. The 
objective of this report is to summarize experimental data 
on PRRSV MLV efficacy following challenge with eight 
genetically diverse PRRSV isolates. 
Materials and Methods 
Field isolates 1 (1-18-2) and 2 (1-4-4) were isolated in 
2008 and 2011, respectively, from herds in the upper 
midwest. Field isolate 3 had a RFLP type of 1-5-2. All 
strains were associated with reproductive problems and 
high mortality in growing pigs.  Conventional pigs were 
vaccinated at approximately 3 weeks of age and 
challenged at either 21 or 28 days post vaccination.  Pigs 
were challenged with a 2ml intranasal dose of 5.92 log 
TCID50/ml, 5.13 log TCID50/ml, or 4.78 log TCID50/ml 
viral stock, respectively for Isolate 1, 2 and 3.  All pigs 
were humanely euthanized and necropsied 14 days 
following challenge.  Lungs were collected and scored for 
percent pneumonia associated with PRRSV exposure.  
Studies involving the remaining challenge isolates 
[NADC, VR2332, SDSU 73, 1-8-4 and 1-4-2] have been 
previously described.1 Table 1 provides a summary of the 
genetic diversity of the challenge isolates. 
Table 1. Summary of the percent nucleotide similarity of 
challenge isolates to Ingelvac PRRS® MLV & ATP 
based on ORF 5 sequence. 
Challenge isolate Lineage† Ingelvac 
ATP
Ingelvac
MLV
U66394 (NADC) 5.1 91% 94% 
AF535152 (VR2332) 5.1 90% 100% 
AY656993 (SDSU73) 8 90% 89% 
Field isolate 1 (1-18-2) 1 87% 87% 
Field isolate 2 (1-4-4) 1 86% 86% 
Field isolate 3 (1-5-2) NC* 87% 88% 
17198-6 (1-4-2) 9 92% 90% 
EF484031 (1-8-4) 1 86% 87% 
*NC= not classified based on the analysis
†Lineage classification based on Shi, M. et al. 2010.  J 
Virol 84(17):8700
Results
Table 2 provides a summary of lung lesions (percentage) 
by treatment for multiple studies using various challenge 
isolates.  Differences between vaccinated and challenge 
control animals for all studies are statistically significant 
(p<0.05) 
Table 2. Lung lesions (%) in vaccinated and non-
vaccinated pigs challenged with PRRSv.
 Lung lesions, %  
Study Vaccinated 
Non-
Vaccinated 
Challenge
isolate
1* 1.0 31.6 NADC 
2* 10.0 37.5 VR 2332 
3† 17.8 70.1 SDSU 73 
4† 37.1 82.0 SDSU 73 
5† 5.8 23.3 VR 2332 
6* 0.7 26.0 17198-6 (1-4-2) 
7* 0.3 37.7 SDSU 73 
8* 0.6 14.8 17198-6 (1-4-2) 
9* 12.0 39.9 MN 1-8-4 
10* 10.4 36.2 MN 1-8-4 
11† 8.7 62.5 MN 1-8-4 
12* 8.0 47.0 SDSU 73 
13* 15.9 52.7 SDSU 73 
14* 29.8 36.0 MN 1-8-4 
15† 27.4 46.6 SDSU 73 
16* 4.5 32.9 MN 1-8-4 
17† 13.8 58.1 FI 1 1-18-2 
18* 1.4 18.0 FI 3 (1-5-2) 
19† 0.7 18.0 FI 3 (1-5-2) 
20* 37.4 52.9 FI 2 (1-4-4) 
21* 2.4 17.6 MN 1-8-4 
* Ingelvac PRRS® MLV, †Ingelvac PRRS® ATP , 
FI=Field isolate 
Discussion and Conclusion 
Use of a modified-live PRRSV vaccine significantly 
reduced lung lesions in multiple challenge models which 
used genetically diverse heterologous PRRSV isolates. 
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PRRSV FIELD EXPOSURE AND MORTALITY RELATIONSHIP ANALYSIS IN NON-
VACCINATED AND VACCINATED FINISHER PIG BARNS 
Jose Angulo1, Reid Philips1, Kari Saddoris-Clemons1, Perry Harms3
1Boehringer Ingelheim Animal Health GmbH, Ingelheim am Rhein, Germany 
1Boehringer Ingelheim Vetmedica, Inc., St Joseph, Missouri USA 
3Smithfield Premium Genetics Group, NC USA 
Introduction
Modified live vaccination has been used as a 
primary tool for minimizing mortality rate due to 
PRRSv1,2. Vaccination reduces shedding and 
excretion of wild-type virus in vaccinated pigs, 
but did not prevent infection2. The objective of 
this study was to analyze mortality rate in non-
vaccinated control and vaccinated finisher barns 
with different levels of wild type PRRS (WT 
PRRSv) exposure in a large production system. 
Materials and Methods
A barn-level side by side study was conducted in 
a large production system located in the USA. 
The pig flow was selected from PRRSv Stable 
Sow Farms, defined as PRRSv negative or <20% 
positive PRRS PCR 5:1 pooled serum samples at 
weaning. Pigs in the vaccinated groups were 
vaccinated with Ingelvac PRRS® MLV (2ml) at 
nursery placement. Treatment group and 
matched pair integrity was maintained upon 
movement of pigs from the nursery to the 
finisher sites. The study evaluated 60 vaccinated 
finishing barns and 59 non-vaccinated finishing 
barns within the same finisher sites. The 
sampling protocol during the finisher phase 
utilized oral fluids from 6 ropes per barn, for 
PRRS PCR at 15-16 wks of age. All PCR 
positive samples were sequenced (ORF5). 
Percent mortality from the Finisher group/barn 
closeouts was used for the analysis. For each 
finisher barn in the study, the proportion of 
positives at 15-16 weeks of age and its 
respective mortality were analyzed through a run 
chart using MINITAB 16.2 with WT PRRSv 
proportion on axis X and mortality on axis Y. 
The run chart included two tests for randomness 
(No. of runs about the median & No. of runs up  
and down) to indicate whether there were any 
statistically significant patterns or evidence of 
non‐randomness.     
 
Results 
Figure 1. Run Charts for Finisher Barns
 Control Vaccinated 
P-Value for clustering 0.022* 0.910 
P-Value for Mixtures 0.978 0.090 
P-Value for Trends 0.391 0.710 
P value for Oscillation 0.609 0.290 
Conclusions and Discussion  
Results showed that in control barns, the higher 
the percentage of OF sample positive for WT 
PRRSv, the higher the mortality (clustering P-
value=0.022), however, vaccinated barns 
showed no indication of a relationship between 
high mortality and PRRSv WT proportion 
(clustering P value 0.910) confirming that 
vaccination does not prevent infection, but 
significantly reduces mortality due to PRRSv.  
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REDUCTION OF WILD-TYPE PRRS VIRUS SHEDDING IN AEROSOL OF GROWING PIGS 
BY MODIFIED-LIVE VIRUS VACCINATION AT WEANING
Pipestone Research Committee1, Thomas Wetzell2, Jean Paul Cano2, Justin Rustvold2
Pipestone Applied Research, Pipestone,USA1, Boehringer Ingelheim Vetmedica Inc, St. Joseph USA2
Introduction
The risk of area-spread of porcine reproductive 
and respiratory syndrome virus (PRRSV) 
continues to be high in swine-dense regions 
potentially because of PRRSV shedding from 
large populations of growing pigs. The 
therapeutic use of modified-live virus (MLV) 
vaccine in infected pigs has been shown to 
reduce the duration of wild-type virus (WTV) 
shedding to sentinels and in aerosol.1,2 The 
objective of this study was to quantify the effect 
of MLV vaccine on performance and measure 
WTV shedding in pigs vaccinated at weaning 
and challenged 4 weeks later. 
Materials and Methods 
A total of 2100 PRRS-negative weaned pigs 
were randomly allocated to either a non-
vaccinated control (NVC) or to a MLV 
vaccinated group, each housed in separated 
rooms. Biosecurity protocols were implemented 
to avoid PRRSV transmission between rooms. 
Pigs in the MLV group were IM vaccinated with 
Ingelvac PRRS® MLV (Boehringer Ingelheim 
Vetmedica, Inc) at 4 weeks of age. Four weeks 
post-vaccination 10% of the pigs in each group 
were IM inoculated with 1 mL of PRRS WTV 
RFLP pattern 1-18-2 at a concentration of 
4.2x107 RNAc/mL. Infection dynamics was 
monitored by PCR and ELISA tests on serum 
and oral fluid (OF) samples. Daily air samples 
were collected from each group at 8 AM using 
Liquid Cyclonic Collectors (Midwest MicroTek, 
Brookings, SD) placed in front of exhaust fans 
for 30 minutes and tested by PCR. Mortality, 
cull rate, ADG and feed conversion (FC) were 
recorded for wean to finish performance.   
Results 
Mild clinical signs developed in both groups 
following inoculation with PRRS WTV. No 
significant differences between groups were 
detected in PCR or ELISA results in serum or 
OF samples. MLV vaccine was not detected in 
the NVC group. The duration and frequency of 
PRRSV RNA detection in air was significantly 
higher in NVC than in the MLV group 
(p<0.0001) (Table 1). Performance is 
summarized in Table 2.    
Table 1. Detection of PRRSV in air by PCR 
Parameter (days) NVC MLV 
Frequency post-vaccination 0/28 5/28 
Duration post-vaccination 0 6 
Frequency post-inoculation 21/118 4/118 
Duration post-inoculation 36 6 
   
Table 2. Vaccination to market performance 
Parameter NVC MLV 
Mortality % 4.8 5.1 
Cull rate % 5.9 2.8 
ADG (lbs) 1.57 1.63 
FC (lbs) 2.38 2.40 
Conclusions  
The prophylactic use of PRRS MLV vaccine in 
growing pigs at risk of infection represents a 
valuable tool to reduce the risk of transmission 
between herds in swine-dense-areas. The 
observed performance benefits as well as 
shedding reduction in MLV vaccinated pigs 
challenged with WTV support the 
recommendation of MLV vaccination of 
growing pigs at risk of infection.       
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TRANSPORT TRUCK SURVEILLANCE FOR PRRS VIRUS IN SUMMER AND WINTER 
MONTHS 
R. Philips1, T. J. Fangman1, M. T. Fangman2, and K.L Saddoris-Clemons1
1 Boehringer Ingelheim Vetmedica Inc., St Joseph,USA 
2University of Kansas Medical Center, Kansas City, USA
Objectives 
PRRS virus prevalence in central Missouri is 
low; however, the risk of contamination of 
trucks at slaughter facilities is hypothesized to 
be potentially moderate to high. The study 
objectives were to determine if PRRS virus 
could be detected via PCR from transport trucks 
arriving at a central Missouri site to load pigs for 
market. A second objective was to determine if 
the risk of PRRSv detection increased in 
transport trucks during the winter months 
compared to summer months.   
Materials and Methods 
Trucks were swiffered from June 6th to July 5th
2012 (summer, n=42) and from Nov 14th 2012 to 
Feb 20th 2013 (winter, n=40). During the 
summer period there were 3 transport companies 
and 10 drivers identified. During the winter 
period there were 3 transport companies and 9 
drivers identified. Drivers completed a short 
questionnaire about their specific truck wash 
protocol upon arrival to the farm. Three, 6 foot 
diameter areas, were swiffered in the truck 
trailer on all 82 trucks. The swiffered areas 
consisted of the trailer floor near the rear of 
truck, trailer loading ramp, and a random area 
observed to be wet or noticeably dirty in the 
truck trailer.  A 6 foot diameter area was 
swiffered in each location. Gloves were changed 
between each sample.  Individual Swiffer 
Sweepers® were pre-packed with 20 ml of 
transport media.  The transport media was 
squeezed from the swiffer prior to swabbing the 
trailers (media remained in the bag).
Immediately following sampling, the swiffer 
was returned to media. The media was 
reabsorbed back into the swiffer and squeezed to 
release the fluid three times. The fluid was 
transferred to a snap-top tube, frozen and later 
shipped to the BI-HMC for PRRS PCR 
evaluation (246 PCR samples total).  
Results 
All trucks were washed and disinfected prior to 
entering the farm (Table 1).   Seven trailers were 
observed to have standing water and 19 
contained an observable dirty area on the floor. 
No PCR positive PRRS samples were obtained 
from any of the 3 locations sampled in each of 
the 82 truck trailers.  
Table 1: Questionnaire responses for truck 
cleaning procedures prior to entering farm  
Truck driver response  
Activity  Yes  No 
Washed truck prior 
to arrival  82/82 (100%)  0/82 (0%) 
Disinfected truck 
prior to arrival  82/82 (100%)  0/82 (0%) 
Commercially power 
washed truck  79/82(96%)  3/82 (4%) 
Truck  dried prior to 
arrival  74/82 (90%)  8/82 (10%) 
Conclusions
Study limitations prevented sampling of trucks 
upon exit from the slaughter facilities so 
prevalence of PRRSv prior to washing is 
unknown.  Although no PRRSv positive samples 
were obtained during this study, it can not be 
concluded that there is no risk of PRRSv 
transport within transport trucks. However, the 
various truck wash protocols utilized by drivers 
in this study appeared to reduce the risk of 
PRRSv contamination from transport vehicles.   
PRRS PCR and PRRS ELISA Responses in Feeder Pigs After Vaccination with Fostera™PRRS 
 
A.J. Frischmeyer D.V.M.1 
J.D. Loomis D.V.M.1 
D.D. King D.V.M.2 
 
1 Grinnell Veterinary Clinic, Grinnell, Iowa, USA 
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Introduction 
Recent estimates regarding Porcine reproductive 
and respiratory syndrome virus (PRRSV) show 
that more than half of weaning-age PRRSV-
negative pigs become infected with PRRSV 
before going to market.1 Vaccination and other 
control measures are required to help growing 
pigs defend themselves against PRRSV.  A field 
study was undertaken in order to examine post-
vaccination responses to Fostera™ PRRS™ as 
assessed by PCR and ELISA, comparing 
responses in pigs mass-vaccinated by a 
vaccination crew to those of pigs individually 
vaccinated.2 To evaluate economic return, close-
out results from this vaccinated group were 
compared to the previous group of pigs placed at 
this site. 
 
Materials and Methods 
The non-clinical vaccine-response study 
involved 5000 feeder pigs approximately 8 
weeks of age that were sourced from a PRRS-
naïve sow farm and placed at a commercial 
finishing site located in Iowa.  After 1 week in 
the finisher, pigs were vaccinated with Fostera 
PRRS on study day 0. The vaccine was either 
mass-administered by a vaccination crew or pigs 
were individually vaccinated. For monitoring of 
vaccine responses, 10 pigs in each of 5 separate 
pens (total of 50 pigs) were randomly selected 
and tagged for blood sampling during the study.  
Of these 50 pigs, 5 pigs were unvaccinated 
controls, 18 pigs were individually vaccinated, 
and 27 pigs were mass vaccinated with the rest 
of the pigs on the site.  Blood samples were 
collected from designated pigs on study days 0, 
8, 16, 21, and 29 and analyzed for PRRSV status 
using PCR and ELISA.  Close-out production 
data was compared to the previous grow-finish 
cycle at the same site involving feeder pigs from 
the same source that did not receive PRRS 
vaccination. During both production cycles, pigs 
experienced a natural challenge with PRRS field 
virus at approximately week 14 of finishing. 
 
Results 
By 8 days post-vaccination 100% of the 
individually vaccinated pigs were PCR positive 
compared to 96% of the crew-vaccinated pigs. 
Non-vaccinated control animals were 100% 
PCR-positive on day 21. By day 16 100% of 
individually vaccinated pigs were ELISA 
positive compared to only 70% of crew-
vaccinated pigs. At day 21, 81% of crew-
vaccinates were fully ELISA positive, but the 
response rate rose to 93% by day 29. For non-
vaccinated controls, sero-conversion did not 
occur until day 29.  Based on close-out 
comparisons, mortality was reduced and ADG, 
feed/gain, and marketing parameters were 
improved during the study finishing period that 
included administration of Fostera PRRS 
vaccine compared to the previous production 
cycle involving non-vaccinated pigs. 
 
Discussion 
In this study differences in effective 
immunization achieved by typical mass 
vaccination compared to more careful individual 
vaccination were shown as evidenced by 
delayed PCR and ELISA responses in crew-
vaccinated pigs.  Improved performance of the 
study group was noted when pigs were 
vaccinated with Fostera PRRS prior to natural 
PRRSV challenge compared to non-vaccinated 
pigs comprising the previous production cycle 
resulting in an estimated 10:1 return-on-
investment at this commercial operation. 
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PRESENCE OF PORCINE CIRCOVIRUS TYPE 2 ANTIBODIES AND VIRUS IN FINISHING 
PIGS AFTER WIDESPREAD USE OF PCV2 VACCINATION.
C.M.T. Dvorak, N. Sharma, Y. Yan, L. Tan, and M.P. Murtaugh 
Department of Veterinary and Biomedical Science, University of Minnesota, St.Paul, MN, USA 
Introduction
Porcine circovirus 2 (PCV2), one of the most 
economically important pathogens of pigs, is the 
causative agent of porcine circovirus associated 
disease (PCVAD). Widespread availability and 
use of PCV2 vaccines, starting in 2006, 
ameliorated PCVAD in finishing pigs so 
successfully that nearly all pigs in the US are 
currently vaccinated at or before weaning. In a 
commercial setting, vaccination of piglets 
around the time of weaning eliminates disease, 
decreases the level of PCV2 in serum, and 
increases production performance, but does not 
eliminate infection. Thus suggesting that nearly 
all finishing pigs are infected with PCV2 which 
has been confirmed in recent studies. However, 
widespread use of PCV2 vaccination may 
decrease the PCV2 viral load in pigs. The aim of 
this study is to examine and compare the PCV2 
viral load and antibody levels in finishing pigs 
after years of widespread PCV2 vaccination and 
compare this with levels obtained in 2006, prior 
to vaccine use. 
Materials and Methods 
Serum samples were collected as part of the 
USDA National Animal Health Monitoring 
System’s (NAHMS) Swine 2012 study focusing 
on operations with 100 or more pigs in 13 states. 
Approximately 15 serum samples from each of 
100 farms were chosen from this collection for 
the analysis of both PCV2-specific antibody 
levels and PCV2 viral levels in serum. 
PCV2-specific antibody levels were determined 
by indirect ELISA using either recombinant 
PCV2 capsid or replicase protein. PCV2 viral 
DNA levels were determined using a PCV2 
quantitative real-time PCR assay. Results from 
both antibody and viral load analysis were 
compared to that of the NAHMS 2006 study. 
Results 
PCV2 viral loads in serum were similar between 
animals on the same farm. However, between 
farms, viral loads varied from barely detectable 
in many of the farms to low viral levels present 
on other farms. High viral levels were not 
observed in animals from any of the farms, 
contrary to serum loads observed in farms from 
just a few years ago. 
PCV2 capsid-specific antibodies were found to 
be present in the majority of animals, but at 
much lower levels than that seen in animals 
sampled just a few years ago. Antibodies to the 
PCV2 replicase protein were observed low 
levels, but some animals had high levels of 
PCV2 replicase antibodies.
Conclusions and Discussion 
Widespread use of PCV2 vaccines has been able 
to control PCVAD and has greatly decreased, 
but not eliminated PCV2 virus in swine herds 
throughout the US. PCV2 viremia today, if 
observed at all, is observed at low levels in 
finishing pigs. PCV2 viremia levels before 
widespread vaccination (in 2006) showed high 
levels of virus in serum from the majority of 
animals and all farms were infected. As 
compared to a few years ago, antibodies to 
PCV2 are still present in the majority of animals, 
but the antibody levels are lower than that 
observed previously. Thus, widespread 
vaccination of animals for PCV2 is able to 
decrease the viral load on farms, while still 
maintaining protective antibody levels. This 
decrease in viral load may be able to lead to the 
production of PCV2-free animals in the future.  
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INTERPRETATION OF PCV2 ELISA RESULTS, A NEW APPROACH. 
Eric van Esch1
1.Technical Director BioChek BV, Reeuwijk, Netherlands 
 
Introduction
PCV2 is endemic in almost all swine herds in 
the world and therefore antibodies against 
PCV2 can easily be found in animals. Serology 
is commonly used to establish herd profiles to 
evaluate the PCV2 dynamics. Since there are 
no DIVA vaccines for PCV2 on the market, 
one cannot easily discriminate between field 
infected or vaccinated animals. This paper 
describes an approach to discriminate between 
vaccinated and field infected animals. 
Materials and methods
Sera and ELISA
Sera from natural (field) infected animals and 
from vaccinated animals where evaluated with  
the BioChek Porcine Circovirus 2 (PCV2) 
Antibody Test Kit. Sera were obtained from 
different herds, different breeds and different 
ages. For vaccination different commercial 
vaccines were used. 
Calculation 
S/P ratios were recalculated in titres using the 
formula: 
Log10 Titre = 1.1 * Log (SP) + 3.361 
Antilog = Titre 
From one herd or group of animals a mean titre 
and standard deviation was calculated using 
Microsoft Excel. Percentage of coefficient 
variance was calculated using the formula: 
(Standard deviation/mean titre)*100= %cv 
Results 
In table 1, a summary of the results is  given, 
showing mean titre, %cv and number of 
positives.
Table 1. Summary of results in field infected 
and vaccinated animals. 
Group Mean 
Titre
CV% Number 
Positive 
Number 
Negative 
vaccinated* 3000 
-
6000 
<30% >95% <5% 
non
vaccinated 
0 - 
7000 
>30% varies varies 
*Different vaccines and vaccination programs 
can give different mean titres. 
Discussion 
From the results it is clearly evident that 
although the mean titre can be the same in field 
infected and vaccinated animals, the %cv is 
different. The vaccinated animals are showing 
a lower %cv indicating a more uniform 
immunity. The differences between field 
infected and vaccinated animals were 
consistent for almost all commercial vaccines, 
proving that the approach for interpretation is 
meaningful. Establishing more specific 
baselines for different vaccines and 
vaccination protocols is on-going. 
Conclusion 
When using mean titre and %cv it is possible 
to discriminate between PCV2 field infected 
animals and PCV2 vaccinated animals. 
Baselines for this are essential for 
interpretation.
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FIELD COMPARISON OF TWO COMMERCIAL VACCINES FOR CONTROLLING 
MUTANT PORCINE CIRCOVIRUS TYPE 2 VIREMIA 
Brad Thacker1, Matt Harris1, James Lehman1, Amy Woods2
1Merck Animal Health, Desoto, Kansas; 2Advanced Veterinary Services, Wolcott, Indiana 
Introduction- Recently a new strain of porcine 
circovirus Type 2 has been identified in the US 
based on genetic sequencing.2 This virus has a 
similar sequence pattern to a virus previously 
identified in China and is often referred to as the 
“Chinese mutant” or mutant PCV2 (mPCV2). 
Some concern has been expressed regarding the 
ability of current US commercial vaccines to 
protect against this new strain. As part of a 
producer initiated PCV2 vaccine evaluation, we 
were provided the opportunity to monitor the 
PCV2 viremia and antibody status of pigs 
undergoing field exposure to mPCV2. 
Materials and Methods- The pigs originated 
from a herd free of PRRSv and Mycoplasma 
hyopneumoniae  (Mhp) and were part of a larger 
field evaluation comparing the performance 
between two commercial PCV2 vaccines: 
FosteraTM PCV (FOST) (Zoetis, Florham, NJ) 
and Circumvent® PCV (CVENT) (Merck 
Animal Health, Summit, NJ). This study used a 
“barn level” design. The pigs that were 
monitored for PCV2 viremia by PCR and PCV2 
antibody by 4-dilution IFA were housed in two 
adjacent finisher barns. The FOST pigs were 
vaccinated once at weaning (3 weeks of age). 
For CVENT vaccination, the producer elected to 
administer the two vaccinations at processing (3 
days of age) and at weaning.   The pigs were 
tagged after arrival to separate nurseries and the 
same pigs were sampled at 4, 11, 16 and 19 
weeks of age. Forty pigs from the source sow 
herd were sampled at 10 days of age. All 
laboratory testing was performed by routine 
methods at the ISU-VDL. Samples for PCR 
were tested in pools of 5. To confirm the 
presence of mPCV2 in each barn, oral fluids 
from 5 pens and blood from 10 light weight, 
non-tagged pigs were collected at 19 weeks of 
age. Several positive samples were sequenced 
and all sequences indicated mPCV2. Based on 
serotesting at 19 weeks of age, the pigs remained 
free of PRRSv and Mhp. Statistical analysis was 
performed by ANOVA and a P value <0.05 was 
considered significant.
Results- The 10-day-old pigs from the source 
herd were not viremic and had a geomean IFA 
titer of 190.3. The following table presents the 
PCR and IFA results from the tested serum: 
Age
(wks)
PCR – Pools 
Pos./Tested 
Geomean IFA 
Titers 
CVENT FOST CVENT FOST
4 0/5 0/5 498.7a 131.8b
11 0/5 0/5 560.8a 86.9b
16 0/4 5/5 266.6a 139.3b
19* 0/5 5/5 216.3b 844.3a
19** 1/2 2/2 139.3b 735.2a
a,b If different within a row, P < 0.05. * Tagged 
pigs. ** Light weight pigs. 
The average cycle times (CTs) for the positive 
pools from the FOST pigs at 16 and 19 weeks of 
age were 27.90 and 23.84, respectively. For the 
light weight pigs, the two FOST pools had CTs 
of 25.00 and 22.10, and the CT of the single 
CVENT positive pool was 26.4. For the oral 
fluids, the average CTs were 23.54 for the FOST 
barn and 33.53 for the CVENT barn. 
Conclusions and Discussion- The data 
presented clearly illustrates the ability of 
CVENT to protect against mPCV2 viremia. In 
addition, the declining IFA titers in the CVENT 
pigs indicate protection. This finding was 
reported in a previous field study that compared 
non-viremic, CVENT vaccinated pigs (declining 
tiers) to viremic, non-vaccinated controls (rising 
titers).1 The oral fluid results indicate a lower 
level (approximately 1,000 times less) of virus 
shedding in the CVENT barn. 
References 
1. Thacker, B. et al (2013) Proc AASV, 217.  
2. Xiao, C. et al (2012) J Virol 86:12469. 
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LONGITUDINAL EVALUATION OF PORCINE CIRCOVIRUS TYPE 2 ANTIBODY 
LEVELS IN FIELD STUDY PIGS USING THREE ASSAYS  
Brad Thacker1, John Johnson2
1Merck Animal Health, Desoto, Kansas; 2Iowa State University, Ames, Iowa 
Introduction- Porcine circovirus Type 2 
serotesting is performed to determine the time of 
infection, evaluate maternal antibody levels and 
measure post-vaccination responses. Several 
types of tests are available worldwide. In the 
US, IFA performed by several laboratories and 
an ELISA performed by the ISU-VDL are the 
main tests used. In a previous report and 
subsequent field experiences, the ISU-VDL 
ELISA and IFA test results sometimes disagree, 
especially with regard to maternal antibody 
status and the antibody response following 
vaccination with Circumvent® PCV (Merck 
Animal Health, Summit, New Jersey).1 To 
provide insight into these discrepancies, sera 
from a vaccination field study was evaluated by 
IFA, the ISU-VDL ELISA and a commercially 
available ELISA not commonly used in the US. 
Materials and Methods- The sera were obtained 
from a field study to evaluate the growth and 
viremia status of pigs until market weight.2 Pigs 
were vaccinated at 3 and 6 weeks of age with 
Circumvent® PCV M (Merck Animal Health, 
Summit, New Jersey) or kept as non-vaccinated 
controls. Field exposure began as early as 1 
week of age based on PCV2 PCR testing. In 
addition to the 4-dilution IFA testing previously 
reported2, the samples were tested by the ISU-
VDL in-house ELISA (ISU-ELISA) and a 
commercial ELISA (COM-ELISA; Ingezim 
Circo IgG, Ingenasa, Madrid, Spain). All testing 
was performed at the ISU-VDL. Titer results are 
presented for each sampling age as the group 
geometric mean and S/P ratios as averages. Each 
group contained 20-25 pigs. 
Results- In general, the tests provided similar 
results. At 1 week, the maternal antibody levels 
measured by the COM-ELISA were at low-to-
moderate levels while the IFA showed low 
levels. With regard to post-vaccination titers, all 
three assays detected a slight rise in titers after 
the first vaccination. Following the second 
vaccination, titers peaked at 8 weeks for the 
ISU-ELISA and at 10 weeks for the COM-
ELISA and IFA. For all assays, titers in the 
control group started to increase at 10 weeks and 
peaked at 19 or 25 weeks. Titers in the 
vaccinated group were declining by 25 weeks, 
especially with the COM-ELISA and IFA. 
Test: Unit 
Age 
(Wks) 
Group 
PCVM CONT 
Ingenasa 
ELISA: 
Titer
1 2,231 2,070 
3 633 639 
6 998 274 
8 20,172 268 
10 15,010 996 
19 1,563 8,017 
25 878 5,706 
ISU 
ELISA: SP 
Ratio 
1 ND ND 
3 0.398 0.381 
6 0.942 0.387 
8 1.911 0.417 
10 1.714 0.664 
19 1.269 0.878 
25 1.209 1.261 
4-dilution 
IFA: Titer 
1 35 53 
3 ND ND 
6 303 127 
8 893 143 
10 1,178 604 
19 640 983 
25 338 1,076 
Conclusions and Discussion- Each test has 
positive and negative attributes. IFA is labor 
intensive and tends to be subjective. The ISU-
ELISA sometimes provides confusing results 
and the scale of S/P ratios is less discriminating 
than a titer. The COM-ELISA appears to work 
well with regard to evaluating post-vaccination 
responses but more evaluation is needed. 
References 
1. Thacker, B. et al (2008) Proc AASV, 153. 
2. Thacker, B. et al (2013) Proc AASV, 217. 
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COMPARATIVE STUDY EVALUATING THE IMPACT OF TWO DIFFERENT PCV2 
VACCINES ON AVERAGE DAILY GAIN (ADG) AND BODY TEMPERATURE POST-
VACCINATION 
I. Hernández-Caravaca1, A.Torres2, A.Ballesta2 , L.Vieira3 , V.Rodriguez-Vega1, S.Figueras Gourgues1
1Boehringer-Ingelheim España S.A. Spain 2Belmonse S.A. 
3 Department of Physiology, Faculty of Veterinary Science, University of Murcia Spain 
Introduction
PCV2 piglet vaccination is widely used in the 
swine industry today. While protective efficacy 
remains the most relevant criteria to choose a 
PCV2 vaccine, it has been shown that 
differences in safety between vaccines may also 
have an impact on production performance (1). 
In addition, it has been reported that the 
immediate period after weaning has a significant 
impact on the pigs’ lifetime performance, 
influencing growth and variability of weights 
through the end of finishing (2,3). The objective 
was to evaluate the impact of two different 
PCV2 vaccines on body temperature and 
performance post-vaccination. 
Materials and Methods 
The study was conducted on a 1,600 sow herd 
positive for PRRS, PCV2 and M hyo located in 
the southeast of Spain. Pigs are weaned at 3 
weeks of age. One week after weaning (4 weeks 
of age) 500 clinically healthy pigs were ear-
tagged, individually weighed and randomly 
allocated to one of two treatment groups. One 
day later piglets received either one dose of 
Ingelvac CircoFLEX® (1 ml) or Suvaxyn® 
PCV (2 ml, marketed in North America under 
the trade name Fostera® PCV) and were 
weighed. Both vaccines were used in 50ds 
presentations and vaccines were allowed to 
reach room temperature (23.6°C) before 
application. All pigs were vaccinated on the left 
side of the neck. Needles were changed every 25 
piglets (pen size) and between treatments. On 
the vaccination day, body temperature was 
measured before and 8h post vaccination in 70 
animals per treatment group. Piglets were 
weighed individually again at 24h and 48h post 
vaccination to calculate ADG. Body temperature 
and ADG were analyzed by ANOVA using 
GLM analysis with treatment as fixed effect. 
Differences between least square means were 
compared through Tukey test. Fisher’s exact test 
was used to evaluate the association between the 
presence of injection site lesions and treatment. 
Level of significance was set at p < 0.05.
Results 
Results are summarized in Tables 1 and 2.  
Table 1: Body temperature and ADG. 
Parameter Circo-
FLEX® 
Chimeric 
vaccine 
P-
value 
Number of pigs 250 250  
Weight d 0 (kg) 6.04 a 6.07 a 0.79 
Body temp. before 
vaccination* 39.9
a 40.0a 0.25 
Body temp.8h post-
vaccination* 40.1
a 40.7b <0.001 
ADG 0-24h (g/day) 167a 79 b 0.001
ADG 0-48h (g/day) 160a 125 b 0.003
a,b value with a different superscript, differ significantly (p < 
0.05), *subset of 70 animals/group 
Table 2: Prevalence of injection site lesions on 
day 9 post-vaccination 
Parameter Circo-
FLEX®
Chimeric 
vaccine
P-
value
 % Piglets with 
cervical lesion  0.41
a 3.54b 0.02 
a,b value with a different superscript, differ significantly (p < 0.05) 
Conclusions and Discussion 
Animals vaccinated with the chimeric PCV2 
vaccine showed a significantly higher body 
temperature (+0.62ºC) at 8h post vaccination 
compared to the CircoFLEX vaccinated group. 
In addition, there was a significant difference 
observed in injection site lesions on day 9 post 
vaccination. This is in line with previous 
publications indicating a higher reactivity of the 
chimeric vaccine. 
The different impact of the two vaccines resulted 
in significant differences in ADG post-weaning, 
as measured for the first 48h post-vaccination. 
These results confirm that Ingelvac 
CircoFLEX® is very safe and less reactive than 
the chimeric PCV2 vaccine. The time 
immediately after weaning is a critical period in 
the pig’s life and can affect performance up to 
slaughter. In addition to efficacy, safety should 
be considered when applying vaccines around 
weaning. 
References 
1. Potter et al.(2012)J Anim Sci: 90(11):4063-71 
2. Cole and Varley (2000) Proc 5th Semin. Int. Porc., 
Spain, p. 37-52 
3. Tokach et al. (1992) Report of Progress 667. KSU 
Agricultural Experiment Station and Cooperative 
Extension Service, Manhattan, KS. p 15-17. 
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MONITORING OF PCV2 MATERNAL DERIVED ANTIBODIES LEVELS IN 3 WEEKS OLD 
PIGLETS IN 6 SPANISH COMMERCIAL FARMS 
S. Figueras Gourgues, I. Hernández-Caravaca, V. Rodriguez-Vega  
Boehringer-Ingelheim España S.A. Spain 
Introduction 
Protective immune response in face of high 
levels of MDA has been repeatedly 
demonstrated for Ingelvac CircoFLEX, an 
aqueous 1-ds ORF2 based subunit vaccine (1,2), 
and no restrictions apply with regard to MDA 
levels at vaccination according to the product 
information (3). However, for other PCV2 
vaccines, the benefits of vaccination in pigs with 
high levels of mAb have not been demonstrated 
or the vaccines must to be administered a second 
time in pigs with high levels of MDA (4,5).  
Typically, antibody levels > 8-10 log2 are 
classified as ‘high’ (6). The objective of this 
study was to evaluate the prevalence of high 
levels of maternal antibodies at weaning in 
piglets deriving from non-vaccinated sows.  
Materials and Methods 
The study was conducted on 6 commercial farms 
located in different regions of Spain. Five two-
site and one multisite production system were 
selected. Overall 270 blood samples, 45 samples 
per sow herd were collected as follows. Five 
piglets (3 weeks of age) from 3 sows of each of 
the following three parity groups: parity 1-2, 
parity 3-4 and parity 5-6.  
Sows and piglets were unvaccinated against 
PCV2 at the time of sampling and cross-fostered 
piglets were excluded. Piglets were vaccinated 
against PCV2 after the blood sampling. 
The serum samples were analyzed for PCV2 
antibodies with the Serelisa® PCV2 Ab Mono 
Blocking ELISA (Synbiotics Corp). The results 
are expressed as log2 titers with titers of 10 or 
above classified as ‘high’.  
Results 
Figure 1 reveals that, in total, 68% of the piglets 
showed high MDA levels (>10 log2) and 
piglets with high MDA levels were present in 
each of the sampled farms (ranging from 36% in 
farm F to 89% in farm E). Only in one of the 6 
farms (farm F) less than 50% of the piglets had 
high titer levels.  
All parity groups (across herds) had a prevalence 
of high titers in piglets of more than 50%. While 
61% of piglets from younger sows (parity 1&2) 
had high levels of MDA, 72% of pigs from 
parity 3&4 and 73% of the pigs from the older 
sows (parity 5&6) displayed those.  
Figure 1. Percentage of piglets (%) with high 
MDA titers (>10 log2, dark gray) and MDA 
titers < 10 log2 (light gray) per farm (A to F) and 
across all farms (Total).  
Conclusions and Discussion 
This study indicates that in Spanish commercial 
sow herds the majority of piglets deriving from 
non-vaccinated sows have high levels of MDA 
at the time of weaning (3 weeks of age). Across 
all farms and parity groups 68% of the piglets 
had a titer of 10 or above. For some vaccines 
(including a 2-ds product) a possible 
interference with high levels of maternal 
antibodies is suggested based on the product 
information or field data. In contrast, Ingelvac 
CircoFLEX®, a single dose ORF2 based subunit 
vaccine, has demonstrated to provide solid and 
consistent protection independent of maternal 
antibody titres (1, 2). 
References 
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POSITIVE IMPACT OF PCV2 VACCINATION OF GILTS AND SOWS ON REPRODUCTIVE 
PERFORMANCE DEMONSTRATED IN A SIDE-BY-SIDE FIELD OBSERVATION 
E. Kostuchenko1, S. Kukushkin2, T. Bondarenko2, O. Duran3, P. Maass3
1“Dymov.Yug” farm, Krasnodarskiy Krai, Russia, 2Boehringer Ingelheim LLC, Moscow, Russia; 
3Boehringer Ingelheim Animal Health GmbH, Ingelheim, Germany 
Introduction and Background 
PCV2 is one of the viral pathogens with the 
most important economical impact in the pork 
industry. In the last six years vaccination of pigs 
against PCV2 has become routine worldwide. In 
addition, it has been experimentally shown that 
PCV2 can cause reproductive failure1,2. Some 
field studies have demonstrated a positive effect 
of PCV2 gilt and sow vaccination on 
reproductive parameters3,4. The aim of this study 
was to investigate the effectiveness of 
vaccinating gilts and sows against PCV2 in a 
commercial farm without obvious clinical signs 
of PCVD in the reproductive herd. 
Materials and Methods 
The study was conducted between April and 
September 2012 in a 2-site, PRRS-negative, 950 
sow farrow-to-finish farm situated in the South 
of Russia. Since January 2012, pigs were 
vaccinated at 19 days of age against PCV2 with 
Ingelvac CircoFLEX® (Boehringer Ingelheim). 
In April 2012, 98 clinically healthy gilts and 326 
sows were randomized into treatment and 
control groups. Gilts and sows in the treatment 
group were vaccinated with 1 dose (1 ml) of 
Ingelvac CircoFLEX® at 3 weeks before 
insemination. The control animals were not 
vaccinated. Vaccinate and control pigs were 
housed side-by-side in alternating pens in the 
same air space and under the same management 
and climatic conditions. Pigs from the 
subsequent litter were weaned at 22-23 days of 
age. Cross-fostering of piglets was only allowed 
within treatment groups. 
Results 
Results are shown in Tables 1 and 2.  
Discussion and Conclusions 
In this study, PCV2 vaccination of gilts and 
sows with Ingelvac CircoFLEX® improved 
reproductive performance compared to non-
vaccinated animals and provided an additional 
62.7 weaned pigs for each 100 reproductive 
animals. Similar results were described in 
Mexico and Canada3,4. However, to our 
knowledge this is the first large scale side-by-
side study demonstrating a positive effect of 
PCV2 vaccination on reproductive performance.  
Table 1: Vaccination results for gilts 
Parameters Vacc. Control Diff. 
Inseminated, n  48 50  
Pregnancy rate,%  83.3 82.0 1.3% 
Abortion rate,% 2.5 2.4 0.1% 
Farrowing rate,% 81.3 80.0 1.3% 
Total born/litter, n 9.8 9.3 0.5 
Born alive/litter, n 9.3 8.6 0.5 
Stillborn/litter, n 0.5 0.7 0.2 
Mummified/litter,n 0.1 0.1 0.0 
Weak/litter, n 0.3 0.3 0.0 
Weaned/litter, n 8.4 7.6 0.8 
Survivability,% 90.6 88.9 1.7% 
Table 2: Vaccination results for sows 
Parameters Vacc. Control Diff. 
Inseminated, n  166 160  
Pregnancy rate,%  91.6 88.8 2.8% 
Abortion rate,% 0.7 2.8 -2.2% 
Farrowing rate,% 91.0 86.3 4.7% 
Total born/litter, n 10.6 10.4 0.2 
Born alive/litter, n 10.2 9.8 0.4 
Stillborn/litter, n 0.3 0.5 -0.2 
Mummified/litter,n 0.0 0.1 -0.1 
Weak/litter, n 0.2 0.3 -0.1 
Weaned/litter, n 9.7 8.8 0.9 
Survivability,% 94.6 89.5 5.1% 
References 
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COMPARING PLACENTA AND PRESUCKLE PIGLET PCV2 STATUS BETWEEN TWO 
BREEDING SITES 
D Baumert1, T Fangman2, J Rustvold2
1Cargill Pork, Wichita, USA, 2 Boehringer Ingelheim Vetmedica Inc., St Joseph, USA
Objectives  
The study objectives were to determine if the 
placenta PCV2 status could be compared across 
farms to determine PCV2 status in pre-suckling 
pigs.
Materials and Methods 
Site A (avg. parity 2.8) and B (avg. parity (2.3) 
are 1,600 and 5,000 head commercial farrow-to-
wean herds, respectively, where PCVAD had 
been diagnosed in weaned pigs from Site A but 
not Site B. Assorted-parity litters were identified 
at Site A (n=21) and Site B (n=26).  Farrowings 
were attended and eight pre-suckling pigs per 
litter were sampled. Piglet handling procedures 
included: new born piglets were towel-dried, 
tails were docked using side-cutters and tail-
stump blood samples were collected using a 
flocked swab in Amies’ solution. The expelled 
placental material was collected a minimum of 
four hours after expulsion at Site A and 
immediately after expulsion at Site B. Three 
placental umbilical cords from each placenta 
were milked out into a single blood tube to 
create a single sample per placenta. Swiffer® 
Sweeper Dry Cloths were used to collect 
environmental samples from the farrowing crate. 
Blood was collected from the 47 sows and tested 
on PCV2 PCR. 
Results
PCV2 diagnostic results for Site A and Bs’ pigs, 
placentas, dams and farrowing crate 
environments are shown in Table 1. 
Table 1: PCV2 diagnostic results
Sample PCV2 
Test 
Site A Site B 
Placental umb. 
cord serum 
PCR
17/21  
81.0% 
3/26 
11.5% 
Presuckle
piglet serum 
54/168  
32.1% 
5/246 
2.0% 
Environmental 
cloth
20/20†  
100% 
10/24† 
41.7% 
Sow serum 5/2123.8% 
1/26 
10.0% 
Litters with ? ?
positive pigs 
16/21 
76.2% 
3/26 
11.5% 
† 20 of 21 and 24 of 26 crates sampled due to 
on-site supply avail. 
Table 2: Comparing PCV2 PCR results on pig 
and placenta level per dam 
  Litter status* 
  - + 
Dam’s 
placenta
- 24 3 
+ 4 16 
*positive litter contained at least one positive pig 
Conclusions
Differences in PCV2 status of litters, placenta, 
sows and farrowing crate environment exist 
between breed-to-wean sites. Placenta and piglet 
percent positives closely match one another in 
both herds. This supports the potential use of the 
placenta as an indicator of the PCV2 status. It is 
noted that a consistent protocol for placental 
sampling should be developed as environmental 
contamination is a possibility. Sow serum PCR 
was not as sensitive as placenta or piglet testing 
in determining PCV2 status. PCV2 sow herd 
testing, utilizing the placenta, may be useful 
when evaluating interventions that may impact 
PCV2 stability status. These studies are 
currently being conducted.
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DIAGNOSTIC INVESTIGATION TO DETERMINE HERD STABILITY OF A SOW HERD 
WITH DOWNSTREAM PCVAD IN NURSERY PIGS  
T Fangman1, D Baumert2, J Rustvold1
1Boehringer Ingelheim Vetmedica Inc., St Joseph, MO, 2Cargill Pork, Wichita, KS,
Objectives 
The objective was to determine if the sow herd 
supplying a nursery flow demonstrating PCVAD 
was stable for PCV2. Blood collected from 
placental umbilical cords, pre-suckle piglets, and 
sows were evaluated to determine the prevalence 
of neonatal PCV2 viremia at birth and dam 
PCV2 viremia. Additionally, environmental 
samples were collected to assess presence of 
PCV2 in the environmental. 
Materials and Methods 
The 1,200 sow farrow-to-wean operation was 
selected based on nursery pigs experiencing 
PCVAD. The average parity was 2.82.  Twenty-
one mixed-parity litters due to farrow in a 48 
hour period were identified. Immediately post-
farrowing and pre-suckle, eight new-born piglets 
per sow were towel-dried, approximately one-
third of their tails were removed using a side 
cutter, a tail-stump blood samples were collected 
on a flocked swab, and placed into a test tube 
containing transport media. The expelled 
placental material was collected a minimum of 
four hours after expulsion. The placenta was 
manipulated to expose the glossy, ‘fetal’ surface 
and fluid samples were manually expressed into 
a blood collection tube from a minimum of 3 
placental umbilical cord stumps. Each placenta 
was handled with new gloves to minimize 
transfer of PCV2 between placentas. Swiffer® 
Sweeper Dry Cloths were used to collect 
environmental samples from the exposed surface 
of the farrowing crate deck. Dam’s serum was 
tested for PCV2 antibodies and virus via ELISA 
and PCR, respectively.  
Results
Serum and environmental test results are shown 
in Table 1. Table 2 illustrates that 15 of the 16 
positive litters were associated with at least 1 
PCV2 PCR positive piglet.
Table 1: PCV2 antibody and virus results
Sample PCV2 Test Results 
Umb. cord serum 
PCR
17/21  
(81.0%) 
Presuckle serum 54/168  (32.1%) 
Environmental 
cloth
20/20  
(100%) 
Sow serum 
5/21  
(23.8%) 
ELISA 21/21  (100%) 
Table 2: Comparing PCV2 PCR results on 
pig and placenta level per dam 
  Dam’s piglets 
  - +* 
Dam’s 
placenta 
- 3 1 
+ 2 15 
* positive litter contained at least one positive pig sample 
Conclusions
This sow herd was shedding PCV2 to its 
intrauterine piglets at a prevalence higher than 
expected. Previous diagnostic work in this 
system would suggest that <9% of sows were 
PCV2 positive via PCR. This diagnostic 
investigation suggests that serum from placental 
umbilical cords could be a good indicator of the 
PCV2 status of the pre-suckle piglets at birth. 
The comparable findings of this diagnostic 
investigation suggest that additional studies are 
indicated to determine the future application of 
the placenta and environmental testing for 
predicting PCV2 stability status of a sow herd.
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PCV2 VACCINE PROTOCOLS REDUCE PCV2 VIREMIA IN LOW PCV2 CHALLENGES  
Keith Bretey, DVM, Amanda Sponheim, DVM, Kari Saddoris-Clemons, PhD, Brian Payne, DVM 
Boehringer Ingelheim Vetmedica, Inc, St. Joseph, USA 
Introduction and Objectives 
Previous studies indicate that PCV2 viremia levels do 
not influence ADG in PCV2 vaccinated pigs; 
however, veterinarians still inquire about viremia.1,2,3
An objective of these trials was to compare the 
average PCV2 log levels in non-vaccinated and 
vaccinated pigs under field conditions. 
Materials and Methods 
Two trials were conducted. Both included non-
vaccinated control groups and two PCV2 vaccination 
protocol groups (Table 1).  Vaccination occurred per 
label instructions for all products. All pigs were 
serially sampled at 6 time points (Table 1). Serum 
was evaluated using an updated PCV2 qPCR protocol 
(Health Management Center, Ames, IA). The low 
end cut-off for percent positives of the updated 
protocol was 2 logs at 45 cycles. Average log level of 
viremia was calculated for each group at each time 
period. Results were analyzed by MANOVA 
repeated measures. Preset contrast were utilized to 
compare differences between vaccinated and non-
vaccinated pigs and to compare vaccinated groups in 
trial A and Tukey’s HSD was used to discern 
differences in trial B.   
Table1: Trial group description 
Trial Group N serially bled 
Weeks of age 
sampled 
A
NVC† 60 
3, 10, 13,  
16, 19, 22 FLEX
‡ 60 
PCVM^ 60 
B
NVC† 10 
3, 7, 10,  
14, 19, 23 CF
* 30 
PCV# 30 
†Sterile saline; ‡Ingelvac CircoFLEX-MycoFLEX® (Boehringer-
Ingelheim Vetmedica, In., St. Joseph, MO); ^Circumvent PCVM 
(Merck Animal Health, Summit, NJ); *Ingelvac CircoFLEX ® 
(Boehringer-Ingelheim Vetmedica, In., St. Joseph, MO); # Fostera 
PCV (Pfizer, New York, NY) 
Results 
Vaccination statistically decreased viremia compared 
to non-vaccinates in trial A on weeks 10, 13, 19, and 
22 (P=0.01, P=0.02, P<0.0001, P<0.0001, 
respectively) and in trial B, week 23 (P<0.0001). In 
trial A, percent positive samples peaked at 19 weeks 
and was 75% (NVC), 41% (FLEX) and 39% 
(PCVM). Peak percent positive in trial B occurred at 
23 weeks and was 71% (NVC), 19% (CF) and 20% 
(PCV). Viremia between the vaccinated groups was 
not different (P>0.10) at any time points measured in 
either trial (Tab. 2 and Fig. 1). 
Table 2: Trial A average serum quantitative PCV2 
PCR by group at specified weeks of age 
Treatment P-value 
Age, 
wks NVC FLEX PCVM 
Vx 
vs.
NVx 
FLEX
vs.
PCVM 
3 0.00 0.00 0.00  -  - 
10 0.68 0.07 0.36 0.01 0.19 
13 1.27 0.75 0.62 0.02 0.68 
16 1.74 1.26 1.42 0.19 0.64 
19 2.86 1.41 1.26 <.0001 0.63 
22 2.60 1.03 0.99 <.0001 0.90 
Figure 1: Trial B average serum quantitative PCV2 
PCR, log level, by group at specified weeks of age 
0
1
2
3
4
5
3 7 10 14 19 23
Weeks  of Age
NVC
CircoFLEX
Fostera
Discussion and Conclusions 
Both studies represent low PCV2 field challenges (<4 
logs average). However, commercial PCV2 vaccines 
continue to significantly reduce viremia compared to 
non-vaccinate controls and reduce viremia by the 
same magnitude. These viremia studies also indicate 
that vaccines do not completely eliminate viremia. 
More sensitive quantitative PCV2 tests (< 4 logs 
detection limit) should be considered in field trials in 
order to more accurately assess PCV2 status of pigs. 
This study continues to add to the body of evidence 
the industry requests on PCV2 viremia. 
.
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RELATIVE REDUCTION IN PCV2 VIREMIA IN VIREMIC REPLACEMENT FEMALES,  
COMPARING TWO VACCINE PROTOCOLS. A PILOT STUDY. 
Jason Hocker, DVM, MS1, Keith Bretey, DVM2, Brian Payne, DVM2
1AMVC Management Services, Audubon, USA;  
2Boehringer Ingelheim Vetmedica, Inc, St. Joseph, USA 
Introduction and Objectives 
The objective of this study was to observe the 
potential efficacy of PCV2 vaccines in reducing 
or eliminating PCV2 viremia in replacement 
gilts when vaccinated at weaning and boostered 
at a typical selection age and weight of 22 weeks 
of age and 200-275 pounds.  
Materials and Methods 
Pigs were weaned from a commercial sow farm 
and randomly allocated to one of three treatment 
groups at weaning. Viremic animals (n=81) 
weighing between 200-270 lbs (22 weeks of 
age) were selected from the commercial 
finishing facility and administered the 
appropriate booster vaccination (Table 1). All 
pigs were commingled and serially bled at 22, 
27, 28, 29, 30 and 31 weeks of age. PCV2 qPCR 
viremia levels were analyzed. The 
positive/negative cut-off was 2 logs, 100 viral 
equivalents (HMC, Ames, IA).1 Lung and 
lymphoid tissue were collected at marketing for 
PCV2 tissue burden assessment (ISU VDL, 
Ames, IA). 
Table 1: Trial group description 
Group N Treatment Timing(Wk of age) Dose
A 27 Non-VacControlsa 3, 6, 22 3 x2 ml  
B 27 FLEX
b
CFc
3
22
1 x 2ml  
1x 1 ml  
C 27 PCVM
d
PCVe
3, 6 
22
2x 2 ml  
1 x 2 ml 
aSterile Saline, bIngelvac® CircoFLEX-MycoFLEX®, cIngelvac 
CircoFLEX® (Boehringer Ingelheim Vetmedica, Inc., St Joseph, 
MO); dCircumvent® PCVM, eCircumvent® PCV (Merck Animal 
Health, Summit, NJ) 
Results 
Total and percent of positive pigs are displayed 
in Table 2. Figure 1 shows the average of log 
level for positive pigs. Histopathology and IHC 
results were negative on all tissues from all 
animals. 
Table 2: Total and percent positive PCV2 qPCR  
Treatment Contrast P-
value
Age
wks A B C 
A vs. 
B/C
B vs. 
C
22 27/27(100%)
27/27
(100%)
27/27
(100%) - - 
27 14/27(51.9%) 
11/27
(40.7%) 
6/27
(22.2%) 0.09 0.24 
28 17/27(63.0%) 
8/27
(29.6%) 
4/27
(14.8%) 0.0005 0.33 
29 16/27(59.3%) 
9/27
(33.3%) 
6/27
(22.2%) 0.008 0.54 
30 22/27(81.5%) 
9/27
(33.3%) 
13/27
(48.2%) 0.008 0.41 
31 13/27(48.2%) 
6/27
(22.2%) 
3/27
(11.1%) 0.004 0.47 
Figure 1: Average log qPCR by weeks of age (only 
positive animals included) 
Discussion and Conclusions 
Even with lower PCV2 field challenge (<4.5 
logs maximum average in any one treatment 
group) commercial PCV2 vaccines significantly 
reduced the percent of PCV2 qPCR positives 
compared to non-vaccinated controls. While 
both vaccines reduced viremia by the same 
magnitude, neither vaccine eliminated viremia. 
In this study, viremia was not a predictor of 
tissue PCV2 burden. Further field trials are 
underway to understand PCV2 vaccine use in 
replacement animals and the role of PCV2 in the 
breeding herd. 
References 
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UTILIZATION OF TAQMAN REAL-TIME PCR TO INCREASE SENSITIVITY IN PCV2 
SAMPLING
 
Wayne Chittick, MS1, Brian Payne, DVM2 
1Health Management Center, BIVI, Ames, USA 
2Boehringer Ingelheim Vetmedica, Inc., St. Joseph, USA 
 
Introduction and Background 
Prior to vaccine availability, viremia levels of ≥7 
log genomic equivalents/ml were commonly 
observed in herds experiencing PMWS.1 
However, these high viremia levels are rarely 
observed today in groups of properly vaccinated 
pigs. Some PCV2 qPCR tests have viral 
detection limits of 4 logs, meaning a “negative” 
result indicates a sample with 0-10,000 virus 
particles/ml). When using an assay with a 4 log 
detection limit, there is high potential for several 
false negative results. A more sensitive set of 
TaqMan real-time PCR reagents (Life 
Technologies Corp., Grand Island, NY) has 
recently been developed and can reliably detect 
down to 2 logs (100 genomic equivalents / ml) 
with 45 PCR cycles.2 This more sensitive test 
decreases the chance of false negative results in 
samples that have virus levels between 2-4 logs.  
A comparison was conducted between 4 log 
detection limit PCV2 qPCR test and the 2 log 
detection limit PCV2 qPCR test to evaluate the 
potential reduction in false negatives when 
utilizing the more sensitive qPCR test. 
 
Materials and Methods 
Four studies that included serially bleeding of 
individual pigs were conducted and PCV2 qPCR 
utilizing the Life Technologies qPCR was 
utilized to test for virus particles in individual 
pigs. Results of samples were categorized into 0-
2 logs (reported as negative), 2-4 logs 
(detectable but below less sensitive qPCR tests, 
and >4 logs (were detected and would have been 
detected by less sensitive qPCR tests). 
 
Results 
The majority (75.9%) of the samples would not 
have been detectable by either test and 6.3% 
would have been detected by both tests (Table 
1). The test utilizing the new assay detected 
PCV2 virus in 17.8% of the samples that would 
have been undetectable by the older assay. 
 
 
Table 1: Categorized results from Life 
Technologies PCV2 qPCR test in 4 trials. 
 Total 
N 
Number of samples (%) 
between log range: 
Trial  0-2 2-4 logs >4 
A 525 500 (95.2%) 
15 
(2.9%) 
10 
(1.9%) 
B 1051 765 (72.8%) 
206 
(19.6%)
80 
(7.6%) 
C 486 248 (51.0%) 
184 
(37.9%)
54 
(11.1%)
D 293 274 (93.5%) 
15 
(5.1%) 
4 
(1.4%) 
All 2355 1787 (75.9%) 
420 
(17.8%)
148 
(6.3%) 
Discussion and Conclusions 
In certain cases, the previous PCR test was 
dramatically underestimating the percent PCV2 
virus positives in a barn. Of all the positives, 
73.9% were between 2-4 logs, undetectable by 
the old PCR test. The new PCR test increased 
the number of positives by 37.9% in study C and 
increased the total positives from 11.1% to 49%.  
The more sensitive PCR test will be of use in 
diagnostic projects and trials where there is a 
lower level of PCV2 challenge, that would have 
otherwise been undetectable using a threshold 
for positives at 4 logs.3 Additionally, more 
sensitive PCR tests may be applicable in the 
continued discovery of the impact of PCV2 in 
gilts entering the sow herd and sow herd 
stability monitoring for PCV2. The impact of 
PCV2 in unstable herds is not well understood 
and more sensitive PCV2 qPCR tests may be a 
tool to help understand better so that there are 
fewer false negatives.  
References 
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CONTROL OF PORCINE EPIDEMIC DIARRHEA VIRUS THROUGH INTESTINAL FEEDBACK AND 
PARITY SEGREGATION SYSTEM: FIELD CASES IN THAILAND 
D. Nilubol
Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand, 
dachrit@gmail.com
Introduction 
Porcine epidemic diarrhea (PED) re-emerged in Thailand 
in late 20071. Since then, the disease has become 
endemic causing sporadic outbreaks throughout Thai 
swine herds, especially herds located in high pig 
proximity areas and herds located in other regions in 
which previously experienced an outbreak. Attempts to 
control PED including vaccination whole herd exposure 
with minced intestinal of infected piglets have been 
implemented but gained varying degree of success. 
Furthermore, well vaccinated herds including quarterly 
mass sow herd vaccination and pre-farrow vaccination 
have experienced re-breaks. The timing of the periods of 
disease recurrence is variable. The study reports the 
establishment of PED control through management of 
gilts.  
Materials and Methods 
Herd selection and history: Four farrow-to-finish 
PRRSV positive herds designated herds S, N, R and M 
with inventory of 1,200 – 2,700 sows and no history of 
PED vaccine used were selected for PED control using 
this procedure. Herds S and N are located in the highest 
pigs proximity of Thailand in contrast to herds R and M. 
All 4 herds had history of epidemic PED outbreaks. 
Herds S and N experienced the epidemic outbreak in 
January 2008 while herds R and M broke with PED in 
January 2009. Farrowing and nursery facilities of all 
herds operate all-in/all-out by building on weekly basic. 
Parity segregation system has been implemented in all 
herds for the purpose of PED and PRRSV control. 
Following outbreaks, PED control in all herds was 
through mass exposure of sow herds and replacement 
gilts with minced intestine of affected piglets. The 
episodes of outbreak were last for 3 – 4 weeks of 
production. To prevent the PED re-occurrence, gilts 
acclimatization with minced piglet intestine and strict 
biosecurity of gilts isolation and acclimatization were 
implemented.   
Intestinal feedback: Following the outbreak, pig intestine 
with lesions suggesting PED was collected from pigs and 
assayed for the presence of PEDV by PCR. PEDV was 
isolated and grown on cell culture. The virus stock was 
detected for any pathogen contamination prior to piglet 
administration and used to orally inoculate the piglets in 
isolation facilities. The process was done once and then 
the piglet intestines were used to re-infect the piglets to 
make the next batch. 
Sources of replacement gilts, and isolation and 
acclimatization facilities: Replacement gilts of herds R 
and M are internally produced. Herds S and N introduce 
external gilt replacement from negative PED positive 
herds, respectively. The isolation and acclimatization 
facilities are located at least 150 meters from all 
production facilities. Replacement gilts were orally 
administered with minced piglet intestine at least 8 
weeks prior to introduction to the P1 units. Sentinel 
program and strict biosecurity were implement to assure 
the shedding status of gilts prior to introduction and 
prevent personal movement.       
Results and Conclusion 
Sentinel pigs commingled with gilts at 4 weeks post 
intestine administration displayed clinical disease 
associated with PED in contrast to sentinel pigs 
introduced at 6 and 8 weeks that featured no clinical 
signs.  
Herds S and N have never experienced the re-occurrence 
of PED since the implementation of the control methods. 
Herd M, however, experienced the re-occurrence in the 
P1 unit in January 2011. The source of the outbreak was 
unable to determine. Herd R experienced 2 episodes of 
the disease re-occurrence in one multi-parous and the P1 
unit, a month apart. The sources of the reoccurrence were 
from premature introduction of replacement gilts into 
both units. In conclusion, the results suggests the oral 
administration with piglet intestine and parity 
segregation system can be used in the herd to control 
PED even through herds are located in the highest pig 
density.  
References 
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DETECTION AND TYPING OF INFLUENZA A VIRUS IN PIG FARMS IN CHILE DURING 
2012 
B. Parra1, F. Gonzalez1, D. Fuentes1, J.A. Tobar1
1Departamento de Investigación y Desarrollo Biológico, Laboratorio Virbac-Centrovet Ltda. Santiago, 
Chile.
Introduction
Since 1918, there are reports for the presence of 
influenza A virus in pig populations2. At the 
present, it is described that the virus has 
cosmopolitan distribution and subtypes most 
frequently detected in pigs are H1N1, H1N2 and 
H3N23, however the background of the situation 
in Latin America has not published in deep. The 
primary objective of this study was to detect the 
virus in nasal swab samples from pigs, and 
therefore to generate the first report of detection 
and subtyping of influenza A in swine farms in 
Chile.
Materials and Methods 
During 2012, 635 nasal swabs samples were 
obtained from pigs ranging 3 to 10 weeks of age, 
which showed clinical signs of respiratory disease 
such as coughing, sneezing and nasal discharge. 
All samples were taken under field conditions and 
involved about 42% of the country's commercial 
farms. Once obtained, the nasal swabs were 
transported in cooled (4°C) nutrient medium to 
the laboratory. Later, each sample was inoculated 
into MDCK cell culture, and those which shown 
cytopathic effect were analyzed by RT-PCR 
looking for swine influenza virus subtypes, using 
specific primers for H1/H3 or N1/N21.
Results
In all farms analyzed was possible to detect the 
presence of genetic material consistent with type 
A influenza virus. The most common subtype 
detected corresponded to H1N2 with over 60% of 
samples. However, also was possible to detect 
subtypes H1N1, H3N2 and H3N1 (Table 1). 
Table 1. Detection of influenza virus subtypes 
from nasal swabs from pigs during 2012 in 
commercial farms in Chile. 
Subtypes of virus 
influenza  
Percentage detected 
during the 2012 
H1N1 11% 
H1N2 63% 
H3N2 19% 
H3N1 7% 
Conclusions and Discussion 
The results obtained in this study confirmed the 
presence of influenza virus in pigs which showed 
signs of respiratory disease in Chile, whose as far 
as we known to constitute the first report of the 
influenza virus subtypes circulating in pig farms 
in our country. In this way, in previous reports 
similar percentages were described for H1N2 
subtype in Spanish farms2. Additionally during the 
last years, detections of H1N1, H1N2 and H3N2 
subtypes were made in Brazil and Argentina, 
however the analysis performed in those countries 
indicate that these subtypes genetically differ from 
those present in North America3, so it’s probable 
that influenza viruses detected in Chile also differ 
from circulating in other countries, however 
further studies are needed to corroborate it. 
References
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2. Torremorell et al., 2012. Transbound 
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DETECTION OF PORCINE EPIDEMIC DIARRHEA VIRUS IN AIR SAMPLES AT VARYING 
DISTANCES TO EPIDEMIC FARMS IN OKLAHOMA 
D Goede1, R Robbins2, L Dufresne2, M Engle3, RB Morrison1
1 University of Minnesota Veterinary Population Medicine, St Paul, MN, US 
2 Seaboard Farms Inc., Guymon, OK, US 
3 Pig Improvement Company, Hendersonville, TN, US 
 
Introduction
Porcine Epidemic Diarrhea (PED) was first 
detected in the United States in 2013. The 
disease is financially devastating for a farm due 
to high preweaning mortality.3 A cluster of 
farms in the Oklahoma panhandle were all 
infected within such a short period of time and 
with no common sources that aerosol spread was 
suspected. Coronaviruses similar to PEDv are 
known to be relatively stable in arid conditions1
that may also increase potential for aerosol 
spread at long distances.4  There is a need to 
determine if PEDv can be detected in air 
samples. 
Materials and Methods 
Air collection was performed with a high-
volume air sampler (Midwest Micro-Tek, 
Brookings, SD, USA). It was run for 30 minutes 
starting with 11 ml of transport media (MEM, 
anti-anti, BSA, trypsin, & gentamycin) in the 
reservoir at each sampling location. Air was 
sampled at varying distances from farms 
experiencing a PED outbreak. The remaining 
transport media was poured off into a 15 ml 
Falcon tube and kept on dry ice until submission 
to the U of MN VDL for PED PCR. Post-
sampling residue was rinsed off with distilled 
water. Disinfection was with a 70% ethanol or 
10% chlorine solution liberally sprayed on every 
surface and within the reservoir of the collectors 
and equipment was allowed to sit for >30 
minutes between samples. Prior to sampling 
again, disinfectant residue was rinsed off with 
distilled water and dried with paper towel. The 
collector reservoir and spinning mechanism was 
then sampled with a sterile swab (liquid Stuart 
media) and submitted for PED PCR. 
Consecutive samples were taken down wind of 
the infected farms starting furthest away.2
ResultsPED PCR-positive air samples were 
detected outside of multiple mechanically-
ventilated sow units and naturally-ventilated 
finishing units. Distances of 60 ft, 300 ft, ¼ 
mile, ½ mile, 1 mile, 2 miles, 3 miles, 5 miles, 
10 miles, and 15 miles downwind of known 
positive farms were sampled yielding 64 
samples in total with 11 positives. Positive 
samples were found at 60 ft (3/6), ½ mile (1/5), 
1 mile (3/13), 3 miles (3/7), and 10 miles (1/3). 
Average CT values of positive S Gene PCR 
results positively correlated with distance 
sampled from the farm r=0.7892 (33.025 at 60 
ft, 39.71 at 1 mile, and 38.72 at 10 miles).  
Conclusions and Discussion 
These results have confirmed that PEDv can 
be detected in the air as much as 10 miles from a 
herd. The analysis of CT value versus distance 
indicates a higher concentration of viral RNA in 
the air closer to the farm. This preliminary study 
was not extensive enough to fully characterize 
risk factors of aerosol spread of PED virus. 
Preliminary results did not show live virus as 
testing was performed with PCR. 
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DEVELOPMENT AND VALIDATION OF ELISA TESTING FOR SEROLOGICAL 
MONITORING AND SURVEILLANCE OF PORCINE EPIDEMIC DIARRHEA VIRUS 
B. Wier, C.M.T. Dvorak, and M.P. Murtaugh 
Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN, USA 
Introduction
Porcine epidemic diarrhea virus (PEDv), a 
member of the Coronaviridae family, causes 
acute outbreaks of severe diarrhea and vomiting 
in suckling and growing pigs, leading to 
significant mortality.  PEDv was first observed 
in Europe in 1971 and became endemic in Asia 
by 1982. Its emergence in the United States was 
first confirmed in May 2013 and has been 
identified in 15 states as of mid-July. Due to this 
emergence, the US swine industry has an 
immediate need for rapid, high-throughput 
diagnostic tests for serological monitoring and 
surveillance of PEDv. To that end, we have 
created a PEDv ELISA assay to detect the 
presence of antibodies to PEDv in swine serum. 
Materials and Methods 
PCR primers were designed to amplify 
nucleocapsid (N) and spike protein domains 1 
(S1) and 2 (S2). PEDv RNA was extracted from 
infected pig feces, generously provided by D. 
Marthaler, MN Veterinary Diagnostic 
Laboratory, cDNA was synthesized, and PCR-
amplified. The PCR products were cloned into 
two plasmid vectors, pET-25b and pMAL-p5X, 
and gene sequences were confirmed by 
sequencing. Recombinant plasmids were then 
transformed into E. coli Rosetta cells for 
induction of protein expression. Expressed 
proteins were purified using a 6-his tag and 
immobilized metal affinity chromatography 
(pET-25b), or maltose binding protein fusion 
and amylose affinity chromatography (pMAL-
p5x). Purity and concentration of the recovered 
proteins was confirmed by gel electrophoresis 
and spectrophotometry. Purified proteins were 
then used for the development of a direct ELISA 
for the detection of anti-PEDV antibodies. 
Results 
Multiple US PEDv isolates were sequenced and 
found to be >99% similar, thus recombinant 
proteins from any isolate should be 
representative of US PEDv isolates. In an 
ELISA assay all isolates will be expected to 
cross-react due to the high sequence similarity. 
PEDv nucleocapsid (N) and spike protein 
domains 1 (S1) and 2 (S2) amplification was 
achieved from pig fecal samples. Cloning 
success was variable using the Gibson strategy 
and standard ligation methods. Protein 
expression is underway at the time of abstract 
preparation and results will be presented at the 
conference. 
Conclusions and Discussion 
Nucleocapsid and spike proteins in 
coronaviruses are highly immunogenic and have 
been used previously for screening pig serum for 
serological evidence of exposure and previous 
infection by coronaviruses, including PEDv. The 
S1 domain of PEDv spike protein contains the 
neutralization epitope. Thus, this recombinant 
protein might be useful for evaluation of 
neutralization and cross-neutralization activity. 
ELISA development will facilitate screening and 
monitoring of PEDv status of US swine herds 
and are expected to facilitate control and 
eradication of PEDv.  
Acknowledgements 
Student support provided by the University of 
Minnesota Swine Disease Eradication Center. 
Research support provided by the National Pork 
Board.
214 2013 Allen D. Leman Swine Conference
A
bs
tr
ac
ts
A
bstracts
DYNAMICS OF INFLUENZA A VIRUS IN AEROSOLS FROM SWINE FARMS. 
V Neira-Ramirez1, M Torremorell1, P Rabinowitz2, B Paccha2, S Gibbs3,
1 Swine Disease Eradication Center, College of Veterinary Medicine, University of Minnesota, 
St. Paul, MN; 2Occupational and Environmental Medicine Program, Yale School of Medicine, 
New Haven, CT . 3Department of Environmental, Agricultural & Occupational Health, 
University of Nebraska Medical Center, Omaha, Ne. 
Introduction 
Influenza A virus (IAV) causes lethargy, 
sneezing and coughing in pigs; however, 
subclinical infection might have occurred. 
The virus is transmitted mainly by direct 
contact and aerosols1. IAV has been detected 
and isolated in air samples from 
experimentally infected pigs with and without 
immunity2. IAV has also been identified in 
aerosols under field conditions; however, the 
duration of IAV bioaerosols over time has not 
been reported. 
The main objective of this study is to 
characterize the presence of IAV aerosols 
from swine commercial facilities during 
influenza outbreaks over time. An additional 
objective is to estimate the relationship 
between severity of clinical signs and 
detection of IAV in aerosols. 
Material and Methods 
Five swine herds experiencing acute 
influenza like clinical signs were identified 
based on local veterinarian communication. 
Upon confirmation of IAV infection by 
diagnostics, each herd was visited every 3 to 
7 days until the virus could not be detected in 
oral fluids testing. During the first visit, 2 
pens of pigs were conveniently selected and 
evaluated in the follow up visits. At each 
visit, one oral fluid and one air sample were 
collected in each pen, and 2 upwind and 2 
downwind air samples were collected at 
approximately 50m from the barn. Cyclonic 
collectors were used to collect the air 
samples1 (Midwest MicroTek). IAV RT-PCR 
was performed on all samples, and virus 
isolation was attempted in positive and 
suspect samples. Clinical measures of swine 
health including coughing and sneezing 
scores were recording during each visit3.
Farms were visited between day 0 and day 42 
after the reported onset of clinical signs in the 
herd.
Results and Discussion 
Sampling took place between October 2012 
and May 2013. Overall 35 farm visits were  
conducted. In 33 out of 35 visits, IAV was 
detected in at least one sample. Thirty three 
(47%) air samples collected inside the barns 
were positive for IAV by PCR and 8 (11%) 
were suspect. In 22 visits (63%) IAV RNA 
was detected in at least one air sample and 
IAV was detected in all the farms of the 
study. 
All upwind and downwind samples were 
negative, except in one sample where IAV 
RNA was detected downwind. 
Among 59 oral fluid samples, 49 (70%) were 
positive for IAV and 10 (14%) were suspect. 
There was a positive association between 
detection of IAV in air samples and oral 
fluids.  
IAV was generally detected in the air for 10 
to 13 days following the reported onset of 
clinical signs in pigs, except for one herd, 
where IAV was only detected during the first 
visit. In two herds, air samples tested 
negative 16 days after the onset of clinical 
signs but tested positive again at 22 days. At 
one farm, IAV was detected at 42 days from 
the onset of signs. Further testing is needed to 
determine whether the later detection was due 
to the same virus strain detected earlier. IAV 
was isolated from air and oral fluid samples 
in all farms, except for one farm, where IAV 
could not be recovered from the air. 
Preliminary analysis did not show a 
relationship between presence of IAV in 
aerosols and severity of clinical signs in pigs. 
Our results indicate that IAV can be present 
in aerosols in swine production facilities for 
an extended period of time.
References
1 Tellier, R. 2006. Emerg Infect Dis.12:1657-
62.  
2 Corzo C, et al., 2012. Trans and Emerg Dis 
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EVALUATING SAMPLING STRATEGIES TO DIAGNOSE INFLUENZA VIRUS IN PRE-
WEANED PIGS 
C Hill, M Allerson, and M Torremorell 
Swine Disease Eradication Center, College of Veterinary Medicine, University of Minnesota, St. Paul, 
MN 
Introduction: Influenza A virus (IAV) is 
endemic in pigs and despite its widespread 
appearance it may be difficult to diagnose. 
Specifically, IAV is difficult to be reliably 
diagnosed in pre-weaned pigs due to low 
infection prevalence, the short course of clinical 
signs and infection, and variable levels of 
maternal antibodies. Both nasal swabs and 
tissues are used for diagnosis, but it is unclear 
whether one method is superior to the other 
when diagnosing IAV in pre-weaned pigs. The 
objective of this study was to compare two 
sampling strategies, nasal swabs and tissues 
from dead pigs, in their ability to diagnose IAV 
in pre-weaned pigs and consider a farm infected 
with IAV. 
Materials and methods: Two farms in Southern 
Minnesota, known to be IAV positive before the 
study, were selected and monitored over a 4 
week period. In sampling method 1, nasal swabs 
were collected 4 weeks apart from pre-weaned 
pigs at 21 days of age (n=151). In sampling 
method 2, necropsies were performed weekly on 
dead piglets 7 to 21 days of age (n=79); deads 
were due to natural mortality or euthanasia. 
Swabs were collected from the upper respiratory 
tract (nasal cavity) and lower respiratory tract 
(trachea, and main stem bronchi). All samples 
were tested by a real time RT-PCR targeting the 
IAV matrix gene, and positive swabs from RT-
PCR were confirmed positive using virus 
isolation (n=11).  Statistical analyses compared 
two proportions, i.e. proportions of positive pigs 
from sampling methods 1 and 2, using Microsoft 
Office Excel. Results were considered 
statistically significant if p-values were < 0.05. 
Cohen’s kappa coefficient for statistical 
agreement was also calculated between the nasal 
and tissue swabs from dead piglets. 
Results: IAV prevalence was 8.9% (7/79) and 
13.9% (21/151) based on samples from dead or 
live pigs, respectively (p=0.27). Seven nasal 
swabs and 4 lung swabs tested RT-PCR positive 
from samples within a dead pig, and 5 of these 
swabs were positive for IAV using virus 
isolation. There were no statistically significant 
differences between the following parameters: 
nasal to tissue swabs from dead piglets (p=0.35), 
farm 1 to farm 2 (p=0.74), and swabs from live 
piglets to dead piglets (p=0.27). There was 
substantial within-pig agreement between using 
nasal swabs and lung swabs from dead piglets 
(Cohen’s κ = 70.7). Discordant results were 
obtained when comparing nasal swabs from live 
pigs and swabs from dead pigs, due to positive 
swabs from live piglets and negative swabs from 
dead piglets during the same sampling event. 
Weekly detection of IAV throughout the study 
was irregular, which may illustrate the 
intermittent shedding pattern of IAV in infected 
herds. 
Discussion: Detecting IAV in pre-weaned pigs 
can be frustrating. In this study, prevalence 
levels were higher in samples collected from live 
pigs compared to natural mortality. In this study, 
live pigs were older than the naturally occurring 
dead pigs, which may explain why tissue swabs 
did not offer an advantage over nasal swabs 
from live pigs. Overall, this study showed the 
difficulty of diagnosing IAV in pre-weaned pigs 
due to low prevalence levels. In conclusion, 
ongoing diagnostic submissions are necessary in 
order to characterize IAV infections in breeding 
herds. 
Acknowledgements: Swine Disease Eradication 
Center, Holden Farms Inc., and Shetek Farms. 
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IDENTIFICATION, GENETIC DIVERISTY, AND CLASSIFICATION OF PORCINE 
ROTAVIRUS C 
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Matthijnssens3 
 
1 University of Minnesota Veterinary Diagnostic Laboratory, Saint Paul, Minnesota 
2Clinical Research and Development, Novartis Vaccines & Diagnostics, Inc., Cambridge, Massachusetts 
3Laboratory for Clinical and Epidemiological Virology, Department of Microbiology and Immunology, 
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Introduction
Rotaviruses (RVs) possess a 
genome composed of 11 dsRNA segments 
and are classified into eight species (RVA-
RVH). RVA, RVB, RVC, and RVH have 
been detected in both humans and pigs. 
While swine rotavirus C (RVC) was 
identified in 1980’s, more recently, RVC has 
been identified as a major cause of 
gastroenteritis in swine, causing clinical 
disease subclinical infections.  The objective 
of this study was to identify RVC in porcine 
tissues and investigate the genetic diversity 
of the VP7 gene segment.  
 
Material and Methods 
 Porcine samples (n=7,520) were 
submitted to the University of Minnesota 
Veterinary Diagnostic Laboratory between 
December 2009 and October 2011 from 
United States and Canadian swineherds and 
were screened for RVA, RVB, and RVC by 
RT-PCR.  Additionally, lung tissues with 
histological lesions, but negative for 
common porcine respiratory pathogens were 
also screened for RVA, RVB, and RVC by 
RT-PCR. From conveniently selected RVC 
positive samples, the VP7 gene segment was 
sequenced using Sanger technology.  
Phylogenetic analysis was calculated using 
the Kimura 2-parameter correction at the 
nucleotide level while phylogenetic trees 
were constructed utilizing the Neighbor-
joining. 
 
Results 
RVC was detected in 3,447 samples 
(46%) tested.  These porcine intestinal 
tissues samples also had RV-like lesions 
including villus blunting and fusion, 
atrophy, and necrosis. From the 3,447 
positive RVC samples, 1156 samples were 
negative for RVA and RVB, with the 
majority (78%) of single RVC infections in 
the ≤3 day old piglets. A high prevalence of 
RVA (50%), followed by RVC (10%) and 
RVB (5%) was detected in 635 porcine lung 
tissues.  The RVC VP7 gene segment was 
sequenced from 65 samples, yielding 70 
sequences.  An 85% nucleotide percent 
identity cut-off value based on pairwise 
identity frequency graphs was proposed, 
dividing the phylogenetic tree into 9 G 
genotypes.   
 
Conclusion and Discussion 
While RVC is an important cause of 
diarrhea in all swine age groups, piglets (≤3 
and 4-20day age groups) contained the 
highest percentage of single RVC infections. 
RVC’s viremia capability and subsequently 
pneumonia needs further investigating.  
Additionally, 9 VP7 G-genotypes were 
proposed based on an 85% nucleotide 
percent identity cut-off value.  
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IN VITRO PROPAGATION OF U.S. STRAINS OF PORCINE KOBUVIRUS 
Harsha Verma, Sunil K. Mor, Jonhathan Erber, Sagar M. Goyal 
Department of Veterinary Population Medicine, University of Minnesota,  
1333 Gortner Avenue, St. Paul, MN 55108. 
 
 
 
Introduction
Enteric disease is an important cause of morbidity 
and mortality among domestic pigs. The porcine 
kobuvirus was first identified in Hungary in 2007. 
Since then, the virus has been reported from both 
healthy and diarrheic pigs in Hungary, China, 
Thailand, Japan, Korea, and USA (Reuter et al., 
2011; Verma et al., 2013). The cultivation of 
porcine kobuvirus in vitro has not been yet 
reported.  The aim of this study was to determine if 
porcine kobuvirus can be grown in vitro using three 
different cell types.  Another objective was to 
develop a serum neutralization test for detecting 
antibodies against this virus in infected pigs. 
Material and Methods 
In a previous study, porcine kobuvirus was detected 
by RT-PCR in intestinal contents from diarrheic 
piglets submitted to the Minnesota Veterinary 
Diagnostic Laboratory (MVDL) from 15 different 
states. The virus was also found in apparently 
healthy pigs from Minnesota. In the current study,  
four samples from healthy pigs and six from 
diseased pigs (that were positive for porcine 
kobuvirus by RT-PCR) were grown in three 
different cell lines e.g., PK-15 (porcine kidney), 
porcine alveolar macrophages (PAM), and Vero 
(African green monkey kidney) cells.  
Results and Discussion 
Porcine kobuvirus was successfully isolated from 
five samples using PK-15 cells. Two samples were 
from apparently healthy pigs and three from 
diarrheic pigs.  The presence of virus was 
confirmed by RT-PCR and electron microscopy. 
Using the newly isolated virus, we developed a 
serum neutralization test to detect antibody against 
porcine kobuvirus. This study shows that PK-15 
cells are most susceptible for the propagation of 
porcine kobuvirus. The newly developed serum 
neutralization should be helpful in conducting 
seroprevalence studies in swine. 
References 
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MODELING INFLUENZA DYNAMICS IN SWINE HERDS 
Reynolds JJH, Torremorell M, Allerson M and Craft ME 
Department of Veterinary Population Medicine, University of Minnesota 
St Paul, USA
Introduction                                                  
Influenza virus infections are widespread in swine 
herds across the world. This negatively affects swine 
health and production, and represents a significant 
threat to public health due to the risk of zoonotic 
infections, with swine herds acting as reservoirs for 
potentially pandemic strains. By using mathematical 
modeling based on empirical data, we aim to analyze 
the dynamics of influenza in swine farms, and to 
compare the efficiency of different vaccination 
strategies.
Materials and Methods 
We have constructed a metapopulation model of a 
typical Midwestern swine breeding farm, 
incorporating realistic demographic and transmission 
parameters. Numbers of Susceptible, Exposed, 
Infectious and Recovered animals are tracked 
through time using a SEIR model framework. 
Empirical studies1,2 were used to inform and 
parameterize the model.   
To make this model representative of a breeding 
farm, we defined separate SEIR equations for each
class of swine (e.g. gilts, sows and piglets) in each 
location on the farm (e.g. gilt development units, 
farrowing rooms and gestation areas). The model 
incorporates movement between these at appropriate 
times and frequencies. 
Results
Our model predicts the impact and duration of 
influenza outbreaks in a breeding farm (see figure). 
We used this model to compare the effectiveness of 
different vaccination strategies that are currently 
employed. We tested (i) mass vaccination of sows 
and (ii) 3-5 week pre-farrow vaccination (targeting 
piglet immunity), each with either a heterologous or 
homologous vaccine. 
Figure: Influenza dynamics in a swine breeding 
farm, resulting from one infected gilt entering into a 
naïve population, with no vaccination. 
We find that vaccination delays the onset of an 
influenza outbreak. Both regimes with heterologous 
vaccines have little effect on the magnitude of an 
outbreak, whereas homologous vaccines significantly 
reduce this. Homologous mass vaccination prevents 
the spread of influenza in sows, but not in piglets. 
Homologous pre-farrow vaccination reduces the 
number of infectious sows and gilts at the infection 
peak, yet results in more infectious individuals after 
the initial outbreak. 
Conclusions and Discussion 
Our results highlight the need for an understanding of 
the effects of intervention strategies such as 
vaccination on the dynamics of influenza at the herd 
level. Our findings also raise an important question: 
is (a) a high level of infection over a short time, or (b) 
a moderate level of persistent infection, of the most 
concern?
Acknowledgements: This material is based upon 
work supported by the Cooperative State Research 
Service, U.S. Department of Agriculture, under 
Project No. MINV 62-042.  
References:  1. Allerson M et al.: 2013, Vaccine
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2. Romagosa A et al.: 2011, Vet 
Res 42: 120-13
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CROSS-PROTECTION OF FLUSURE® XP IN PIGS CHALLENGED WITH A GAMMA 
CLUSTER H1N1/pH1N1 REASSORTANT SWINE INFLUENZA VIRUS 
VJ Rapp-Gabrielson1, MC Lenz1, M Kuhn2, LP Taylor1, MR Culhane 3, L Kesl4, R Saltzman4 
1VMRD, Zoetis, Kalamazoo, MI; 2 Pork Technical Services, Zoetis, Cascade, IA; 3University of Minnesota 
Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Saint Paul, MN; 
4Veterinary Resources Inc., Ames, IA 
Introduction
Characterization of swine influenza virus (SIV) 
from the US since the introduction of pH1N1 
influenza virus has demonstrated multiple 
reassortant events between pH1N1 and endemic 
SIV, resulting in H1 and H3 variant viruses with 
internal genes from pH1N1, most notably the 
pH1N1 M gene that was of Eurasian swine 
origin.1,2,3  The objective of this study was to 
evaluate the efficacy of a Swine Influenza Vaccine, 
Killed Virus, H1N1, H1N2 & H3N2 (FluSure® XP) 
in pigs challenged with a heterologous 
contemporary field isolate that is a reassortant 
between SIV H1N1 (gamma-cluster) and pH1N1.4 
 
Materials and Methods 
Forty-five weaned, 3-week-old SIV-negative pigs 
were randomly assigned to treatment using a 
generalized block design. Pigs were vaccinated 
twice, 3 weeks apart, with either an Amphigen® 
placebo (T01, n=20), FluSure XP (T02, n=20), or 
held as non-vaccinated, non-challenged controls 
(NTX, n=5). Pigs were challenged 8 days after re-
vaccination with A/Swine/Minnesota/PAH-618/ 
2012 (H1N1), a gamma-cluster field isolate that 
contains the M gene of pH1N1. Based on amino 
acid similarity the HA gene of the virus is ~ 92.8% 
similar to the FluSure XP gamma vaccine strain. 
Pigs were necropsied 5 days post-challenge. The 
primary variable analyzed was lung lesions at 
necropsy. Virus isolation from nasal swabs and 
bronchial aveolar lavage fluids (BALF), clinical 
observations, rectal temperatures, and HI antibody 
titers were analyzed as secondary variables. The 
level of significance was set at 0.05. This study was 
conducted in accordance with the guidelines of the 
Veterinary Resources Inc. IACUC. 
 
Results 
Vaccinated pigs had significantly lower percentage 
of lung with lesions at necropsy, significantly fewer 
pigs ever with fever, significantly lower virus titers 
in nasal swabs collected on 4 of 5 post-challenge 
days (P≤0.05, data not shown), a significantly lower 
percentage of pigs ever shedding virus, and a 
significantly lower percentage of pigs positive for 
virus isolation from BALF at necropsy (Table 1).  
 
Table 1. Results  
Group % Lung 
Lesions* 
% Pigs Ever Postive 
Fever Nasal 
Shedding 
BALF 
Placebo 12.1% 60% 100% 100% 
FluSure 
XP 
1.1% 10% 20% 0% 
P value 0.0001 0.0050 0.0001 0.0001 
*Back transformed LS Mean. 
Conclusions 
 Under the conditions of this study, pigs 
vaccinated with FluSure XP were protected 
against challenge with a contemporary gamma- 
cluster H1N1/pH1N1 reassortant SIV.  
 It has been previous reported that FluSure XP 
helped to protected pigs challenged with 
A/swine/Ohio/ 02973 /2010, a contemporary 
gamma-cluster H1N1 virus that does not 
contain the pH1N1 M gene.5 
 These studies demonstrated that FluSure XP 
can help protect pigs experimentally challenged 
with contemporary gamma-cluster viruses 
representative of the field isolates currently 
circulating in the US swine population. 
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Introduction
Mycoplasma hyopneumoniae (M. hyo) is the 
main component of PRDC and enzootic 
pneumonia (1). PCV2 is considered the 
necessary factor to trigger PCVAD (2). This 
study describes under field conditions the 
growth performance of animals vaccinated either 
with a mixture of one shot M. hyo and PCV2 
vaccines or with both vaccines applied 
separately. 
Materials and Methods 
The study was performed in a 3 site farm with 
7000 sows under intensive production in the 
Metropolitan Region of Chile. 510 fourteen days 
old piglets were randomly allocated into 3 study 
groups: Group A (n = 30) was injected in the 
neck with 2 ml IM of sterile saline solution. 
Group B (n = 240) was injected with 2 ml of  a 
mixture of 1 mL of an subunitary one shot PCV2 
vaccine and 1 mL of an one shot M.hyo aqueous 
adjuvanted vaccine. Group C (n = 240) was 
vaccinated with the traditional farm protocol, 
injecting 1 mL of the same vaccines separately 
on the right and left side of the neck. Animals 
were monitored during 7 days post injection in 
search of local or systemic adverse reactions. 
The experimental unit was the pig. Individual 
weights were registered after each stage of 
production and estimated average daily gain 
weight (ADGW) was calculated for each study 
group. ANOVA and Tukey post hoc tests were 
utilized to establish statistical significant 
differences among groups. 
Results
No adverse local or systemic reactions were 
documented after vaccination. Figure 1 describes 
the average liveweight in the different treatment 
groups. At 140 days of age there is statistically 
significant difference between the weight of 
group A with groups B and C (P<0.05). 
Similarly ADGW in groups B and C were 
statistically higher than group A during finishing 
and wean to finish intervals (Table 1). 
Figure 1. Average liveweight (kg) of pigs in 
each study group at different production ages. 
Table 1. Average daily gain weight (grams (SD)) 
at different weight intervals in each study group. 
Period Group A Group B Group C 
14-70 days 0.382a
(0.098)
0.376a
(0.095)
0.373ª 
(0.088)
70-140 days 0.849a
(0.157)
0.978b
(0.151)
0.969b
(0.163)
14-140 days 0.617a
(0.107) 
0.683b
(0.101)
0.676b
(0.103)
Conclusions and Discussion 
Under the conditions of this study, one shot 
vaccination against M. hyo and PCV2 improved 
liveweight and ADGW regardless of the 
administration procedure. Vaccinated groups (B 
and C) were similar throughout the study and 
superior to the control non vaccinated group in 
the evaluated parameters (P>0.05). 
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Introduction
Vaccination is a key point of sanitary programs 
in contemporary swine production. In many 
systems vaccine administration is being held by 
needle injection. Over the last decades new 
needleless devices have provided an alternative 
to traditional methods. This study describes 
under field conditions the effect on average daily 
gain weight (ADGW) and feed conversion rate 
(FCR) of needle and needleless injection for 
Mycoplasma hyopneumoniae (M. hyo) and 
PCV2 vaccines. 
Materials and Methods 
The study was performed in a wean to finish 
farm with 1500 sows under intensive production 
in Maule Region of Chile. 420 twenty one days 
old piglets were randomly allocated into 2 study 
groups: Group A (n= 210) was needleless 
injected with 2 ml IM of a mixture of 1 mL of an 
subunitary one shot PCV2 vaccine and 1 mL of 
an one shot M.hyo aqueous adjuvanted vaccine. 
Group B (n= 210) was vaccinated IM by needle 
injection with the same mixture of vaccines. 
Animals were monitored during 7 days post 
injection in search of local or systemic adverse 
reactions. Feed was delivered manually on ad
libitum basis. Consumption was daily monitored 
by registering the amount of feed in kg placed in 
each feeder - 30 pigs capacity – pen. Each pig 
was individually weighted at 21, 70 and 160 
days of age and ADGW between these periods 
was calculated, statistical significant differences 
between groups were assessed by means of 
ANOVA and Student T test. FCR was obtained 
per pen and was statistically analyzed using 
Wilcoxon Test. 
Results 
No adverse local or systemic reactions were 
documented after vaccination. Tables 1 and 2 
describe ADGW and FCR through different 
production periods. There were no statistically 
significant differences (P <0.05) between 
treatments groups in these parameters.  
Table 1. ADGW (g) for both treatment groups in 
different productive periods. 
Groups 21-70 days 70-160 days 21-160 days
A 447,7 g 945,7 g 780,6 g 
B 451,3 g 939,1 g 777,9 g 
Table 2. FCR (kg/kg) for both treatment groups 
in different productive periods. 
Group 21-70 days 70-160 days 21-160 days
A 1,47 2,67 2,44 
B 1,48 2,71 2,45 
Conclusions and Discussion 
In line with existing evidence that sustains the 
efficacy in the use of needle free injection 
devices (1,2,3,4), under the conditions of this 
study, needleless administration of PCV2 and 
M.hyo vaccines was as safe and efficacious as 
the traditional needle injection in terms of ADG 
and FCR performance. 
References 
1. Chuo et al., 2008. 18th IPVS Congress 
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COMPARATIVE EVALUATION OF ONE AND TWO DOSE PCV/
Mycoplasma hyopneumoniae VACCINATION PROTOCOLS IN SWINE CHALLENGED 
WITH PCV AND Mycoplasma hyopneumoniae 
B. Cowlesa,*, L. L. Greinerb, D. Neubergera, G. P. Nitzelc, V. Rapp-Gabrielsonc, M. Smutzerc, D. 
M. Amodiea  
a Zoetis LLC,  Florham Park NJ,  United States b Innovative Swine Solutions, LLC, Carthage IL , 
United States c Zoetis, VMRD, Kalamazoo MI, United States 
Introduction
Vaccination is considered an essential strategy 
for prevention of porcine circovirus associated 
disease (PCVAD) caused by porcine circovirus 
type 2 (PCV2), a swine pathogen present in 
herds worldwide.  The study evaluated the post-
challenge serologic response, viremia, and 
productivity performance in pigs vaccinated 
with various PCV2/Mycoplasma hyopneumoniae 
vaccines.1   
 
Materials and Methods
Healthy pre-weaned pigs were negative by PCR 
for PRRSV and PCV and the herd was 
Mycoplasma hyopneumoniae stable.  Animals 
were randomly assigned to one of five test 
groups: nonvaccinated controls (T1, n = 84), 
vaccination with Respisure One at 3-7 days of 
age and Fostera™ PCV2 at weaning (T2, n = 
86), vaccination with Circumvent PCV M at 
weaning and 3 weeks later (T3, n = 77), 
vaccination with Ingelvac CircoFLEX-
MycoFLEX at weaning (T4, n = 80), 
vaccination with Respisure One at 3-7 days of 
age and Fostera™ PCV2 at weaning and 3 
weeks later (T5, n = 86) and a one bottle 
PCV2/M. hyopneumoniae combination vaccine 
(PCV2/M Hyo combo), one dose at weaning 
(T6, n=85).  All groups were challenged with M.
hyopneumoniae at eight weeks of age and 
PCV2b at ten weeks of age.   
 
Results and Discussion 
Four PCVAD fatalities occurred, all in group 
T1. Compared to groups given a single PCV2 
vaccine dose (T2, T4, and T6), groups given two 
PCV2 vaccine doses (T3 and T5) had 
significantly (p ≤ 0.05) higher least squares 
means (LSM) PCV2 serologic responses and 
significantly (p ≤ 0.05) lower levels of post-
challenge (PC) PCV2b viremia and fecal 
shedding as determined by qPCR assay.  
Nonvaccinated controls (T1) had significantly (p 
≤ 0.00001) higher levels of PCV viremia 
compared to all vaccinated groups, and 100% of 
control pigs tested for fecal shedding was 
PCV2b-positive for up to 80 days following 
PCV2 challenge.  Average daily gain (ADG) on 
Day 146 was significantly greater (P ≤ 0.05) for 
T2, T3, T4 and T6 vaccinated groups compared 
to nonvaccinated controls (≥1.61 lbs vs. 1.56 
lbs), but ADG among the vaccinated groups was 
not significantly different. (Table 1) 
     This dual-challenge study demonstrated that 
a 1- or 2-dose regimen of Fostera PCV and the 
PCV2/M. Hyo combination vaccine effectively 
helped control PCVAD and helped reduce PCV2 
viremia and fecal shedding, which helped 
vaccinated pigs sustain favorable growth 
performance. No differences (P > 0.05) in 
viremia, shedding, or ADG outcomes were 
detected between the Fostera PCV regiments, 
PCV2/M. Hyo combination vaccine and 
competitor vaccines/regimens. In addition, the 
M. hyopneumoniae challenge infection was 
successfully controlled by early vaccination with 
RespiSure-ONE.  Fostera PCV (one or two 
dose) and a one dose PCV2/M. Hyo combination 
vaccine represents an effective and versatile 
vaccines that helps provide excellent control of 
PCV2 viremia, which is a critical feature for 
helping reduce fecal shedding (exposure risk for 
other pigs) and for helping sustain profitable 
growth performance. 
1. Data on file, Study Report No 
12ORBIOPORK01, Zoetis Inc. 
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EFFICACY AND SAFETY OF A ONE DOSE ONE BOTTLE PORCINE 
CIRCOVIRUS/MYCOPLASMA HYOPNEUMONIAE COMBINATION VACCINE 
DS Fredrickson1, JW Bubolz1, VJ Rapp-Gabrielson1, PL Runnels1, GP Nitzel1, LP Taylor1, JC Johnson1,
SA Zager2
1VMRD, Zoetis, Kalamazoo, MI; 2 VMRD, Zoetis, Lincoln, NE 
Introduction
PCV2 associated disease (PCVAD) and M.
hyopneumoniae (M. hyo) are two of the most 
economically important swine diseases worldwide. 
Three studies were conducted to demonstrate 
efficacy against PCV2 and M. hyo challenges and 
safety in the field of a bivalent product containing 
both cPCV1-2 and M hyo antigen fractions. 
Materials and Methods 
Commercially available pigs were vaccinated 
intramuscularly with 2 mL at approximately three 
weeks of age in all three studies.  Individual PCV2 
and M. hyo efficacy studies were designed with four 
treatment groups each and a control group 
containing the monovalent version of the non-test 
fraction and tested against their respective challenge 
pathogens at approximately six weeks of age.  For 
purposes of this presentation, only one treatment 
and the control group are shown.  The primary 
variable for PCV2 efficacy was viremia and 
secondary variables were serology, shedding and 
lymphoid lesions and colonization.  The primary 
variable for M. hyo was lung lesions and the 
secondary variable was serology.  A field safety 
study was conducted at three separate commercial 
farms.   A total of 632 animals were vaccinated 
with two different vaccine lots and an additional 
158 pigs were vaccinated with sterile saline as 
controls.   All pigs were observed for injection site 
reactions and adverse clinical reactions at weekly 
intervals following vaccination for three weeks and 
then returned to herd.  These studies were 
conducted in accordance with the guidelines of 
Zoetis’ IACUC or Ethical Review Board.   
Results 
In the PCV2 efficacy study, PCV2 vaccinated pigs 
compared to control pigs had a significant reduction  
in the percent of PCV2 ever viremic pigs 
(P<0.0001; Table 1), significantly lower PCV2 
DNA copies/mL in the serum (P<0.0001), 
significantly higher PCV2 antibody titers post-
challenge (P<0.0001), as well as significant 
reductions in the percent of pigs shedding PCV2 
(P=0.0002), the number of PCV2 DNA copies/mL 
in the feces (P<0.0001), the total amount of PCV2 
antigen detected in tissues (P<0.0003), and 
lymphoid depletion (P<0.0053). In the M. hyo
efficacy study, M. hyo vaccinated pigs had 
significantly lower percentage of lung with lesions 
at necropsy (P<0.0001; Table 2), and significantly 
higher M. hyo antibody titers post-challenge 
(P<0.0001).  In the field safety study, 7 pigs out of 
632 (0.01%) were observed with mild injection site 
reactions a day after administration, which all 
resolved within three days.  There were no adverse 
events related to the vaccines.
Table 1. PCV2 Viremia 
Group  N 
Percent Ever 
Viremia 
Positive 
P‐value vs 
T01 
T01 24 95.8 
T02 24 8.3 <0.0001 
Table 2. M. hyo Percent Lung with Lesion 
Group  N 
Percent Lung 
Lesions* 
P‐value vs 
T01 
T01 30 7.01 
T02 30 1.66 <0.0001 
*Back transformed LS Mean. 
Conclusions 
These studies demonstrated that this one bottle 
PCV2/M. hyo combination vaccine is safe and 
efficacious against PCV2 and M. hyo experimental 
challenges when administered intramuscularly as a 
single 2 mL dose.  
References 
Data on file, Study Report Nos. B822R-US-12-046, 
B823R-US-13-136, and B921R-US-12-009, Zoetis 
Inc.
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EFFICACY AND SAFETY OF A TWO DOSE ONE BOTTLE PORCINE 
CIRCOVIRUS/Mycoplasma hyopneumoniae COMBINATION VACCINE 
JW Bubolz1, DS Fredrickson1, VJ Rapp-Gabrielson1, PL Runnels1, GP Nitzel1, LP Taylor1, JC Johnson1, 
SA Zager2  
 
1VMRD, Zoetis, Kalamazoo, MI; 2 VMRD, Zoetis, Lincoln, NE 
Introduction
PCV2 associated disease (PCVAD) and M. 
hyopneumoniae (M. hyo) are responsible for 
significant production and economic losses 
worldwide.  Two studies were conducted to 
demonstrate vaccine efficacy against PCV2 and M.
hyo challenges following vaccination with a 
bivalent vaccine containing both cPCV1-2 and M
hyo antigen fractions.  
  
Materials and Methods 
Commercially available pigs were intramuscularly 
vaccinated with 1 mL at approximately three weeks 
of age and again at five weeks of age in the two 
studies.  Individual PCV2 and M. hyo efficacy 
studies were designed with one treatment group 
(T02) and a control group (T01) containing the 
monovalent version of the non-test fraction and 
tested against their respective challenge pathogens 
at approximately six weeks of age. The primary 
variable for PCV2 efficacy was PCV2 viremia and 
secondary variables were serology, fecal shedding 
and lymphoid lesions and colonization.  The 
primary variable for M. hyo was lung lesions and 
the secondary variable was serology.  These studies 
were conducted in accordance with the guidelines 
of the Zoetis IACUC. 
 
Results 
In the PCV2 efficacy study, all PCV2 vaccinated 
pigs compared to control pigs had a significant 
reduction in the percent of PCV2 ever viremic pigs 
(P<0.0001; Table 1), significantly lower PCV2 
DNA copies/mL in the serum (P=0.0001), 
significantly higher PCV2 antibody titers seven 
days post-second vaccination until necropsy 
(P≤0.0014), as well as significant reductions in the 
percent of pigs shedding PCV2 (P≤0.0061), 
significant reduction in the number of PCV2 DNA 
copies/mL in the feces (P≤0.0001), and significant 
reduction of microscopic lesions (Lymphoid 
Depletion) in lymphoid tissues (P≤0.0235).  In the 
M. hyo efficacy study, all M. hyo vaccinated pigs 
had significantly lower percentage of lungs with 
lesions at necropsy (P<0.0001; Table 2), and 
significantly higher M. hyo antibody titers prior to 
challenge and at necropsy (P≤0.0001).   
 
 
Table 1. PCV2 Viremia 
Group N 
Percent Ever 
Viremic 
P-value vs 
T01 
T01 28 92.9 
T02 29 0 <0.0001 
 
 Table 2. M. hyo Percent Lung with Lesion 
Group N 
Percent Lung 
Lesions* 
P-value vs 
T01 
T01 31 8.70 
T02 32 1.59 <0.0001 
*Back transformed LS Mean. 
    
Conclusions 
These studies demonstrated that this one bottle 
PCV2/M. hyo combination vaccine is efficacious 
against PCV2 and M. hyo experimental challenges 
when administered intramuscularly in a two – 1 mL 
dose regimen.  
References 
Data on file, Study Report Nos. B822R-US-12-111, 
B822R-US-12-112, Zoetis Inc. 
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ANTIBIOTIC RESISTANCE OF K88+ESCHERICHIA COLI STRAINS  ISOLATED IN 1997 
AND 2012 FROM DIARRHEA IN POST-WEANED PIGS IN BRAZIL 
KL Takeuti1, JPH Sato², MCS Almeida¹, PKV Koerich³, DESN Barcellos1
¹Faculdade de Veterinária, UFRGS, Porto Alegre, Brazil, davidbarcellos@terra.com.br ²Escola de 
Veterinária, UFMG, Belo Horizonte, MG, Brazil ³BRF, Curitiba, PR, Brazil 
Introduction 
E. coli K88 is an important agent of diarrhea in 
post-weaned pigs2. The disease is difficult to 
control due to the capacity of the bacteria to 
develop and disseminate mechanisms of 
resistance to antibiotics used to treat the disease1.
The aim of this work was to compare the 
resistance to 14 antibiotics of E. coli K88 + 
strains from post-weaned piglets with diarrhea 
collected in two periods in southern Brazil. 
Materials and Methods 
Fecal samples were collected in 1997 and in 
2012 from post-weaning piglets with diarrhea in 
two states of southern Brazil. The samples were 
cultured in Blood Agar and Mac Conkey Agar.
After E. coli isolation, the genes for fimbrial 
adhesins (K88, K99, F18 and F41) were studied 
by Multiplex PCR using the NewGene Amp kit. 
Forty three K88 + strains isolated in 1997 and 
119 from 2012 were selected and tested to 14 
antibiotics commonly used in the pig industry, 
using the disk diffusion method. The antibiotic 
sensitivity was determined by the inhibition zone 
diameter and classified as sensitive and resistant 
using CLSI recommendations. 
Results
The results of antibiograms are shown in Table 1. 
Resistance was not found against 8 out of 14 
antibiotics tested to strains collected in 1997. 
Resistance developed to the same antibiotics in 
strains collected in 2012. Five other antibiotics 
presented less than 10% resistance to strains 
collected in 1997, and only AMO presented more 
than 25% resistance.  From strains collected in 
2012, there was a high resistance (>90%) to 
FLO, TET and OXY. This high frequency of 
resistance to OXY and TET was also found in 
other studies¹,3. COL resistance remained stable 
(9.3%-10.1%). The occurrence of COL 
resistance is uncommon2,5 and the disk diffusion 
method is not recommended to detect its 
resistance4. Despite the common usage of CEF5,
there was no resistance in samples of 1997 and 
little resistance was found (1,7%) in strains of 
2012. Other drug that presented less than 25% 
resistance in 2012 were NEO and LIN.  
Table 1. Frequency of resistant strains of E. coli
K88 + collected in 1997 and 2012 
Antibiotic             Year 
    1997         2012     
Ciprofloxacin (CIP) 0%*  65.5% 
Enrofloxacin (ENR) 0% 75.6% 
Norfloxacin (NOR) 0% 58.0% 
Doxycycline (DOX) 0% 83.2% 
Trimethoprim-sulfa (TRI) 0% 86.5% 
Ceftiofur (CEF) 0% 1.7% 
Neomycin (NEO) 0% 23.5% 
Lincospectin (LIN) 0% 10.9%
Oxytetracycline (OXY) 2.3% 96.6% 
Tetracycline (TET) 4.7% 98.3% 
Florfenicol (FLO) 4.7% 96.6% 
Ampicillin (AMP) 9.3% 58.8% 
Colistin (COL) 9.3% 10.1% 
Amoxicillin (AMO) 27.9% 59.7% 
* % of resistant strains 
Conclusions and Discussion 
All tested E. coli strains presented increase  in 
resistance between the two tested periods. Five 
antibiotics with no resistance in 1997 presented 
in 2012 high percentage of resistant strains 
(>57%) and three had resistance below 24%. 
Three antibiotics presented very high level of 
resistance (>90%, OXY, TET, FLO), all were 
widely used in the farms of origin of the strains. 
The most effective antibiotic was CEF, with only 
1.7% resistant strains in 2012. The results show a 
significant increase in resistance to all tested 
products with time and suggest a need for 
alternative measures for disease control and a 
prudent use of antibiotics in pig industry. 
References
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PRE-INOCULATION FECAL MICROBIOTA OF PIGS WITH DIFFERENT 
CLINICAL OUTCOMES FOLLOWING CHALLENE WITH Brachyspira hampsonii CLADE 
II (STRAIN 30446) 
Costa, M.O.1, Chaban, B.1, Harding, J. C. S.2, Hill, J. E.1
Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan. Department 
of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan. 
Introduction and objective 
Brachyspira species can cause colitis and diarrhea 
in grow-finish pigs, resulting in economic losses 
worldwide. Recently, a novel species 
provisionally designated “Brachyspira 
hampsonii" has been found to cause 
mucohaemorrhagic diarrhea in pigs1. During herd 
outbreaks, a proportion of pigs remain unaffected 
despite likely exposure. Similarly, in a recent 
inoculation trial with "B. hampsonii" clade II 
strain 30446, the pathogen was detected by 
culture and/or species-specific qPCR in 12/12 
inoculated pigs following inoculation, although 
mucohaemorrhagic diarrhea was observed in only 
8/12 inoculated pigs1. This prompted us to 
investigate why some animals do not develop 
diarrhea. 
In this study we characterized and compared the 
pre-inoculation fecal microbiota of pigs that did 
or did not develop mucohaemorrhagic diarrhea 
following inoculation with "B. hampsonii" clade 
II to determine if host intestinal microbiota 
composition might be a contributing factor to 
susceptibility.  
Material and methods 
Pigs (n=12) were obtained from a commercial 
facility and housed at the Animal Care Unit 
(University of Saskatchewan). During an 
acclimation period of 8 days, fecal samples were 
collected from all pigs 8, 5, 3 and 0 days pre-
inoculation. Total DNA was extracted from feces 
using a commercial kit. The total bacterial 
population was estimated using a qPCR targeting 
the bacterial 16S rRNA gene. For microbiome 
profiling, samples (n=47) were used as template 
for a PCR protocol targeting the universal cpn60
gene, and purified PCR products were subjected 
to pyrosequencing. Resulting data was analyzed 
using the mPUMA bioinformatics pipeline3.
Results and discussion 
Out of the 12 pigs inoculated with pure cultures 
of “B. hampsonii” clade II, 8 broke with 
mucohaemorrhagic diarrhea (MH) and 4 did not 
(Non-MH)2 following inoculation with 108
genome equivalents on three consecutive days. 
Over 600,000 high-quality sequence reads were 
obtained from the cpn60 amplicon libraries, with 
a mean length of 451 bp and an average of 40.000 
reads per sample. cpn60 sequences were 
assembled into operational taxonomic units 
(OTU) and sequences were compared to the 
cpnDB reference database for identification. Fecal 
microbiomes of non-MH and MH pigs were 
dominated by Bacteroidetes, followed by 
Firmicutes, Proteobacteria, Actinobacteria and 
other phyla. The proportion of Proteobacteria was 
significantly different (p<0.05) between groups at 
8 days pre-inoculation, with pigs in the Non-MH 
group having higher counts. However, this 
difference was not observed on subsequent days. 
There were no statistical differences observed in 
richness and diversity measurements (Chao1, 
Shannon index, Simpson's reciprocal index) 
between the MH and non-MH groups.  
Interestingly, a sequence similar to Flavonifractor 
plautii was detected only in MH pigs on day 0 
(6/8 MH, 0/4 non-MH). Whether the significant 
difference in the abundance of this anaerobic 
species is indicative of a general difference 
between the groups remains to be investigated.  
No statistical differences were observed between 
groups in terms of total bacterial population 
estimated by 16S rRNA gene copies at 8, 5 or 3 
days pre-inoculation. However, on day 0, a 
significant difference was observed (p<0.05). The 
mean for Non-MH pigs was 9.7x1010 16S rRNA 
copies, while the mean for MH was 2.82x1011 
copies.  
This study including a small number of samples 
identified some interesting differences in the fecal 
microbiota of MH and non-MH-groups that 
warrant further investigation. Identification of 
susceptibility factors in the intestinal microbiota 
could lead to novel strategies for Brachyspira 
disease reduction through manipulation of the 
intestinal microbial community.
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THE EVALUATION OF MOLECULAR EPIDEMIOLOGICAL RELATEDNESS 
WITHIN ST5 Staphylococcus aureus ISOLATED FROM SWINE VETERINARIANS IN 
THE USA.  
J Sun, L Linhares, M Yang, S Sreevatsan, P Davies* 
Department of Veterinary Population Medicine, University of Minnesota, Saint Paul, MN, USA 
The livestock associated Staphylococcus 
aureus (LA-MRSA) ST 398 has been 
isolated frequently from livestock, 
especially pigs, worldwide since first 
detected from pigs and pig farmers in the 
Netherland in 20051. Subsequent studies are 
revealed greater genetic diversity in LA-
MRSA using molecular epidemiologic 
characteristics. Several studies reported that 
ST9 isolates are predominate among MRSA 
isolates from pigs in Asian countries, while 
both ST398 and ST5 lineages have been 
found in pigs and livestock workers in North 
America3,4. Unlike ST398, which is rarely 
involved in significant human infections, the 
occurrence of ST5sequence type in pig 
industry is of some public health concern as 
this ST5 lineage has long been associated 
with human MRSA infections related the 
USA100 group (defined by sma1 PFGE)2,5.
In a pilot study of pig farms in Minnesota, 
the predominant spa types found were t034 
(ST398), and t002 (ST5), comprising 37% 
and 29% of isolates respectively (all MSSA). 
The aim of this study was to investigate the 
prevalence of ST5 S. aureus nasal swabs in 
US swine veterinarians, and to evaluate the 
diversity of spa type t002 isolates using 
PFGE with SmaI.
Similar to our findings in pigs, the most 
prevalent spa types found in US swine 
veterinarians were t034-ST398 and t002-
ST5. ST9 spa types (t337, t3446, t2498) 
were also common. Sixty (19%) of 308 
MSSA isolates and 6 (19%) of 32 MRSA 
isolates detected were spa type t002 (ST5). 
Other ST5 MSSA spa types found included 
t045 (14), t062 (6), t570 (3) and t2049 (1).  
Sma1 PFGE analysis of 23 isolates indicated 
that t002 isolates from the swine 
veterinarians were not clonal but 
heterogeneous between isolates. Fifteen 
distinct pulsotypes were seen, and eight 
isolates were classified as USA100. Given 
previous reports of t002-ST5 MRSA in 
North American pigs, our findings of 
diverse ST5 spa types as well as genetic 
diversity within spa type t002, provide 
improved understanding of ST5 lineage, 
which may have long association with pigs 
overtime after introduction from human. 
Further investigation of ST5 lineage is 
warranted to better understand their 
potential implications for human health. 
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Figure 1: Average optical density (OD) and the percent 
PCR positive animals for flow A and B.  
A SERIAL STUDY TO DETERMINE PIGLET VACCINATION AGE BASED ON MATERNAL 
ANTIBODY DECAY, TIME OF INFECTION AND POTENTIAL AEROSOLIZATION OF 
Mycoplasma hyorhinis
E Spronk1, BS; D Murray2, DVM; A Sponheim3, DVM; M Clavijo1, DVM; A Rovira1, DVM,MS, PhD 
1University of Minnesota College of Veterinary Medicine , St Paul, USA  2New Fashion Pork, Jackson, 
USA. 3Boehringer Ingelheim Vetmedica Inc, St Joseph, USA 
Introduction
Mycoplasma hyorhinis is a bacterium commonly 
found in the upper respiratory tract of swine. This 
bacterium primarily causes polyserositis and 
arthritis in post weaning pigs.1,2 In addition to 
these lesions, it is considered a common cause of 
condemnations due to lung peel outs at 
slaughter.3 The objectives of the study were (1) to 
determine the age at which M. hyorhinis maternal 
antibodies decay and nasal colonization occurs; 
(2) determine if M. hyorhinis is capable of 
aerosolization.  
Materials and methods  
The sampling was initiated at a 6000 (flow A) 
and a 4000 (flow B) head sow unit. Both herds 
were experiencing polyserositis and lameness 
cases in nursery pigs, where M. hyorhinis was
consistently detected in lesions by PCR. Piglets 
were followed through the nursery stage. Forty 
piglets (1 barrow and 1 gilt/litter) were selected at 
each sow unit from 20 mixed parity sows. Nasal 
swabs and blood samples were collected. The 
sows were sampled at day 0 and piglets were 
sampled weekly starting at day 0 (parturition) for 
10 weeks. Serum samples were tested using a 
research M. hyorhinis ELISA. ELISA testing was 
performed at days 0, 7, 14 then biweekly until the 
end of the nursery stage (Flow A day 70 and 
Flow B day 56). Nasal swabs were tested using 
an M. hyorhinis gel based PCR.  PCR target 
testing dates were determined by the history of 
the flow’s clinical signs. Target testing was 
performed for Flow A at days 0, 7, 14, 28, 63 and 
70 and for flow B at days 0, 7, 14, 21 and 28.. A
cyclonic air collector with Hayflick's media was 
placed outside the exhaust fans during the nursery 
stage once a week for 30 minutes. Samples were 
tested using M. hyorhinis PCR and Mycoplasma 
culture.
Results and Discussion 
The ELISA values of both flows had similar 
decays over time (Figure 1). At day 70, 100% 
(35/35) animals were PCR positive in flow A. In 
flow B, 89% (31/35) were PCR positive at day 
28. Flow A had no positive PCR samples or 
cultures from the air collectors. In flow B, 3/10 
(day 35, 49, 56) aerosol samples were PCR 
positive and 1/10 (day 35) aerosol samples was 
culture positive. This indicates that M. hyorhinis
is capable of aerosolization and is a potential 
form of transmission. The positive air samples 
collected from flow B occurred after the majority 
of animals tested M. hyorhinis PCR positive by 
nasal swab. This study demonstrated that 
maternal antibodies for M. hyorhinis have a 
gradual decay over the nursery stage and may 
allow for an increase in nasal colonization. Due 
to the drastic differences in colonization between
flow A and B, vaccine timing should be flow 
specific. 
References 
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A NOVEL MYCOPLAMSA HYOPNEUMONIAE ELISA, SPECIALLY DESIGNED FOR 
HIGH SPECIFICITY 
Eric van Esch1
1. Technical Director BioChek BV, Reeuwijk, Netherlands 
Introduction 
Mycoplasma hyopneumoniae (M.hyo) 
diagnostics are considered to be a dilemmaa.
For serology there is no true Gold Standard 
available and until now serological assays 
lacked specificity. On this basis there is a 
strong need for a highly specific assay with 
good sensitivity . This paper describes the first 
set of results with a high specificity M.hyo 
ELISA. 
Materials and Methods 
Sera sensitivity panel
This panel contains 108 samples from 
experimental infected animals (CReSa, Spain). 
Testing was done at CReSa with the BioChek 
ELISA. 
Sera specificity panel 
In total, 1695 samples from SPF herds from 
different geographical regions were tested. 
Samples were taken from animals of different 
ages, different breeds and different farm 
management systems. Samples were send by 
veterinary practioners to BioChek B.V., 
Reeuwijk, Netherlands for testing. 
ELISA 
The BioChek Mycoplasma hyopneumoniae 
Antibody Test Kits was used. This ELISA is 
based on a recombinant antigen for M.hyo and 
is supposed to be specific for M.hyo.  
Statistical analysis 
For test evaluation, WinEpiscope 2.0 was used 
to calculate Sensitivity and Specificity with a  
95% confidence level. 
Results and discussion
Table 1. Results on Mycoplasma hyopneumoniae 
antibody positive and negative samples  
 Mycoplasma hyopneumoniae 
positive and negative samples 
(n=1803) 
 Sample True 
Positive 
Sample True 
Negative 
ELISA 
positive 
92 13 
ELISA 
negative 
16 1682 
To serologically confirm the M.hyo free status 
of herds, it is imperative that the test has high 
specificity combined with good sensitivity to 
be sure that recent outbreaks are not missed. In 
the  study described, the specificity of the 
ELISA is high, 99.2%, [95%CI: 98.8; 99.6] 
while at 21 days post infection the sensitivity is 
85.2% [95%CI: 78.5; 91.6]. This is 
considerably sufficient in monitoring programs 
and therefore, based on the overall results, the 
ELISA is suitable for this purpose. 
Conclusion 
The evaluated ELISA demonstrates high 
specificity and very good sensitivity which 
makes this ELISA suitable for monitoring 
M.hyo free herds. 
Reference 
aBuddle, J.R, O’Hara, A.J., 2005, 
Aus.Vet.Journal, vol.83, no.3, 134-139 
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EFFICACY OF DRAXXIN® 25 INJECTABLE SOLUTION (TULATHROMYCIN 25 MG/ML) 
FOR TREATMENT AND CONTROL OF SWINE RESPIRATORY DISEASE  
RG Nutsch1, MJ Lucas1, W Collard1, SP Lesman1, JF Boucher1, JKS Tena1, M Senn2,
1Zoetis, Kalamazoo, MI USA and 2Zoetis, Florham Park, NJ USA 
Introduction: DRAXXIN® 25 Injectable Solution 
(25 mg tulathromycin/mL) was recently approved 
in the US for the treatment and control of swine 
respiratory disease (SRD). DRAXXIN 25 is 
administered at 2.5 mg/kg BW, the same dose of 
DRAXXIN Injectable Solution (DRAXXIN 100; 
100 mg tulathromycin/mL) used in pigs for SRD, 
but in a larger injection volume of 1.0 mL/22 lb 
that makes it easier to accurately dose younger, 
light weight pigs. DRAXXIN 25 Injectable 
Solution is indicated for the treatment of (SRD) 
associated with  Actinobacillus pleuropneumoniae,
Pasteurella multocida, Bordetella bronchiseptica,
Haemophilus parasuis, and Mycoplasma 
hyopneumoniae; and for the control of SRD 
associated with  A. pleuropneumoniae, P. 
multocida, and M. hyopneumoniae. This abstract 
presents data supporting the efficacy of this new 
lower concentration formulation of tulathromycin. 
Materials and Methods: Effectiveness of 
DRAXXIN 25 was established using a plasma 
bioequivalence approach. A PK study was 
conducted using gilts and barrows (n=32 each sex) 
comparing DRAXXIN 25 to DRAXXIN 100. Pigs 
weighed 17 – 24.7 kg at start of study. There were 
4 animals of each sex within each of 8 pens. 
Within pen and sex, pigs were randomly assigned 
to receive one of the 2 products administered IM in 
the neck at 2.5 mg/kg BW. Blood samples were 
collected at 24 h prior to dosing and after dosing at 
20 and 40 min and 1, 1.5, 2, 3, 4, 7, 10, 24, 48, 96, 
144, 192, 240, 288 and 336 h. Plasma samples 
were assayed for tulathromycin using a validated 
LC-MS/MS assay. 
Results: Summary PK statistics are presented in 
Table 1. Table 2 shows the assessment of 
bioequivalence for AUC0-t(last) and Cmax. These 
confirm that bioequivalence criteria were met for 
both variables. Demonstration of bioequivalence of 
plasma concentrations of tulathromycin between 
both products provides substantial evidence of 
effectiveness of DRAXXIN 25 for treatment and 
control of swine respiratory disease. Plots of the 
geometric mean plasma concentration of 
tulathromycin are presented in Figure 1.  
Table 1. Comparative tulathromycin
pharmacokinetics in swine (LS mean ± SD) after 
IM administration of DRAXXIN 25 or DRAXXIN 
100.
PK Variable DRAXXIN 25 DRAXXIN 100 
Cmax (ng/mL) 437 ± 122 509 ± 154 
AUC0-t(last) 
(h·ng/mL) 
8200 ± 1190 7710 ± 1220
tmax (h)  0.68 ± 0.64 0.39 ± 0.12 
t1/2 (h) 71.7 ± 14.5 72.9± 16.7 
Cmax  – observed maximum plasma concentration 
AUC0-t(last)  - the area under the plasma concentration - time 
curve from time of dosing to the last observed concentration 
above the limit of quantification of  the assay (3 ng/mL) 
Tmax – the time from dosing to Cmax
T1/2 –  plasma elimination half life 
 
Table 2. Assessment of bioequivalence: Ratio of 
DRAXXIN 100 to DRAXXIN 25 with 90 % 
confidence limits (CL) for AUC0 –  t(last) and Cmax
Variable Ratio 90% CL
AUC0-t(last)
(h·ng/mL) 
0.94 0.89, 1.0* 
Cmax (ng/mL) 1.17 1.04, 1.31†
* Must be completely contained within 0.80, 1.25 to 
conclude bioequivalence. 
† Must be completely contained within 0.70, 1.43 to 
conclude bioequivalence.
Figure 1. Tulathromycin geometric mean plasma 
concentration after a single 2.5 mg/kg BW dose 
DRAXXIN 25 or DRAXXIN 100. 
Conclusion: This study supports the efficacy of 
DRAXXIN 25 for treatment and control of SRD 
including M. hyopneumoniae.
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DRAXXIN AT WEANING FOR CONTROL OF SWINE RESPIRATORY DISEASE IN A 
NATURAL INFECTION 
R. Fleck1, K. Lechtenberg2, T. Schieber2, J. Seagren2, D. Amodie1 
1Zoetis Inc, Florham Park, NJ USA and 2Midwest Veterinary Services, Inc Oakland NE USA 
 
Introduction
Swine respiratory disease (SRD) is commonly 
found in weaned pigs and is attributable to both 
viral and bacterial pathogens. DRAXXIN 
(tulathromycin) is labeled for the control of SRD 
associated with Pasteurella multocida, 
Actinobacillus pleuropneumoniae and 
Mycoplasma hyopneumoniae (M.hyo). The 
purpose of this study was to evaluate the derived 
production benefits of controlling SRD in piglets 
with one dose of DRAXXIN per label at 
weaning.   
Materials and Methods 
One thousand, one hundred weaned pigs from 
two commercial sow farms with a documented 
history of M. hyo, Pasteurella multocida and 
PRRS associated SRD in the post weaning phase 
of production were blocked by gender and sow 
farm source and 550 pigs were randomly 
enrolled to either DRAXXIN or saline control 
groups. The Draxxin group received 
tulathromycin at 2.5 mg/kg IM at weaning 
whereas the control group received a 
comparable dose volume of saline IM. The pigs 
were weighed at enrollment, study day 54 and 
study day 152. Starting from study day 1, if any 
pigs demonstrated a respiratory or depression 
score of ≥1 out of a 0-3 score range, the pigs 
were treated with EXCEDE for swine per label. 
The pigs were ear notched and could not be 
retreated for seven days. If the pigs continued to 
exhibit qualifying respiratory and depression 
scores after seven days, they were treated with 
Baytril per label and another seven days were 
allowed to elapse. The Baytril could then be 
repeated one more time, for a total of three 
retreatments. The pigs were maintained on 
unmedicated feed for the first 21 days of the 
study. Any pig that was pulled into a hospital 
pen was recorded and was kept on test. Any pigs 
that died or were euthanized were recorded. 
Initial weight was included as a covariate in the 
analyses of weight gain and ADG, which were 
analyzed by a linear Mixed Model approach.  
Percent retreatments, moved to hospital pen and 
mortality were defined as binary variables and 
analyzed using a Generalized Linear Mixed 
Model (GLMM). If the interaction of treatment-
by-gender was significant at the 5% level for 
any parameter, an analysis was preformed for 
that parameter separately for each gender.  
 
Results 
Pasteurella multocida, Haemophilus parasuis 
and  Streptococcus suis were isolated from the 
pneumonic lung tissue samples of pigs that died 
or were euthanized. Piglets were PRRS positive 
at enrollment and at study day 33. Unvaccinated, 
sentinel pigs seroconverted to M. hyo by day 
152, confirming exposure to this pathogen.  
Table 1. Results Summary 
 DRAXXIN Saline 
ADG day 0-54 0.79a 0.75b 
ADG day 0-152 1.44a 1.41b 
% pulls to hospital pen 3.04b 7.18a 
% retreatments gilts 40.5b 56.9a 
%retreatments barrows 51.2 55.4 
% mortality 16.8b 21.4a 
Different superscripts significantly different at p<0.05 
 
Twenty nine extra pigs and 8,137 extra pounds 
of pork were produced in DRAXXIN group. 
This study demonstrates that controlling SRD in 
pigs at weaning with DRAXXIN brings value by 
reducing  mortality, morbidity and labor for 
retreatments as well as by increasing pounds of 
pork available for market.   
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COMPARISON OF TWO SAMPLE TYPES FOR DETECTION OF 
Mycoplasma hyopneumoniae IN NATURALLY INFECTED PIGS
Prado, C1, Ertl, J.1, Payne, B.2, Wetzell, T.2, Bretey, K.2, Pieters, M1.
1College of Veterinary Medicine, University of Minnesota, St. Paul, MN 
2 Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 
 
Introduction
Nasal swabs are a common and rapid sample type 
used to detect Mycoplasma hyopneumoniae (M.
hyopneumoniae) using molecular diagnostic tools1.
Laryngeal swabs can also be used to detect M.
hyopneumoniae genetic material in live pigs. 
However, a comparison of both sample types for 
M. hyopneumoniae detection in naturally infected 
pigs has not been performed. A study was 
conducted to compare nasal vs. laryngeal swabs 
for detection of M. hyopneumoniae in naturally 
colonized and infected pigs at different ages. 
Materials and methods 
Paired nasal and laryngeal swabs were collected 
randomly from 108 piglets at weaning age in sow 
farm A. Also, paired nasal and laryngeal swabs 
were collected randomly from 60 pigs (>20 weeks 
of age) in two finishing sites sourced from sow 
farm B. Nasal swabs were collected by introducing 
a swab into each nostril at 45o angle latero-medial 
towards the nasal septum, then straightened and 
inserted carefully as rostral as possible, meanwhile 
rotating the swab clockwise and counterclockwise 
upon entry and exit. Laryngeal swabs were 
collected by opening the mouth with a mouth gag, 
depressing the tongue using a laryngoscope to 
expose the larynx, and introducing a swab guided 
by the laryngoscope blade to swab the laryngeal 
area. In older pigs, a sanitized BIC® pen fits snug 
in the cap of a double swab (BBL™), and acts as 
an extension to reach the laryngeal area. Samples 
were refrigerated and transported immediately 
after collection and were submitted to the U of 
MN VDL for real time PCR (rt-PCR) testing2.
Results   
The percentage of positive pigs by rt-PCR testing 
of all nasal and laryngeal swabs is shown in Fig.1. 
At weaning age, 33/108 pigs (31%) were positive 
by nasal swabs, 13/108 (12%) were positive by 
laryngeal swabs, and 41/108 (38%) by combining 
the result of both sample types (Na+La). At market 
age, 10/60 pigs (17%) were positive by nasal 
swabs, 18/60 (30%) were positive by laryngeal 
swabs, and 18/60 (30%) by combining the result of 
both sample types.   
Figure 1. Detection of M. hyopneumoniae by RT-PCR in nasal, 
laryngeal and nasal laryngeal swabs. A) Samples collected at weaning 
age. B) Samples collected at market age. 
Discussion and conclusions 
Sensitive, fast and practical samples are needed for 
in vivo diagnosis and further control of M.
hyopneumoniae4. The most common sample type 
used to detect M. hyopneumoniae in the field is the 
nasal swab. On the other hand, experimental trials 
and field studies indicate that more sensitive 
sampling sites are located in the lower part of the 
respiratory tract, specifically the trachea and the 
bronchi3,4. Results from this investigation showed 
that at weaning age more nasal than laryngeal 
swabs tested positive, and the combination of both 
sample types increased the level of detection by 
7%. At market age, more positive pigs were 
detected using laryngeal swabs. Results from this 
study suggest that the detection rate of M.
hyopneumoniae could be increased by selecting a 
sample type based on the estimated time interval 
between pathogen exposure and sampling time 
point. 
Acknowledgements  
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INVESTIGATING RISK FACTORS FOR Mycoplasma hyopneumoniae PIGLET 
COLONIZATION DURING THE LACTATION PERIOD 
Pieters, M.,1 Payne, B.,2 Rendahl, A.1
1 College of Veterinary Medicine, University of Minnesota, St. Paul, MN. 2 Boehringer Ingelheim Vet 
Medica, St. Joseph, MO.
Introduction
Sow-to-piglet transmission is considered one of 
the most important aspects of the epidemiology 
of Mycoplasma hyopneumoniae. The degree of 
piglet colonization at weaning age has been 
suggested as a predictor of clinical disease at 
market age1. However, sow-to-piglet 
colonization widely varies among farms and 
weaning groups, and even within the same 
farm2-3. Therefore, the objective of this study 
was to identify risk factors associated with M.
hyopneumoniae piglet colonization during the 
lactation period.  
Materials and methods 
Three sow farms, belonging to three different 
productions systems (A, B, C) were visited and 
samples were collected in at least 5 weaning 
groups at each farm. The following samples 
were collected at every sampling event: 54 dam 
nasal swabs, paired piglet nasal swabs and sera. 
Sampled dams were randomly selected, while 
stratified by parity. One piglet per dam was 
randomly selected for sampling. A series of pig 
specific data were collected from each sampled 
group, along with climatic data collected on-site 
during the lactation period. Swabs were 
analyzed by real-time PCR (Life Technologies) 
at the UMN-VDL. Sera were tested by ELISA 
(IDEXX) for antibody detection. A generalized 
linear mixed model was fitted to test for the 
association of 9 factors on the risk of piglet PCR 
positivity at weaning age.  
Results 
All PCR results obtained from Farm A and C 
were negative. Positive PCR results were 
obtained in piglets and/or dams in 5/7 farm visits 
in Farm B. M. hyopneumoniae prevalence at 
weaning ranged 0-56%, with negative groups 
detected in between sampling periods with 
positive results. Dam PCR positive status and 
piglet weaning age were significantly associated 
(p<0.001) with piglet M. hyopneumoniae
colonization at weaning age. A relationship 
between dam PCR status and piglet age was 
observed, and is presented in Fig. 1. 
Figure 1. Piglet probability of M. hyopneumoniae
colonization as a result of dam PCR status and piglet age.   
Conclusions and discussion 
Identifying risk factors for colonization at 
weaning age is of crucial importance to better 
design control strategies for M. hyopneumoniae
infections. Under the conditions of this study, 
shedding of the dam during lactation 
significantly influenced the probability of piglet 
colonization at weaning, and this probability 
increased with piglet age in groups where at 
least one dam was positive. Our results highlight 
the influence of the sow in the sow to piglet 
colonization process, as previously reported2-3.
Our results contribute to a more comprehensive 
understanding of the epidemiology of M.
hyopneumoniae infections.        
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 RATIONALE FOR THE USE OF TILMICOSIN FOR THE CONTROL OF BACTERIAL 
PNEUMONIA COMPLICATED BY COINFECTION WITH Mycoplasma hyopneumoniae
Reinbold JB,1 Weber TE,1 Keffaber KK,1 and Marsteller TA.1 
1Elanco Animal Health; Greenfield, IN USA
Introduction
Mortality and production losses caused by 
bacterial pneumonia complicated by 
Mycoplasma hyopneumoniae (MH) coinfection 
is a concern of swine industry stakeholders. 
Significant advances in animal husbandry 
practices and new MH vaccines have improved 
the welfare of swine at risk for MH infection. 
Antibiotics also serve an essential role in swine 
welfare once infection with MH has occurred. A 
rationale for the selection of tilmicosin when 
attempting to control bacterial pneumonia 
complicated by MH coinfection is presented 
here. 
Materials and Methods 
Minimum inhibitory concentration (MIC) results 
(n = 132) for tilmicosin against MH were 
reviewed from published and unpublished data 
(1970-2011) worldwide.1,2,4-6,8-11 Datum was 
excluded if a result was not for a wild type strain 
or individual results were not reported. MIC 
values were rank ordered and a modal MIC 
determined. Tilmicosin concentration was 
determined in secretions and at cellular and 
tissue levels in 6 male and 6 female healthy 
swine fed tilmicosin ad libitum at 363 g/ton for 
7 days.3 Tilmicosin concentrations were then 
compared to the modal MIC. 
Two clinical experiments that compared various 
antibiotics provided to 5- to 6-week old pigs 
challenged with Pasteurella multocida (PM), 
Actinobacillus pleuropneumoniae (AP), and MH 
were reviewed.7 Pigs were inoculated with MH,
PM, and AP on days 1, 8, and 15, respectively. 
Treatment was initiated on day 9 and continued 
for 12 days in each experiment. Results 
associated with the feeding of tilmicosin at 0 
(control) and 363 g/ton (medicated-1) or 273 
g/ton (medicated-2) only were further reviewed. 
Results 
The modal MIC (n = 106) was determined to be 
≤ 2 μg/mL. Mean tilmicosin concentration was 
2.5, 1.4, 1.7, 1.9, 5.3, and 4.9 μg/mL for nasal 
secretions, nasal turbinate mucosa, tonsils, 
tracheal mucosa, pulmonary alveolar 
macrophages, and peripheral neutrophils, 
respectively. Tilmicosin concentration in nasal 
secretions, pulmonary alveolar macrophages, and 
peripheral neutrophils exceeded the modal MIC. 
Decreases in clinical score, occurrence of 
pneumonia, lung lesion score, and MH re-isolation 
in medicated-1 and medicated-2 pigs differed 
significantly from that of control pigs. Body 
weight gain was significantly greater in 
medicated-1 pigs compared to that of control pigs. 
Conclusions and Discussion 
A rationale for the use of tilmicosin for the control 
of bacterial pneumonia complicated by coinfection 
with MH is supported by historical MIC data, in 
vivo tilmicosin concentration, and clinical study 
results. Tilmicosin has the ability to accumulate at 
the microenvironment of infection in nasal 
secretions, pulmonary alveolar macrophages, and 
peripheral neutrophils at concentrations exceeding 
the modal MIC determined here. In clinical 
challenge studies, tilmicosin-fed pigs had 
decreases in occurrence of pneumonia, clinical 
score, lung lesion score, and MH re-isolation 
compared with control pigs. 
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SINGLE FIXED-TIME INSEMINATION IN GILTS USING pLH AT ESTRUS ONSET 
R.R. Ulguim1; D.L Fontana1; J.Z. Rampi1; M.L. Bernardi2; I. Wentz1; F.P Bortolozzo1
1Setor de Suínos – Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. 
2Departamento de Zootecnia, Faculdade de Agronomia, UFRGS, Porto Alegre, Brazil. 
Introduction 
In addition to the reduction in labor time, a 
fixed-time artificial insemination (FTAI) 
protocol is a strategy to optimize the use of 
genetically superior boars. As the control of 
ovulation time is critical to define the time of 
artificial insemination (AI), hormones such as 
porcine luteinizing hormone (pLH) have been 
used to induce ovulation for the 
implementation of FTAI protocols. This study 
aimed to evaluate the reproductive 
performance of gilts submitted to single FTAI 
using pLH at estrus onset. 
Materials and Methods 
Estrous detection was carried out twice a day 
(7a.m and 7 p.m) in 318 Agroceres PIC gilts 
using backpressure test in front of mature 
male. Gilts were uniformly distributed 
according to number of estrus (2 or 3), time of 
flushing and average daily gain of weight 
during flushing period in two treatments: 
Control - without hormonal application and AI 
at 12, 36 and 60 h after estrus detection and 
FTAI - 2.5 mg pLH injection (Lutropin-
V®Bioniche Animal Health, Belleville, 
Ontario, Canada) by vulvar submucosal route 
at estrus onset and a single FTAI 12 h after 
pLH. The application route, pLH dose and the 
moment of FTAI were defined in previous 
experiments (unpublished data). Split-samples 
AI doses were produced and contained 2 
billion of motile sperm cells. Farrowing rate 
(FR), adjusted farrowing rate (AFR) and total 
born piglets (TBP) were analyzed using the 
software Statistical Analysis System (SAS, 
9.1) through Chi-square test for FR and AFR 
and MIXED procedure for TBP. 
Results
Gilts of control group received 2.3 ± 0.6 AI 
doses whereas one dose was used in FTAI 
group. Gilts that received a single FTAI had 
lower FR (P=0.084) and AFR (P=0.028) 
compared to Control gilts but TBP was not 
different (P=0.512) between treatments (Table 
1). The number of total born piglets per AI 
dose was 12.3 ± 0.3 for FTAI gilts and 6.0 ± 
0.3 for control group (P<0.05). 
Conclusions and Discussion 
Single insemination has been evaluated in 
multiparous sows [1, 4] with induced 
ovulation. However, more than one fixed-time 
AI has been used in gilts after estrus 
synchronization with progestagens followed by 
follicular growth and ovulation induced by 
hormones [2, 3]. The observed reduction in FR 
contrasts with results of studies performed in 
sows, since higher [1] or similar [4] FR were 
observed with single fixed-time AI compared 
to control AI protocols. The fact that a single 
FTAI did not affect the TBP corroborates the 
similar number of embryos and percentage of 
recovered embryos observed in gilts receiving 
two fixed-time AI in comparison to those 
traditionally inseminated [2]. Similarly, litter 
size was not affected by single insemination in 
sows [1, 4]. This study shows the possibility of 
using a single FTAI in gilts whose ovulation 
was induced by pLH at estrus onset. 
Considering the moderate reduction in FR and 
no impairment of litter size, this protocol might 
be suggested mainly for contingency plans. 
Table 1 – Reproductive performance of gilts 
submitted to a single fixed-time AI (FTAI) or a 
traditional AI protocol (Control) 
Treatment FR (%) AFR (%) TBP 
Control 145/159 
(91.2) 
145/155 
(93.6) 
12.5 ± 0.2 
FTAI 135/159 
(84.9) 
135/157 
(86.0) 
12.3 ± 0.2 
P-value 0.084 0.028 0.512 
FR-farrowing rate; AFR-adjusted farrowing rate; 
TBP-total born piglets 
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THE IMPACT OF PIG HEALTH ON PUBLIC HEALTH: QUANTITATIVE DATA FOR RISK 
ASSESSMENTS
A. DeClercq,1 H.S. Hurd1, A. Ramirez 1, T. Frana.1
1Iowa State University Veterinary Diagnostic and Production Animal Medicine, Ames, IA, USA 
Introduction
While clinically ill animals will not pass ante-
mortem inspection, it is possible that animals 
with subclinical illness or lesions could pass 
inspection and be harvested. These animals 
could be more likely to harbor pathogens that 
could cause food-borne illness, such as 
Salmonella.
One possible source of contamination is what is 
referred to as a peel-out, or a pleural adhesion 
which does not allow for complete removal of 
the viscera, requiring extra trimming. A previous 
study found that approximately 7% or 1 in 15 
carcasses had some degree of pleural adhesions, 
and carcasses with peel-outs were 90% more 
likely to be contaminated with Salmonella.1
The objectives of this study are threefold: 1) 
estimate a national prevalence of peel-outs, 2) 
determine what respiratory pathogens are more 
likely to be associated with peel-outs, and 3) 
determine if peel-outs are associated with an 
increase in Salmonella.
Materials and Methods
Six different slaughtering facilities were 
selected. Lung samples and pleural swabs were 
collected. Cases and controls were identified in 
random order. The total number of carcasses 
was counted to determine peel-out frequency.   
A piece of lung was taken right after 
evisceration. After the final trimming and before 
the final carcass wash, both sides of the carcass 
were swabbed using Whirl-Pak bags with Speci-
Sponges hydrated with buffered peptone water.  
Lung and pleural swabs were incubated on 
Tergitol 7 as well as 5% sheep blood agar and 
4% bovine blood agar with Staph nurse. Typical
Haemophilus parasuis, Actinobacillus 
pleuropneumoniae, Pasteurella multocida,
Streptococcus suis, and Actinobacillus suis 
isolates were identified with biochemical testing, 
gram stain, and matrix-assisted laser desorption 
time of flight mass spectrometry.
Buffered peptone water was transferred to 
Rappaport-Vassiliadis broth, incubated, and then 
streaked onto XLT4 and Brilliant Green with 
Novobiocin agars. Suspect colonies were 
confirmed as Salmonella with biochemical 
analysis (lysine-iron agar, motility-indole-lysine 
agar) and slide agglutination with polyvalent 
anti-O sera. 
Results
Data was analyzed using logistic regression. The 
prevalence of peel-outs varied significantly 
between plants, with a range of 2.64%-28.39%, 
with an average of 8.11%. Actinobacillus 
pleuropneumoniae, Haemophilus parasuis, and 
Actinobacillus suis were not found in a high 
enough frequency to run a statistical analysis. 
Lesioned carcasses were 1.44 times more likely 
to be contaminated with Salmonella, 1.164 
likely to be contaminated with Streptococcus
suis, and 0.768 more likely to be contaminated 
with Pasteurella multocida. However, these data 
did not have significant p-values.  
Discussion and Conclusions
Based on previous research, it was hypothesized 
that carcasses exhibiting peel-outs would be 
more likely to be contaminated with Salmonella,
and that common respiratory pathogens would 
cause peel-outs. However, the data gathered 
does not support these hypotheses. While this 
study did have a significantly larger sample size 
than the previous study, we were only able to 
spend one day at each plant for each sampling 
period. Because bacteria counts and peel-out 
prevalence could vary from day to day, it would 
be beneficial if sampling was taken over 
multiple days. Also, it is possible that there are 
other respiratory pathogens that are more 
associated with peel-outs. Additional microbial 
testing could help answer this research question.  
References
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UNDERSTANDING GENOME-ENABLED SELECTION 
CE Abell1, JCM Dekkers1 and KJ Stalder1
1Department of Animal Science, Iowa State University, Ames, IA 50011-3150 
Introduction
The common method to estimate breeding 
values and rank animals based on genetic merit 
is known as traditional BLUP (best linear 
unbiased prediction) selection. This method 
relies on phenotypic information on animals and 
their relatives to determine the expected genetic 
potential for all animals. Researchers have 
established ways to incorporate information of 
the genetic make-up of individuals into breeding 
programs. The process of integrating this 
genomic information into a selection strategy is 
known as genome-enabled selection.  
For genome-enabled selection, a tissue or blood 
sample is collected and used to obtain genetic 
information; the genetic information from an 
individual animal’s sample is decoded or 
sequenced to determine the specific genetic code 
at certain points along the entire DNA sequence. 
This information, specifically the areas where 
the sequence is different at a single location 
(called a single nucleotide polymorphism, or 
SNP, which simply means at a single point there 
are differences in the DNA code) can be used to 
enhance traditional breeding value estimation. 
There are two approaches to genome-enabled 
selection: genome-enhanced BLUP and SNP-
effect models. 
Genome-enhanced BLUP utilizes genomic 
information by modifying the relationship 
among animals involved in the analyses 
(relationship matrix) that is used in traditional 
BLUP selection. Typically, the relationship 
between animals used in genetic evaluations is 
based on pedigree relationships. Genome-
enhanced BLUP utilizes the actual genomic 
relationship among relatives rather than just 
using the average relationship based on 
pedigree. This approach can be extended to 
incorporate phenotypes from individuals that are 
not genotyped in what is called single-step 
genome-enhanced BLUP. 
In SNP effect models, the effect of each position 
(or SNP) on phenotype is simultaneously 
estimated for all genotyped SNPs in what is 
called a training population (Erbe et al., 2010). 
The resulting SNP-key is then used to predict 
the breeding value of animals that are genotyped 
but have no phenotype by summing the 
estimated effects at each genotyped SNP. To 
incorporate information from individuals that are 
not genotyped, the resulting genomic prediction 
is ‘blended’ with an estimate of the breeding 
value derived using traditional BLUP. This 
blended estimate is used as the final genetic 
index value for each animal, combining both 
traditional BLUP and genomic information.
The expected benefit from genome-enabled 
selection is improved accuracy of EBV and 
obtaining more accurate EBV at a younger age, 
since there is no need to wait for phenotypes 
(Meuwissen et al., 2001). Increasing EBV 
accuracy will proportionally increase the rate of 
genetic gain expected. Having more accurate 
EBV at a younger age allows selection decisions 
to made earlier (if possible given reproductive 
age), which reduces the generation interval and 
increases genetic gain per unit of time. 
Impact 
Genome-enabled selection has been 
implemented in some pig breeding programs 
(e.g. PIC). Because generation intervals are 
already low in pigs, the greatest impact is on 
increasing accuracy of selection. The greatest 
impact of genome-enabled selection is expected 
for lowly heritable traits that are hard to measure 
or measured late in life such as disease 
resistance, feed efficiency, and longevity. 
Disease resistance is not easily defined and 
systematically measured. Feed efficiency is 
expensive to measure directly and sow longevity 
is a sex limited trait that is not recorded until the 
sow is culled from the herd. 
References 
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EFFECTS OF FEEDING DRIED DISTILLERS GRAINS WITH SOLUBLES (DDGS) TO 
IMMUNOLOGICALLY CASTRASTED PIGS 
 E. K. Harris1, A. M. Hilbrands2, L. J. Johnston2, C. Calhoun3, G. C. Shurson2 
1University of Minnesota, Department of Animal Science, St. Paul, 55108 USA 
2University of Minnesota, West Central Research and Outreach Center, Morris, 56267, USA 
3Zoetis, Inc. Florham Park, NJ 07940, USA 
 
Introduction
Current swine production practices in the US have 
included physically castrating (PC) male pigs 
within days following birth. This prevents 
unpalatable off-odors in pork that occur with the 
onset of puberty in intact males. Reducing growth 
promoting androgens by PC early in life results in 
pigs with slower lean gain, increased fat deposition, 
and reduced gain efficiency compared with intact 
males. Temporary immunological castration (IC) 
with Improvest® (gonadotropin releasing factor  
analog - diphtheria toxoid conjugate; Zoetis, Inc., 
Florham Park, NJ) during the finishing period 
allows male pigs to remain intact for a longer 
period thus capturing the advantages in lean growth 
efficiency and carcass lean while eliminating off-
odors in pork prior to harvest. Information is 
limited regarding growth and carcass characteristics 
of IC pigs fed high dietary levels (40%) DDGS and 
marketed at different harvest time points. 
 
Materials and Methods 
Crossbred boar pigs (n=863) were assigned 
randomly to one of 12 treatments in a completely 
randomized design using a 4 x 3 factorial 
arrangement (BW = 21.5 ± 0.2 kg). Dietary 
treatments were fed in four phases (Table 1).  
 
Table 1. Dietary treatments of DDGS inclusion fed 
in 4 phases for 3, 4, 4, and 5 weeks, respectively 
 Dietary Treatment (DDGS, %)a 
Phase PCon SD WD NCon 
1 0% 40% 40% 40% 
2 0% 30% 40% 40% 
3 0% 20% 40% 40% 
4 0% 10% 0% 40% 
aPCon=Positive Control; SD=DDGS Stepdown; 
WD=DDGS Withdrawal; NCon=Negative Control 
 
All pigs received the first dose of Improvest at 11 
weeks of age and the second dose at either 15, 17, 
or 19 weeks of age to correspond with 9 (IC-9), 7 
(IC-7), or 5 (IC-5) weeks prior to harvest, 
respectively. Pigs were weighed individually and 
pen feed disappearance was determined. Pen ADG, 
ADFI, and G:F were calculated.  Prior to harvest, 
10th rib backfat (BF) and longissimus muscle area 
(LMA) were measured using real-time ultrasound. 
Pigs were harvested at a commercial abattoir, 
where hot carcass weight (HCW) was collected and 
used to calculate fat-free lean (FFL). Data were 
analyzed using PROC MIXED in SAS.  
 
Results 
Overall ADFI was greater (P ≤ 0.05) in pigs fed 
WD-IC9 compared with NC-IC5 and NC-IC9 pigs, 
and tended (P = 0.09) to be greater in WD-IC9 
compared with SD-IC5 pig.Pigs fed PCon had 
greater (P ≤ 0.05) ADG compared with pigs fed 
WD, or NCon. Gain efficiency was poorer (P ≤ 
0.05) in pigs fed WD and NCon compared with 
pigs fed PCon or SD. Gain efficiency was improved 
(P ≤ 0.05) in IC-5 pigs compared with IC-7 and IC-
9 pigs. Pigs fed NCon had lighter (P ≤ 0.05) ending 
live weight compared to PCon fed pigs, while 
ending live weight of pigs fed SD and WD was not 
different compared with  NCon and PCon pigs. Hot 
carcass weight of SD, WD, and NCon fed pigs was 
lighter (P ≤ 0.05) compared with pigs fed PCon. 
Carcass yield was greater (P ≤ 0.05) in pigs fed 
PCon, compared to pigs fed NCon. Percentage FFL 
was not affected (P ≥ 0.35) by diet or IC treatment.  
 
Conclusion
Use of a DDGS SD feeding strategy mitigated the 
negative effects on overall ADG, G:F, HCW, and 
carcass yield that occurred when feeding 40% 
DDGS to IC pigs. Feeding a WD diet mitigated the 
negative effects of feeding 40% DDGS on carcass 
traits but not the negative effect on growth 
response. Time of marketing after the second 
Improvest dose did not influence carcass yield or 
FFL percentage, but marketing IC pigs 5 weeks 
post-second dose of Improvest resulted in the 
highest overall gain efficiency. 
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INTESTINAL BARRIER DYSFUNCTION DURING  
CONSTANT AND CYCLICAL HEAT STRESS IN PIGS  
M Bandrick,1 BE Bass,2 JW Frank,2 T Looft,1 HK Allen,1 T Casey,1 TB Stanton1
1USDA National Animal Disease Center, Ames, IA, USA; 2Diamond V, Cedar Rapids, IA, USA 
Introduction: Economic losses to the livestock 
industry due to heat stress (HS) are estimated to 
be greater than $2.0 billion annually.1 HS is a 
chronic burden in tropical/arid environments 
and, along with global climate change, HS 
represents an evolving challenge to livestock 
producers worldwide. HS morbidity and 
mortality in pigs is linked to the disruption of 
normal intestinal tract (IT) absorptive and 
barrier functions and is often manifested as 
decreased performance. Extreme HS may result 
in severe IT dysfunction, reproductive failure, 
multi-organ failure, and death. HS models often 
consist of constant exposure to high heat, unlike 
the cyclical heat pattern pigs are exposed to 
during production. The goal of this study was to 
compare two HS models, constant heat (CH) 
versus variable heat (VH), in terms of health 
statistics, performance, and immune endpoints. 
Materials and Methods: Pigs were divided into 
three treatment groups (n=12/group) at weaning 
(21 d old): CH, VH, and control (C). All pigs 
were allowed free access to water and a standard 
nursery diet. The HS period started 4 weeks later 
and lasted for 7 d. CH pigs were subjected to 
33oC during the entire HS period. VH pigs were 
subjected to a repeated cycle of 40oC for 5 hrs 
then 25oC for 19 hrs2. C pigs were maintained at 
25oC. Endpoints included performance, health, 
and immune measurements. Samples/data were 
collected prior to and during the HS period.  
Results: Both CH and VH animals responded to 
HS as evidenced by lower ADG and ADFI and 
higher respiratory rates and skin and rectal 
temperatures (during HS) compared to controls 
(Fig. 1). 
Immune function was altered during HS. Non-
specific immune function was lower in both CH 
and VH animals compared to control. Only heat-
stressed pigs had lymphoproliferative responses 
(indicator of barrier dysfunction) to a sonicate of 
12 bacteria isolated by our lab from the IT 
mucosa of healthy pigs (Fig. 2).  
Conclusions and Discussion: Pigs in both HS 
groups were stressed by our criteria. In general, 
pigs were more affected by variable HS than by 
constant HS. A healthy IT permits absorption of 
nutrients and protects from penetration of toxic 
compounds and pathogenic microbes; however, 
heat-stressed pigs experienced IT dysfunction as 
evidenced by lymphoproliferative responses to 
IT mucosal bacteria.  
The results indicate that both the constant and 
variable temperature stresses are acceptable 
models of HS in this age pig. The VH design is 
more representative of what the commercial pig 
experiences. Future studies will apply the VH 
design to optimize HS mitigation at the level of 
the IT in order to strategically reduce the burden 
of HS and to quicken recovery following a HS 
event.   
Acknowledgement: Thanks to Sam Humphrey 
and Steph Jones for scientific and technical 
advice and the engineers and animal care staff at 
NADC for their invaluable service. *This study 
was partially funded by Diamond V.
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EFFECT OF SKYCIS, DIET NUTRIENT DENSITY AND FEEDER TYPE ON GROW-FINISH 
PIG PERFORMANCE 
MC Brumm1, S Spindler1, and R Arentson2
1SVC Research, LLC, St Peter, MN and 2Elanco Animal Health, Greenfield, IN 
Introduction
Skycis is approved for addition to grow-finish 
diets for improvement of weight gain and feed 
conversion (18.1-27.2 g/t) and weight gain 
(13.6-27.2 g/t) when fed for at least 4 weeks. 
There is no published information regarding 
possible interactions between Skycis addition, 
diet ingredients or feeder type on the response to 
this ionophore. 
Materials and Methods 
At weaning, 1728 pigs (Danbred 241 x PIC 359, 
13.3 lb [SE = 0.01 lb]) were assigned to 
experimental treatments within sex to double 
stocked (54 pigs/pen) fully slatted pens in a 
tunnel ventilated facility in a 2x2x2 factorial 
arrangement of treatments in a randomized 
complete block design with 32 pens. Treatments 
were wean-finish feeder type (shelf wet/dry vs 
dry feeder – 4-15” holes per pen), grow-finish 
diet (25% DDGS reduced to 20% prior to 
slaughter with no added fat vs 10% DDGS with 
3% added fat reduced to 5% DDGS prior to 
slaughter) and Skycis in grow-finish diets (13.6 
vs 0 g/t). Pigs were individually weighed at 57d 
post-wean and split into 2 pens of 25 pigs/pen 
within sex (7.2 ft2/pig) with pigs randomly 
identified prior to weighing for removal to attain 
this reduction. Sales of pigs on the dry feeder 
were delayed one week to attain sale weights 
similar to pigs on the wet/dry feeder.  Pigs were 
individually weighed prior to the sale of the first 
pig to slaughter within sex by feeder type 
combinations. The randomized complete block 
ANOVA included treatment block, Skycis level, 
diet, feeder type and all 2 and 3-way interactions 
for pig performance. The pen of pigs was the 
experimental unit. Removals and death loss was 
examined using the ChiSquared statistic. 
Results 
There were no 2 or 3-way interactions between 
experimental treatments. Pigs fed diets 
containing 13.6 g/t Skycis from 65 lb to 
slaughter had a 4.3 lb heavier sale weight to the 
primary slaughter plant (286.3 vs 282.0 lb, 
P=0.002 )and 4.6 lb heavier overall sale weight 
including cull pigs (285.8 vs 281.0 lb, P=0.001) 
compared to pigs fed diets with no added Skycis. 
Grow-finish feed conversion was improved by 
0.04 units (2.53 vs 2.57, P<0.0001) with the 
addition of Skycis to the meal diets. The 
difference in live weight at slaughter resulted in 
a heavier carcass for pigs fed Skycis (212.7 lb vs 
209.0 lb, P=0.022). There was no effect of 
Skycis addition on carcass yield (P=0.16) or lean 
% (P=0.912). Pigs fed grow-finish diets with 
lower levels of DDGS plus added fat and amino 
acids had a heavier sale weight in the winter trial 
(284.2 vs 282.1 lb, P=0.049), an improvement in 
feed conversion (2.46 vs 2.64, P<0.0001) and no 
difference in carcass lean percentage or yield 
(P>0.50). The number of pigs removed during 
the grow-finish phase (deads plus pulled pigs 
that lived) was reduced for pigs fed the high 
DDGS diets (1.76% vs 3.75%, P=0.016) with 
the reduction in deaths identified as fewer 
intestinal torsions or ulcers. Pigs on the wet/dry 
feeder were 1.4 lb heavier on D52 post-wean 
(P=0.010) with no difference in feed conversion 
during the double stock period (P=0.621). While 
sale weights were heavier for pigs on the dry 
feeder due to the differences in sale dates (284.6 
vs 282.2 lb, P=0.077), daily gain during the 
grow-finish period was faster for pigs fed on the 
wet/dry feeder (2.15 vs 2.05 lb/d, P<0.0001) 
with a reduction in within pen variation for daily 
gain (8.9 vs 9.9% CV, P=0.042) and no 
difference in grow-finish feed conversion (2.55 
vs 2.54, P=0.288).  
Conclusion
The 2.4% and 1.6% improvements in ADG and 
F/G with 13.6 g/t Skycis additions to grow-
finish diets were independent of diet and feeder 
type. 
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EFFECTS OF FEEDING RACTOPAMINE TO PHYSICALLY AND IMMUNOLOGICALLY 
CASTRATED PIGS ON GROWTH PERFORMANCE AND CARCASS CHARACTERISTICS 
B.K. Lowe*1, G.D. Gerlemann2, A.L. Schroeder3, S.N. Carr4, P.J. Rincker4, D.B. Petry5, F.K. McKeith1,
A.C. Dilger1, and G.L. Allee2.
1University of Illinois, Urbana, IL, 2University of Missouri, Columbia, MO,  3Pfizer Animal Health, 
Kalamazoo, MI, 4Elanco Animal Health, Greenfield, IN, 5Newsham Choice Genetics, West Des Moines, 
IA
Introduction
Immunological castration (IC) with Improvest®
(gonadotropin releasing factor  analog - 
diphtheria toxoid conjugate; Zoetis, Inc., Florham 
Park, NJ) allows male pigs to capture the 
advantages in lean growth efficiency and carcass 
lean while eliminating off-odors in pork. 
Information is limited regarding growth and 
carcass characteristics of IC pigs fed ractopamine 
(Paylean®, Elanco, Greenwood, IN).  
Materials and Methods 
Sixty-four pens with 22 pigs per pen were used to 
evaluate effects of feeding ractopamine (RAC; 5 
mg/kg) to physically castrated (PC) and 
immunologically castrated (IC) pigs. Male pigs 
were randomly assigned to sex treatments at birth 
and fed the same nursery diets prior to allotment 
in a grow-finish barn. Pigs in the PC treatment 
were castrated at 5d of age and pigs in the IC 
treatment were immunized at 11& 18 wk of age 
with Improvest.  Diet treatments (control or RAC) 
were initiated on d87. Final treatment was a 2x2 
factorial of sex and diet.  Body weights were 
collected at d0 (allotment), d21, d42, d65 (2nd
Improvest injection), d87 (start of diet treatment), 
d99 (1st marketing), d106 (2nd marketing), and 
d120 (final marketing).  Pens were standardized to 
17 pigs per pen for marketing group 1, 9 pigs per 
pen for marketing group 2, and all remaining pigs 
were marketed in group 3.  Growth performance 
data were analyzed using PROC MIXED in SAS 
with fixed effects of sex, diet, and their 
interaction. Carcass characteristics were analyzed 
as a split-plot with treatment combination serving 
as the whole plot and market group serving as the 
split-plot. Pen was the experimental unit.    
Results and Discussion 
From d 21-65, IC pigs had 12% greater (P<0.01)
G:F and 11% less (P<0.01) ADFI than PC pigs 
while having similar (P=0.38) ADG.  From d 65-
87, IC pigs had 7% greater (P<0.01) ADG and 
12% greater (P<0.01) G:F than PC pigs while 
having similar (P=0.16) ADFI.  Neither sex 
(P=0.32) nor diet (P=0.65) had an effect on diet 
treatment starting (d 87) BW.  From d 87-120, IC 
pigs had 10% greater (P<0.01) ADG and 10% 
greater (P<0.01) ADFI than PC pigs while having 
similar (P=0.64) G:F. Additionally, RAC-fed pigs 
had 17% greater (P<0.01) ADG and 18% greater 
(P<0.01) G:F than control-fed pigs while having 
similar (P=0.42) ADFI from d 87-120.  There 
were no significant interactions between sex and 
diet on growth performance from d 87-120.  For 
the entire study (d 0-120), IC pigs had 2% greater 
(P<0.01) ADG, 4% decreased (P<0.01) ADFI, 
and 7% greater (P<0.01) G:F than PC pigs.  For 
carcass characteristics, IC pigs were 2.5 kg 
heavier (P<0.01) at slaughter, had similar 
(P=0.10) carcass weights, and a 1.8 percentage 
unit less (P<0.01) dressing yield than PC pigs.  
Additionally, PC pigs had 1.3 mm more (P<0.01)
carcass fat and 1.7 mm deeper (P<0.01) loins than 
IC pigs.  Also, RAC-fed pigs were 2.9 kg heavier 
(P<0.01) at slaughter and had 2.3 kg heavier 
(P<0.01) carcasses than control-fed pigs while 
having similar (P=0.21) dressing yields.  
Carcasses from RAC-fed pigs had 2.2 mm deeper 
(P<0.01) loins and tended (P<0.10) to have 0.4 
mm less fat than control-fed pigs. Market group 3 
pigs were the heaviest (P<0.01) at slaughter, had 
the heaviest (P<0.01) carcasses, greatest (P<0.01)
dressing yields, and the most (P<0.01) carcass fat 
of the market groups.  For leanness, RAC-fed IC 
pigs were estimated to be the leanest (P<0.05) of 
pigs in the first market group; control-fed PC pigs 
were estimated to have the least amount of lean 
(P<0.05) of pigs in the second market group; and 
RAC-fed pigs were estimated to be the leanest 
(P<0.05) of pigs in the third.  
These results show that the effects of 
immunological castration and feeding RAC are 
additive in terms of improving growth 
performance and carcass characteristics.   
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AGGREGATE ECONOMIC IMPACTS OF IMMUNOLOGICAL CASTRATION ADOPTION IN 
THE U.S.  
Glynn Tonsor1, Brian Buhr2, Kelly Zering3, Terrance Hurley4, and Dennis DiPietre5
1Agri-Food Analytics, LLC, St. George, KS 66535; 2EconAnalytics, LLC, Chisago City, MN 55013; 3Dept of 
Agriculture and Resource Economics, North Carolina State University, Raleigh, NC 27695; 4Dept of Applied 
Economics, University of Minnesota, St. Paul, MN 55108; 5KnowledgeVentures, LLC, Columbia, MO 65201 
Introduction 
Improvest® (gonadotropin releasing factor 
analog-diphtheria toxoid conjugate) is an FDA-
approved veterinary prescription product to 
manage boar taint and allows producers to 
replace physical castration with immunological 
castration.  Direct economic impacts identify the 
benefit of Improvest® adoption to a single 
producer and associated entities that slaughter, 
process, and sell the meat. However, they do not 
measure the overall market impact of adopting 
Improvest industry wide.  When multiple 
adjustments are introduced into the vertically-
related pork chain, the net impacts on quantities 
and prices are important to estimate.   
Materials and Methods 
An equilibrium displacement model (EDM) was 
used to estimate changes in quantities and prices 
that drive the overall industry-wide market 
impacts on segments of the supply chain.  The 
EDM is a structural supply and demand model 
of the vertically linked livestock and meat 
marketing chain composed of three sectors in the 
hog and pork chain: 1) retail pork (consumer), 2) 
wholesale pork (processor/packer), and 3) 
slaughter hogs (producer) as well as four beef 
and two poultry chain sectors. Considering 
Improvest adoption over 10 years, changes in 
market prices and quantities were estimated.   
Results and Discussion 
Quantities at all three market levels in the hog 
and pork marketing chain increase and prices 
decline at the retail and wholesale pork levels 
for all 10 years. Hog prices initially increase but 
subsequently decline beginning in year 6 as the 
marketing chain adjusts to the production 
expansion triggered by Improvest adoption. 
Consumer and producer surplus are used to 
quantify the net economic impact of Improvest 
adoption following changes in market prices and 
quantities. Consumer surplus is the difference 
between what consumers are willing to pay and 
the price they actually pay. Producer surplus 
quantifies the difference between what 
producers are willing to sell product for and 
what they actually receive from the market. In 
aggregate, pork industry producers and 
consumers benefit from the introduction of 
Improvest. Combining all surplus measures of 
producers and consumers across beef, pork, and 
poultry the cumulative ten-year present value is 
a societal surplus gain of $3.66 billion in the 
base model considered.  The cumulative ten-year 
present value of Improvest introduction is $1.48 
billion for hog producers, $104.39 million for 
packers at the wholesale pork level, and $362.63 
million for pork retailers.  Total meat consumer 
surplus also increases by $1.81 billion.  
Across several scenarios, numerous key findings 
emerge including hog producers, packers, and 
retailers each stand to benefit from Improvest 
adoption and all segments are significantly 
better off when higher and faster adoption 
occurs. Since the U.S. is not the first country to 
have Improvest available for adoption, “no 
adoption” or “slow adoption” scenarios place the 
US in a declining comparative advantage to 
other pork exporting countries which have 
adopted Improvest and this result would be 
detrimental to all protein sources in the U.S. 
This underscores the economic importance of 
the various levels of the industry working 
together for successful product introduction.  
Finally, several aspects of this EDM based 
analysis were conservatively conducted 
indicating actual benefits to adopters likely 
exceed those inferred from estimated market-
level impacts. 
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BEHAVIOR AND WELLBEING OF IMMUNOLOGICALLY CASTRATED PIGS  
Kimberly Guay, Brittany L. Backus, and John J McGlone 
Pork Industry Institute, Texas Tech University, Lubbock, TX 79409-2141
Introduction
Physical castration (PC) is a common management 
practice on commercial pig farms that reduces boar taint 
in pork, aggressive behavior in post-pubertal male pigs 
and undesirable pregnancy at slaughter. However, 
production losses associated with PC are substantial and 
include increased preweaning mortality (1.6%), reduced 
feed efficiency (6-10%), and loss of carcass lean (4-8%). 
Attempts to reduce the pain and distress of PC with local 
or general anesthetics have been unsuccessful. 
Immunological castration (IC) using Improvest®
(gonadotrophin releasing factor analog – diphtheria 
toxoid conjugate, Zoetis, Inc., Florham Park, NJ) is an 
alternative to PC that yields a carcass without boar taint 
and may improve pig welfare by reducing the stress of 
physical castration. We present two studies investigating 
behavior associated with IC.  Study 1 investigated the 
behavior of Improvest managed pigs on a commercial 
farm. Study 2 compared the stress of handling and 
injections to the pain and stress of PC.
Study 1: Commercial farm behavior   
The objectives of this study were to evaluate the effects 
of IC on human-pig interactions, aggressiveness, 
feeding, social, mounting, and lying behaviors on the 
home farm, as well as behavior during loading and 
unloading. Pigs were in two adjacent barns containing 
48 pens per barn initially stocked with 2,304 pigs. Pigs 
were a cross of widely used commercial lines. Observers 
used a scan sampling method to record behavior in each 
pen every 12 min for 24 h. A modified fear test4 was 
used to assess pig fear. Handling during loading and 
unloading of trailers going to market were also 
quantified. Data were converted to a percentage of pigs 
expressing each behavior over time. Data were 
summarized by hour over the 24 h observation period. 
Data were then converted to percentages of time each 
hour that pigs expressed each behavior. Prior to analysis, 
percentage data were subjected to square root-arcsine 
transformation. Statistical Analysis Systems (SAS) 
General Linear Models (GLM) was used for all analyses.  
The percentage of time each pig showed a specific 
behavior throughout the study was recorded (Phases 1-
3).  Prior to the first injection, intact males showed 
increased aggression (P = 0.014) and mounting (P = 
0.048) while the PC barrows spent more time feeding (P
= 0.003) than boars. The treatment by time interaction 
were significant for lying (P = 0.018), aggression (P = 
0.0001) and standing (P = 0.009) behaviors. Few 
differences were observed in pig-human interactions 
between PC barrows and IC barrows. IC approached 
people in the same amount of time as PC barrows but 
were more aggressive in their chewing and rubbing on 
the test person’s pant leg and boots. When handling and 
loading for processing in the home barn, PC barrows 
were more vocal than IC barrows (P < 0.05). Fewer dead 
and down pigs were observed among IC (zero) 
compared with PC barrows (1.17%). IC may result in 
similar or improved animal welfare compared to 
physical castration without pain relief. 
Study 2: Stress associated with injections 
The stress of the handling associated with IC (or other 
immunizations) has not been assessed. Our objectives 
were to determine if subcutaneous (SC) or intramuscular 
(IM) injections were more painful or stressful than PC 
for piglets as well as measure the pain and stress 
associated with receiving a SC or IM injection in 
finishing pigs. 
We conducted two experiments in which litter served as 
blocks in this randomized complete block design. After 
farrowing, 3-5d old male piglets were randomly assigned 
to nothing (NO), SHAM handling (SHAM), IM, SC or 
PC with no pain relief. Piglets were videotaped and 
behavior was sampled for 1h prior and 1h post treatment. 
Behavior monitored included standing, walking, lying, 
nursing, lying with sow contact and signs of pain 
(standing hunched over, shaking). Finishing pigs 
received SC, IM, SHAM or NO injection. Finishing pigs 
were also monitored for 1 h pre and post treatment, and 
monitored for eating, drinking, lying, standing, walking, 
vocalization, open mouth breathing, blotchy skin and 
signs of irritation (rubbing the injection site). Blood was 
collected from all pigs for cortisol analysis 60 min post 
treatments so that the handling of blood collection did 
not impact the pig behavior. Analysis was performed in 
SAS using GLM procedure.  
PC piglets showed less (P < 0.05) lying in contact with 
sows and more (P < 0.05) pain-like behaviors than IM, 
NO, or SHAM treatments, but SC did not differ from 
PC. SHAM finishing pigs spent more time lying than the 
pigs in other treatment groups (P < 0.05). Cortisol did 
not differ among treatments for neither piglets nor 
finishing pigs. IM injections do not change piglet 
behaviors relative to no handling or sham handling. SC 
injections caused a small change in piglet and finishing 
pig behaviors. PC caused measureable pain-like 
behaviors and general behavioral dysregulation whereas 
SC or IM caused barely measurable behavioral effects.  
244 2013 Allen D. Leman Swine Conference
A
bs
tr
ac
ts
A
bstracts
IMMUNOLOGICAL CASTRATION SIGNIFICANTLY IMPROVES FEED EFFICIENCY 
BEFORE AND AFTER IMMUNIZATION  
Martha A. Mellencamp1, Bobby Cowles1, Paulo J. U. de Moraes1 and Mark Bertram2
1Zoetis,Inc, Florham Park, NJ and 2First Choice Livestock, Urbandale, IA 50323 
Introduction
Physical castration (PC) early in life is effective 
in controlling boar taint. However, production 
losses associated with its use are substantial and 
include increased preweaning mortality (1.6%), 
reduced feed efficiency (6-10%), and loss of 
carcass lean (4-8%). Immunological castration 
(IC) offers producers an alternative to PC that 
uses the animal’s own immune system to 
suppress testicular function close to the time of 
slaughter.  Immunized animals temporarily 
become like PC barrows with similar control of 
boar taint and aggressive behavior. The 
difference in timing allows pigs that are IC to 
grow as intact males for most of their life, 
benefitting from the natural improvements in 
feed conversion and carcass composition.  
 Improvest® (gonadotropin releasing 
factor analog-diphtheria toxoid conjugate) is an 
FDA-approved veterinary prescription product 
that eliminates the need for PC. The 1st dose is 
given after 9 wk of age to prime the immune 
system. The 2nd dose is given at least 4 wk after 
the first and 3-10 wk before harvest. This 
approach allows the IC barrow to express its 
naturally efficient growth potential resulting in 
substantial feed savings per pound of gain 
compared to PC barrows. After the 2nd dose, the 
pig transitions to castrate-like metabolism. Feed 
intake increases and fat in the carcass increases 
to a desirable level for primal cut characteristics. 
The objective of this trial was to compare the 
performance of IC harvested at the early (3 wk) 
and later (9&10 wk) limits of the Improvest 
marketing window with contemporary PC and 
intact males (IM).       
Materials and Methods 
Male pigs (n=978) were blocked by body weight 
at 7±3 d of age, allotted to pen and allotted to 4 
treatment groups: IC1, IC2, PC or IM. Pigs were 
weaned at 20±3 d and moved to a wean-to-finish 
facility with 19 pigs/pen and 12 pens per 
treatment. IC1 received dose 1 at 9 wk of age. 
IC2 received dose 1 at 16 wk of age. Both 
groups received dose 2 at 20 wk of age. IC were 
harvested at 3, 9 or 10 wk after dose 2, along 
with a similar number of PC and IM.    
Results
There were no statistical differences between 
IC1 and IC2 at each processing date so data 
were pooled. Wean-to-finish results are 
presented. IC had significantly (P<0.05) higher 
ADG and significantly (P<0.05) lower F:G than 
PC for all marketing periods (Table 1). No 
significant (P>0.05) differences in ADG or F:G 
were observed between IC and IM. IC feed 
intake was significantly (P<0.05) less than PC 
before the 2nd immunization and no different 
from (P>0.05) PC after the 2nd immunization.  
Table 1. Wean-to-finish performance of IC and 
PC barrows. 
Age
(wk)
Marketing
Period IC 
(wk)a
ADG 
% Changeb
F:G
% Changeb
24 3 6.76 -13.69 
29 9 9.74 -8.08 
30 10 10.14 -7.95 
aIC barrows were harvested at 3 time periods 
after the 2nd Improvest immunization. A similar 
number of age-matched PC barrows and intact 
males were harvested at the same time.      
b% Change = (IC-PC)-1 
Discussion 
These results demonstrate that the improved 
feed efficiency advantage associated with 
Improvest is retained when harvest occurs later 
in the Improvest marketing window. Later 
harvest gives the producer flexibility in 
management, allows for higher market weights 
and increased revenue, and achieves desired 
packer primal and belly characteristics. 
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LIFE-CYCLE ENVIRONMENTAL BENEFITS DERIVED FROM IMMUNOLOGICAL 
CASTRATION OF PIGS AS COMPARED TO PHYSICAL CASTRATION: FROM A GLOBAL 
PERSPECTIVE TO A UNITED STATES SPECIFIC MODEL 
Garth Boyd1, Greg Thoma2, Marty Matlock2, Gian Luca Baldo3
1The Prasino Group, Wilmington, NC; 2University of Arkansas, Fayetteville, AR; and 3Life Cycle 
Engineering Sri, Torino, Italy 
Introduction
As the world’s population grows, global meat 
consumption will also increase. There is 
pressure from all sectors of society to produce 
food more sustainably. This will mean further 
intensification and industrialization of livestock 
production and adoption of technology that 
improves production efficiencies while also 
accounting for animal welfare issues. 
Improvest® (gonadotropin releasing factor 
analog-diphtheria toxoid conjugate, Zoetis, 
Florham Park, NJ) reduces boar taint and 
eliminates the need for physical castration and is 
approved for use in 63 countries. This product 
works with the pig’s immune system. Boars 
grow to their full potential with all the inherent 
advantages of intact males; improved feed 
conversion, less manure, and carcasses with a 
greater percentage of lean meat than barrows. 
These efficiencies and resource savings provide 
significant life cycle environmental benefits (1).  
Objective 
This life cycle assessment (LCA) quantified the 
potential environmental benefits of using 
Improvest in US pork production. 
Materials and Methods 
During 2009-2011, a global study was 
conducted using life cycle burden data collected 
from modern farms with intensive pig 
production where pigs were physically castrated  
(PC) and compared to data collected from the 
same/similar farms in the same countries where 
pigs were immunologically castrated (IC). The 
study was conducted using LCA ISO compliant 
guidelines. Data were collected by direct 
interviews in modern farms and abattoirs in 
many countries and an Environmental Product 
Declaration was published in early 2012 (2). 
When Improvest was introduced in the US in 
2011, the global LCA model was adapted to the 
US specific inputs according to the University of 
Arkansas LCA model (3).   
Results and Discussion 
The main contributions to the global warming 
potential (GWP) are related to the production of 
feed given to pigs and pig manure management. 
The US LCA key input was feed conversion 
from 8 US product approval trials. Feed 
conversion for IC barrows was improved by 
8.4%, which resulted in feed savings of 26 
kg/pig. Based on USDA crop yields during 2009 
–2011 (2012 yield data was excluded due to 
drought conditions), a land savings (devoted to 
crop production) of 31 m2/pig was realized. 
Reduction in pig manure was assumed to be 
directly proportional to the reduction in feed 
intake. IC pigs had a 6.1% lower GWP than PC 
pigs when comparing live weight results and 
3.8% for carcass weight results. With an average 
of 124 kg of pig live weight at harvest, the use 
of Improvest reduces GWP by ~28.6 kg CO2
equivalents per pig. If only 33% of the 53.3M 
male pigs (2011 data) raised annually in the US 
were IC, that is equivalent to approximately 
508,000 mt of avoided GHG emissions per year, 
equivalent to removing emissions of 99,579 
passenger vehicles/year or the carbon 
sequestered by 164,850 hectares of pine forests. 
Table 1. Carbon footprint of immunological 
castration compared with physical castration.  
Global warming 
potential 
PC
kg CO2e
IC
kg CO2e
Live wt, per kg  3.71 3.48 
Carcass wt, per kg 4.95 4.76 
References 
1. Moraes P., et al. 2013. J. Env. Assmt. Pol. 
Mgmt. 15:1-26. 
2. www.environdec.com
3.  Frank J. and East C., 2011. Univ. Arkansas. 
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OPTIMAL FINISH WEIGHTS AND GROSS MARGINS FOR IMMUNOLOGICALLY 
CASTRATED BARROWS  
Brian Buhr1, Kelly Zering2, Terrance Hurley3, Glynn Tonsor4, and Dennis DiPietre5
1EconAnalytics, LLC, Chisago City, MN 55013; 2Dept of Agriculture and Resource Economics, North 
Carolina State University, Raleigh, NC 27695; 3Dept of Applied Economics, University of Minnesota, St. 
Paul, MN 55108; 4Agri-Food Analytics, LLC, St. George, KS 66535, 5KnowledgeVentures, LLC, 
Columbia, MO 65201 
Introduction
Improvest® (gonadotropin releasing factor 
analog-diphtheria toxoid conjugate) is an FDA-
approved veterinary prescription product to 
manage unpleasant aromas that can occur when 
cooking pork from some male pigs. Improvest 
use in male pigs improves feed efficiency, 
changes lean composition and may reduce the 
variation in finished weights of pigs compared to 
physical castrate males.  These impacts result in 
cost and revenue changes for Improvest 
managed pigs. Typical analyses of these changes 
simply simulate the change in cost impacts but 
do not consider the fact that as producers adopt 
Improvest they will optimize its use by altering 
finish weights to capture maximum benefits. 
Similarly, producers using physical castration 
will also optimize their pig weights.  These 
optimal weights affect lean composition and 
cutout values which in turn affect prices paid by 
packers through their quality premium 
programs. Carcass weight, carcass cutout yields 
and cutout proportions in turn affect the returns 
packers receive for cutouts. 
Materials and Methods
We use partial budgeting techniques followed by 
a stochastic optimization method to evaluate the 
net return over feed costs to producers using 
Improvest® compared to those using physical 
castration with hogs sold at optimal weights 
based on market base prices and packer quality 
grids. This analysis included consideration of the 
variation of growth and performance of pigs to 
replicate pig marketing under real world 
conditions. Based on results of the producer 
optimized weights, an additional model was 
developed to analyze the impact of the change in 
pork cutout yields and proportions to estimate 
returns to packers. 
Results and Discussion 
Partial budgeting analysis prior to optimization 
reveals that stopping castration is expected to 
reduce direct costs (labor and materials), 
decrease pre-weaning mortality (an average of 
1.6% for male pigs) and increase total gross 
margin due to increased livability.   The sum of 
these effects is expected to total $1.61/head on 
average (Table 1). Using prices and costs from 
the period 2007-2011, we estimate that the 
Improvest® managed animal will be marketed 
from 10-12 lb heavier (5-6 lb in the carcass) 
compared to physically castrated animals at their 
profit optimal weight, resulting in an added 
revenue on average of $6.71/head.  This revenue 
results from added weight, improved lean and 
less variation in finished weights (sort loss is 
lessened, all things being equal).  In addition, the 
Improvest® managed males are expected to 
achieve this added weight with just over $2.00 in 
feed savings compared to physical castrates.  
Altogether, the Improvest® animal is expected to 
produce $10.32 in added benefits ($1.61 + $6.71 
+ $2.00) netted against a cost of purchasing and 
administering the product of $5.00 per head, 
resulting in an expected improved net return of 
$5.32 per head. 
Table 1. Summary of Improvest producer 
benefits.
Producer Impacts IC PC 
Carcass wt, lb 205.70 201.15
Live wt, lb 284.79 272.18
Net profit, $/hd $75.64 $65.32
Improvest benefits, $/hd  $10.32 $0 
    From noncastration, $/hd $1.61 $0 
    From feed savings, $/hd $2.00 $0 
    From revenue, $/hd $6.71 $0 
Producer returns, % change 15.80 0 
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OPTIMIZING LONG-TERM FEEDING AND BUILDING DECISIONS ON FARMS USING 
IMMUNOLOGICAL CASTRATION  
Terrance Hurley1, Brian Buhr2, Kelly Zering3, Glynn Tonsor4, and Dennis DiPietre5
1Dept of Applied Economics, University of Minnesota, St. Paul, MN 55108; 2EconAnalytics, LLC, 
Chisago City, MN 55013; 3Dept of Agriculture and Resource Economics, North Carolina State 
University, Raleigh, NC 27695; 4Agri-Food Analytics, LLC, St. George, KS 66535, 5KnowledgeVentures,
LLC, Columbia, MO 65201 
Introduction
Improvest® (gonadotropin releasing factor 
analog-diphtheria toxoid conjugate) is an FDA-
approved veterinary prescription product to 
manage unpleasant aromas that can occur when 
cooking pork from some male pigs, and allows 
pork producers to replace physical castration by 
immunological castration.  Male pigs receiving 
Improvest® grow intact at substantial feed 
efficiency improvements compared to physical 
castrated barrows while maintaining the same 
meat quality characteristics. We wanted to 
understand the longer run optimization questions 
which face today’s Improvest adopters.  We 
gathered information necessary to examine how 
producers adopting Improvest might be incented 
to alter current building and feeding structures as 
well as pig flow to more fully realize the 
benefits of adoption over time.  Four basic 
facilities and management options were 
examined over a 20 year period for a baseline 
5,000 sow farrow-to-finish operation. 
    
Materials and Methods 
The four options included first, a mixed-sex barn 
with animals fed a mixed-sex diet. This was the 
baseline model without Improvest® as its use is 
disqualified when males are not separated for 
management of Improvest® administration.  The 
second option was a mixed-sex barn with 
animals separated by sex on each side of the 
barn so that a split-sex diet could be utilized.  
The third option included separate-sex barns 
with animals fed separate-sex diets and lastly, a 
double-stocked wean-to-finish building flow 
with females (or males) removed at feeder pig 
stage to separate-sex finishing.  Separate-sex 
diets were fed after the move.  Each of the 
options (except as noted, the baseline mixed-sex 
option) was run assuming no Improvest® was 
utilized and then with Improvest® adoption 
leading to a total of seven separate scenarios.  
We evaluated which of these several proposed 
long run adaptations is likely to produce the 
greatest net return under conditions of risky 
input and output prices and whether one strategy 
dominates others when risk is accounted.  In 
addition, the payback period or liquidity 
outcome of each choice was determined.  
Because building costs differ widely throughout 
the United States, each alternative was estimated 
without upfront costs of facilities or facility 
changes specified.  This generates a breakeven 
type analysis which reveals how much a 
producer could spend under each option to 
reconfigure the farm for greater returns.   
Results and Discussion 
When Improvest® is adopted; the greatest 
present value of net returns accrues to split-sex 
feeding in separate barns.  Producers who 
already have this configuration would have the 
greatest advantage in adopting Improvest®, all 
other things being equal.  Split-sex, mixed-barn 
with sexes in separate space is second with split-
sex, double stocking last.  However, since fewer 
buildings are required to execute the double 
stocking strategy, producers who are changing 
from their current configuration to any of these 
choices should carefully weigh the total building 
cost of implementing each option, as the 
building cost savings of double stocking may, 
when added to the net present value of expected 
returns, may make this option become superior 
to the others. 
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EFFECTS OF CASTRATION ON PREWEANING MORTALITY 
B Cowles, MA Mellencamp, MK Senn 
Zoetis, Inc. Florham Park, NJ 07940, 
Introduction
In the US, as in most countries, male pigs are 
physically castrated (PC) during the first week 
of life, primarily to reduce boar taint. 
Improvest® (gonadotrophin releasing factor 
analog – diphtheria toxoid conjugate, Zoetis) is 
a PC alternative which allows male pigs to 
remain intact for most of their life. Pigs are 
immunologically castrated (IC) later in life by 
immunization against endogenous 
gonadotrophin releasing factor (GnRF). The 2nd
immunization (given 3-10 wk before slaughter) 
results in a temporary IC by suppressing 
testicular function and, consequently, reducing 
boar taint. Many anecdotal reports indicate that 
castration causes a small but significant level of 
preweaning mortality (PWM). A meta-analysis 
of 15 Improvac trials in Europe showed that 
PWM was 1.6% higher in physical castrates 
(PC) than intact males (IM)1. In 24 trials in 
China, the PWM difference was 2.8%2. 
Objective 
The objective of this study was to determine pre-
weaning death loss of PC and IM on 4 US farms 
with different types of management.  
Materials and Methods 
Four different commercial sow farms in the 
Midwest were enrolled in the study. The study 
began on the day of processing (age 4-7days). 
Male piglets needed to weigh at least 2.2 lb and 
be in good health. Study pigs were randomized 
to treatment by selecting every other pig for 
castration. Castration was performed by the 
farm’s usual method.  Records were kept of all 
animals that died. 
Results 
Records were available for 4,099 PC and 4,071 
IM (farm A: 963, 958; farm B: 994, 995; farm 
C: 1110, 1110; farm D: 1000, 1000, 
respectively).  PWM on all farms ranged from 
1.0% to 4.98% (Table 1), which is less than the 
US industry average (12.9%)3. However, this is 
most probably due to starting the study on the 
day of processing, weight requirement, and 
health status of the animals. Three sites showed 
a reduction in PWM for IM compared with PC. 
This reduction ranged from 1.3% to 2.69%. 
Farm B showed 0.61% less mortality in PC than 
IM. Overall, there was a 1.3% difference in 
PWM between IM and PC.  
Table 1. Preweaning mortality from day of 
processing to weaning of physical castrates (PC) 
and intact males (IM) on 4 US farms.5
Farm
% PWM 
PC IM Differencea
A 4.98 3.13 1.85 
B 1.0 1.61 -0.61 
C 3.69 1.0 2.69 
D 4.9 3.6 1.3 
Com-
bined 3.64±1.86 2.34±1.2 1.31±1.40 
aIntact male – physical castrate 
Conclusions 
The design of the study was to determine the 
effects of castration on PWM on US farms under 
different management systems. This study 
confirms that, depending on the management 
system, most farms will have a reduction in 
PWM when castration is discontinued. On 
average for all farms in the study, PC increased 
PWM. Implementation of Improvest and 
eliminating castration can increase the number 
of animals that survive to weaning, which in the 
long run will impact the pounds of marketable 
product to the producer and the profitability of 
that operation. Economic modeling indicates this 
savings will be about $1.61 per pig.4
References 
1.Allison, JR et al. (2010). Proc. 21st IPVS.
2.Liu, Z et al. (2012). Proc. 22nd IPVS. 
3.USDA NAHMS (2006).  
4. DiPietre, D et al (2013). Proc. 44th AASV. 
5. Study on file at Zoetis LLC 
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THE IMPACT OF IMMUNOLOGICAL CASTRATION ON WEAN TO FINISH BODY 
WEIGHT VARIATION 
L. Greiner, R. Barrett, and J. Connor 
Innovative Swine Solutions, LLC, Carthage, IL 
Introduction
Physical castration (PC) early in life is effective 
in controlling boar taint. However, production 
losses associated with its use are substantial and 
include increased preweaning mortality (1.6%), 
reduced feed efficiency (6-10%), and loss of 
carcass lean (4-8%). Immunological castration 
(IC) offers producers an alternative to PC that 
uses the animal’s own immune system to 
suppress testicular function close to the time of 
slaughter.  Immunized animals temporarily 
become like PC barrows with similar control of 
boar taint and aggressive behavior. The 
difference in timing allows IC pigs to grow as 
intact males for most of their life, benefitting 
from the natural improvements in feed 
conversion and carcass composition.  
Improvest® (gonadotropin releasing factor 
analog - diphtheria toxoid conjugate, Zoetis, 
Florham Park, NJ) is an FDA-approved 
veterinary prescription product that eliminates 
the need for PC. The 1st dose is given after 9 wk 
of age to prime the immune system. The 2nd dose 
is given at least 4 wk after the first and 3-10 wk 
before harvest. This approach allows the IC 
barrow to express its naturally efficient growth 
potential resulting in substantial feed savings per 
pound of gain compared to PC barrows. After 
the 2nd dose, the pig transitions to castrate-like 
metabolism. Feed intake increases and fat in the 
carcass increases to a desirable level for primal 
cut characteristics. 
Objective 
The objective of this study was to determine the 
impact of Improvest on reducing wean to finish 
body weight variation.  
Materials and Methods 
Twelve hundred PIC 359 X C29 male pigs were 
enrolled in the study.  Male pigs were randomly 
allocated to one of two treatments (PC or IC) at 
3 days of age.  Pigs allocated to the PC group 
were physically castrated at 3-5 days of age.  
Improvest was administered on days 64 and 122 
days of age. All pigs were individually weighed 
at weaning, immediately before first market, and 
at the time of market.
Results 
At the time of first market, 1,164 pigs were on 
study (583 PC barrows and 581 IC barrows).  
The pigs that were remaining in the facility at 
the time of first market had a weaning standard 
deviation of 2.82 vs 2.91 lbs. respectively.  The 
standard deviation at the time of market was 
24.6 lbs for the PC barrow vs 22.6 lbs for the IC 
barrow.  In addition, the coefficient of variation 
of the barn was 10.5 lbs for PC barrows vs 9.4 
lbs for IC barrows.  One hundred sixty-five pigs 
were removed from the facility for the first 
group marketed.  Of those 165 pigs, 96 pigs 
were PC barrows and 69 pigs were IC barrows.  
Upon further evaluation, the average weight of 
first market group was 270.7 vs 276.2 lbs. with a 
10.3 vs 7.8 lbs standard deviation, respectively.  
Pigs were marketed over a 5 week period in 
which the target weight for the PC barrows was 
275 lbs. and the IC barrows 285 lbs. At the time 
of emptying the barn, 112 PC barrows averaged 
267.2 lbs with a 15.0 lbs standard deviation 
compared to 65 IC barrows that averaged 279.3 
lbs with a 13.6 lbs standard deviation.  In 
addition, there were a total of 3 PC barrows and 
2 IC barrows as culls.
Conclusions 
In conclusion, the utilization of Improvest 
reduced the variation at the time of market 
compared to physical castration. 
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FLOCKED SWAB LITERATURE REVIEW AND CURRENT USE IN THE SWINE INDUSTRY 
Fred Sylvia, Wayne Chittick 
Health Management Center, Boehringer Ingelheim Vetmedica, Inc., Ames, IA 
Introduction and Background 
Flocked swabs have gained popularity since 
their introduction (2006) due to their unique 
perpendicular arrangement of the Nylon® fibers 
resulting from flocking where fibers are sprayed 
onto the swab tip while in an electrostatic field. 
Unlike traditional swabs, flocked swabs have no 
internal absorbent core to entrap the specimen 
maintaining the sample close to the surface for 
fast and complete elution. 
Current Application 
Flocked swabs are popular in human medicine 
and forensic sciences. In human medicine, 
flocked swabs are a best practice for collecting 
respiratory viruses due to superior pathogen 
yields and ease of collection1-7. Research 
showed nylon flocked swabs were not 
significantly different8-11 or were significantly 
superior for bacteria transport12-14, storage12,
culture15,16, PCR detection15, and released more 
bacterium13,14,17,18 compared to cotton swabs. 
Flocked swabs were not significantly different 
than polyester swabs19, but were superior to 
sponge applicator swabs20,21. Flocked swabs 
have been shown to not be significantly different 
in influenza detection rates22,23, but yielded 
significantly more cells for Herpes simplex 
virus24 compared to cotton swabs. Pre-wetting 
flocked swabs resulted in significantly better 
bacterium carriage rates25 and a higher 
bacterium yield with two repeat samples with 
the same swab26.
There is relatively little flocked swab research 
for veterinary diagnostics. Cost is not the 
primary factor as flocked swabs are only slightly 
more expensive than cotton swabs ($0.03-0.04). 
Studies found no statistical differences in M.
gallisepticum and M. synoviae rtPCR results by 
flocked, cotton, or polyester swabs27. Flocked 
swabs were more sensitive at lower dilutions and 
equivalent to cotton swabs at higher dilutions28 
for Steptococcus equi PCR testing.  
Discussion and Conclusions 
The application of flocked swabs in veterinary 
diagnostics is apparent for collection, transport 
and analysis of field sampling. Additional 
research utilizing flocked swabs for swine viral 
and bacteria infection is underway. More 
education on the benefits of flocked swabs 
should be completed.  
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INFLUENCE OF A PHYTOGENIC FEED ADDITIVE ON THE PERFORMANCE OF SOWS  
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High culling rates, in early parities, reduce the 
average utilization time of sows, thus affecting 
lifetime performance. 
Several studies have shown the positive 
influence of phytogenic feed additives on sow 
and litter performance when used in the 
lactation feed. Sows had higher feed intake 
during lactation, produced more milk, 
converted the ingested feed more efficiently, 
lost less body weight, and their litters grew 
better.  
The objective of this study was to explore the 
influence of the continuous use of a 
Phytogenic Feed Additive (PFA) during 
lactation and gestation on production 
parameters. The study was carried out in a 
large scale sow unit maintaining two separate 
herds, each with an average inventory of more 
than 4,700 sows of Danish genetics. 
Both herds were fed under the same feeding 
program, with the same basal diet. A four 
phase feeding concept was employed 
consisting of lactation-, insemination-, early 
gestation-, and gestation feeds. Early gestation 
feed was supplemented by stillage and 
gestation feed by spent grains and stillage. 
Digestarom® Sow, a blend of herbs, spices and 
essential oils, was applied at a concentration of 
150 g/t complete feed (88% DM-base) in all 
diets of the trial herd. 
 
Herd comparisons are based on production 
parameters commonly recorded at the farm 
(sow planner). Piglet Index (number of live 
born piglets/litter x farrowing rate x 100) was 
calculated additionally. 
 
The study showed that continuous 
supplementation of the diets with the PFA 
Digestarom® Sow improved performance 
parameters in sows. 
Overall sow fertility was enhanced, culling 
rates were reduced by more than 30% in the 
trial herd, especially in early parities (Figure 
1). 
In addition, production parameters such as 
farrowing rate, piglet index and number of 
piglets weaned at proper weight were 
enhanced over all parities. 
Figure 1: Sows culled for fertility issues 
                (06.06.2011 – 16.06.2012)
 
 
In the first production cycle, the PFA was 
applied, the trial herd showed higher and more 
stable piglet indexes. These differences were 
most apparent in the second production cycle 
when applying this Phytogenic Feed Additive 
(Table 1).  
 
Table 1: Piglet indexes of different parity 
numbers and their relative differences in the 
first and second reproduction cycle of PFA use 
 
Parity 
Number 
1st Reprod. Cycle 2nd Reprod. Cycle 
Contr. PFA Relat.Diff. Contr. PFA 
Relat. 
Diff. 
1 1005 1007 0.20 918 957 4.13
2 1212 1254 3.35 1147 1279 10.30
3 1286 1350 4.79 1212 1322 8.29
4 1271 1310 2.98 1134 1260 10.00
5 1193 1265 5.69 1159 1298 10.71
6 1091 1217 10.35 1050 1211 13.36
7 978 1138 14.06 1001 1213 17.48
≥ 8 1017 1112 8.54 950 1096 11.17
2 - 8 1150 1238 6.92 1093 1236 11.55
 
Finally the replacement rate was reduced in 
the trial herd (51.5%) compared to the control 
herd (54.9%), resulting in a longer utilization 
time and higher lifetime performance of the 
sows. 
This field trial showed in a large scale sow 
unit that the continuous use of the Phytogenic 
Feed Additive Digestarom® Sow not only 
enhances the zoo-technical performance, but 
also contributes to a better lifetime 
performance of the sows.  
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